"","title","link","pubDate","Site","Lead","Symbol","Company"
"1","GlaxoSmithKline PLC ADR GSK (US: NYSE)","http://quotes.wsj.com/GSK","2011-02-11 06:54:19","Wall Street Journal","News GlaxoSmithKline PLC ADRGSK. Significant News Only. 04/18/17; Dow Jones Newswires. Glaxo JV Submits New Drug Application for Shingles Vaccine in Japan.","GSK"," GlaxoSmithKline"
"2","Glaxosmithkline plc and Theravance announces FDA approval of BREO ELLIPTA for treatment of adults with asthma in the US","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3204592","2015-04-30 15:17:00","Reuters Key Development","Glaxosmithkline plc and Theravance announces FDA approval of BREO ELLIPTA for treatment of adults with asthma in the US","GSK"," GlaxoSmithKline"
"3","Glaxosmithkline PLC declares first interim dividend","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3207140","2015-05-06 07:00:00","Reuters Key Development","Glaxosmithkline PLC declares first interim dividend","GSK"," GlaxoSmithKline"
"4","Glaxosmithkline plc gives FY 2015 EPS below analysts&#39; estimates - Conferance Call","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3208998","2015-05-06 09:30:00","Reuters Key Development","Glaxosmithkline plc gives FY 2015 EPS below analysts' estimates - Conferance Call","GSK"," GlaxoSmithKline"
"5","Perrigo to buy portfolio of OTC brands from Glaxosmithkline","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3223175","2015-06-02 06:27:00","Reuters Key Development","Perrigo to buy portfolio of OTC brands from Glaxosmithkline","GSK"," GlaxoSmithKline"
"6","Avalon Rare Metals Inc and Glaxosmithkline plc Launch Three New Companies with Series A Financing and R&amp;D Support as Part of Ongoing Collaboration","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3229400","2015-06-15 08:00:00","Reuters Key Development","Avalon Rare Metals Inc and Glaxosmithkline plc Launch Three New Companies with Series A Financing and R&D Support as Part of Ongoing Collaboration","GSK"," GlaxoSmithKline"
"7","Pfizer Inc to acquire Nimenrix And Mencevax from GlaxoSmithKline Plc","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3232665","2015-06-22 07:08:00","Reuters Key Development","Pfizer Inc to acquire Nimenrix And Mencevax from GlaxoSmithKline Plc","GSK"," GlaxoSmithKline"
"8","GlaxoSmithKline Plc declares dividend","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3254046","2015-07-29 07:00:00","Reuters Key Development","GlaxoSmithKline Plc declares dividend","GSK"," GlaxoSmithKline"
"9","Novartis buys remaining rights to GlaxoSmithKline Plc treatment","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3264458","2015-08-21 01:25:00","Reuters Key Development","Novartis buys remaining rights to GlaxoSmithKline Plc treatment","GSK"," GlaxoSmithKline"
"10","Glaxosmithkline plc and Theravance Inc announces results from the SUMMIT COPD CV survival study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3270960","2015-09-08 14:40:00","Reuters Key Development","Glaxosmithkline plc and Theravance Inc announces results from the SUMMIT COPD CV survival study","GSK"," GlaxoSmithKline"
"11","GlaxoSmithKline plc (ADR), AbbVie Inc: Attractive High-Yield Dividend Pharma ...","http://etfdailynews.com/2015/09/14/glaxosmithkline-plc-adr-abbvie-inc-attractive-high-yield-dividend-pharma-stocks-to-buy/","2015-09-14 12:00:58","ETF Daily News","yield Bob Ciura: The stock market sell-off is painful for investors who own stocks, but the good news is that declining stock prices present new buying opportunities.","GSK"," GlaxoSmithKline"
"12","Pfizer Inc completes acquisition of nimenrix and mencevax from GlaxoSmithKline Plc","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3280167","2015-10-01 08:00:00","Reuters Key Development","Pfizer Inc completes acquisition of nimenrix and mencevax from GlaxoSmithKline Plc","GSK"," GlaxoSmithKline"
"13","Glaxosmithkline plc Nucala receives approval from US FDA","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3296175","2015-11-05 02:00:00","Reuters Key Development","Glaxosmithkline plc Nucala receives approval from US FDA","GSK"," GlaxoSmithKline"
"14","Valneva signs new research and development collaboration with GlaxoSmithKline","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3329606","2016-02-08 01:00:00","Reuters Key Development","Valneva signs new research and development collaboration with GlaxoSmithKline","GSK"," GlaxoSmithKline"
"15","GSK says its meningitis vaccine achieves study goals","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3374332","2016-05-13 06:15:55","Reuters Key Development","GSK says its meningitis vaccine achieves study goals","GSK"," GlaxoSmithKline"
"16","Glaxosmithkline and Innoviva report positive headline results in Salford Lung study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3380494","2016-05-24 05:54:42","Reuters Key Development","Glaxosmithkline and Innoviva report positive headline results in Salford Lung study","GSK"," GlaxoSmithKline"
"17","GSK says gene therapy for immune disorder meets main goal","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3381235","2016-05-25 05:09:39","Reuters Key Development","GSK says gene therapy for immune disorder meets main goal","GSK"," GlaxoSmithKline"
"18","GlaxoSmithKline appoints Vivienne Cox to board","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3383144","2016-05-27 09:56:02","Reuters Key Development","GlaxoSmithKline appoints Vivienne Cox to board","GSK"," GlaxoSmithKline"
"19","Regulus expands clinical trial collaboration with GSK","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3385271","2016-06-01 08:00:00","Reuters Key Development","Regulus expands clinical trial collaboration with GSK","GSK"," GlaxoSmithKline"
"20","GlaxoSmithkline accelerates filing of COPD triple-therapy drug","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3385696","2016-06-02 02:00:07","Reuters Key Development","GlaxoSmithkline accelerates filing of COPD triple-therapy drug","GSK"," GlaxoSmithKline"
"21","Mylan launches generic rythmol sustained-release capsules","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3385903","2016-06-02 07:00:00","Reuters Key Development","Mylan launches generic rythmol sustained-release capsules","GSK"," GlaxoSmithKline"
"22","GSK rheumatoid arthritis, SLE drug meets late stage study goal","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3388521","2016-06-08 05:38:05","Reuters Key Development","GSK rheumatoid arthritis, SLE drug meets late stage study goal","GSK"," GlaxoSmithKline"
"23","ViiV Healthcare says FDA approves sNDA for dolutegravir","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3389724","2016-06-10 09:10:55","Reuters Key Development","ViiV Healthcare says FDA approves sNDA for dolutegravir","GSK"," GlaxoSmithKline"
"24","GlaxoSmithKline says vaccines chairman Slaoui to retire in 2017","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3390787","2016-06-14 05:58:50","Reuters Key Development","GlaxoSmithKline says vaccines chairman Slaoui to retire in 2017","GSK"," GlaxoSmithKline"
"25","GlaxoSmithKline says lung drug meets late-stage study goals","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3393169","2016-06-20 02:02:24","Reuters Key Development","GlaxoSmithKline says lung drug meets late-stage study goals","GSK"," GlaxoSmithKline"
"26","Why GlaxoSmithKline plc (ADR) (GSK) Stock Is Higher Today","http://investorplace.com/2016/06/glaxosmithkline-gsk-stock/","2016-06-20 13:23:59","Investorplace.com","It found the treatment to be more effective than rival AstraZeneca plc (ADR)'s (AZN) Symbicort. “Triple combination therapy is already a reality for many patients with COPD and is dispensed in multiple inhalers,” Dave Allen, GlaxoSmithKline's head ...","GSK"," GlaxoSmithKline"
"27","Mylan launches generic version of GSK&#39;s avodart capsules","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3395866","2016-06-24 11:44:00","Reuters Key Development","Mylan launches generic version of GSK's avodart capsules","GSK"," GlaxoSmithKline"
"28","ARIA study shows superior efficacy of Triumeq for treatment-naïve women with HIV","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3406900","2016-07-18 06:16:10","Reuters Key Development","ARIA study shows superior efficacy of Triumeq for treatment-naïve women with HIV","GSK"," GlaxoSmithKline"
"29","GlaxoSmithKline ships 2016-17 seasonal influenza vaccines for US market","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3408521","2016-07-20 15:51:00","Reuters Key Development","GlaxoSmithKline ships 2016-17 seasonal influenza vaccines for US market","GSK"," GlaxoSmithKline"
"30","GSK CEO: UK competitive post-Brexit but questions over drug regulation, science","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3412627","2016-07-27 07:00:00","Reuters Key Development","GSK CEO: UK competitive post-Brexit but questions over drug regulation, science","GSK"," GlaxoSmithKline"
"31","Vectura initiates legal proceedings against GSK in the U.S.","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3412881","2016-07-27 12:19:40","Reuters Key Development","Vectura initiates legal proceedings against GSK in the U.S.","GSK"," GlaxoSmithKline"
"32","GlaxoSmithKline plc (ADR)(GSK) and Alphabet Inc (GOOGL) Team Up for Joint Venture","http://www.thecountrycaller.com/85905-glaxosmithkline-plc-adrgsk-and-alphabet-inc-googl-team-up-for-joint-venture","2016-08-01 10:03:45","TCC","GlaxoSmithKline plc (ADR) (NYSE:GSK) and Alphabet Inc's (NASDAQ:GOOGL) Verily Life Sciences, formerly known as Google Life Sciences, come together to form a new joint venture.","GSK"," GlaxoSmithKline"
"33","Gsk Consumer Healthcare says FDA approved Flonase Sensimist allergy relief as OTC treatment","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3418121","2016-08-03 08:03:00","Reuters Key Development","Gsk Consumer Healthcare says FDA approved Flonase Sensimist allergy relief as OTC treatment","GSK"," GlaxoSmithKline"
"34","GlaxoSmithKline plc (NYSE:GSK) Offers Money Back Guarantees on Rare ...","http://www.thecountrycaller.com/66019-glaxosmithkline-plc-adr-gsk-offers-money-back-guarantees-on-rare-pathological-ailments","2016-08-15 11:02:32","TCC","Multiple companies around the globe are now offering the option of money back guarantees to expand the exposure of their costly therapies.","GSK"," GlaxoSmithKline"
"35","GlaxoSmithKline plc (ADR) (NYSE:GSK) Survive From New Respiratory Molecule ...","http://www.thecountrycaller.com/50021-will-glaxosmithkline-gsk-survive-from-new-respiratory-molecule-induction/","2016-08-15 11:33:45","TCC","GlaxoSmithKline's plc (ADR) (NYSE:GSK) respiratory franchise is going through a tough time due to fierce competition after the patent expiration of the company's blockbuster drugs and with the induction of generics in the therapeutic market.","GSK"," GlaxoSmithKline"
"36","GSK Consumer Healthcare announces Flonase allergy relief for OTC use in Canada","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3435725","2016-08-31 17:09:00","Reuters Key Development","GSK Consumer Healthcare announces Flonase allergy relief for OTC use in Canada","GSK"," GlaxoSmithKline"
"37","DR. Reddy&#39;s laboratories says launch of Bupropion HCL extended-release tablets, USP (sr) in U.S. market","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3436850","2016-09-02 11:32:00","Reuters Key Development","DR. Reddy's laboratories says launch of Bupropion HCL extended-release tablets, USP (sr) in U.S. market","GSK"," GlaxoSmithKline"
"38","GlaxoSmithKline sees positive results from COPD Salford Lung study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3437026","2016-09-05 02:00:06","Reuters Key Development","GlaxoSmithKline sees positive results from COPD Salford Lung study","GSK"," GlaxoSmithKline"
"39","GSK presents positive results from phase III FULFIL study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3437818","2016-09-06 09:45:00","Reuters Key Development","GSK presents positive results from phase III FULFIL study","GSK"," GlaxoSmithKline"
"40","Will GlaxoSmithKline plc (ADR) (GSK) Exhibit Growth After Patent Cliff?","http://www.thecountrycaller.com/71245-will-glaxosmithkline-plc-adr-gsk-exhibit-growth-after-patent-cliff","2016-09-10 08:00:00","TCC","Majority of the investors are skeptical about the future prospects of GlaxoSmithKline plc (ADR) (NYSE:GSK) due to its performance in 2015, as it was hit hard by the patent cliff.","GSK"," GlaxoSmithKline"
"41","Aspen Pharma to buy almost entire of GSK&#39;s anaesthetics portfolio","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3439698","2016-09-12 03:00:22","Reuters Key Development","Aspen Pharma to buy almost entire of GSK's anaesthetics portfolio","GSK"," GlaxoSmithKline"
"42","GSK appoints Emma Walmsley as new CEO","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3442740","2016-09-20 02:00:08","Reuters Key Development","GSK appoints Emma Walmsley as new CEO","GSK"," GlaxoSmithKline"
"43","Medecins Sans Frontieres Happy with GlaxoSmithKline plc (ADR) (NYSE:GSK) Price ...","http://marketexclusive.com/medecins-sans-frontieres-happy-glaxosmithkline-price-reduction-synflorix/32571/","2016-09-20 09:18:45","Market Exclusive","Numerous complaints by medical charity Medecins Sans Frontieres over the cost of pneumococcal vaccine given to refugees by GlaxoSmithKline plc (ADR)(NYSE:GSK) have yielded fruit. The British drugmaker says that it will lower the price of Synflorix, ...","GSK"," GlaxoSmithKline"
"44","GSK files regulatory submissions in U.S. and Europe for lupus drug","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3444496","2016-09-23 04:44:14","Reuters Key Development","GSK files regulatory submissions in U.S. and Europe for lupus drug","GSK"," GlaxoSmithKline"
"45","Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3444643","2016-09-23 08:00:00","Reuters Key Development","Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis","GSK"," GlaxoSmithKline"
"46","GSK, Oncodesign announce agreement for Oncodesign&#39;s Acquisition of GSK&#39;s Research Centre in France","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3446090","2016-09-28 01:30:00","Reuters Key Development","GSK, Oncodesign announce agreement for Oncodesign's Acquisition of GSK's Research Centre in France","GSK"," GlaxoSmithKline"
"47","Oncodesign to buy François Hyafil research centre from GSK","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3446085","2016-09-28 01:30:00","Reuters Key Development","Oncodesign to buy François Hyafil research centre from GSK","GSK"," GlaxoSmithKline"
"48","GSK says to sell remaining stake in Aspen Pharmacare","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3446530","2016-09-28 11:19:59","Reuters Key Development","GSK says to sell remaining stake in Aspen Pharmacare","GSK"," GlaxoSmithKline"
"49","GSK gets 477 mln stg gross proceeds from Aspen Pharmacare stake sale","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3446845","2016-09-29 02:54:38","Reuters Key Development","GSK gets 477 mln stg gross proceeds from Aspen Pharmacare stake sale","GSK"," GlaxoSmithKline"
"50","Aspen Pharmacare says GSK sells remaining stake in co","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3446847","2016-09-29 03:05:09","Reuters Key Development","Aspen Pharmacare says GSK sells remaining stake in co","GSK"," GlaxoSmithKline"
"51","GlaxoSmithKline appoints new consumer healthcare CEO","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3447064","2016-09-29 07:40:19","Reuters Key Development","GlaxoSmithKline appoints new consumer healthcare CEO","GSK"," GlaxoSmithKline"
"52","Glaxo to pay $20 mln to resolve SEC charges&lt;GSK.L&gt;","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3448139","2016-09-30 14:15:05","Reuters Key Development","Glaxo to pay $20 mln to resolve SEC charges<GSK.L>","GSK"," GlaxoSmithKline"
"53","GSK submits U.S. application for Shingles vaccine","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3458737","2016-10-24 02:00:06","Reuters Key Development","GSK submits U.S. application for Shingles vaccine","GSK"," GlaxoSmithKline"
"54","GlaxoSmithKline plc (ADR) (GSK) Seeks FDA Approval for New Shingles Vaccine","http://investorplace.com/2016/10/glaxosmithkline-shingles-shingrix-gsk/","2016-10-24 12:41:15","Investorplace.com","GlaxoSmithKline plc (ADR) (NYSE:GSK), a healthcare company, is seeking approval from the U.S. Food and Drug Administration for a shingles vaccine.","GSK"," GlaxoSmithKline"
"55","GlaxoSmithKline plc (ADR) (GSK) Q3 Earnings: What Merrill Lynch Expects","http://smartstocknews.com/57462-glaxosmithkline-plc-adr-gsk-q3-earnings-what-merrill-lynch-expects/","2016-10-24 12:50:22","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","GlaxoSmithKline plc (ADR) (NYSE:GSK) is slated to report third-quarter financial results for fiscal year 2016 on Wednesday, October 26.","GSK"," GlaxoSmithKline"
"56","Fimbrion, GSK to develop novel antibacterial therapy for UTIs","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3460547","2016-10-25 09:45:00","Reuters Key Development","Fimbrion, GSK to develop novel antibacterial therapy for UTIs","GSK"," GlaxoSmithKline"
"57","GlaxoSmithKline plc (ADR) (NYSE:GSK) Teams Up With Fimbrion Therapeutics, Inc.","http://marketexclusive.com/glaxosmithkline-plc-adr-nysegsk-teams-fimbrion-therapeutics-inc/35047/","2016-10-26 07:04:55","Market Exclusive","Under the partnership, the two companies will mainly work on a joint project between GSK Discovery Partnerships with Academia (DPAc) and Fimbrion Therapeutics.","GSK"," GlaxoSmithKline"
"58","GSK CEO says weak pound hasn&#39;t impacted company&#39;s UK pricing","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3461487","2016-10-26 07:15:00","Reuters Key Development","GSK CEO says weak pound hasn't impacted company's UK pricing","GSK"," GlaxoSmithKline"
"59","GlaxoSmithKline plc (ADR) (NYSE:GSK) Steps Ahead in Vaccine Combination","http://smartstocknews.com/43796-glaxosmithkline-plc-adr-gsk-steps-ahead-in-vaccine-combination/","2016-11-01 08:21:57","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","GSK's Shingrix belongs to the non-live recombinant category indicated for the prevention of shingles in a very minimal side effect profile.","GSK"," GlaxoSmithKline"
"60","GSK gets European nod for Boostrix vaccine label changes","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3466965","2016-11-01 09:06:37","Reuters Key Development","GSK gets European nod for Boostrix vaccine label changes","GSK"," GlaxoSmithKline"
"61","GSK Stock: GlaxoSmithKline PLC Is a High-Dividend Stock","https://www.incomeinvestors.com/gsk-stock-glaxosmithkline-plc-high-dividend-stock/8252/","2016-11-12 07:03:41","Income Investors","One sector that is known for large gross margins is the healthcare sector. Typically, high-gross-margin businesses are not looked at by dividend investors, the reason being that there is often no dividend.","GSK"," GlaxoSmithKline"
"62","GSK files regulatory submission in U.S. for COPD treatment","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3481804","2016-11-21 02:11:35","Reuters Key Development","GSK files regulatory submission in U.S. for COPD treatment","GSK"," GlaxoSmithKline"
"63","GSK files regulatory submission of candidate vaccine","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3482055","2016-11-21 06:30:00","Reuters Key Development","GSK files regulatory submission of candidate vaccine","GSK"," GlaxoSmithKline"
"64","GSK files regulatory submission in US for once-daily closed triple combination therapy ff/umec/vi for patients with COPD","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3482101","2016-11-21 07:00:00","Reuters Key Development","GSK files regulatory submission in US for once-daily closed triple combination therapy ff/umec/vi for patients with COPD","GSK"," GlaxoSmithKline"
"65","GSK receives FDA approval for expanded indication for flulaval® quadrivalent (influenza vaccine) for infants 6 months and older","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3482145","2016-11-21 08:28:00","Reuters Key Development","GSK receives FDA approval for expanded indication for flulaval® quadrivalent (influenza vaccine) for infants 6 months and older","GSK"," GlaxoSmithKline"
"66","Here&#39;s Our Take On Theravance Biopharma Inc (TBPH) And GlaxoSmithKline PLC ...","http://www.insidermonkey.com/blog/heres-our-take-on-theravance-biopharma-inc-tbph-and-glaxosmithkline-plc-adr-gsks-latest-submission-489531/","2016-11-22 09:48:45","Insider Monkey (blog)","With Closed Triple, GlaxoSmithKline plc (ADR) (NYSE:GSK) is trying to eliminate this pressure - it's a triple combination of fluticasone furoate, umeclidinium, and vilanterol, and it's delivered by way of one of the company's proprietary powder ...","GSK"," GlaxoSmithKline"
"67","GSK&#39;s Mepolizumab meets endpoints in phase 3 EGPA study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3483295","2016-11-23 02:05:26","Reuters Key Development","GSK's Mepolizumab meets endpoints in phase 3 EGPA study","GSK"," GlaxoSmithKline"
"68","GlaxoSmithKline submits marketing application for shingles vaccine to EMA","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3485182","2016-11-25 08:35:13","Reuters Key Development","GlaxoSmithKline submits marketing application for shingles vaccine to EMA","GSK"," GlaxoSmithKline"
"69","GSK&#39;s lung drug gains approval in Japan","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3488725","2016-12-02 02:01:39","Reuters Key Development","GSK's lung drug gains approval in Japan","GSK"," GlaxoSmithKline"
"70","GSK applies for EU marketing nod for COPD drug cocktail","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3489268","2016-12-02 09:15:00","Reuters Key Development","GSK applies for EU marketing nod for COPD drug cocktail","GSK"," GlaxoSmithKline"
"71","GSK files EU submission for closed triple combination therapy for patients with COPD","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3489299","2016-12-02 10:12:32","Reuters Key Development","GSK files EU submission for closed triple combination therapy for patients with COPD","GSK"," GlaxoSmithKline"
"72","Analyst Insights on Price Target Estimates: GlaxoSmithKline plc (ADR) (NYSE:GSK)","http://postregistrar.com/2016/12/03/analyst-insights-on-price-target-estimates-glaxosmithkline-plc-adr-nysegsk/","2016-12-03 08:30:00","Post Registrar","GlaxoSmithKline plc (ADR) (NYSE:GSK) soared 0.72% during previous trade, a total of 3.91M shares exchanged hands compared with its average trading volume of 4.48M shares whereas its relative volume is 1.10.","GSK"," GlaxoSmithKline"
"73","What Smart Money Thinks About GlaxoSmithKline plc (ADR) (GSK)","http://www.insidermonkey.com/blog/what-smart-money-thinks-about-glaxosmithkline-plc-adr-gsk-491777/","2016-12-04 17:07:30","Insider Monkey (blog)","Is GlaxoSmithKline plc (ADR) (NYSE:GSK) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.","GSK"," GlaxoSmithKline"
"74","GSK submits regulatory application in Japan for belimumab","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3494065","2016-12-13 04:21:10","Reuters Key Development","GSK submits regulatory application in Japan for belimumab","GSK"," GlaxoSmithKline"
"75","GlaxoSmithKline plc&#39;s (ADR) (NYSE:GSK) Opens Its First Fully Dedicated ...","https://marketexclusive.com/glaxosmithkline-plcs-adr-nysegsk-opens-first-fully-dedicated-vaccines-rd-center-rockville/46670/","2016-12-15 09:15:00","Market Exclusive","GlaxoSmithKline plc (ADR) (NYSE:GSK) is celebrating another milestone; the opening of its newest global vaccines R&D center in Rockville, Maryland.","GSK"," GlaxoSmithKline"
"76","GSK announces start of phase III trails for asthma therapy","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3497319","2016-12-19 04:32:43","Reuters Key Development","GSK announces start of phase III trails for asthma therapy","GSK"," GlaxoSmithKline"
"77","GSK&#39;s Viiv announces positive results from initial HIV phase III studies","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3497917","2016-12-20 02:00:10","Reuters Key Development","GSK's Viiv announces positive results from initial HIV phase III studies","GSK"," GlaxoSmithKline"
"78","GlaxoSmithKline PLC (ADR) (GSK) Phase 3 Trials Looks Positive: Will Gilead ...","http://www.insidermonkey.com/blog/glaxosmithkline-plc-adr-gsk-phase-3-trials-looks-positive-will-gilead-sciences-inc-gild-endure-512585/","2016-12-21 13:22:30","Insider Monkey (blog)","Efforts by GlaxoSmithKline plc (ADR) (NYSE:GSK) in carrying out a large study on its new HIV drug are yielding positive results.","GSK"," GlaxoSmithKline"
"79","NeRRe, A GlaxoSmithKline PLC (ADR) (GSK) Spinout Raises £23 Million For NK ...","http://www.insidermonkey.com/blog/nerre-a-glaxosmithkline-plc-adr-gsk-spinout-raises-23-million-for-nk-antagonists-514967/","2017-01-06 10:56:15","Insider Monkey (blog)","NeRRe Therapeutics, which is a GlaxoSmithKline PLC (ADR) (NYSE:GSK) spinout, has raised £23 million ($28 million) in a Series B financing round.","GSK"," GlaxoSmithKline"
"80","Adaptimmune says confirms GSK nomination of second adaptimmune target under strategic multi-target collaboration","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3505807","2017-01-09 08:01:00","Reuters Key Development","Adaptimmune says confirms GSK nomination of second adaptimmune target under strategic multi-target collaboration","GSK"," GlaxoSmithKline"
"81","GSK&#39;s pharmaceuticals president Abbas Hussain to leave in 2017","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3510711","2017-01-19 02:05:58","Reuters Key Development","GSK's pharmaceuticals president Abbas Hussain to leave in 2017","GSK"," GlaxoSmithKline"
"82","GlaxoSmithKline appoints Luke Miels President, Global Pharma","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3510721","2017-01-19 02:09:25","Reuters Key Development","GlaxoSmithKline appoints Luke Miels President, Global Pharma","GSK"," GlaxoSmithKline"
"83","EMA recommends approval of two biosimilars from Amgen","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3516643","2017-01-27 07:21:30","Reuters Key Development","EMA recommends approval of two biosimilars from Amgen","GSK"," GlaxoSmithKline"
"84","Analysts Keeping an Eye on: GlaxoSmithKline plc (ADR) (NYSE:GSK)","http://postregistrar.com/2017/02/01/analysts-keeping-an-eye-on-glaxosmithkline-plc-adr-nysegsk/","2017-02-01 08:41:15","Post Registrar","GlaxoSmithKline plc (ADR) (NYSE:GSK) soared 0.79% during previous trade, a total of 3.49M shares exchanged hands compared with its average trading volume of 3.42M shares whereas its relative volume is 0.88.","GSK"," GlaxoSmithKline"
"85","Pernix Therapeutics provides update on arbitration","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3520428","2017-02-03 08:00:00","Reuters Key Development","Pernix Therapeutics provides update on arbitration","GSK"," GlaxoSmithKline"
"86","GSK says launched flonase sensimist allergy relief nationwide","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3522863","2017-02-08 07:00:00","Reuters Key Development","GSK says launched flonase sensimist allergy relief nationwide","GSK"," GlaxoSmithKline"
"87","New GSK CEO likely to give strategy update in H2 2017","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3522879","2017-02-08 07:45:00","Reuters Key Development","New GSK CEO likely to give strategy update in H2 2017","GSK"," GlaxoSmithKline"
"88","ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3526432","2017-02-13 18:55:53","Reuters Key Development","ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine","GSK"," GlaxoSmithKline"
"89","GSK announces positive final stage results for two-drug HIV treatment","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3526688","2017-02-14 02:00:05","Reuters Key Development","GSK announces positive final stage results for two-drug HIV treatment","GSK"," GlaxoSmithKline"
"90","Bank of America ML Didn&#39;t Change HIV Estimates for GlaxoSmithKline plc (ADR) (GSK)","http://smartstocknews.com/37721-bank-of-america-ml-didnt-change-hiv-estimates-for-glaxosmithkline-plc-adr-gsk/","2017-02-14 12:24:19","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Gilead reported PII data for bictegravir (potential competitor to GlaxoSmithKline plc's (ADR) (NYSE:GSK) integrase inhibitor Tivicay), at the CROI HIV conference, that, as expected shows similarly strong efficacy to GlaxoSmithKline plc's (ADR) (NYSE ...","GSK"," GlaxoSmithKline"
"91","Gilead HIV Drug Tops GSK Combo, But Rivalry &#39;Intense&#39; With GSK Doublet","http://www.investors.com/news/technology/gilead-hiv-drug-tops-gsk-combo-but-rivalry-intense-with-gsk-doublet/","2017-02-14 14:17:10","Investor's Business Daily","Gilead Sciences' (GILD) newest HIV regimen topped a rival combo from GlaxoSmithKline (GSK), in trial results released late Monday, but a doublet from GSK will keep ""intense competitive pressure"" on Gilead's HIV unit, Leerink analyst Geoffrey Porges says.","GSK"," GlaxoSmithKline"
"92","Gilead, Glaxo Pitted In HIV Battle; Both Struggle Vs. Standard Drugs","http://www.investors.com/news/technology/gilead-gsk-pitted-in-hiv-battle-both-struggle-vs-standard-drugs/","2017-02-22 13:29:37","Investor's Business Daily","Gilead Sciences (GILD) and GlaxoSmithKline (GSK) will have a tough time divorcing HIV patients from their traditional three-pill regimens, Leerink analyst Geoffrey Porges predicted Wednesday following the Conference on Retroviruses and Opportunistic ...","GSK"," GlaxoSmithKline"
"93","GSK reports positive results in study for controlled asthma","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3533893","2017-02-23 04:46:39","Reuters Key Development","GSK reports positive results in study for controlled asthma","GSK"," GlaxoSmithKline"
"94","Aspen completes acquisition of a portfolio of anaesthetics with GlaxoSmithKline","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3538497","2017-03-01 02:00:27","Reuters Key Development","Aspen completes acquisition of a portfolio of anaesthetics with GlaxoSmithKline","GSK"," GlaxoSmithKline"
"95","GlaxoSmithKline PLC (GSK) Dividend Payout Ratio","http://www.moneyflowtrends.com/2017-03-01-glaxosmithkline-plc-gsk-dividend-payout-ratio/","2017-03-01 09:37:30","Money Flow Index & Trends","GlaxoSmithKline plc (ADR) Last issued its quarterly earnings results on Feb 3, 2016. The company reported $0.18 EPS for the quarter.","GSK"," GlaxoSmithKline"
"96","GlaxoSmithKline says for results positive in asthma study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3539665","2017-03-02 05:02:17","Reuters Key Development","GlaxoSmithKline says for results positive in asthma study","GSK"," GlaxoSmithKline"
"97","GSK says asthma drug Nucala (Mepolizumab) meets primary endpoints","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3541437","2017-03-06 09:49:46","Reuters Key Development","GSK says asthma drug Nucala (Mepolizumab) meets primary endpoints","GSK"," GlaxoSmithKline"
"98","R-Squared Dividend Growth of GlaxoSmithKline PLC (GSK)","https://www.highlandmirror.com/2017-03-15-r-squared-dividend-growth-of-glaxosmithkline-plc-gsk","2017-03-15 06:41:15","Highland Mirror","The dividend growth rate of GlaxoSmithKline PLC(GSK) calculated based on 20 historical quarterly dividends is -3.41% while the R-Squared dividend growth rate regression is 0.17.","GSK"," GlaxoSmithKline"
"99","GSK announces U.S. regulatory submission seeking expanded indication for Fluarix Quadrivalent for infants 6 months and older","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3548109","2017-03-15 11:13:00","Reuters Key Development","GSK announces U.S. regulatory submission seeking expanded indication for Fluarix Quadrivalent for infants 6 months and older","GSK"," GlaxoSmithKline"
"100","Zacks Rank on GlaxoSmithKline PLC (GSK) based on Estimated Earnings","http://www.moneyflowtrends.com/2017-03-17-zacks-rank-on-glaxosmithkline-plc-gsk-based-on-estimated-earnings/","2017-03-17 11:00:00","Money Flow Index & Trends","GlaxoSmithKline plc (ADR) Last issued its quarterly earnings results on Feb 3, 2016. The company reported $0.18 EPS for the quarter.","GSK"," GlaxoSmithKline"
"101","Stock Price of GlaxoSmithKline PLC (GSK) Increases 2.18%","https://www.highlandmirror.com/2017-03-20-stock-price-of-glaxosmithkline-plc-gsk-increases-2-18","2017-03-20 03:30:00","Highland Mirror","GlaxoSmithKline PLC stock performance trend indicates that the stock price has rallied 10.22% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -1.99 ...","GSK"," GlaxoSmithKline"
"102","Jeff Auxier Reduces, Exits Multiple Positions in 4th Quarter","http://www.nasdaq.com/article/jeff-auxier-reduces-exits-multiple-positions-in-4th-quarter-cm764828","2017-03-22 18:30:00","Nasdaq","The guru reduced his holding in GlaxoSmithKline PLC ADR ( GSK ) by 15.62%, reducing its portfolio space by -0.16%. The company creates, discovers, develops, manufactures and markets pharmaceutical products, including vaccines, over-the-counter ...","GSK"," GlaxoSmithKline"
"103","GOOGL Stock Is Falling Into a Funk","http://investorplace.com/2017/03/alphabet-is-falling-into-a-funk-googl/","2017-03-23 10:15:00","Investorplace.com","Other companies that have dropped their YouTube ads include HSBC Holdings plc (ADR) (NYSE:HSBC), GlaxoSmithKline plc (ADR) (NYSE:GSK) and Enterprise. The price target drop - from $970 to $950 - betrayed the downgrade a little, as that still ...","GSK"," GlaxoSmithKline"
"104","10 Least Obese Countries in the World","http://www.insidermonkey.com/blog/10-least-obese-countries-in-the-world-566121/","2017-03-26 14:33:45","Insider Monkey (blog)","The 10 least obese countries in the world are mostly from Asia and Africa. Changing food habits, improving medical care and awareness about one's health have contributed towards the betterment of public health over the last century.","GSK"," GlaxoSmithKline"
"105","Stocks Worth Chasing- Coty Inc (NYSE:COTY), GlaxoSmithKline plc (ADR) (NYSE:GSK)","http://www.wallstreetnews24.com/stocks-worth-chasing-coty-inc-nysecoty-glaxosmithkline-plc-adr-nysegsk/","2017-03-28 08:13:12","Wall Street Times (press release)","Coty Inc (NYSE:COTY) traded at a yearly high level of $31.60 during the last trading session. The last session's volume of 4.68 million shares was lower than its average volume of 5.19 million shares.","GSK"," GlaxoSmithKline"
"106","Mylan says no comment at this point on U.S. generic Advair application","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3557930","2017-03-29 07:30:35","Reuters Key Development","Mylan says no comment at this point on U.S. generic Advair application","GSK"," GlaxoSmithKline"
"107","Pernix Therapeutics Holdings Inc (NASDAQ:PTX) Dip Could Be A Discount Entry ...","https://www.insiderfinancial.com/pernix-therapeutics-holdings-inc-nasdaqptx-dip-could-be-a-discount-entry-opportunity/120459/","2017-03-29 11:11:15","Insider Financial","What we're here to highlight is something that wider markets look to have overlooked - that the numbers on which financial media outlets are basing their headlines in response to the company's earnings release are skewed by the GlaxoSmithKline plc (ADR ...","GSK"," GlaxoSmithKline"
"108","GlaxoSmithKline plc (ADR) (NYSE:GSK) has been downgraded to Hold in a ...","http://breakingfinancenews.com/investing/glaxosmithkline-plc-adr-nysegsk-has-been-downgraded-to-hold-in-a-statement-by-zacks-investment-research-earlier-today/217841/","2017-03-29 12:52:30","Breaking Finance News","Zacks Investment Research has downgraded GlaxoSmithKline plc (ADR) (NYSE:GSK) to Hold in a statement released on Wednesday March 29, 2017.","GSK"," GlaxoSmithKline"
"109","Mylan receives CRL for generic Advair Diskus ANDA","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3558198","2017-03-29 13:16:00","Reuters Key Development","Mylan receives CRL for generic Advair Diskus ANDA","GSK"," GlaxoSmithKline"
"110","Advair Generic Developed By Mylan NV (NASDAQ:MYL) Rejected By The FDA","https://marketexclusive.com/advair-generic-developed-mylan-nv-nasdaqmyl-rejected-fda/87859/","2017-03-30 06:30:00","Market Exclusive","Mylan NV (NASDAQ:MYL) has revealed that its generic version of Advair did not get the approval of the U.S. Food and Drug Administration.","GSK"," GlaxoSmithKline"
"111","50 Advertisers Boycott YouTube Advertising, And It Won&#39;t Mean More Than A 1 ...","https://www.benzinga.com/tech/17/04/9228381/50-advertisers-boycott-youtube-advertising-and-it-wont-mean-more-than-a-1-dip-in-","2017-04-01 08:45:00","Benzinga","Some European companies, including Guardian, GlaxoSmithKline plc (ADR) (NYSE: GSK) and HSBC Holdings plc (ADR) (NYSE: HSBC) announced their intentions to boycott advertising on Google's YouTube channel due to YouTube airing objectionable ...","GSK"," GlaxoSmithKline"
"112","Phase III Study Of GlaxoSmithKline plc (ADR) (NYSE:GSK) Mepolizumab Kicks Off ...","https://marketexclusive.com/phase-iii-study-glaxosmithkline-plc-adr-nysegsk-mepolizumab-kicks-off-test-safety-efficacy/89067/","2017-04-03 08:22:30","Market Exclusive","The Phase 3 study of GlaxoSmithKline plc (ADR) (NYSE:GSK) Mepolizumab, for use in patients who are suffering from severe hypereosinophilic syndrome (HES), has begun.","GSK"," GlaxoSmithKline"
"113","GlaxoSmithKline files for debt shelf of up to $10 bln - SEC Filing","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3561843","2017-04-03 17:45:01","Reuters Key Development","GlaxoSmithKline files for debt shelf of up to $10 bln - SEC Filing","GSK"," GlaxoSmithKline"
"114","GlaxoSmithKline plc (ADR) (GSK) is Upgraded by Exane BNP Paribas to ” Neutral”","https://www.highlandmirror.com/2017-04-05-glaxosmithkline-plc-adr-gsk-is-upgraded-by-exane-bnp-paribas-to-neutral","2017-04-05 08:00:00","Highland Mirror","GlaxoSmithKline plc (ADR) (GSK) was Upgraded by Exane BNP Paribas to ” Neutral”. Earlier the firm had a rating of “Underperform ” on the company shares.","GSK"," GlaxoSmithKline"
"115","Watch These Stocks: Lockheed Martin Corporation (NYSE:LMT), Deutsche Bank AG ...","https://stockmarketdaily.co/2017/04/05/8829/","2017-04-05 08:00:00","Stock Market Daily","GlaxoSmithKline plc (ADR) (NYSE:GSK) stock needs to be watched after the company recalled over 593,000 ventlolin asthma inhalers from hospitals, pharmacieis, retailers and wholesalers in the United States.","GSK"," GlaxoSmithKline"
"116","Anthrax And Government Contracts: PharmAthene And Altimmune Ahead Of Merger","https://www.benzinga.com/general/biotech/17/04/9258122/anthrax-and-government-contracts-pharmathene-and-altimmune-ahead-of-me","2017-04-06 15:52:30","Benzinga","This intra-nasally administered vaccine could replace AstraZeneca plc (ADR) (NYSE: AZN)'s FluMist, recently pulled from the market, as well as GlaxoSmithKline plc (ADR) (NYSE: GSK), Sanofi SA (ADR) (NYSE: SNY) and CSL's traditional flu vaccines, which ...","GSK"," GlaxoSmithKline"
"117","Stocks to Keep Your Eyes on GlaxoSmithKline plc (ADR) (NYSE:GSK), Diana ...","http://www.journalfinance.net/2017/04/stocks-to-keep-your-eyes-on-glaxosmithkline-plc-adr-nysegsk-diana-shipping-inc-nysedsx/","2017-04-07 08:56:15","Daily News Journal","On Thursday, GlaxoSmithKline plc (ADR) (NYSE:GSK) stock opened its trade at $41.49 and after floating in a range of $41.35 to $41.59, settled at $41.42.","GSK"," GlaxoSmithKline"
"118","Analysts Speculate on: GlaxoSmithKline plc (ADR) (NYSE:GSK)","http://postregistrar.com/2017/04/10/analysts-speculate-on-glaxosmithkline-plc-adr-nysegsk/","2017-04-10 09:26:16","Post Registrar","GlaxoSmithKline plc (ADR) (NYSE:GSK) soared 0.12% during previous trade, a total of 3.67M shares exchanged hands compared with its average trading volume of 2.81M shares whereas its relative volume is 1.11.","GSK"," GlaxoSmithKline"
"119","Sterneck Capital Management Lowered Its Glaxosmithkline Plc (GSK) Holding ...","http://kgazette.com/sterneck-capital-management-lowered-its-glaxosmithkline-plc-gsk-holding-momenta-pharmaceuticals-inc-mnta-covered-by-4-bulls/","2017-04-10 10:27:40","Key Gazette","Glaxosmithkline Plc now has $100.44B valuation. The stock declined 0.02% or $0.01 reaching $41.46 per share. About 403,042 shares traded.","GSK"," GlaxoSmithKline"
"120","GSK makes changes to financial reporting; sees growth in emerging markets","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3566396","2017-04-11 07:02:56","Reuters Key Development","GSK makes changes to financial reporting; sees growth in emerging markets","GSK"," GlaxoSmithKline"
"121","Greylin Investment Mangement Has Boosted By $1.86 Million Its Glaxosmithkline ...","https://kgazette.com/greylin-investment-mangement-has-boosted-by-1-86-million-its-glaxosmithkline-plc-gsk-stake-netscout-systems-inc-ntct-had-1-analysts-last-week/","2017-04-11 21:23:49","Key Gazette","Glaxosmithkline Plc now has $100.37B valuation. The stock rose 0.82% or $0.34 reaching $41.64 per share. About 685,036 shares traded.","GSK"," GlaxoSmithKline"
"122","Kanaly Trust Co Has Lowered Glaxosmithkline Plc (GSK) Position By $530176 ...","http://utahherald.com/kanaly-trust-co-has-lowered-glaxosmithkline-plc-gsk-position-by-530176-raging-capital-management-has-cut-compugen-ltd-cgen-holding/","2017-04-12 09:41:39","UtahHerald.com","Glaxosmithkline Plc now has $101.50B valuation. The stock declined 0.05% or $0.02 reaching $41.76 per share. About 4,482 shares traded.","GSK"," GlaxoSmithKline"
"123","Stocks in News – GlaxoSmithKline plc (ADR) (NYSE:GSK), American Axle ...","http://www.wallstreetnews24.com/stocks-in-news-glaxosmithkline-plc-adr-nysegsk-american-axle-manufact-holdings-inc-nyseaxl/","2017-04-12 10:06:03","Wall Street Times (press release)","GlaxoSmithKline plc (ADR) (NYSE:GSK) traded at a yearly high level of $45.58 during the last trading session. The last session's volume of 3.22 million shares was higher than its average volume of 2.82 million shares.","GSK"," GlaxoSmithKline"
"124","EPS for HUGO BOSS AG SPON ADR EA REPR 1 5 ORD (BOSSY) Expected At $0.00 ...","http://utahherald.com/eps-for-hugo-boss-ag-spon-adr-ea-repr-1-5-ord-bossy-expected-at-0-00-hilltop-holdings-lowered-by-317794-its-glaxosmithkline-plc-gsk-holding/","2017-04-12 14:33:45","UtahHerald.com","HUGO BOSS AG SPON ADR EA REPR 1 5 ORD (OTCMKTS:BOSSY) has risen 21.95% since September 6, 2016 and is uptrending. It has outperformed by 14.29% the S&P500.","GSK"," GlaxoSmithKline"
"125","Stock Movers- PNC Financial Services Group Inc (NYSE:PNC), GlaxoSmithKline plc ...","http://www.wallstreetnews24.com/stock-movers-pnc-financial-services-group-inc-nysepnc-glaxosmithkline-plc-adr-nysegsk/","2017-04-13 09:48:28","Wall Street Times (press release)","PNC Financial Services Group Inc (NYSE:PNC) traded at a yearly high level of $131.83 during the last trading session. The last session's volume of 3.04 million shares was higher than its average volume of 2.74 million shares.","GSK"," GlaxoSmithKline"
"126","Kornitzer Capital Management Trimmed Glaxo Smithkline Adr (GSK) Stake By ...","http://www.bibeypost.com/kornitzer-capital-management-trimmed-glaxo-smithkline-adr-gsk-stake-by-528580-5-analysts-bullish-hercules-capital-htgc/","2017-04-14 13:31:12","Bibeypost.com","Glaxo Smithkline Adr now has $101.15 billion valuation. The stock decreased 0.17% or $0.07 on April 13, reaching $41.81. About shares traded.","GSK"," GlaxoSmithKline"
"127","Loring Wolcott &amp; Coolidge Fiduciary Advisors Llp Lifted Unilever Plc Sponsored ...","https://wolcottdaily.com/loring-wolcott-coolidge-fiduciary-advisors-llp-lifted-unilever-plc-sponsored-adr-ul-stake-glaxosmithkline-plc-adr-gsk-had-6-bullish-analysts/","2017-04-14 14:56:15","Wolcott Daily","Loring Wolcott & Coolidge Fiduciary Advisors Llp increased Unilever Plc Sponsored Adr (UL) stake by 3.43% reported in 2016Q4 SEC filing.","GSK"," GlaxoSmithKline"
"128","As Drug Prices Fall, These Stocks Could Rise","http://www.barrons.com/articles/as-drug-prices-fall-these-stocks-could-rise-1492230223","2017-04-15 00:18:45","Barron's","... on its Diskus device—a disc-shaped inhaler (see above) that releases powdered medicine from a blister pack—expires this year.","GSK"," GlaxoSmithKline"
"129","Nokia Oyj (ADR) (NYSE:NOK)-Brnaded Phones to Enter in Iranian Market","http://www.benchmarkmonitor.com/nokia-oyj-adr-nysenok-brnaded-phones-to-enter-in-iranian-market/205950","2017-04-17 06:29:58","Benchmark Monitor","At the movement GlaxoSmithKline plc (NYSE:GSK) is under coverage by number of analysts. Buy rating has been given by 2 analysts to the company stock whereas no analyst given UNDERPERFORM rating to stock and 2 analysts given HOLD rating.","GSK"," GlaxoSmithKline"
"130","Stocks Under Consideration: Ally Financial Inc (NYSE:ALLY), GlaxoSmithKline ...","http://www.wallstreetnews24.com/stocks-under-consideration-ally-financial-inc-nyseally-glaxosmithkline-plc-adr-nysegsk-adobe-systems-incorporated-nasdaqadbe/","2017-04-17 09:46:47","Wall Street Times (press release)","Analysts gives GlaxoSmithKline plc (ADR) (NYSE:GSK) a mean recommendation of 2.00. The company has grown 8.68% in past 3 months and in the last five trades has moved up 0.94%.","GSK"," GlaxoSmithKline"
"131","Stocks in the Spotlight -GlaxoSmithKline plc (ADR) (NYSE:GSK), GNC Holdings ...","http://stocksnewstimes.com/2017/04/17/stocks-in-the-spotlight-glaxosmithkline-plc-adr-nysegsk-gnc-holdings-inc-nysegnc/","2017-04-17 09:52:26","Stock Watch (press release)","GlaxoSmithKline plc (ADR) (NYSE:GSK) traded 2,684,700 shares on last trading session with closing price of $41.81. GSK was trading -4.82% below its 52-week high and 13.97% above its 52-week low.","GSK"," GlaxoSmithKline"
"132","GSK seeks Japanese approval for shingles vaccine","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3569791","2017-04-18 04:16:15","Reuters Key Development","GSK seeks Japanese approval for shingles vaccine","GSK"," GlaxoSmithKline"
"133","Stock&#39;s Buzz on These Trending Stocks: JD.Com Inc (ADR) (NASDAQ:JD), EXACT ...","https://www.wallstreetnews24.com/stocks-buzz-on-these-trending-stocks-jd-com-inc-adr-nasdaqjd-exact-sciences-corporation-nasdaqexas-glaxosmithkline-plc-adr-nysegsk/","2017-04-18 08:17:26","Wall Street Times (press release)","GlaxoSmithKline plc (ADR) (NYSE:GSK) stock price escalated 0.07% to finalize at $41.84 throughout previous buying and selling session.","GSK"," GlaxoSmithKline"
"134","GlaxoSmithKline plc (ADR) (GSK) Reaches $41.04 After 7.00% Gap Down; Total ...","http://kgazette.com/glaxosmithkline-plc-adr-gsk-reaches-41-04-after-7-00-gap-down-total-system-services-inc-tss-covered-by-12-bullish-analysts-last-week/","2017-04-18 12:52:30","Key Gazette","Among 19 analysts covering Total System Services (NYSE:TSS), 12 have Buy rating, 0 Sell and 7 Hold. Therefore 63% are positive. Total System Services had 33 analyst reports since July 21, 2015 according to SRatingsIntel.","GSK"," GlaxoSmithKline"
"135","Form 487 Advisors Disciplined","https://www.streetinsider.com/SEC+Filings/Form+487+Advisors+Disciplined/12787317.html","2017-04-18 13:03:45","StreetInsider.com","... 2.49 82.38 3,707 46 MDT Medtronic PLC (4) 2.48 80.36 3,697 28 SYK Stryker Corporation 2.46 130.97 3,667 24 TMO Thermo Fisher Scientific, Inc. 2.48 153.70 3,689 (continued) 4 Investment Summary ANGELS PORTFOLIO, SERIES 2017-2Q (ADVISORS ...... HIMCO ...","GSK"," GlaxoSmithKline"
"136","GlaxoSmithKline plc (ADR) (GSK) Reaches $41.20 After 7.00% Gap Down, Evoke ...","http://kgazette.com/glaxosmithkline-plc-adr-gsk-reaches-41-20-after-7-00-gap-down-evoke-pharma-evok-sellers-increased-by-3-59-their-shorts/","2017-04-18 16:48:41","Key Gazette","The stock of GlaxoSmithKline plc (ADR) (NYSE:GSK) gapped down by $0.24 today and has $38.32 target or 7.00% below today's $41.20 share price.","GSK"," GlaxoSmithKline"
"137","GlaxoSmithKline plc (ADR)(NYSE:GSK) Applauds Togo For Eliminating Lymphatic ...","https://marketexclusive.com/glaxosmithkline-plc-adrnysegsk-applauds-togo-eliminating-lymphatic-filariasis/94407/","2017-04-19 07:03:45","Market Exclusive","Togo has eliminated Lymphatic filariasis (LF) from being a public health problem. The historic achievement, which comes after decades of persistent efforts has been applauded by many institutions among them GlaxoSmithKline plc (ADR)(NYSE:GSK) and the ...","GSK"," GlaxoSmithKline"
"138","Stockman Asset Management Has Boosted By $335274 Its Glaxosmithkline Plc Adr ...","https://huronreport.com/stockman-asset-management-has-boosted-by-335274-its-glaxosmithkline-plc-adr-gsk-holding-17-analysts-are-bullish-bank-of-america-bac-last-week/","2017-04-19 07:48:45","HuronReport","Stockman Asset Management increased Glaxosmithkline Plc Adr (GSK) stake by 17.34% reported in 2016Q4 SEC filing. Stockman Asset Management acquired 8,823 shares as Glaxosmithkline Plc Adr (GSK)'s stock declined 10.90%. The Stockman Asset ...","GSK"," GlaxoSmithKline"
"139","Sometimes the Road to Wealth Is Paved by Tech - and Toothpaste","https://moneymorning.com/investing/sometimes-the-road-to-wealth-is-paved-by-tech-and-toothpaste/","2017-04-19 09:30:00","Money Morning","GlaxoSmithKline Plc. (NYSE ADR: GSK) decided back in 2014 to smooth out its cash flow and R&D spending by moving into consumer healthcare.","GSK"," GlaxoSmithKline"
"140","GlaxoSmithKline plc (ADR) (GSK) EPS Estimated At $0.59; Helmerich &amp; Payne (HP ...","http://kgazette.com/glaxosmithkline-plc-adr-gsk-eps-estimated-at-0-59-helmerich-payne-hp-shorts-raised-by-5-65/","2017-04-19 12:30:00","Key Gazette","Analysts expect GlaxoSmithKline plc (ADR) (NYSE:GSK) to report $0.59 EPS on April, 26.They anticipate $0.02 EPS change or 3.51% from last quarter's $0.57 EPS.","GSK"," GlaxoSmithKline"
"141","Stocks on the Move - Oracle Corporation (NYSE:ORCL), Chevron Corporation (NYSE ...","https://www.wallstreetnews24.com/stocks-on-the-move-oracle-corporation-nyseorcl-chevron-corporation-nysecvx-glaxosmithkline-plc-adr-nysegsk/","2017-04-19 12:41:15","Wall Street Times (press release)","GlaxoSmithKline plc (ADR) (NYSE:GSK) stock price declined -1.34% to finalize at $41.28 throughout previous buying and selling session.","GSK"," GlaxoSmithKline"
"142","GlaxoSmithKline PLC (LON:GSK) Stock “Buy” Rating Reiterated at Jefferies ...","https://normanobserver.com/glaxosmithkline-plc-longsk-stock-buy-rating-reiterated-at-jefferies-international-the-price-objective-given-is-gbx-1800-00-bnc-bancorp-bncn-has-1-8-sentiment/","2017-04-20 08:45:00","NormanObserver.com","About 3.58 million shares traded. GlaxoSmithKline plc (LON:GSK) has declined 4.32% since September 20, 2016 and is downtrending. It has underperformed by 14.24% the S&P500.","GSK"," GlaxoSmithKline"
"143","What Would A $5.8 Billion NIH Cut Look Like? Devastation","https://www.benzinga.com/news/17/04/9308625/what-would-a-5-8-billion-nih-cut-look-like-devastation","2017-04-20 13:37:30","Benzinga","The budgets of Johnson & Johnson (NYSE: JNJ), Novartis AG (ADR) (NYSE: NVS), Pfizer Inc. (NYSE: PFE), Eli Lilly and Co (NYSE: LLY), Merck & Co.","GSK"," GlaxoSmithKline"
"144","Three Companies Spearheading a Shift in the Hepatitis B Healthcare Space","https://www.equities.com/news/three-companies-spearheading-a-shift-in-the-hepatitis-b-healthcare-space","2017-04-20 14:11:15","Equities.com","No new treatments have hit the shelves in more than a decade, and both the vaccine side and the treatment (antiviral) side of the space are dominated by a slow moving incumbent - GlaxoSmithKline plc (ADR) (NYSE:GSK) and Gilead Sciences, Inc.","GSK"," GlaxoSmithKline"
"145","Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) Asthma Inhaler To Compete ...","https://marketexclusive.com/teva-pharmaceutical-industries-ltd-asthma-inhaler-to-compete-with-glaxosmithkline-advair/95508/","2017-04-21 05:22:30","Market Exclusive","The launch of an asthma inhaler by Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) is likely to put GlaxoSmithKline plc (ADR)(NYSE:GSK) best-selling Advair in a tight spot. AirDuo RespiClick from Teva is an inhalation powder. While it may not be a ...","GSK"," GlaxoSmithKline"
"146","GlaxoSmithKline PLC (LON:GSK) “Hold” Rating Reiterated at Shore Capital ...","https://wolcottdaily.com/glaxosmithkline-plc-longsk-hold-rating-reiterated-at-shore-capital-profile-of-1-analysts-covering-lindsay-lnn/","2017-04-21 06:30:00","Wolcott Daily","Gemmer Asset Limited Company owns 32 shares or 0% of their US portfolio. Geode Cap accumulated 78,311 shares. 109,815 were reported by Fenimore Asset Mngmt.","GSK"," GlaxoSmithKline"
"147","Stocks Bulletin: Abercrombie &amp; Fitch Co. (NYSE:ANF), GlaxoSmithKline plc (ADR ...","https://www.wallstreetnews24.com/stocks-bulletin-abercrombie-fitch-co-nyseanf-glaxosmithkline-plc-adr-nysegsk-knight-transportation-nyseknx/","2017-04-21 09:37:52","Wall Street Times (press release)","Analysts gives GlaxoSmithKline plc (ADR) (NYSE:GSK) a mean recommendation of 2.00. The company has grown 6.53% in past 3 months and in the last five trades has moved down -2.75%.","GSK"," GlaxoSmithKline"
"148","Movers to Watch GlaxoSmithKline plc (ADR) (NYSE:GSK), E*TRADE Financial Corp ...","http://www.journalfinance.net/2017/04/movers-to-watch-glaxosmithkline-plc-adr-nysegsk-etrade-financial-corp-nasdaqetfc/","2017-04-21 11:56:15","Daily News Journal","On Thursday, GlaxoSmithKline plc (ADR) (NYSE:GSK) stock opened its trade at $40.89 and after floating in a range of $40.71 to $40.90, settled at $40.71.","GSK"," GlaxoSmithKline"
"149","AstraZeneca PLC gives FY 2015 guidance","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3198728","2015-03-06 01:00:00","Reuters Key Development","AstraZeneca PLC gives FY 2015 guidance","AZN","AstraZeneca"
"150","AstraZeneca PLC and Innate to collaborate in immuno-oncology","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3198703","2015-04-24 02:00:00","Reuters Key Development","AstraZeneca PLC and Innate to collaborate in immuno-oncology","AZN","AstraZeneca"
"151","AstraZeneca PLC reaffirms FY 2015 guidance","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3198735","2015-04-24 02:00:00","Reuters Key Development","AstraZeneca PLC reaffirms FY 2015 guidance","AZN","AstraZeneca"
"152","AstraZeneca PLC announces positive phase III results for two antibiotics, zinforo and investigational ceftazidime-avibactam","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3200305","2015-04-27 05:00:00","Reuters Key Development","AstraZeneca PLC announces positive phase III results for two antibiotics, zinforo and investigational ceftazidime-avibactam","AZN","AstraZeneca"
"153","AstraZeneca to invest in biologics manufacturing facility in Sweden","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3214330","2015-05-18 04:30:00","Reuters Key Development","AstraZeneca to invest in biologics manufacturing facility in Sweden","AZN","AstraZeneca"
"154","AstraZeneca to collaborate with Lilly on solid tumours clinical trial","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3221371","2015-05-29 02:00:00","Reuters Key Development","AstraZeneca to collaborate with Lilly on solid tumours clinical trial","AZN","AstraZeneca"
"155","AstraZeneca PLC announces phase III results for lesinurad in combination with febuxostat in tophaceous gout patients","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3228953","2015-06-13 09:00:00","Reuters Key Development","AstraZeneca PLC announces phase III results for lesinurad in combination with febuxostat in tophaceous gout patients","AZN","AstraZeneca"
"156","AstraZeneca to collaborate with the University of Michigan","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3230442","2015-06-17 02:02:00","Reuters Key Development","AstraZeneca to collaborate with the University of Michigan","AZN","AstraZeneca"
"157","Clearance of Innate Pharma co-development with AstraZeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3241014","2015-07-07 01:04:00","Reuters Key Development","Clearance of Innate Pharma co-development with AstraZeneca","AZN","AstraZeneca"
"158","AstraZeneca PLC not importing enough of diabetes drug: Lee Pharma - Business Standard","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3242172","2015-07-07 20:00:00","Reuters Key Development","AstraZeneca PLC not importing enough of diabetes drug: Lee Pharma - Business Standard","AZN","AstraZeneca"
"159","AstraZeneca gets US FDA approval for IRESSA (gefitinib) tablets","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3243762","2015-07-13 14:27:00","Reuters Key Development","AstraZeneca gets US FDA approval for IRESSA (gefitinib) tablets","AZN","AstraZeneca"
"160","AstraZeneca PLC enters option agreement with Kyowa Hakko Kirin for commercialisation of benralizumab in Japan","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3245602","2015-07-16 02:05:00","Reuters Key Development","AstraZeneca PLC enters option agreement with Kyowa Hakko Kirin for commercialisation of benralizumab in Japan","AZN","AstraZeneca"
"161","Astrazeneca PLC AZ completes agreement with Tillotts for Entocort","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3246330","2015-07-17 02:05:00","Reuters Key Development","Astrazeneca PLC AZ completes agreement with Tillotts for Entocort","AZN","AstraZeneca"
"162","AstraZeneca PLC recommends an unchanged first interim dividend of $0.90","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3252843","2015-07-30 02:03:00","Reuters Key Development","AstraZeneca PLC recommends an unchanged first interim dividend of $0.90","AZN","AstraZeneca"
"163","Isis Pharmaceuticals Inc and AstraZeneca to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3254727","2015-08-03 02:00:00","Reuters Key Development","Isis Pharmaceuticals Inc and AstraZeneca to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases","AZN","AstraZeneca"
"164","AstraZeneca Plc&#39;s Medimmune and Mirati Therapeutics partner on immuno-oncology combination in lung cancer","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3256450","2015-08-05 02:03:00","Reuters Key Development","AstraZeneca Plc's Medimmune and Mirati Therapeutics partner on immuno-oncology combination in lung cancer","AZN","AstraZeneca"
"165","AstraZeneca Plc&#39;s Medimmune enters into strategic cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3258934","2015-08-10 03:01:00","Reuters Key Development","AstraZeneca Plc's Medimmune enters into strategic cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals","AZN","AstraZeneca"
"166","AstraZeneca PLC and Valeant to partner on brodalumab","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3268280","2015-09-01 02:04:00","Reuters Key Development","AstraZeneca PLC and Valeant to partner on brodalumab","AZN","AstraZeneca"
"167","AstraZeneca enters license agreement with Daiichi Sankyo","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3269173","2015-09-02 03:10:00","Reuters Key Development","AstraZeneca enters license agreement with Daiichi Sankyo","AZN","AstraZeneca"
"168","AstraZeneca PLC US FDA approves expanded indication for brilinta","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3269828","2015-09-04 03:00:00","Reuters Key Development","AstraZeneca PLC US FDA approves expanded indication for brilinta","AZN","AstraZeneca"
"169","AstraZeneca to invest in oncology bioinformatics collaboration-Reuters","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3270721","2015-09-08 02:28:00","Reuters Key Development","AstraZeneca to invest in oncology bioinformatics collaboration-Reuters","AZN","AstraZeneca"
"170","AstraZeneca buys manufacturing facility in U.S. from Amgen-Reuters","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3272378","2015-09-11 02:04:00","Reuters Key Development","AstraZeneca buys manufacturing facility in U.S. from Amgen-Reuters","AZN","AstraZeneca"
"171","AstraZeneca PLC diabetes drug combination faces delay after FDA rebuff - Reuters","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3287427","2015-10-15 20:00:00","Reuters Key Development","AstraZeneca PLC diabetes drug combination faces delay after FDA rebuff - Reuters","AZN","AstraZeneca"
"172","AstraZeneca PLC opens new $224 mln drug factory in Russia - Reuters","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3287484","2015-10-19 20:00:00","Reuters Key Development","AstraZeneca PLC opens new $224 mln drug factory in Russia - Reuters","AZN","AstraZeneca"
"173","Igenica Biotherapeutics enters into a strategic oncology research agreement with AstraZeneca PLC&#39;s MedImmune","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3291764","2015-10-28 08:30:00","Reuters Key Development","Igenica Biotherapeutics enters into a strategic oncology research agreement with AstraZeneca PLC's MedImmune","AZN","AstraZeneca"
"174","AstraZeneca PLC presents positive update on Lesinurad Renal Data in Gout Patients","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3297663","2015-11-09 08:00:00","Reuters Key Development","AstraZeneca PLC presents positive update on Lesinurad Renal Data in Gout Patients","AZN","AstraZeneca"
"175","Celgene in Collaboration with AstraZeneca Announce Initiation of Fusion Clinical Development Program in Immuno-Oncology","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3307881","2015-12-07 07:30:00","Reuters Key Development","Celgene in Collaboration with AstraZeneca Announce Initiation of Fusion Clinical Development Program in Immuno-Oncology","AZN","AstraZeneca"
"176","AstraZeneca PLC completes acquisition of ZS Pharma","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3314152","2015-12-16 19:00:00","Reuters Key Development","AstraZeneca PLC completes acquisition of ZS Pharma","AZN","AstraZeneca"
"177","AstraZeneca PLC and Moderna Therapeutics announce new collaboration to Co-Develop and Co-Commercialize Immuno-Oncology mRNA Therapeutics(tm)","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3319162","2016-01-11 06:59:00","Reuters Key Development","AstraZeneca PLC and Moderna Therapeutics announce new collaboration to Co-Develop and Co-Commercialize Immuno-Oncology mRNA Therapeutics(tm)","AZN","AstraZeneca"
"178","Incyte Corp and AstraZeneca Inc announce new lung cancer clinical trial collaboration","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3319165","2016-01-11 07:00:00","Reuters Key Development","Incyte Corp and AstraZeneca Inc announce new lung cancer clinical trial collaboration","AZN","AstraZeneca"
"179","AstraZeneca says US FDA grants Lynparza BTD for prostate cancer<U+200D><U+200B>","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3325224","2016-01-28 02:03:00","Reuters Key Development","AstraZeneca says US FDA grants Lynparza BTD for prostate cancer<U+200D><U+200B>","AZN","AstraZeneca"
"180","AstraZeneca PLC says Zurampic approved in EU for gout patients","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3333082","2016-02-19 02:00:00","Reuters Key Development","AstraZeneca PLC says Zurampic approved in EU for gout patients","AZN","AstraZeneca"
"181","AstraZeneca enters licensing deal with China Medical System","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3336612","2016-02-29 02:59:00","Reuters Key Development","AstraZeneca enters licensing deal with China Medical System","AZN","AstraZeneca"
"182","AstraZeneca to sell rights for constipation drug in Europe","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3337216","2016-02-29 19:00:00","Reuters Key Development","AstraZeneca to sell rights for constipation drug in Europe","AZN","AstraZeneca"
"183","AstraZeneca says FDA approves new indication for FASLODEX","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3338283","2016-03-02 18:57:00","Reuters Key Development","AstraZeneca says FDA approves new indication for FASLODEX","AZN","AstraZeneca"
"184","AstraZeneca acquires rights to Orexo OX-CLI project","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3344365","2016-03-17 03:00:00","Reuters Key Development","AstraZeneca acquires rights to Orexo OX-CLI project","AZN","AstraZeneca"
"185","AstraZeneca says launches and prices 2.2 bln euro of bonds","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3369333","2016-05-09 12:35:02","Reuters Key Development","AstraZeneca says launches and prices 2.2 bln euro of bonds","AZN","AstraZeneca"
"186","Weekly Biotech Report Part I – FDA To Decide On AstraZeneca plc (ADR) (NYSE ...","http://marketexclusive.com/weekly-biotech-report-part-astrazeneca-plc-adr-nyseazn-zs-9/6758/","2016-05-16 09:23:11","Market Exclusive","On May 26th, the FDA will issue its final decision on AstraZeneca PLC (ADR) (NYSE:AZN) drug ZS-9 for hyperkalemia, a condition that is caused by too much potassium in blood serum.","AZN","AstraZeneca"
"187","AstraZeneca receives complete response letter from U.S. FDA for sodium zirconium cyclosilicate","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3382659","2016-05-27 02:00:47","Reuters Key Development","AstraZeneca receives complete response letter from U.S. FDA for sodium zirconium cyclosilicate","AZN","AstraZeneca"
"188","AstraZeneca announces positive results in breast cancer trial","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3382656","2016-05-27 02:03:02","Reuters Key Development","AstraZeneca announces positive results in breast cancer trial","AZN","AstraZeneca"
"189","EU health agency recommends approval of new hepatitis C drugs","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3382994","2016-05-27 07:21:42","Reuters Key Development","EU health agency recommends approval of new hepatitis C drugs","AZN","AstraZeneca"
"190","Adherium says Astrazeneca will use its Smartinhaler platform in US clinical study&lt;ADR.AX&gt;&lt;AZN.L&gt;","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3390450","2016-06-13 18:16:55","Reuters Key Development","Adherium says Astrazeneca will use its Smartinhaler platform in US clinical study<ADR.AX><AZN.L>","AZN","AstraZeneca"
"191","AstraZeneca confirms CDC interim recommendation on flu vaccine","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3394966","2016-06-23 02:00:08","Reuters Key Development","AstraZeneca confirms CDC interim recommendation on flu vaccine","AZN","AstraZeneca"
"192","AstraZeneca says life sciences competitivess, drug access key after Brexit","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3395524","2016-06-24 02:00:06","Reuters Key Development","AstraZeneca says life sciences competitivess, drug access key after Brexit","AZN","AstraZeneca"
"193","U.S. FDA says continues to find benefits of flumist quadrivalent outweigh any potential risks","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3397191","2016-06-28 13:57:18","Reuters Key Development","U.S. FDA says continues to find benefits of flumist quadrivalent outweigh any potential risks","AZN","AstraZeneca"
"194","Valeant Pharmaceuticals announces new licensing arrangement for Brodalumab in Europe","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3399039","2016-07-01 02:00:00","Reuters Key Development","Valeant Pharmaceuticals announces new licensing arrangement for Brodalumab in Europe","AZN","AstraZeneca"
"195","Fibrogen announces receipt of $62 million license payment from Astrazeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3402497","2016-07-08 04:00:00","Reuters Key Development","Fibrogen announces receipt of $62 million license payment from Astrazeneca","AZN","AstraZeneca"
"196","Astrazeneca&#39;s lung cancer drug meets primary endpoint in late-stage trial","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3406735","2016-07-18 02:00:08","Reuters Key Development","Astrazeneca's lung cancer drug meets primary endpoint in late-stage trial","AZN","AstraZeneca"
"197","AstraZeneca says new diabetes treatment gets European approval","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3407752","2016-07-19 09:15:02","Reuters Key Development","AstraZeneca says new diabetes treatment gets European approval","AZN","AstraZeneca"
"198","Astrazeneca and Moderna files first clinical trial application in RNA therapeutics","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3411568","2016-07-26 07:00:00","Reuters Key Development","Astrazeneca and Moderna files first clinical trial application in RNA therapeutics","AZN","AstraZeneca"
"199","Hutchison China, AstraZeneca amend savolitinib co-development agreement","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3415923","2016-08-01 02:21:58","Reuters Key Development","Hutchison China, AstraZeneca amend savolitinib co-development agreement","AZN","AstraZeneca"
"200","AstraZeneca plc (ADR) (AZN): Double Success in Oncology Portfolio Could Prove ...","http://www.thecountrycaller.com/65107-astrazeneca-plc-adr-azn-double-success-in-oncology-portfolio-could-prove-to-be-highly-lucrative","2016-08-08 10:37:30","TCC","AstraZeneca plc (ADR) (NYSE:AZN) has announced mutual collaboration with Rpositive, a Cambridge software firm, for the research and development of oncology molecules to treat different categories.","AZN","AstraZeneca"
"201","AstraZeneca says increased Moderna stake to 9 pct","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3423432","2016-08-10 09:41:39","Reuters Key Development","AstraZeneca says increased Moderna stake to 9 pct","AZN","AstraZeneca"
"202","AstraZeneca plc (ADR) (AZN) Got Breakthrough In The UK Market","http://www.thecountrycaller.com/37057-astrazeneca-plc-adr-azn-got-breakthrough-in-the-uk-market","2016-08-15 07:37:30","TCC","AstraZeneca plc (ADR) (NYSE:AZN) has huge expectations with its blood thinner drug Brilinta (ticagrelor) to generate revenue in the years to come.","AZN","AstraZeneca"
"203","Adherium to provide Smartinhalers to Astrazeneca Australia","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3427269","2016-08-16 07:00:00","Reuters Key Development","Adherium to provide Smartinhalers to Astrazeneca Australia","AZN","AstraZeneca"
"204","AstraZeneca plc (ADR) (NYSE:AZN) Cope with the Future Challenges?","http://www.thecountrycaller.com/52950-will-astrazeneca-plc-adr-anz-cope-with-the-future-challenges","2016-08-16 08:39:03","TCC","AstraZeneca's plc (ADR) (NYSE:AZN) is increasing its pace on multiple aspects to enhance its revenue in order to compete with the launching of generics and biosimilars in different therapeutic markets.","AZN","AstraZeneca"
"205","Lilly and Astrazeneca receive FDA fast track designation for AZD3293","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3430135","2016-08-22 06:00:00","Reuters Key Development","Lilly and Astrazeneca receive FDA fast track designation for AZD3293","AZN","AstraZeneca"
"206","AstraZeneca, Lilly receive FDA fast track designation for AZD3293","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3430162","2016-08-22 06:03:51","Reuters Key Development","AstraZeneca, Lilly receive FDA fast track designation for AZD3293","AZN","AstraZeneca"
"207","PFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)&#39;s Antibiotic Business","http://investorplace.com/2016/08/pfizer-astrazeneca-antibiotic-pfe-azn/","2016-08-24 10:37:30","Investorplace.com","Pfizer Inc. (NYSE:PFE) has announced that it will be acquiring part of AstraZeneca plc (ADR)'s (NYSE:AZN) antibiotic business.","AZN","AstraZeneca"
"208","AstraZeneca announces results from SYMBICORT study","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3435716","2016-08-31 17:00:00","Reuters Key Development","AstraZeneca announces results from SYMBICORT study","AZN","AstraZeneca"
"209","Astrazeneca completes Aspen agreement","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3435911","2016-09-01 02:00:10","Reuters Key Development","Astrazeneca completes Aspen agreement","AZN","AstraZeneca"
"210","Aspen Pharmacare to buy exclusive rights to commercialise AstraZeneca&#39;s anaesthetics portfolio","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3435884","2016-09-01 02:00:46","Reuters Key Development","Aspen Pharmacare to buy exclusive rights to commercialise AstraZeneca's anaesthetics portfolio","AZN","AstraZeneca"
"211","Astrazeneca says asthma drug shows positive results in phase III trials","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3437011","2016-09-05 01:05:13","Reuters Key Development","Astrazeneca says asthma drug shows positive results in phase III trials","AZN","AstraZeneca"
"212","Will AstraZeneca plc&#39;s (ADR) (AZN) Asthma Molecule Diminish Patent Cliff Effects?","http://www.thecountrycaller.com/29031-will-astrazeneca-plcs-adr-azn-asthma-molecule-diminish-patent-cliff-effects","2016-09-05 13:55:00","TCC","AstraZeneca plc (ADR) (NYSE:AZN) is working on multiple options in order to be in the mainstream of the pharmaceutical industry.","AZN","AstraZeneca"
"213","Astrazeneca says to withdraw EU marketing application for cancer drug","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3443478","2016-09-21 06:11:25","Reuters Key Development","Astrazeneca says to withdraw EU marketing application for cancer drug","AZN","AstraZeneca"
"214","FDA approves Astrazeneca&#39;s blood-based companion diagnostic for Tagrisso (osimertinib)","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3447053","2016-09-29 07:25:17","Reuters Key Development","FDA approves Astrazeneca's blood-based companion diagnostic for Tagrisso (osimertinib)","AZN","AstraZeneca"
"215","Allergan Plc enters licensing agreement with Astrazeneca for worldwide rights to Medi2070","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3448322","2016-10-03 02:00:00","Reuters Key Development","Allergan Plc enters licensing agreement with Astrazeneca for worldwide rights to Medi2070","AZN","AstraZeneca"
"216","AstraZeneca plc (ADR) (NYSE:AZN) Inks License Deal With Allergan plc Ordinary ...","http://www.thecountrycaller.com/72812-astrazeneca-plc-adr-azn-inks-license-deal-with-allergan-plc-ordinary-shares-agn","2016-10-03 11:22:30","TCC","AstraZeneca plc (ADR) (NYSE:AZN) has finalized the licensing deal with Allergan in relation to the global rights of MEDI2070.","AZN","AstraZeneca"
"217","AstraZeneca exec: $3.5 bln Brilinta sales goal no longer attainable","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3448959","2016-10-04 03:21:55","Reuters Key Development","AstraZeneca exec: $3.5 bln Brilinta sales goal no longer attainable","AZN","AstraZeneca"
"218","Insmed announces worldwide license agreement with AstraZeneca for oral DPP1 inhibitor","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3449534","2016-10-05 06:55:00","Reuters Key Development","Insmed announces worldwide license agreement with AstraZeneca for oral DPP1 inhibitor","AZN","AstraZeneca"
"219","Here&#39;s Why AstraZeneca plc (ADR) (AZN) is Trimming its Drug Pipeline","http://smartstocknews.com/34064-heres-why-astrazeneca-plc-adr-azn-is-trimming-its-drug-pipeline/","2016-10-06 10:51:23","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","AstraZeneca PLC (ADR) (NYSE:AZN) is working on the idea of investing more in oncological ailments. In order to accomplish the task, it is handing over its molecules to other companies.","AZN","AstraZeneca"
"220","3 Big Stock Charts: Chesapeake Energy Corporation (CHK), AstraZeneca plc (ADR ...","http://investorplace.com/2016/10/3-big-stock-charts-chesapeake-energy-corporation-chk-astrazeneca-plc-adr-azn-and-groupon-inc-grpn/","2016-10-07 09:52:30","Investorplace.com","The market will spend much of this Friday digesting the latest jobs report and its implications on the upcoming interest rate decision.","AZN","AstraZeneca"
"221","Wil AstraZeneca plc (ADR) (AZN) Compete in Lung Cancer Treatment?","http://www.voiceobserver.com/90091-wil-astrazeneca-plc-adr-azn-compete-in-lung-cancer-treatment/","2016-10-10 08:45:00","The Voice Observer","AstraZeneca Plc (ADR) (NYSE:AZN) is working on the research and development (R&D) of oncology molecules, keeping in view the prospects of the pharmaceutical arena.","AZN","AstraZeneca"
"222","Allergan says FDA accepts supplemental new drug application for avycaz","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3451804","2016-10-11 08:01:00","Reuters Key Development","Allergan says FDA accepts supplemental new drug application for avycaz","AZN","AstraZeneca"
"223","Synairgen says AstraZeneca decided to stop phase IIa AZD9412 trial","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3452249","2016-10-12 02:00:16","Reuters Key Development","Synairgen says AstraZeneca decided to stop phase IIa AZD9412 trial","AZN","AstraZeneca"
"224","FDA accepts AstraZeneca&#39;s new Hyperkalaemia drug application for review","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3455613","2016-10-18 02:00:10","Reuters Key Development","FDA accepts AstraZeneca's new Hyperkalaemia drug application for review","AZN","AstraZeneca"
"225","AstraZeneca says Lynparza late-stage study succeeds","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3461031","2016-10-26 02:00:05","Reuters Key Development","AstraZeneca says Lynparza late-stage study succeeds","AZN","AstraZeneca"
"226","AstraZeneca plc (ADR) (AZN) Is Up Against Tesaro For Expanded US Ovarian ...","http://smartstocknews.com/24417-astrazeneca-plc-adr-azn-is-up-against-tesaro-for-expanded-us-ovarian-cancer-market/","2016-10-26 12:31:14","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","AstraZeneca plc (ADR) (NYSE:AZN) reported positive headline data on Wednesday for its Phase 3 'Solo2' trial, testing the PARP inhibitor Lynparza as a maintenance therapy in second-line, platinum-sensitive, BRCA-mutated ovarian cancer.","AZN","AstraZeneca"
"227","AstraZeneca says FDA puts partial hold on patient enrolment for head and neck cancer trials","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3463296","2016-10-27 11:51:26","Reuters Key Development","AstraZeneca says FDA puts partial hold on patient enrolment for head and neck cancer trials","AZN","AstraZeneca"
"228","AstraZeneca Canada announces Lynparza trial results","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3466870","2016-11-01 08:00:00","Reuters Key Development","AstraZeneca Canada announces Lynparza trial results","AZN","AstraZeneca"
"229","Earnings Whispers: AstraZeneca plc (ADR) (AZN) &amp; Himax Technologies, Inc. (ADR ...","http://www.thecountrycaller.com/21067-earnings-whispers-astrazeneca-plc-adr-azn--himax-technologies-inc-adr-himx","2016-11-09 11:41:15","TCC","AstraZeneca plc (ADR) (NYSE:AZN) and Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) are set to report their third quarter of fiscal year 2016 (3QFY16) financial results before the opening bell on Thursday.","AZN","AstraZeneca"
"230","AstraZeneca CEO: drug price pressure won&#39;t go away under Trump","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3474648","2016-11-10 05:04:31","Reuters Key Development","AstraZeneca CEO: drug price pressure won't go away under Trump","AZN","AstraZeneca"
"231","Takeover Talk Inspires AstraZeneca plc (AZN) Option Bulls","http://www.schaeffersresearch.com/content/options/2016/11/11/takeover-talk-inspires-astrazeneca-plc-azn-option-bulls","2016-11-11 13:45:16","Schaeffers Research (blog)","AstraZeneca plc (ADR) (NYSE:AZN) stock volume is surging today, running in the 98th percentile of its annual range, as rumors swirl that fellow drugmaker Novartis AG (ADR) (NYSE:NVS) is considering buying the company.","AZN","AstraZeneca"
"232","Novartis AG (NVS) May Fancy AstraZeneca plc (AZN) for Takoever: Reports","http://smartstocknews.com/56404-novartis-ag-nvs-may-fancy-astrazeneca-plc-azn-for-takoever-reports/","2016-11-12 09:48:45","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","The American depository receipts of AstraZeneca plc (ADR) (NYSE:AZN) traded up over 1% on the New York exchange Friday, after a report suggested that the company may attract a takeover interest from Novartis AG (ADR) (NYSE:NVS).","AZN","AstraZeneca"
"233","Emerging Markets: Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) Leading the ...","http://smartstocknews.com/65935-emerging-markets-pfizer-inc-pfe-astrazeneca-plc-adr-azn-leading-the-pharmaceutical-arena/","2016-11-21 08:30:00","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Giant pharma companies such as Pfizer Inc (NYSE:PFE) and others are working diligently on emerging markets to expand their drug portfolios.","AZN","AstraZeneca"
"234","AstraZeneca PLC (ADR) (AZN), Ranbaxy Laboratories Limited (ADR) (RBXLY) Wins ...","http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-ranbaxy-laboratories-limited-adr-rbxly-wins-over-illegal-deal-case-490092/","2016-11-23 11:07:30","Insider Monkey (blog)","The 1st US Circuit Court of Appeals has recently ruled in favor of AstraZeneca plc (ADR) (NYSE:AZN) and Ranbaxy Laboratories Limited (ADR) (OTCMKTS:RBXLY) on a long-lasting class action lawsuit involving an illegal agreement between the two ...","AZN","AstraZeneca"
"235","Analyst Upgrades: Apple Inc., AstraZeneca plc, and Ctrip.com International, Ltd.","http://www.schaeffersresearch.com/content/news/2016/11/25/analyst-upgrades-apple-inc-astrazeneca-plc-and-ctrip-com-international-ltd","2016-11-25 09:15:00","Schaeffers Research (blog)","Analysts are weighing in on iPhone maker Apple Inc. (NASDAQ:AAPL), drugmaker AstraZeneca plc (ADR) (NYSE:AZN), and online travel stock Ctrip.","AZN","AstraZeneca"
"236","AstraZeneca PLC (ADR) (AZN) Relocating Jobs At UK Division","http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-relocating-jobs-at-u-k-division-499733/","2016-12-06 09:48:45","Insider Monkey (blog)","AstraZeneca plc (ADR) (NYSE:AZN) plans to cut some back office jobs in the U.K. as the company works toward cost-cutting and operation consolidation.","AZN","AstraZeneca"
"237","Lilly, Astrazeneca to develop potentially disease-modifying Alzheimer&#39;s treatment","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3492833","2016-12-09 07:00:00","Reuters Key Development","Lilly, Astrazeneca to develop potentially disease-modifying Alzheimer's treatment","AZN","AstraZeneca"
"238","Analyst Upgrades: Biogen Inc, AstraZeneca plc, and Broadcom Ltd","http://www.schaeffersresearch.com/content/news/2016/12/09/analyst-upgrades-biogen-inc-astrazeneca-plc-and-broadcom-ltd","2016-12-09 09:29:03","Schaeffers Research (blog)","Analysts are weighing in on drug stocks Biogen Inc (NASDAQ:BIIB) and AstraZeneca plc (ADR) (NYSE:AZN), as well as Apple Inc. (NASDAQ:AAPL) supplier Broadcom Ltd (NASDAQ:AVGO).","AZN","AstraZeneca"
"239","Astrazeneca says durvalumab gets FDA’s priority review status in bladder cancer","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3492973","2016-12-09 10:05:42","Reuters Key Development","Astrazeneca says durvalumab gets FDA’s priority review status in bladder cancer","AZN","AstraZeneca"
"240","AstraZeneca PLC (ADR) (AZN) Cuts Jobs, Signs New Collaboration With Eli Lilly ...","http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-cuts-jobs-signs-new-collaboration-with-eli-lilly-and-co-lly-503600/","2016-12-09 10:09:43","Insider Monkey (blog)","Due to low revenue anticipation in the year ahead, AstraZeneca plc (ADR) (NYSE:AZN) had been forced to make tough decisions to remain consistent with its growth prospects.","AZN","AstraZeneca"
"241","Knight Therapeutics announces exclusive license agreement with AstraZeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3495775","2016-12-15 07:30:00","Reuters Key Development","Knight Therapeutics announces exclusive license agreement with AstraZeneca","AZN","AstraZeneca"
"242","Almirall receives $30 million in milestone payment from Astrazeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3496499","2016-12-16 04:35:36","Reuters Key Development","Almirall receives $30 million in milestone payment from Astrazeneca","AZN","AstraZeneca"
"243","Ionis earns $28 mln from Astrazeneca for drug to treat cancer","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3496622","2016-12-16 07:29:44","Reuters Key Development","Ionis earns $28 mln from Astrazeneca for drug to treat cancer","AZN","AstraZeneca"
"244","AstraZeneca completes sale of antibiotics business to Pfizer","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3500067","2016-12-23 02:00:05","Reuters Key Development","AstraZeneca completes sale of antibiotics business to Pfizer","AZN","AstraZeneca"
"245","Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3500132","2016-12-23 02:05:00","Reuters Key Development","Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca","AZN","AstraZeneca"
"246","AstraZeneca plc (AZN): What does the Future Hold?","http://smartstocknews.com/59771-astrazeneca-plc-azn-what-does-the-future-hold/","2017-01-03 08:38:46","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","AstraZeneca plc (ADR) (NYSE:AZN) has faced various ups and downs in the financial year (FY2016) concerning patent cliff side effects.","AZN","AstraZeneca"
"247","AstraZeneca plc (ADR) (AZN): Merill Lynch Analysts view on MYSTIC","http://smartstocknews.com/34920-astrazeneca-plc-adr-azn-merill-lynch-analysts-view-on-mystic/","2017-01-04 12:21:29","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Questions have mainly revolved around trial layout, with much discussion of just how to interpret AstraZeneca plc (ADR) (NYSE:AZN) comments through its roadshow in late 16. In ML's view, AZN's R&D call 15th December went a long way to answering ...","AZN","AstraZeneca"
"248","GlaxoSmithKline appoints Luke Miels President, Global Pharma","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3510720","2017-01-19 02:09:25","Reuters Key Development","GlaxoSmithKline appoints Luke Miels President, Global Pharma","AZN","AstraZeneca"
"249","AstraZeneca plc (ADR) (AZN) MYSTIC Change Incrementally Positive for Merck ...","http://smartstocknews.com/45126-astrazeneca-mystic-change-incrementally-positive-for-merck-and-less-so-for-bristol-myers-squibb/","2017-01-19 09:37:30","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","BMO Capital Markets believes AstraZeneca plc (ADR) (NYSE:AZN) endpoint change for the MYSTIC trial in 1L NSCLC and the delay in IO combo data are incrementally positive for BMO's Top Pick Merck & Co.","AZN","AstraZeneca"
"250","AstraZeneca says asthma drug granted paediatric exclusivity in U.S.","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3515704","2017-01-26 05:00:03","Reuters Key Development","AstraZeneca says asthma drug granted paediatric exclusivity in U.S.","AZN","AstraZeneca"
"251","Clovis Oncology Inc (CLVS)&#39;s Ovarian Cancer Drug Faces Stiff Competition From ...","http://www.insidermonkey.com/blog/clovis-oncology-inc-clvss-ovarian-cancer-drug-faces-stiff-competition-from-astrazeneca-plc-adr-azn-tesaro-inc-tsro-529367/","2017-01-31 12:59:53","Insider Monkey (blog)","Trials of rival drugs from AstraZeneca PLC (ADR) (NYSE:AZN) and TESARO Inc (NASDAQ:TSRO) will determine the adoption of the PARP inhibitor, Rubraca from Clovis Oncology Inc (NASDAQ:CLVS).","AZN","AstraZeneca"
"252","AstraZeneca CEO says MYSTIC cancer drug trial &quot;not binary&quot;","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3519508","2017-02-02 02:41:35","Reuters Key Development","AstraZeneca CEO says MYSTIC cancer drug trial ""not binary""","AZN","AstraZeneca"
"253","Pharma stocks to watch: Merck &amp; Co., Inc. (NYSE: MRK) and AstraZeneca plc (ADR ...","http://fxdailyreport.com/pharma-stocks-watch-merck-co-inc-nyse-mrk-astrazeneca-plc-adrnyse-azn/","2017-02-02 12:26:15","FX Daily Report","AstraZeneca plc (ADR)(NYSE:AZN) stock opened on a weak note on February 2nd, 2017 impacted by the lower than estimated results.","AZN","AstraZeneca"
"254","Astrazeneca says will get $130 mln as milestone payment after Brodalumab approval","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3529441","2017-02-16 07:01:01","Reuters Key Development","Astrazeneca says will get $130 mln as milestone payment after Brodalumab approval","AZN","AstraZeneca"
"255","Analyst: Buy AstraZeneca On The Turnaround Story","https://www.benzinga.com/analyst-ratings/analyst-color/17/02/9076198/analyst-buy-astrazeneca-on-the-turnaround-story","2017-02-22 07:22:30","Benzinga","Following AstraZeneca plc (ADR) (NYSE: AZN)'s strong start to 2017, including a positive data report for breast cancer treatment Lynparza, investors await a barrage of news highlighting significant findings and potential approvals for various portfolio ...","AZN","AstraZeneca"
"256","EU regulator recommends condition approval of Shire&#39;s chronic hypoparathyroidism medicine","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3535218","2017-02-24 07:00:00","Reuters Key Development","EU regulator recommends condition approval of Shire's chronic hypoparathyroidism medicine","AZN","AstraZeneca"
"257","Astrazeneca says U.S. FDA approves once-daily qtern for type-2 diabetes","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3537155","2017-02-28 01:51:44","Reuters Key Development","Astrazeneca says U.S. FDA approves once-daily qtern for type-2 diabetes","AZN","AstraZeneca"
"258","AstraZeneca plc&#39;s (ADR) (AZN) Roxadustat Updates from Fibrogen Call","http://smartstocknews.com/53533-astrazeneca-plcs-adr-azn-roxadustat-updates-from-fibrogen-call/","2017-03-02 12:03:45","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Bank of America Merrill Lynch provides feedback from the Fibrogen call, which has important readthrough for AstraZeneca plc's (ADR) (NYSE:AZN) roxadustat (anaemia, partnered with FBGN). Overall, BAML believes updates are positive and broadly ...","AZN","AstraZeneca"
"259","Sanofi Pasteur and Medimmune collaborate on monoclonal antibody to prevent illnesses associated with RSV","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3540287","2017-03-03 02:00:31","Reuters Key Development","Sanofi Pasteur and Medimmune collaborate on monoclonal antibody to prevent illnesses associated with RSV","AZN","AstraZeneca"
"260","AstraZeneca plc (ADR) (AZN): 5 Broad Metrics From The New Management ...","http://smartstocknews.com/70835-astrazeneca-plc-adr-azn-5-broad-metrics-from-the-new-management-remuneration-policy/","2017-03-08 12:15:00","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","In its annual report published yesterday, AstraZeneca plc (ADR) (NYSE:AZN) has outlined a new management remuneration policy, detailed below, to be put forward for a shareholder vote at the 2017 AGM.","AZN","AstraZeneca"
"261","AstraZeneca plc (ADR) (AZN) is Initiated by Liberum to “Buy”","https://www.highlandmirror.com/2017-03-09-astrazeneca-plc-adr-azn-is-initiated-by-liberum-to-buy","2017-03-09 10:00:00","Highland Mirror","AstraZeneca plc (ADR) (AZN) was Initiated by Liberum to “Buy”. Liberum advised their Clients and Investors in a research report released on Mar 9, 2017.","AZN","AstraZeneca"
"262","Stocks for your portfolio – AstraZeneca plc (ADR) (NYSE:AZN), Deere &amp; Company ...","http://www.wallstreetnews24.com/stocks-for-your-portfolio-astrazeneca-plc-adr-nyseazn-deere-company-nysede/","2017-03-13 08:45:00","Wall Street Times (press release)","AstraZeneca plc (ADR) (NYSE:AZN) traded at a yearly high level of $35.04 during the last trading session. The last session's volume of 3.93 million shares was lower than its average volume of 5.94 million shares.","AZN","AstraZeneca"
"263","AstraZeneca plc (ADR) (NYSE:AZN) Rejected Drugs To Be Reconsidered","https://marketexclusive.com/astrazeneca-plc-adr-nyseazns-rejected-drugs-reconsidered/82102/","2017-03-14 08:33:45","Market Exclusive","AstraZeneca plc (ADR) (NYSE:AZN) is reconsidering some of its rejected drugs as they could possess potential in curing a disease they were not initially meant to treat.","AZN","AstraZeneca"
"264","Here&#39;s What Just Happened With AstraZeneca plc (ADR) (NYSE:AZN), TESARO Inc ...","https://marketexclusive.com/heres-just-happened-astrazeneca-plc-adr-nyseazn-tesaro-inc-nasdaqtsro-clovis-oncology-inc-nasdaqclvs/82656/","2017-03-15 09:07:30","Market Exclusive","It's been a big week for PARP inhibitors. AstraZeneca plc (ADR) (NYSE:AZN) just put out data from a phase 3 investigation of its lead PARP asset Lynparza, and the data came out as impressive.","AZN","AstraZeneca"
"265","AstraZeneca plc (ADR) (NYSE:AZN)&#39;s Lynparza Trial Results Positive In ...","https://marketexclusive.com/astrazeneca-plc-adr-nyseazns-lynparza-trial-results-positive-competitive-threat-clovis-oncology-inc-nasdaqclvs-tesaro-inc-nasdaqtsro/82634/","2017-03-16 11:22:30","Market Exclusive","Lynparza, an ovarian cancer treatment developed by AstraZeneca plc (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression.","AZN","AstraZeneca"
"266","AstraZeneca receives FDA response to hyperkalaemia drug application","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3549671","2017-03-17 03:00:08","Reuters Key Development","AstraZeneca receives FDA response to hyperkalaemia drug application","AZN","AstraZeneca"
"267","Circassia to secure certain U.S. commercial rights to Tudorza, Duaklir from AstraZeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3549649","2017-03-17 03:00:08","Reuters Key Development","Circassia to secure certain U.S. commercial rights to Tudorza, Duaklir from AstraZeneca","AZN","AstraZeneca"
"268","Astrazeneca signs deal with Circassia over Almirall&#39;s products","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3549695","2017-03-17 03:13:44","Reuters Key Development","Astrazeneca signs deal with Circassia over Almirall's products","AZN","AstraZeneca"
"269","AstraZeneca PLC (ADR) (AZN) In Respiratory Drug Deal With Circassia ...","http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-in-respiratory-drug-deal-with-circassia-pharmaceuticals-567620/","2017-03-20 20:11:15","Insider Monkey (blog)","In an effort to enhance collaboration with Circassia Pharmaceuticals, AstraZeneca PLC (ADR) (NYSE:AZN) has acquired an equity stake valued at $50 million in the respiratory biopharmaceutical firm.","AZN","AstraZeneca"
"270","FDA Sends Complete Response Letter To AstraZeneca PLC (ADR) (AZN) Following ...","http://www.insidermonkey.com/blog/fda-sends-complete-response-letter-to-astrazeneca-plc-adr-azn-following-rejection-of-hyperkalemia-drug-568034/","2017-03-21 13:26:15","Insider Monkey (blog)","AstraZeneca PLC (ADR) (NYSE:AZN) has acknowledged the receipt of the Complete Response Letter (CRL) from the U.S. Food and Drug Administration for ZS-9, a drug designed to treat hyperkalemia.","AZN","AstraZeneca"
"271","Large Outflow of Money Witnessed in Astrazeneca PLC (AZN)","https://www.highlandmirror.com/2017-03-23-large-outflow-of-money-witnessed-in-astrazeneca-plc-azn","2017-03-23 16:48:45","Highland Mirror","AstraZeneca plc (ADR) Last issued its quarterly earnings results on Feb 2, 2017. The company reported $1.21 EPS for the quarter, beating the analyst consensus estimate by $ 0.03.","AZN","AstraZeneca"
"272","Primecap Sells NVIDIA, Microsoft, Union Pacific","http://www.nasdaq.com/article/primecap-sells-nvidia-microsoft-union-pacific-cm765340","2017-03-23 17:11:15","Nasdaq","The guru raised its shares of AstraZeneca PLC ADR ( AZN ) by 50.06% with an impact of 0.23% on the portfolio. It is a biopharmaceutical company engaged in the discovery and development of new products, which are then manufactured, marketed and sold.","AZN","AstraZeneca"
"273","AstraZeneca plc (ADR) Receives Key Lung Cancer Drug Approval In China","https://stocknews.com/news/azn-astrazeneca-plc-adr-receives-key-lung-cancer-drug-approval-in/","2017-03-25 07:15:07","StockNews.com (blog)","AstraZeneca plc (ADR) (NYSE:AZN) disclosed late Friday that a key lung cancer drug has received approval from Chinese regulators, opening up a potentially very lucrative new market in a country where millions suffer from the disease.","AZN","AstraZeneca"
"274","AstraZeneca plc (ADR) (NYSE:AZN) Tagrisso Wins Approval In China","https://marketexclusive.com/astrazeneca-tagrisso-wins-approval-china/86445/","2017-03-27 05:11:15","Market Exclusive","Tragrisso, a drug developed by AstraZeneca plc (ADR) (NYSE:AZN), has been granted approval in China. The treatment is designed to assist patients who are suffering from cancer and who have particular genetic mutations that are commonly found in the ...","AZN","AstraZeneca"
"275","Dow Jones Industrial Average Futures Plummet on Trump Doubts","http://www.schaeffersresearch.com/content/ezines/2017/03/27/dow-jones-industrial-average-futures-plummet-on-trump-doubts","2017-03-27 08:56:15","Schaeffers Research (blog)","After winning approval in China for its lung cancer drug, Tagrisso, AstraZeneca plc (ADR) (NYSE:AZN) stock is set to add 1% at the open.","AZN","AstraZeneca"
"276","AstraZeneca says U.S. FDA accepts new drug application for Lynparza","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3556798","2017-03-28 07:00:00","Reuters Key Development","AstraZeneca says U.S. FDA accepts new drug application for Lynparza","AZN","AstraZeneca"
"277","How The Market For Tesaro&#39;s Niraparib Plays Out Following Early FDA Approval","https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9223296/how-the-market-for-tesaros-niraparib-plays-out-following","2017-03-28 08:45:00","Benzinga","Nierengarten mentioned that the data from the SOLO-2 study for AstraZeneca plc (ADR) (NYSE: AZN)'s LYNPARZA in gBRCA patients revealed comparable PFS and hazard ration (HR) to niraparib's NOVA trial.","AZN","AstraZeneca"
"278","Impax announces favorable ruling regarding patent validity for Zomig Nasal Spray","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3559511","2017-03-30 16:52:00","Reuters Key Development","Impax announces favorable ruling regarding patent validity for Zomig Nasal Spray","AZN","AstraZeneca"
"279","Fibrogen wins China clearance to conduct key study testing roxadustat","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3560549","2017-03-31 07:05:00","Reuters Key Development","Fibrogen wins China clearance to conduct key study testing roxadustat","AZN","AstraZeneca"
"280","IPO News: Is This Extremely Secretive $4.7 Billion Company About to Go Public?","https://moneymorning.com/2017/03/31/ipo-news-is-this-extremely-secretive-4-7-billion-company-about-to-go-public/","2017-03-31 13:59:07","Money Morning","In 2013, this private business signed a deal for a $240 million cash payment with AstraZeneca Plc. (NYSE ADR: AZN), a biopharmaceutical company worth nearly $80 billion.","AZN","AstraZeneca"
"281","Beaufort Securities Restated “Hold” Rating For AstraZeneca PLC (LON:AZN ...","http://www.mmahotstuff.com/2017/04/03/beaufort-securities-restated-hold-rating-for-astrazeneca-plc-lonazn-findlay-park-partners-llp-has-lowered-by-52-65-million-its-accenture-plc-ireland-acn-position.html","2017-04-03 07:03:45","MoneyMakingArticles","Today, Beaufort Securities reaffirmed their “Hold” rating on AstraZeneca PLC (LON:AZN)'s stock in analysts report revealed to investors and clients.","AZN","AstraZeneca"
"282","Stocks to bet on- Citigroup Inc (NYSE:C), AstraZeneca plc (ADR) (NYSE:AZN)","http://www.wallstreetnews24.com/stocks-to-bet-on-citigroup-inc-nysec-astrazeneca-plc-adr-nyseazn/","2017-04-04 10:15:00","Wall Street Times (press release)","Citigroup Inc (NYSE:C) traded at a yearly high level of $62.53 during the last trading session. The last session's volume of 15.46 million shares was lower than its average volume of 18.28 million shares.","AZN","AstraZeneca"
"283","What is Recommendation from Analysts on: AstraZeneca plc (ADR) (NYSE:AZN)","http://postregistrar.com/2017/04/06/what-is-recommendation-from-analysts-on-astrazeneca-plc-adr-nyseazn/","2017-04-06 09:07:30","Post Registrar","AstraZeneca plc (ADR) (NYSE:AZN) fell -2.62% during previous trade. UBS issued rating on the stock of AstraZeneca plc (ADR) (NYSE:AZN) in a research note issued to investors on Apr-05-17, the stock received “Downgrade” rating from Buy to Neutral.","AZN","AstraZeneca"
"284","Anthrax And Government Contracts: PharmAthene And Altimmune Ahead Of Merger","https://www.benzinga.com/general/biotech/17/04/9258122/anthrax-and-government-contracts-pharmathene-and-altimmune-ahead-of-me","2017-04-06 15:52:30","Benzinga","This intra-nasally administered vaccine could replace AstraZeneca plc (ADR) (NYSE: AZN)'s FluMist, recently pulled from the market, as well as GlaxoSmithKline plc (ADR) (NYSE: GSK), Sanofi SA (ADR) (NYSE: SNY) and CSL's traditional flu vaccines, which ...","AZN","AstraZeneca"
"285","Stocks to bet on- AstraZeneca plc (ADR) (NYSE:AZN), Starwood Property Trust ...","http://www.wallstreetnews24.com/stocks-to-bet-on-astrazeneca-plc-adr-nyseazn-starwood-property-trust-inc-nysestwd/","2017-04-07 08:45:00","Wall Street Times (press release)","AstraZeneca plc (ADR) (NYSE:AZN) traded at a yearly high level of $35.04 during the last trading session. The last session's volume of 3.93 million shares was lower than its average volume of 4.55 million shares.","AZN","AstraZeneca"
"286","2 Stocks Are Just So Hot Right Now- AstraZeneca plc (ADR) (NYSE:AZN), Amgen ...","https://www.wallstreetnews24.com/2-stocks-are-just-so-hot-right-now-astrazeneca-plc-adr-nyseazn-amgen-inc-nasdaqamgn/","2017-04-10 08:39:06","Wall Street Times (press release)","AstraZeneca plc (ADR) (NYSE:AZN) traded at a yearly high level of $35.04 during the last trading session. The last session's volume of 7.00 million shares was higher than its average volume of 4.62 million shares.","AZN","AstraZeneca"
"287","Cardiovascular Players Could Be Eyeing Esperion","https://www.benzinga.com/general/biotech/17/04/9282574/cardiovascular-players-could-be-eyeing-esperion","2017-04-10 11:45:00","Benzinga","The Seeking Alpha author didn't speculate as to potential bidders, but, according to a PMLive report, AstraZeneca plc (ADR) (NYSE: AZN), Sanofi SA (ADR) (NYSE: SNY) and Merck & Co., Inc. (NYSE: MRK) had the highest sales of cardiovascular products in ...","AZN","AstraZeneca"
"288","Steady Stocks AstraZeneca plc (ADR) (NYSE:AZN), Zayo Group Holdings Inc (NYSE ...","http://www.journalfinance.net/2017/04/steady-stocks-astrazeneca-plc-adr-nyseazn-zayo-group-holdings-inc-nysezayo/","2017-04-11 10:37:30","Daily News Journal","On Monday, AstraZeneca plc (ADR) (NYSE:AZN) stock opened its trade at $29.88 and after floating in a range of $29.83 to $30.03, settled at $29.90.","AZN","AstraZeneca"
"289","Aralez Pharma says co and U.S. Government entered into modification of contract","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3566642","2017-04-11 16:30:00","Reuters Key Development","Aralez Pharma says co and U.S. Government entered into modification of contract","AZN","AstraZeneca"
"290","Incyte: Why This Biotech Beauty Can Stay Hot","http://www.barrons.com/articles/incyte-why-this-biotech-beauty-can-stay-hot-1491998918","2017-04-12 08:08:52","Barron's","And early stage trials are also underway pairing Incyte's drug with those from Roche (RHHBY) and AstraZeneca AZN.LN 0.6048387096774194% AstraZeneca PLC ADR U.S.: NYSE USD29.94 0.18 0.6048387096774194% /Date(1492621934171-0500)/ ...","AZN","AstraZeneca"
"291","Big Movers in the Stock Market- Coupa Software Inc (NASDAQ:COUP), AstraZeneca ...","http://www.wallstreetnews24.com/big-movers-in-the-stock-market-coupa-software-inc-nasdaqcoup-astrazeneca-plc-adr-nyseazn/","2017-04-13 08:44:17","Wall Street Times (press release)","Coupa Software Inc (NASDAQ:COUP) traded at a yearly high level of $41.61 during the last trading session. The last session's volume of 8.23 million shares was higher than its average volume of 455,224 shares.","AZN","AstraZeneca"
"292","Benchmark Cuts MoSys (NDAQ:MOSY) To “Hold”; AstraZeneca plc (ADR) (AZN) Had 12 ...","https://heraldks.com/benchmark-cuts-mosys-ndaqmosy-to-hold-astrazeneca-plc-adr-azn-had-12-analysts-last-week/","2017-04-14 07:03:45","Herald KS","Among 19 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 12 have Buy rating, 1 Sell and 6 Hold. Therefore 63% are positive.","AZN","AstraZeneca"
"293","Pictet North America Advisors Sa Trimmed Its Astrazeneca Plc (AZN) Holding ...","https://heraldks.com/pictet-north-america-advisors-sa-trimmed-its-astrazeneca-plc-azn-holding-denbury-resources-dnr-has-0-66-sentiment/","2017-04-14 16:03:45","Herald KS","Among 19 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 12 have Buy rating, 1 Sell and 6 Hold. Therefore 63% are positive.","AZN","AstraZeneca"
"294","Analysts Consensus For Secure Trust Bank (LON:STB)","http://aliveforfootball.com/2017/04/analysts-consensus-for-secure-trust-bank-lon-stb/","2017-04-17 03:43:15","Alive For Football","JP Morgan downgraded Zurich Insurance Group AG (ADR) (OTCMKTS:ZURVY) on Thursday, January 5 to ""Neutral"" rating. The stock of WH Smith Plc ... AstraZeneca plc (LON:AZN) has declined 2.51% since September 13, 2016 and is downtrending.","AZN","AstraZeneca"
"295","Active Stock News – Gold Fields Limited (ADR) (NYSE:GFI), AstraZeneca plc (ADR ...","http://www.wallstreetnews24.com/active-stock-news-gold-fields-limited-adr-nysegfi-astrazeneca-plc-adr-nyseazn/","2017-04-17 10:13:44","Wall Street Times (press release)","Gold Fields Limited (ADR) (NYSE:GFI) traded at a yearly high level of $6.60 during the last trading session. The last session's volume of 19.20 million shares was higher than its average volume of 6.58 million shares.","AZN","AstraZeneca"
"296","Steady Stocks -Mobil&#39;nye Telesistemy PAO (ADR) (NYSE:MBT), AstraZeneca plc ...","http://stocksnewstimes.com/2017/04/17/steady-stocks-mobilnye-telesistemy-pao-adr-nysembt-astrazeneca-plc-adr-nyseazn/","2017-04-17 10:25:34","Stock Watch (press release)","Mobil'nye Telesistemy PAO (ADR) (NYSE:MBT) traded 2,686,300 shares on last trading session with closing price of $10.47.","AZN","AstraZeneca"
"297","Traders Alert - AstraZeneca plc (ADR) (NYSE:AZN), Avon Products, Inc. (NYSE:AVP)","http://www.journalfinance.net/2017/04/traders-alert-astrazeneca-plc-adr-nyseazn-avon-products-inc-nyseavp/","2017-04-18 09:30:00","Daily News Journal","AstraZeneca plc (ADR) (NYSE:AZN) traded 2,574,077 shares on last trading session with closing price of $30.15. AZN was trading -9.91% below its 52-week high and 21.92% above its 52-week low.","AZN","AstraZeneca"
"298","AstraZeneca plc (ADR) (AZN) Reaches $29.68 After 9.00% Gap Down; Profile of 0 ...","http://www.mmahotstuff.com/2017/04/18/astrazeneca-plc-adr-azn-reaches-29-68-after-9-00-gap-down-profile-of-0-analysts-covering-silver-bay-realty-trust-sby.html","2017-04-18 13:03:45","MoneyMakingArticles","The stock of AstraZeneca plc (ADR) (NYSE:AZN) gapped down by $0.13 today and has $27.01 target or 9.00% below today's $29.68 share price.","AZN","AstraZeneca"
"299","Intrust Bank Na Has Cut Astrazeneca Plc (AZN) Position; Select Medical ...","https://highpointobserver.com/intrust-bank-na-has-cut-astrazeneca-plc-azn-position-select-medical-holdings-sems-sentiment-is-1-23/","2017-04-19 06:07:30","High Point Observer","Astrazeneca Plc now has $74.12B valuation. The stock decreased 1.29% or $0.39 during the last trading session, reaching $29.76. About 1,100 shares traded.","AZN","AstraZeneca"
"300","Sometimes the Road to Wealth Is Paved by Tech - and Toothpaste","https://moneymorning.com/investing/sometimes-the-road-to-wealth-is-paved-by-tech-and-toothpaste/","2017-04-19 09:30:00","Money Morning","Miels had been the head of AstraZeneca Plc.'s (NYSE ADR: AZN) European division. Walmsley made her intentions clear.","AZN","AstraZeneca"
"301","Stocks for Your Portfolio: Cardinal Health Inc (NYSE:CAH), AstraZeneca plc ...","https://www.wallstreetnews24.com/stocks-for-your-portfolio-cardinal-health-inc-nysecah-astrazeneca-plc-adr-nyseazn-dynegy-inc-nysedyn/","2017-04-19 11:14:25","Wall Street Times (press release)","Analysts gives AstraZeneca plc (ADR) (NYSE:AZN) a mean recommendation of 2.20. The company has grown 8.00% in past 3 months and in the last five trades has moved down -0.47%.","AZN","AstraZeneca"
"302","Analysts&#39; Recommendations Stocks to Track: Halliburton Company (NYSE:HAL ...","http://www.journalfinance.net/2017/04/analysts-recommendations-stocks-to-track-halliburton-company-nysehal-astrazeneca-plc-adr-nyseazn/","2017-04-19 14:22:30","Daily News Journal","On Tuesday, Shares of Halliburton Company (NYSE:HAL) lost -0.63% to $48.53. The share price is trading in a range of $48.29 - 48.95.","AZN","AstraZeneca"
"303","Trending Stocks Update: United Continental Holdings Inc (NYSE:UAL ...","https://www.wallstreetnews24.com/trending-stocks-update-united-continental-holdings-inc-nyseual-astrazeneca-plc-adr-nyseazn-vf-corp-nysevfc/","2017-04-20 11:49:41","Wall Street Times (press release)","Analysts gives AstraZeneca plc (ADR) (NYSE:AZN) a mean recommendation of 2.20. The company has grown 7.92% in past 3 months and in the last five trades has moved down -1.36%.","AZN","AstraZeneca"
"304","Eye Catching Stocks SLM Corp (NASDAQ:SLM), AstraZeneca plc (ADR) (NYSE:AZN)","http://www.journalfinance.net/2017/04/eye-catching-stocks-slm-corp-nasdaqslm-astrazeneca-plc-adr-nyseazn/","2017-04-20 14:00:00","Daily News Journal","Shares of AstraZeneca plc (ADR) (NYSE:AZN) inclined 0.03% to $29.77. Stock exchanged hands with the total volume of 1.24 Million shares, as contrast to its average volume of 4.25 Million shares.","AZN","AstraZeneca"
"305","Jefferies International Keeps a “Hold” Rating on AstraZeneca PLC (LON:AZN) and ...","https://wolcottdaily.com/jefferies-international-keeps-a-hold-rating-on-astrazeneca-plc-lonazn-and-gbx-4900-00-target-nuveen-maryland-premium-income-municipal-fund-has-1-58-sentiment/","2017-04-21 06:07:30","Wolcott Daily","About 839,219 shares traded. AstraZeneca plc (LON:AZN) has declined 9.31% since September 21, 2016 and is downtrending. It has underperformed by 20.13% the S&P500.","AZN","AstraZeneca"
"306","AstraZeneca, Valeant, Mattel Downgraded","http://www.schaeffersresearch.com/content/news/2017/04/21/astrazeneca-valeant-mattel-downgraded","2017-04-21 09:52:30","Schaeffers Research (blog)","Analysts are weighing in on drugmakers AstraZeneca plc (ADR) (NYSE:AZN) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX), as well as toy stock Mattel, Inc. (NASDAQ:MAT).","AZN","AstraZeneca"
"307","AstraZeneca plc (ADR) (AZN) EPS Estimated At $0.32, Smartfinancial (SMBK ...","https://normanobserver.com/astrazeneca-plc-adr-azn-eps-estimated-at-0-32-smartfinancial-smbk-shorts-down-by-14-1/","2017-04-21 11:00:00","NormanObserver.com","Analysts expect AstraZeneca plc (ADR) (NYSE:AZN) to report $0.32 EPS on May, 5.They anticipate $0.63 EPS change or 66.32% from last quarter's $0.95 EPS.","AZN","AstraZeneca"
"308","Investor&#39;s Watch List - AstraZeneca plc (ADR) (NYSE:AZN), Colgate-Palmolive ...","http://stocksnewstimes.com/2017/04/21/investors-watch-list-astrazeneca-plc-adr-nyseazn-colgate-palmolive-company-nysecl/","2017-04-21 11:22:11","Stock Watch (press release)","AstraZeneca plc (ADR) (NYSE:AZN) traded 3,179,855 shares on last trading session with closing price of $29.90. AZN was trading -10.66% below its 52-week high and 20.91% above its 52-week low.","AZN","AstraZeneca"
"309","Gilead Sciences Inc announces data for investigational, all-oral, pan-genotypic three-drug regimen of sofosbuvir, GS-5816 and GS-9857 for chronic hepatitis C","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3197585","2015-04-23 01:00:00","Reuters Key Development","Gilead Sciences Inc announces data for investigational, all-oral, pan-genotypic three-drug regimen of sofosbuvir, GS-5816 and GS-9857 for chronic hepatitis C","GILD"," Gilead"
"310","Gilead Sciences Inc raises FY 2015 product sales guidance","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3204618","2015-04-30 16:01:00","Reuters Key Development","Gilead Sciences Inc raises FY 2015 product sales guidance","GILD"," Gilead"
"311","Gilead Sciences Inc declares quarterly cash dividend","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3204599","2015-04-30 16:02:00","Reuters Key Development","Gilead Sciences Inc declares quarterly cash dividend","GILD"," Gilead"
"312","Gilead Sciences acquires EpiTherapeutics","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3207223","2015-05-06 08:30:00","Reuters Key Development","Gilead Sciences acquires EpiTherapeutics","GILD"," Gilead"
"313","China rejects Gilead Sciences Inc&#39;s hepatitis C drug patent -advocacy group - Reuters","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3232224","2015-06-18 20:00:00","Reuters Key Development","China rejects Gilead Sciences Inc's hepatitis C drug patent -advocacy group - Reuters","GILD"," Gilead"
"314","Gilead Sciences Inc submits new drug application to U.S. FDA for single tablet regimen for HIV containing rilpivirine","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3238458","2015-07-01 16:30:00","Reuters Key Development","Gilead Sciences Inc submits new drug application to U.S. FDA for single tablet regimen for HIV containing rilpivirine","GILD"," Gilead"
"315","Gilead Sciences Inc raises FY 2015 product sales guidance","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3251798","2015-07-28 16:01:00","Reuters Key Development","Gilead Sciences Inc raises FY 2015 product sales guidance","GILD"," Gilead"
"316","Gilead Sciences declares cash dividend","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3251807","2015-07-28 16:02:00","Reuters Key Development","Gilead Sciences declares cash dividend","GILD"," Gilead"
"317","Gilead Sciences prices $10 billion of senior unsecured notes","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3271546","2015-09-09 20:57:00","Reuters Key Development","Gilead Sciences prices $10 billion of senior unsecured notes","GILD"," Gilead"
"318","European CHMP adopts positive opinion for Gilead Inc&#39;s single tablet regimen Genvoya","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3277669","2015-09-25 07:33:00","Reuters Key Development","European CHMP adopts positive opinion for Gilead Inc's single tablet regimen Genvoya","GILD"," Gilead"
"319","Gilead Sciences Inc says FDA approves new treatment combination of Gilead&#39;s pulmonary arterial hypertension drug","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3280778","2015-10-02 18:19:00","Reuters Key Development","Gilead Sciences Inc says FDA approves new treatment combination of Gilead's pulmonary arterial hypertension drug","GILD"," Gilead"
"320","Gilead Sciences Inc announces Phase 3 results for Genvoya","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3288636","2015-10-22 07:33:00","Reuters Key Development","Gilead Sciences Inc announces Phase 3 results for Genvoya","GILD"," Gilead"
"321","Gilead Sciences Inc raises FY 2015 product sales guidance","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3291069","2015-10-27 16:00:00","Reuters Key Development","Gilead Sciences Inc raises FY 2015 product sales guidance","GILD"," Gilead"
"322","Gilead Sciences Inc submits NDA to U.S. FDA for fixed-dose combination of sofosbuvir/velpatasvir for treatment of all six genotypes of hepatitis C","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3291992","2015-10-28 17:52:00","Reuters Key Development","Gilead Sciences Inc submits NDA to U.S. FDA for fixed-dose combination of sofosbuvir/velpatasvir for treatment of all six genotypes of hepatitis C","GILD"," Gilead"
"323","Gilead Sciences and WuXi PharmaTech announce collaboration for dedicated analytical and stability testing facility","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3293221","2015-10-29 22:00:00","Reuters Key Development","Gilead Sciences and WuXi PharmaTech announce collaboration for dedicated analytical and stability testing facility","GILD"," Gilead"
"324","Gilead Sciences, Inc says U.S. FDA approves it&#39;s single tablet regimen Genvoya for treatment of HIV-1 infection","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3296563","2015-11-05 12:47:00","Reuters Key Development","Gilead Sciences, Inc says U.S. FDA approves it's single tablet regimen Genvoya for treatment of HIV-1 infection","GILD"," Gilead"
"325","Gilead Sciences Inc announces top-line results from two phase 3 studies evaluating tenofovir alafenamide","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3317720","2016-01-05 08:30:00","Reuters Key Development","Gilead Sciences Inc announces top-line results from two phase 3 studies evaluating tenofovir alafenamide","GILD"," Gilead"
"326","Gilead Sciences Inc submits new drug application for the treatment of chronic hepatitis B","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3319660","2016-01-12 08:30:00","Reuters Key Development","Gilead Sciences Inc submits new drug application for the treatment of chronic hepatitis B","GILD"," Gilead"
"327","Gilead and Galapagos global partnership cleared by U.S. Federal Trade Commission; Gilead to make equity investment in Galapagos","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3320019","2016-01-13 01:42:00","Reuters Key Development","Gilead and Galapagos global partnership cleared by U.S. Federal Trade Commission; Gilead to make equity investment in Galapagos","GILD"," Gilead"
"328","Gilead holds 14.75% of Galapagos shares<U+200B>","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3323408","2016-01-25 01:30:00","Reuters Key Development","Gilead holds 14.75% of Galapagos shares<U+200B>","GILD"," Gilead"
"329","Gilead Sciences Inc&#39;s John C. Martin to assume role of Executive Chairman of the Board","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3326041","2016-01-29 08:00:00","Reuters Key Development","Gilead Sciences Inc's John C. Martin to assume role of Executive Chairman of the Board","GILD"," Gilead"
"330","Gilead Sciences announces declaration of Q1 cash dividend and increases to shareholder return programs","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3327627","2016-02-02 16:01:00","Reuters Key Development","Gilead Sciences announces declaration of Q1 cash dividend and increases to shareholder return programs","GILD"," Gilead"
"331","Gilead Sciences says FDA approves two supplemental indications for Harvoni in chronic Hep C patients","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3332038","2016-02-16 08:30:00","Reuters Key Development","Gilead Sciences says FDA approves two supplemental indications for Harvoni in chronic Hep C patients","GILD"," Gilead"
"332","Gilead Sciences Inc says FDA approves Descovy","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3352851","2016-04-04 14:57:00","Reuters Key Development","Gilead Sciences Inc says FDA approves Descovy","GILD"," Gilead"
"333","Gilead Sciences Inc reiterates FY 2016 guidance","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3365729","2016-04-28 16:01:00","Reuters Key Development","Gilead Sciences Inc reiterates FY 2016 guidance","GILD"," Gilead"
"334","Gilead Sciences, Inc announces quarterly dividend","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3364854","2016-04-28 16:02:00","Reuters Key Development","Gilead Sciences, Inc announces quarterly dividend","GILD"," Gilead"
"335","Galapagos listing of existing shares on Euronext Brussels &amp; Amsterdam","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3376436","2016-05-17 01:05:41","Reuters Key Development","Galapagos listing of existing shares on Euronext Brussels & Amsterdam","GILD"," Gilead"
"336","Galapagos says completed end-of-Phase 2 FDA and EMA consultations in rheumatoid arthritis","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3380837","2016-05-24 16:09:45","Reuters Key Development","Galapagos says completed end-of-Phase 2 FDA and EMA consultations in rheumatoid arthritis","GILD"," Gilead"
"337","Gilead Sciences appoints Kevin Young as COO","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3380848","2016-05-24 16:30:00","Reuters Key Development","Gilead Sciences appoints Kevin Young as COO","GILD"," Gilead"
"338","Gilead says European Commission grants marketing authorization for Odefsey®","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3395263","2016-06-23 07:53:00","Reuters Key Development","Gilead says European Commission grants marketing authorization for Odefsey®","GILD"," Gilead"
"339","Diplomat Pharmacy says to dispense epclusa for treatment of chronic Hepatitis C","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3397233","2016-06-28 16:30:00","Reuters Key Development","Diplomat Pharmacy says to dispense epclusa for treatment of chronic Hepatitis C","GILD"," Gilead"
"340","Ligand enters into Omniab platform license agreement with Gilead Sciences","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3402421","2016-07-08 09:00:00","Reuters Key Development","Ligand enters into Omniab platform license agreement with Gilead Sciences","GILD"," Gilead"
"341","Gilead&#39;s Odefsey meets primary objective in phase 3B studies","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3409438","2016-07-21 16:30:00","Reuters Key Development","Gilead's Odefsey meets primary objective in phase 3B studies","GILD"," Gilead"
"342","EMA adopts positive opinion on expanded approval of Gilead&#39;s HIV drug, Truvada","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3410011","2016-07-22 07:17:00","Reuters Key Development","EMA adopts positive opinion on expanded approval of Gilead's HIV drug, Truvada","GILD"," Gilead"
"343","Gilead Sciences Q2 non-GAAP earnings per share $3.08","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3410919","2016-07-25 16:08:00","Reuters Key Development","Gilead Sciences Q2 non-GAAP earnings per share $3.08","GILD"," Gilead"
"344","Gilead Sciences sets qtrly dividend of $0.47 per share","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3410920","2016-07-25 16:10:00","Reuters Key Development","Gilead Sciences sets qtrly dividend of $0.47 per share","GILD"," Gilead"
"345","BRIEF-Massachusetts attorney general&#39;s office notifies Gilead of decision to suspend co&#39;s obligations under CID until further notice","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3420629","2016-08-05 17:05:06","Reuters Key Development","BRIEF-Massachusetts attorney general's office notifies Gilead of decision to suspend co's obligations under CID until further notice","GILD"," Gilead"
"346","Genmab enters commercial license agreement with Gilead for DuoBody(R)Technology","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3423528","2016-08-10 13:07:11","Reuters Key Development","Genmab enters commercial license agreement with Gilead for DuoBody(R)Technology","GILD"," Gilead"
"347","Gilead Sciences prices $5 bln of senior unsecured notes","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3441667","2016-09-15 22:01:00","Reuters Key Development","Gilead Sciences prices $5 bln of senior unsecured notes","GILD"," Gilead"
"348","Gilead terminates phase 2/3 study of GS-5745 in patients with Ulcerative Colitis","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3443702","2016-09-21 17:00:00","Reuters Key Development","Gilead terminates phase 2/3 study of GS-5745 in patients with Ulcerative Colitis","GILD"," Gilead"
"349","Gilead sciences, WHO announce 5-year visceral leishmaniasis collaboration","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3445934","2016-09-27 16:05:00","Reuters Key Development","Gilead sciences, WHO announce 5-year visceral leishmaniasis collaboration","GILD"," Gilead"
"350","Galapagos Q3 net result turns to 8.1 mln euro profit","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3463978","2016-10-28 01:55:18","Reuters Key Development","Galapagos Q3 net result turns to 8.1 mln euro profit","GILD"," Gilead"
"351","Gilead Q3 earnings per share $2.49","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3467065","2016-11-01 16:01:00","Reuters Key Development","Gilead Q3 earnings per share $2.49","GILD"," Gilead"
"352","Gilead - data for combination of selonsertib, gs-9674 in rodent model of advanced fibrosis resulted in greater anti-fibrotic activity than either agent alone","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3478118","2016-11-14 16:30:00","Reuters Key Development","Gilead - data for combination of selonsertib, gs-9674 in rodent model of advanced fibrosis resulted in greater anti-fibrotic activity than either agent alone","GILD"," Gilead"
"353","GlobeImmune announces updates","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3481082","2016-11-17 17:49:06","Reuters Key Development","GlobeImmune announces updates","GILD"," Gilead"
"354","EMA says patients treated with direct-acting antivirals for hepatitis C may be at risk of hepatitis B re-activation","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3489298","2016-12-02 10:06:49","Reuters Key Development","EMA says patients treated with direct-acting antivirals for hepatitis C may be at risk of hepatitis B re-activation","GILD"," Gilead"
"355","Gilead Sciences submits new drug application to U.S. FDA for Hepatitis C","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3492215","2016-12-08 08:11:00","Reuters Key Development","Gilead Sciences submits new drug application to U.S. FDA for Hepatitis C","GILD"," Gilead"
"356","Gilead says Japan&#39;s Ministry of Health, Labour and Welfare approves co&#39;s Vemlidy for patients with chronic Hepatitis B virus infection","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3497125","2016-12-19 02:03:00","Reuters Key Development","Gilead says Japan's Ministry of Health, Labour and Welfare approves co's Vemlidy for patients with chronic Hepatitis B virus infection","GILD"," Gilead"
"357","Gilead COO says slowdown in patients starting hep C therapies to continue in 2017","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3505956","2017-01-09 14:40:00","Reuters Key Development","Gilead COO says slowdown in patients starting hep C therapies to continue in 2017","GILD"," Gilead"
"358","Gilead Sciences reports Q4 earnings per share $2.34","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3522142","2017-02-07 16:01:00","Reuters Key Development","Gilead Sciences reports Q4 earnings per share $2.34","GILD"," Gilead"
"359","Gilead Sciences sets quarterly dividend of $0.52 per share","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3522141","2017-02-07 16:02:00","Reuters Key Development","Gilead Sciences sets quarterly dividend of $0.52 per share","GILD"," Gilead"
"360","AMYGDALA NEUROSCIENCES ACQUIRES GS-6637 FROM GILEAD SCIENCES","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3529598","2017-02-16 10:03:00","Reuters Key Development","AMYGDALA NEUROSCIENCES ACQUIRES GS-6637 FROM GILEAD SCIENCES","GILD"," Gilead"
"361","Gilead receives approval in Canada for Odefsey for treatment of HIV-1 infection","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3529632","2017-02-16 11:30:00","Reuters Key Development","Gilead receives approval in Canada for Odefsey for treatment of HIV-1 infection","GILD"," Gilead"
"362","Gilead Sciences Canada says Ontario to list Epclusa on public drug plan to treat all six genotypes of chronic Hepatitis C infection","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3533070","2017-02-22 11:36:00","Reuters Key Development","Gilead Sciences Canada says Ontario to list Epclusa on public drug plan to treat all six genotypes of chronic Hepatitis C infection","GILD"," Gilead"
"363","Galapagos announces two Phase 2 studies with filgotinib in small bowel and fistulizing Crohn&#39;s disease","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3544574","2017-03-10 01:30:11","Reuters Key Development","Galapagos announces two Phase 2 studies with filgotinib in small bowel and fistulizing Crohn's disease","GILD"," Gilead"
"364","Gilead Sciences says EPCLUSA added to Liste des médicaments de la RAMQ","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3551077","2017-03-20 12:25:00","Reuters Key Development","Gilead Sciences says EPCLUSA added to Liste des médicaments de la RAMQ","GILD"," Gilead"
"365","Gilead Sciences lists EPCLUSA on public drug plan to treat chronic hepatitis C infection","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3552171","2017-03-21 16:00:00","Reuters Key Development","Gilead Sciences lists EPCLUSA on public drug plan to treat chronic hepatitis C infection","GILD"," Gilead"
"366","Gilead Doesn&#39;t Offer A Compelling Risk/Reward","https://seekingalpha.com/article/4057431-gilead-offer-compelling-risk-reward","2017-03-23 09:52:30","Seeking Alpha","Thus, in this article, I will focus on a quantitative valuation of the company using a DCF analysis and without taking into account any potential M&A that Gilead could announce in 2017, which looks unpredictable, to assess if the market has already ...","GILD"," Gilead"
"367","Gilead Sciences Inc Risk Points versus Health Care","http://news.cmlviz.com/2017/03/23/gilead-sciences-inc-risk-points-versus-health-care.html","2017-03-23 19:15:00","CML News","This is a scatter plot analysis of the critical risk points from the option market for Gilead Sciences Inc (NASDAQ:GILD) compared to its own past and the Health Care ETF.","GILD"," Gilead"
"368","The Best-Case Scenario for Gilead Sciences, Inc.","https://www.fool.com/investing/2017/03/24/the-best-case-scenario-for-gilead-sciences-inc.aspx","2017-03-24 08:00:00","Motley Fool","Gilead Sciences surprised many observers with a dismal outlook for hepatitis C virus (HCV) drug sales in 2017. The company hasn't been able to answer an all-important question: When will HCV sales stabilize? I don't know the answer to that question ...","GILD"," Gilead"
"369","No More Ambiguity, Gilead Sciences, Inc. (GILD) And Its Chart Is Now Crystal Clear","http://nystocknews.com/2017/03/24/no-more-ambiguity-gilead-sciences-inc-gild-and-its-chart-is-now-crystal-clear/","2017-03-24 11:33:45","NY Stock News","The technicals for Gilead Sciences, Inc. (GILD) has spoken via its technical chart and the message is loud and clear.","GILD"," Gilead"
"370","Better Buy: Celgene Corporation vs. Gilead Sciences","https://www.fool.com/investing/2017/03/27/better-buy-celgene-corporation-vs-gilead-science-2.aspx","2017-03-27 09:41:15","Motley Fool","In the other corner stands Gilead Sciences, Inc. (NASDAQ:GILD), an antiviral heavyweight that may be past its prime.","GILD"," Gilead"
"371","Humanitarian groups still after Gilead&#39;s sofosbuvir patent","https://seekingalpha.com/news/3253596-humanitarian-groups-still-gileads-sofosbuvir-patent","2017-03-27 11:33:45","Seeking Alpha","With the aim of increasing patient access to treatment, humanitarian groups Medecins Sans Frontieres and Medecins du Monde have launched a new challenge to the patent covering Gilead Sciences' (GILD +0.2%) sofosbuvir. The two organizations, together ...","GILD"," Gilead"
"372","Jonathon Jacobson&#39;s 4Q Investment Spotlight: Tesla Inc (TSLA), Gilead Sciences ...","https://www.smarteranalyst.com/2017/03/27/jonathan-jacobsons-4q-investment-spotlight-tesla-inc-tsla-gilead-sciences-inc-gild/","2017-03-27 11:47:40","Smarter Analyst","By examining 13F forms filed with the SEC we can see that in Q4 Jacobson boosted the fund's positions in controversial automaker Tesla Inc (NASDAQ:TSLA) and healthcare giant Gilead Sciences, Inc. (NASDAQ:GILD). Jacobson himself has a traditionally ...","GILD"," Gilead"
"373","Gilead Sciences CEO John Milligan&#39;s 2016 total compensation was $13.9 mln- SEC Filing","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3556104","2017-03-27 17:36:23","Reuters Key Development","Gilead Sciences CEO John Milligan's 2016 total compensation was $13.9 mln- SEC Filing","GILD"," Gilead"
"374","Has Gilead Sciences Lost Its Way?","https://www.fool.com/investing/2017/03/30/has-gilead-sciences-lost-its-way.aspx","2017-03-30 10:37:30","Motley Fool","Since John Milligan took over as the CEO of Gilead Sciences (NASDAQ:GILD) roughly one year ago, the biotech's shares have steadily marched lower to the tune of a 24% decline.","GILD"," Gilead"
"375","6 Reasons Gilead Sciences Could Be the World&#39;s Most Perfect Stock","https://www.fool.com/investing/2017/04/03/6-reasons-gilead-sciences-could-be-the-worlds-most.aspx","2017-04-03 12:52:30","Motley Fool","It's been a less-than-stellar year for biotech blue chip Gilead Sciences (NASDAQ:GILD). The company's stock has been mired in a pretty steady downtrend since June 2015, and, over the trailing 12 months, it's off an unsightly 26%.","GILD"," Gilead"
"376","Estimating the intrinsic value of Gilead Sciences Inc (GILD)","https://simplywall.st/news/2017/04/04/estimating-the-intrinsic-value-of-gilead-sciences-inc-gild-2/","2017-04-04 07:02:09","Simply Wall St","Does the April share price for Gilead Sciences (NASDAQ:GILD) reflect its intrinsic value? I am going to calculate it now using a method called discounted cash flow or DCF.","GILD"," Gilead"
"377","Gilead Sciences: The Company Did Exactly As Promised","https://seekingalpha.com/article/4060110-gilead-sciences-company-exactly-promised","2017-04-04 09:43:53","Seeking Alpha","Gilead (NASDAQ:GILD) has been under fire from investors in recent years due to poor performance of its stock. The company invented a cure for hepatitis C, which helped millions of people around the world. Because hepatitis C patients who are cured do ...","GILD"," Gilead"
"378","The Technical Chart For Gilead Sciences, Inc. (GILD) Has Spoken","http://nystocknews.com/2017/04/04/the-technical-chart-for-gilead-sciences-inc-gild-has-spoken/","2017-04-04 10:37:30","NY Stock News","Gilead Sciences, Inc. (GILD) has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.","GILD"," Gilead"
"379","Gilead: Don&#39;t Buy It Based On Sjogren&#39;s Syndrome","https://seekingalpha.com/article/4060424-gilead-buy-based-sjogrens-syndrome","2017-04-05 10:15:00","Seeking Alpha","Six months ago I wrote an article on Gilead (NASDAQ:GILD) that investors should expect that the company will focus on its pipeline rather than M&A.","GILD"," Gilead"
"380","Gilead Will Create Significant Shareholder Wealth","https://seekingalpha.com/article/4060538-gilead-will-create-significant-shareholder-wealth","2017-04-05 16:09:40","Seeking Alpha","Gilead Sciences (NASDAQ:GILD) has wandered back down into the $60s territory, which offers what I view as a strong buy opportunity for value investors.","GILD"," Gilead"
"381","Jefferies on Gilead Sciences, Inc. (GILD) and Vertex Pharmaceuticals ...","http://smartstocknews.com/34202-jefferies-on-gilead-sciences-inc-gild-and-vertex-pharmaceuticals-incorporated-vrtx/","2017-04-06 14:33:45","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","With Gilead Sciences, Inc's. (NASDAQ:GILD) Harvoni Rx's tracking at least in line for 1Q (JEF $1.36B vs. cons.","GILD"," Gilead"
"382","FDA approves two of Gilead&#39;s hepatitis C drugs for pediatric patients","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3564610","2017-04-07 10:11:00","Reuters Key Development","FDA approves two of Gilead's hepatitis C drugs for pediatric patients","GILD"," Gilead"
"383","FDA Approves Expanded Indications for Gilead Sciences, Inc. (GILD) Harvoni and ...","https://www.smarteranalyst.com/2017/04/07/fda-approves-expanded-indications-gilead-sciences-inc-gild-harvoni-sovaldi/","2017-04-07 11:16:42","Smarter Analyst","Gilead Sciences, Inc. (NASDAQ:GILD) announced that the FDA has approved supplemental indications for Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) tablets and Sovaldi® (sofosbuvir 400 mg) tablets for the treatment of chronic hepatitis C virus (HCV) ...","GILD"," Gilead"
"384","Gilead: Taking The LEAP","https://seekingalpha.com/article/4061147-gilead-taking-leap","2017-04-07 15:41:15","Seeking Alpha","I have primarily been a Gilead (NASDAQ:GILD) investor and commentator, rather than a trader, over the last several years. ... This article explains my thinking behind my recent minor foray into Gilead LEAPS (Long Term Equity Anticipation Securities).","GILD"," Gilead"
"385","Jefferies Thinks 3 Red-Hot Biotech Stocks Can Beat Q1 Estimates","http://247wallst.com/healthcare-business/2017/04/10/jefferies-thinks-3-red-hot-biotech-stocks-can-beat-q1-estimates/","2017-04-10 09:41:15","24/7 Wall St.","Gilead Sciences Inc. (NASDAQ: GILD) discovers, develops and commercializes medicines in areas of unmet medical need in North America, South America, Europe and the Asia-Pacific.","GILD"," Gilead"
"386","Gilead: The ContraVir Call Option","https://seekingalpha.com/article/4061453-gilead-contravir-call-option","2017-04-10 12:34:03","Seeking Alpha","Gilead Sciences (NASDAQ:GILD) has been a beacon of hope for individuals with life threatening viruses such has Hepatitis C or AIDS.","GILD"," Gilead"
"387","ANTIPODES PARTNERS Ltd Buys United States Natural Gas Fund LP, Gilead Sciences ...","http://www.nasdaq.com/article/antipodes-partners-ltd-buys-united-states-natural-gas-fund-lp-gilead-sciences-baidu-cm773049","2017-04-11 08:33:45","Nasdaq","ANTIPODES PARTNERS Ltd added to the holdings in Gilead Sciences Inc by 23.41%. The purchase prices were between $65.59 and $76.38, with an estimated average price of $70.32.","GILD"," Gilead"
"388","The Charts For Gilead Sciences, Inc. (GILD) Is Attracting Massive Attention","http://nystocknews.com/2017/04/11/the-charts-for-gilead-sciences-inc-gild-is-attracting-massive-attention/","2017-04-11 12:52:30","NY Stock News","The technicals for Gilead Sciences, Inc. (GILD) have taken shape, and with them a comprehensive picture has emerged.","GILD"," Gilead"
"389","Throwing In The Towel On Gilead","https://seekingalpha.com/article/4061821-throwing-towel-gilead","2017-04-11 17:11:15","Seeking Alpha","The contributing factors were poor guidance, management sales, and a lack of a needle-moving acquisition. In this article, I will be going over why I finally threw in the towel on shares of Gilead (NASDAQ:GILD) after being long and bullish on the stock ...","GILD"," Gilead"
"390","Dodge &amp; Cox Purchases New Position in Gilead Sciences, Inc. (GILD)","https://www.thecerbatgem.com/2017/04/16/dodge-cox-purchases-new-position-in-gilead-sciences-inc-gild.html","2017-04-12 10:26:15","The Cerbat Gem","Gilead Sciences logo Dodge & Cox purchased a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD) during the fourth quarter, according to its most recent disclosure with the SEC.","GILD"," Gilead"
"391","Gilead Sciences, Inc. (GILD) And The Naked Truth Exposed In Its Technicals","http://nystocknews.com/2017/04/12/gilead-sciences-inc-gild-and-the-naked-truth-exposed-in-its-technicals/","2017-04-12 13:03:45","NY Stock News","Gilead Sciences, Inc. (GILD) has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.","GILD"," Gilead"
"392","Another motive To buy these stock: Oracle Corporation (ORCL), Gilead Sciences ...","http://stocknewsjournal.com/2017/04/13/another-motive-to-buy-these-stock-oracle-corporation-orcl-gilead-sciences-inc-gild/","2017-04-13 08:00:00","StockNewsJournal","Oracle Corporation (NYSE:ORCL) market capitalization at present is $181.34B at the rate of $44.18 a share. The firm's price-to-sales ratio was noted 4.86 in contrast with an overall industry average of 289.39.","GILD"," Gilead"
"393","Gilead Sciences Inc. Posted gains of 0.3% in the Last Trade","http://www.freeobserver.com/gilead-sciences-inc-posted-gains-of-0-3-in-the-last-trade/","2017-04-13 08:45:00","Free Observer","Currently, the market capitalization of Gilead Sciences Inc. (GILD) is 86.57 Billion. GILD has a 1-year high price of $ 100.48 and 1-year low price of $64.88.","GILD"," Gilead"
"394","First PREMIER Bank Buys Enbridge, Pfizer, Gilead Sciences, Sells CSX, Spectra ...","http://www.nasdaq.com/article/first-premier-bank-buys-enbridge-pfizer-gilead-sciences-sells-csx-spectra-energy-alerian-mlp-cm773776","2017-04-13 10:48:45","Nasdaq","First PREMIER Bank initiated holdings in Enbridge Inc. The purchase prices were between $40.31 and $44.37, with an estimated average price of $42.25.","GILD"," Gilead"
"395","Gilead Sciences, Inc. (GILD) Exposed Via Its Technical Chart","http://nystocknews.com/2017/04/13/gilead-sciences-inc-gild-exposed-via-its-technical-chart-2/","2017-04-13 11:56:15","NY Stock News","Gilead Sciences, Inc. (GILD) is now trading with a very clear set of technicals. Taken together they paint a very compelling picture of how investors and traders should be approaching GILD.","GILD"," Gilead"
"396","Selling Fear: Why Gilead Puts Look Good","https://seekingalpha.com/article/4062280-selling-fear-gilead-puts-look-good","2017-04-13 12:02:24","Seeking Alpha","The Market Fear Index (the VIX) has spiked (relatively speaking) over the last several trading days, and we believe it presents an outstanding opportunity to pick up some extra income.","GILD"," Gilead"
"397","Gilead And Intellia Therapeutics A Natural Fit","https://seekingalpha.com/article/4062328-gilead-intellia-therapeutics-natural-fit","2017-04-13 14:56:15","Seeking Alpha","There has been no shortage of analysts, investors, and arm-chair quarterbacks weighing in on what Gilead Sciences (NASDAQ:GILD) should do to spur revenue growth and strengthen their pipeline.","GILD"," Gilead"
"398","Edge Wealth Management LLC Buys Gilead Sciences, Qualcomm, Apollo Commercial ...","http://www.nasdaq.com/article/edge-wealth-management-llc-buys-gilead-sciences-qualcomm-apollo-commercial-real-estate-cm773988","2017-04-13 14:56:15","Nasdaq","Edge Wealth Management LLC initiated holdings in CYS Investments Inc. The purchase prices were between $7.46 and $8.02, with an estimated average price of $7.83.","GILD"," Gilead"
"399","Everything You Need to Know Ahead of Gilead Sciences, Inc. (GILD) Q1:17 Earnings","https://www.smarteranalyst.com/2017/04/13/everything-need-know-ahead-gilead-sciences-inc-gild-q117-earnings/","2017-04-13 16:26:15","Smarter Analyst","Gilead Sciences, Inc. (NASDAQ:GILD) hepatitis C franchise will again be in the spotlight when the pharmaceutical giant reports first-quarter earnings, scheduled for May 2, after the markets close.","GILD"," Gilead"
"400","3 Biotech Stocks to Buy on Sale","https://www.fool.com/investing/2017/04/15/3-biotech-stocks-to-buy-on-sale.aspx","2017-04-15 11:56:15","Motley Fool","Luckily, you can still find a variety of companies in the biotech industry with under-appreciated potential. Investors seeking a well established company with steady profits will want to take a closer look at Gilead Sciences, Inc. (NASDAQ:GILD). Those ...","GILD"," Gilead"
"401","Gilead Sciences&#39; (GILD) &quot;Overweight&quot; Rating Reiterated at JPMorgan Chase &amp; Co.","https://www.thecerbatgem.com/2017/04/20/gilead-sciences-inc-gild-receives-overweight-rating-from-jpmorgan-chase-co-updated.html","2017-04-16 06:41:15","The Cerbat Gem","Gilead Sciences, Inc. logo JPMorgan Chase & Co. reaffirmed their overweight rating on shares of Gilead Sciences, Inc. (NASDAQ:GILD) in a research report report published on Thursday morning. JPMorgan Chase & Co. currently has a $82.00 price target on ...","GILD"," Gilead"
"402","Gilead Sciences, Inc. (GILD) Makes It Very Clear Through These Technicals","http://nystocknews.com/2017/04/17/gilead-sciences-inc-gild-makes-it-very-clear-through-these-technicals-2/","2017-04-17 08:33:45","NY Stock News","The technicals for Gilead Sciences, Inc. (GILD) has spoken via its technical chart and the message is loud and clear.","GILD"," Gilead"
"403","BofAML on Gilead Sciences, Inc. (NASDAQ:GILD)","http://www.smartstocknews.com/82098-bofaml-on-gilead-sciences-inc-nasdaqgild/","2017-04-17 13:55:52","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","2,265 new patients started HCV therapies with Gilead Sciences, Inc's (NASDAQ:GILD) products (Sovaldi/ Harvoni/ Epclusa) in the week ending April 7th, down 2.2% from the previous week.","GILD"," Gilead"
"404","Here&#39;s How Gilead Sciences, Inc. (NASDAQ:GILD) Will Make a Comeback","https://www.libraryforsmartinvestors.com/2017/04/heres-gilead-sciences-inc-nasdaqgild-will-make-comeback/41370764.htm","2017-04-18 08:13:12","Library For Smart Investors","Gilead Sciences, Inc. (NASDAQ:GILD) has the biggest market share in the HIV drugs industry. The company reported a total sales of about $12.8 billion in 2016 from its 8 HIV treatments.","GILD"," Gilead"
"405","Moving Stocks: Gilead Sciences Inc. (GILD), Sabre Corporation (SABR)","https://topchronicle.com/moving-stocks-gilead-sciences-inc-gild-sabre-corporation-sabr/","2017-04-18 13:03:45","TopChronicle","Gilead Sciences Inc. (GILD) is currently trading with the volume of 3.6 Million. The Stock opened today's session at $66.59 and currently the price is hovering at $65.73 by showing decrease of -1.45 percent.","GILD"," Gilead"
"406","Commit To Buy Gilead Sciences At $35, Earn 2.7% Using Options","http://www.nasdaq.com/article/commit-to-buy-gilead-sciences-at-35-earn-27-using-options-cm775442","2017-04-18 14:00:00","Nasdaq","Investors considering a purchase of Gilead Sciences, Inc. (Symbol: GILD) stock, but cautious about paying the going market price of $66.08/share, might benefit from considering selling puts among the alternative strategies at their disposal.","GILD"," Gilead"
"407","Who&#39;s Better Pharma Dividend Stock: Gilead Sciences, Inc. (GILD) or AbbVie Inc ...","https://www.smarteranalyst.com/2017/04/18/whos-better-pharma-dividend-stock-gilead-sciences-inc-gild-abbvie-inc-abbv/","2017-04-18 16:03:45","Smarter Analyst","For example, Gilead Sciences, Inc. (NASDAQ:GILD) and AbbVie Inc (NYSE:ABBV) both currently sport above-average dividend yields.","GILD"," Gilead"
"408","Biotech Stocks on Investors&#39; Radar -- Gilead Sciences, Aurinia Pharma, Mast ...","http://www.prnewswire.com/news-releases/biotech-stocks-on-investors-radar----gilead-sciences-aurinia-pharma-mast-therapeutics-and-novavax-619808333.html","2017-04-19 06:07:30"," Gilead Sciences, Aurinia Pharma, Mast ...","Stock-Callers.com today has initiated reports coverage on Gilead Sciences Inc. (NASDAQ: GILD), Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), Mast Therapeutics Inc. (NYSEMKT: MSTX), and Novavax Inc. (NASDAQ: NVAX).","GILD"," Gilead"
"409","Gilead Sciences, Inc.&#39;s (GILD) stock price is Presently Worth at $66.06 while ...","http://www.hotstockspoint.com/gilead-sciences-inc-s-gild-stock-price-is-presently-worth-at-66-06-while-ends-tuesday-with-move-of-0-96/","2017-04-19 06:07:30","Hot Stocks Point","Gilead Sciences, Inc. (GILD) ended its day with loss -0.96% and finalized at the price of $66.06. During its last trading session, Stock traded with the total exchanged volume of 7.36 million shares.","GILD"," Gilead"
"410","These Stock&#39;s are Flying High, But Don&#39;t Go Contrarian Yet: Gilead Sciences ...","http://stocknewsjournal.com/2017/04/19/these-stocks-are-flying-high-but-dont-go-contrarian-yet-gilead-sciences-inc-gild-the-interpublic-group-of-companies-inc-ipg/","2017-04-19 07:26:15","StockNewsJournal","Gilead Sciences, Inc. (NASDAQ:GILD) market capitalization at present is $86.36B at the rate of $66.06 a share. The firm's price-to-sales ratio was noted 2.87 in contrast with an overall industry average of 111.17.","GILD"," Gilead"
"411","Gilead Sciences: Who&#39;s Frustrated Now?","http://blogs.barrons.com/stockstowatchtoday/2017/04/19/gilead-sciences-whos-frustrated-now/","2017-04-19 11:43:09","Barron's (blog)","Last month, I urged investors to stay away from Gilead Sciences (GILD), arguing that it had, in effect, become a value trap (even if I didn't use those exact words.","GILD"," Gilead"
"412","Gilead Sciences, Inc. (NASDAQ:GILD): a Look into Earnings &amp; What Analysts are ...","http://rockvilleregister.com/gilead-sciences-inc-nasdaqgild-a-look-into-earnings-what-analysts-are-expecting/51926/","2017-04-19 14:11:15","Rockville Register","For the most recent quarter, 7 analysts weighing in on Gilead Sciences, Inc. (NASDAQ:GILD) had predicted that the company would report earnings per share of $2.31 for the period ending on 2016-12-31.","GILD"," Gilead"
"413","Can Gilead Sciences, Inc. (NASDAQ:GILD) Grow Their Earnings? Analyst ...","https://hiramherald.com/can-gilead-sciences-inc-nasdaqgild-grow-their-earnings-analyst-perspectives-in-scope-2/","2017-04-19 14:11:15","The Herald","Taking a look at Gilead Sciences, Inc. (NASDAQ:GILD)'s most recent earnings release, we see that 7 analysts had expected that the firm would post earnings of $2.31 for the period ending on 2016-12-31.","GILD"," Gilead"
"414","The Technicals For Gilead Sciences, Inc. (GILD) Have Been Dissected (Brutally)","http://nystocknews.com/2017/04/19/the-technicals-for-gilead-sciences-inc-gild-have-been-dissected-brutally-2/","2017-04-19 15:30:00","NY Stock News","Gilead Sciences, Inc. (GILD) has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment.","GILD"," Gilead"
"415","Alta Capital Management Llc Buys CVS Health, Markel, Celgene, Sells &#39;M Co, VCA ...","http://www.gurufocus.com/news/506723/alta-capital-management-llc-buys-cvs-health-markel-celgene-sells-3m-co-vca-gilead-sciences","2017-04-19 16:37:30","GuruFocus.com","Investment company Alta Capital Management Llc buys CVS Health, Markel, Celgene, Cisco Systems, sells 3M Co, VCA, Gilead Sciences, SPDR S&P 500, Nestle SA during the 3-months ended 2017-03-31, according to the most recent filings of the ...","GILD"," Gilead"
"416","Gilead: Can Psoriatic Arthritis Lift This Sinking Ship?","https://seekingalpha.com/article/4063667-gilead-can-psoriatic-arthritis-lift-sinking-ship","2017-04-20 07:48:45","Seeking Alpha","Gilead Sciences (NASDAQ:GILD) has been a very difficult stock to own the past couple of years due to declining revenues, poor pipeline, and poor prospects of acquisition targets.","GILD"," Gilead"
"417","The Chart Readings For Gilead Sciences, Inc. (GILD) Are In","https://nystocknews.com/2017/04/20/the-chart-readings-for-gilead-sciences-inc-gild-are-in/","2017-04-20 09:18:45","NY Stock News","Gilead Sciences, Inc. (GILD) has been having a set of eventful trading activity and it is clear from an examination of the charts that traders are now fully aware of the company's key metrics.","GILD"," Gilead"
"418","Gilead to Present Clinical and Preclinical Data on Nonalcoholic ...","http://finance.yahoo.com/news/gilead-present-clinical-preclinical-data-133000770.html","2017-04-20 09:35:48","Yahoo Finance","Gilead Sciences, Inc. (GILD) today announced that it will present data from 15 abstracts on the pathogenesis and treatment of NASH this week at The International Liver Congress™ 2017 in Amsterdam.","GILD"," Gilead"
"419","Value Composite Update on Gilead Sciences, Inc. (NasdaqGS:GILD)","http://twincitytelegraph.com/value-composite-update-on-gilead-sciences-inc-nasdaqgsgild/","2017-04-20 11:45:00","TCT","Taking a look at valuation rankings for Gilead Sciences, Inc. (NasdaqGS:GILD), we see that the stock has a Value Composite score of 24.","GILD"," Gilead"
"420","High Rates of Viral Suppression Shown in Gilead Hepatitis B Treatment","https://www.pharmpro.com/news/2017/04/high-rates-viral-suppression-shown-gilead-hepatitis-b-treatment","2017-04-20 11:56:15","Pharmaceutical Processing","Gilead Sciences, Inc. has announced 96-week results from two ongoing Phase 3 studies evaluating the safety and efficacy of daily Vemlidy (tenofovir alafenamide, TAF 25mg) in immune active patients and in patients switching from Gilead's Viread ...","GILD"," Gilead"
"421","Gilead Sciences (GILD) Reports POC Data for GS-0976 in Nonalcoholic ...","https://www.streetinsider.com/Corporate+News/Gilead+Sciences+%28GILD%29+Reports+POC+Data+for+GS-0976+in+Nonalcoholic+Steatohepatitis+at+The+International+Liver+Congress+2017/12799418.html","2017-04-21 05:49:23","StreetInsider.com","Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from an open-label, proof-of-concept study evaluating GS-0976, an investigational inhibitor of Acetyl-CoA carboxylase (ACC), in patients with nonalcoholic steatohepatitis (NASH).","GILD"," Gilead"
"422","These two are the must watch stock&#39;s for the fearless investors: Johnson ...","https://stocknewsjournal.com/2017/04/21/these-two-are-the-must-watch-stocks-for-the-fearless-investors-johnson-johnson-jnj-gilead-sciences-inc-gild/","2017-04-21 07:00:02","StockNewsJournal","Gilead Sciences, Inc. (NASDAQ:GILD) market capitalization at present is $86.93B at the rate of $66.50 a share. The firm's price-to-sales ratio was noted 2.85 in contrast with an overall industry average of 109.95.","GILD"," Gilead"
"423","Stock Rating Report: Gilead Sciences Inc. (GILD)","http://theriponadvance.com/stock-rating-report-gilead-sciences-inc-gild/12173670/","2017-04-21 07:48:45","TRA","Gilead Sciences Inc. (GILD) closed its previous trading session at $66.5 with the gain of 0.33%. The company's market cap is $86.64 Billion, and the average volume is 9.86 Million.","GILD"," Gilead"
"424","3 Reasons Gilead Sciences Is a Better Dividend Stock Than Johnson &amp; Johnson","http://host.madison.com/business/investment/markets-and-stocks/reasons-gilead-sciences-is-a-better-dividend-stock-than-johnson/article_dec1db56-477b-5294-9a04-edbcbe02c4f9.html","2017-04-21 08:22:05","Madison.com","3 Reasons Gilead Sciences Is a Better Dividend Stock Than Johnson & Johnson. newsfeedback@fool.com (Cory ... At recent prices, Johnson & Johnson stock offers a 2.62% yield, but the company is expected to announce its 55th consecutive annual payout bump ...","GILD"," Gilead"
"425","The Charts Expose On Gilead Sciences, Inc. (GILD) Is Causing A Stir","http://nystocknews.com/2017/04/21/the-charts-expose-on-gilead-sciences-inc-gild-is-causing-a-stir-2/","2017-04-21 08:33:45","NY Stock News","The technicals for Gilead Sciences, Inc. (GILD) have taken shape, and with them a comprehensive picture has emerged.","GILD"," Gilead"
"426","Biotech Actives: CytRx Corporation (NASDAQ:CYTR), ImmunoGen, Inc. (NASDAQ:IMGN ...","https://www.benchmarkmonitor.com/biotech-actives-cytrx-corporation-nasdaqcytr-immunogen-inc-nasdaqimgn-gilead-sciences-inc-nasdaqgild/207830","2017-04-21 08:45:00","Benchmark Monitor","CytRx Corporation (NASDAQ:CYTR) announced the U.S. Food and Drug Administration (FDA) has reached an agreement with CytRx on preparations for a New Drug Application (NDA) submission for aldoxorubicin in soft tissue sarcomas (STS).","GILD"," Gilead"
"427","Gilead Sciences, Inc. (NASDAQ:GILD) will present data from 15 abstracts on ...","http://www.benchmarkmonitor.com/gilead-sciences-inc-nasdaqgild-will-present-data-from-15-abstracts-on-pathogenesis-and-treatment-of-nash/207768","2017-04-21 09:18:45","Benchmark Monitor","Gilead Sciences, Inc. (NASDAQ:GILD) announced that it will present data from 15 abstracts on the pathogenesis and treatment of NASH this week at The International Liver Congress™ 2017 in Amsterdam.","GILD"," Gilead"
"428","VC Score Review for Gilead Sciences, Inc. (NASDAQ:GILD)","https://skvnews.com/vc-score-review-for-gilead-sciences-inc-nasdaqgild/44604/","2017-04-21 10:48:45","SKV News","Checking in on shares of Gilead Sciences, Inc. (NASDAQ:GILD), the stock currently has a Value Composite Score of 16.","GILD"," Gilead"
"429","Gilead Sciences, Inc.: M&amp;A A Top Priority For GILD","http://smartstocknews.com/77879-gilead-sciences-inc-ma-a-top-priority-for-gild/","2017-04-21 11:33:45","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Although Gilead Sciences, Inc. (NASDAQ:GILD) has seen significant success in its HIV and HCV franchises, in Bank of America Merrill Lynch's view its pipeline is insufficient to address faster-than-expected decline in HCV sales.","GILD"," Gilead"
"430","Yesterday Trading Recap: Gilead Sciences, Inc. (GILD) ,UDR, Inc. (UDR)","http://www.streetupdates.com/2017/04/21/yesterday-trading-recap-gilead-sciences-inc-gild-udr-inc-udr/","2017-04-21 11:33:45","Street Updates","Gilead Sciences, Inc. (GILD) , a stock from Biotechnology Industry, has a value of $66.50 per share, noted a price change of 0.33% in recent trade close.","GILD"," Gilead"
"431","Gilead Announces Scientific Presentations Demonstrating Efficacy of Harvoni ...","http://www.businesswire.com/news/home/20170421005062/en/Gilead-Announces-Scientific-Presentations-Demonstrating-Efficacy-Harvoni%C2%AE","2017-04-21 11:56:15","Business Wire (press release)","Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from two Phase 2 studies evaluating Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg, LDV/SOF) tablets in chronic hepatitis C virus (HCV)-infected patient ...","GILD"," Gilead"
"432","Gilead announces results from 2 Phase 2 studies evaluating Harvoni tablets in chronic hepatitis C infected patient populations","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3572882","2017-04-21 12:00:00","Reuters Key Development","Gilead announces results from 2 Phase 2 studies evaluating Harvoni tablets in chronic hepatitis C infected patient populations","GILD"," Gilead"
"433","Why You Need To Be Cautious About Gilead Sciences, Inc. (GILD), Brocade ...","http://thewellesleysnews.com/2017/04/21/why-you-need-to-be-cautious-about-gilead-sciences-inc-gild-brocade-communications-systems-inc-brcd/","2017-04-21 13:26:15","W News","Gilead Sciences, Inc. (NASDAQ:GILD) shares ended at $66.5 with 6.37 mln shares exchanging hands. That puts the market capitalization at $86.93 bln.","GILD"," Gilead"
"434","Should Gilead Sciences Acquire NewLink Genetics?","http://host.madison.com/business/investment/markets-and-stocks/should-gilead-sciences-acquire-newlink-genetics/article_4e7d5c9c-55ad-5408-a01e-75b91084c537.html","2017-04-21 13:33:45","Madison.com","(NYSE: MRK) market competing drugs offering similar cure rates and lower prices, and that's forced Gilead Sciences to cut its own prices to maintain its market share.","GILD"," Gilead"
"435","Monarch Capital Management Inc Buys Gilead Sciences, Sells Clarcor, Jacobs ...","http://www.gurufocus.com/news/508067/monarch-capital-management-inc-buys-gilead-sciences-sells-clarcor-jacobs-engineering-group-sunlink-health-systems","2017-04-21 14:33:45","GuruFocus.com","Investment company Monarch Capital Management Inc buys Gilead Sciences, sells Clarcor, Jacobs Engineering Group, SunLink Health Systems during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, ...","GILD"," Gilead"
"436","Odds Shaky on Valeant Pharmaceuticals Intl Inc (VRX), Hint of Promise for ...","https://www.smarteranalyst.com/2017/04/21/odds-shaky-valeant-pharmaceuticals-intl-inc-vrx-hint-promise-gilead-sciences-inc-gild-nash/","2017-04-21 14:33:45","Smarter Analyst","In the battle of the biotech giants, with the battered Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in one corner, hanging on a limb over a debt cliff, and Gilead Sciences, Inc. (NASDAQ:GILD) in another corner, with the potential to back itself out ...","GILD"," Gilead"
"437","Company in View: Gilead Sciences, Inc. (NASDAQ:GILD)","http://aikenadvocate.com/company-in-view-gilead-sciences-inc-nasdaqgild/150566/","2017-04-21 15:07:30","Aiken Advocate","Gilead Sciences, Inc. (NASDAQ:GILD) shares saw trading in the range of $65.75 - 66.68 in the previous trading session.","GILD"," Gilead"
"438","Sanofi partnership with Ypsomed Group to include new project","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3199281","2015-04-23 20:00:00","Reuters Key Development","Sanofi partnership with Ypsomed Group to include new project","SNY","Sanofi Genzyme"
"439","Sanofi says Sanofi FDA grants fast track designation to Genzyme&#39;s therapy","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3201777","2015-04-28 01:03:00","Reuters Key Development","Sanofi says Sanofi FDA grants fast track designation to Genzyme's therapy","SNY","Sanofi Genzyme"
"440","Sanofi SA reaffirms FY 2015 EPS guidance","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3203648","2015-04-30 01:30:00","Reuters Key Development","Sanofi SA reaffirms FY 2015 EPS guidance","SNY","Sanofi Genzyme"
"441","Sanofi and Regeneron announce positive pivotal phase 2b dupilumab data in asthma","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3215042","2015-05-18 12:30:00","Reuters Key Development","Sanofi and Regeneron announce positive pivotal phase 2b dupilumab data in asthma","SNY","Sanofi Genzyme"
"442","Regeneron Pharmaceuticals Inc and Sanofi announce positive topline results from phase 3 studies with sarilumab in patients with rheumatoid arthritis","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3216367","2015-05-21 01:00:00","Reuters Key Development","Regeneron Pharmaceuticals Inc and Sanofi announce positive topline results from phase 3 studies with sarilumab in patients with rheumatoid arthritis","SNY","Sanofi Genzyme"
"443","Sanofi SA announces FDA grants breathrough therapy designation to Genzyme&#39;s Olipudase Alfa","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3224564","2015-06-04 01:00:00","Reuters Key Development","Sanofi SA announces FDA grants breathrough therapy designation to Genzyme's Olipudase Alfa","SNY","Sanofi Genzyme"
"444","Sanofi SA announces positive results for Toujeo in Phase III study extension in Japanese people with uncontrolled diabetes","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3225459","2015-06-06 15:01:00","Reuters Key Development","Sanofi SA announces positive results for Toujeo in Phase III study extension in Japanese people with uncontrolled diabetes","SNY","Sanofi Genzyme"
"445","FDA Advisory Committee recommends approval of Sanofi SA and Regeneron Pharmaceuticals, Inc&#39;s Praluent (alirocumab) Injection for Patients with Hypercholesterolemia","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3226790","2015-06-09 18:41:00","Reuters Key Development","FDA Advisory Committee recommends approval of Sanofi SA and Regeneron Pharmaceuticals, Inc's Praluent (alirocumab) Injection for Patients with Hypercholesterolemia","SNY","Sanofi Genzyme"
"446","Public Citizen said it petitioned U.S. health regulators to withdraw approval of Sanofi SA&#39;s Seprafilm and order a recall - Reuters","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3241688","2015-07-06 20:00:00","Reuters Key Development","Public Citizen said it petitioned U.S. health regulators to withdraw approval of Sanofi SA's Seprafilm and order a recall - Reuters","SNY","Sanofi Genzyme"
"447","Sanofi , Regeneron&#39;s high cholesterol drug Praluent gets EMA nod","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3250218","2015-07-24 07:00:00","Reuters Key Development","Sanofi , Regeneron's high cholesterol drug Praluent gets EMA nod","SNY","Sanofi Genzyme"
"448","Regeneron and Sanofi announce FDA Approval of Praluent Injection","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3250352","2015-07-24 15:17:00","Reuters Key Development","Regeneron and Sanofi announce FDA Approval of Praluent Injection","SNY","Sanofi Genzyme"
"449","AstraZeneca to sell cancer medicine Caprelsa to Sanofi &#39;s Genzyme","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3250575","2015-07-27 02:00:00","Reuters Key Development","AstraZeneca to sell cancer medicine Caprelsa to Sanofi 's Genzyme","SNY","Sanofi Genzyme"
"450","Sanofi says new data analyses support its dengue vaccine","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3251584","2015-07-27 12:00:00","Reuters Key Development","Sanofi says new data analyses support its dengue vaccine","SNY","Sanofi Genzyme"
"451","Regeneron and Sanofi launch major new immuno-oncology collaboration","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3251587","2015-07-28 01:00:00","Reuters Key Development","Regeneron and Sanofi launch major new immuno-oncology collaboration","SNY","Sanofi Genzyme"
"452","Sanofi comments on FY 2015 Business EPS guidance","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3253010","2015-07-30 01:32:00","Reuters Key Development","Sanofi comments on FY 2015 Business EPS guidance","SNY","Sanofi Genzyme"
"453","Ligand enters into commercial license and supply agreement with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3253559","2015-07-30 09:00:00","Reuters Key Development","Ligand enters into commercial license and supply agreement with Sanofi","SNY","Sanofi Genzyme"
"454","Sanofi SA, Evotec enter diabetes partnership","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3258114","2015-08-07 01:00:00","Reuters Key Development","Sanofi SA, Evotec enter diabetes partnership","SNY","Sanofi Genzyme"
"455","Sanofi teams up with Evotec, Apeiron to develop immuno-oncology pills","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3258770","2015-08-10 01:00:00","Reuters Key Development","Sanofi teams up with Evotec, Apeiron to develop immuno-oncology pills","SNY","Sanofi Genzyme"
"456","Sanofi SA to collaborate with Google life sciences","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3268023","2015-08-31 09:00:00","Reuters Key Development","Sanofi SA to collaborate with Google life sciences","SNY","Sanofi Genzyme"
"457","Sanofi SA Genzyme pays $32.59 mln in criminal Seprafilm case - Reuters","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3269855","2015-09-02 20:00:00","Reuters Key Development","Sanofi SA Genzyme pays $32.59 mln in criminal Seprafilm case - Reuters","SNY","Sanofi Genzyme"
"458","PeptiDream announces collaboration agreement with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3272537","2015-09-13 19:45:00","Reuters Key Development","PeptiDream announces collaboration agreement with Sanofi","SNY","Sanofi Genzyme"
"459","Sanofi reports positive top-line results in second pivotal LixiLan Phase III study","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3272791","2015-09-14 01:00:00","Reuters Key Development","Sanofi reports positive top-line results in second pivotal LixiLan Phase III study","SNY","Sanofi Genzyme"
"460","Regeneron Pharmaceuticals Inc and Sanofi SA Announce Approval of Praluent (alirocumab) for the Treatment of Hypercholesterolemia in the European Union","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3277938","2015-09-28 01:00:00","Reuters Key Development","Regeneron Pharmaceuticals Inc and Sanofi SA Announce Approval of Praluent (alirocumab) for the Treatment of Hypercholesterolemia in the European Union","SNY","Sanofi Genzyme"
"461","Eli Lilly and Company and Sanofi reach settlement agreement in U.S. insulin glargine litigation","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3278263","2015-09-28 09:33:00","Reuters Key Development","Eli Lilly and Company and Sanofi reach settlement agreement in U.S. insulin glargine litigation","SNY","Sanofi Genzyme"
"462","Sanofi SA reaches patent settlement on Lantus SoloSTAR with Eli Lilly and Co","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3278267","2015-09-28 09:34:00","Reuters Key Development","Sanofi SA reaches patent settlement on Lantus SoloSTAR with Eli Lilly and Co","SNY","Sanofi Genzyme"
"463","Sanofi SA New Drug Application for lixisenatide accepted for review by FDA","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3278811","2015-09-29 08:00:00","Reuters Key Development","Sanofi SA New Drug Application for lixisenatide accepted for review by FDA","SNY","Sanofi Genzyme"
"464","Sanofi reports positive long-term data for Genzyme&#39;s Lemtrada clinical trials","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3282367","2015-10-08 01:00:00","Reuters Key Development","Sanofi reports positive long-term data for Genzyme's Lemtrada clinical trials","SNY","Sanofi Genzyme"
"465","Sanofi SA (ADR) (SNY) Facing Challenging Environment for Drug Prices","http://investcorrectly.com/20151019/key-challenges-sanofi-sa-adr-sny-latest-developments/","2015-10-19 09:18:45","InvestCorrectly","One of the areas of focus for pharmaceutical firms is that the prices of the drugs should not be very high to avoid criticism. That makes companies like Sanofi SA (ADR) (NYSE:SNY) face significant challenges in terms of marketing, as well as ...","SNY","Sanofi Genzyme"
"466","Sanofi SA - Sanofi U.S. recalls Auvi-Q injections for severe allergy - Reuters","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3292271","2015-10-28 17:11:00","Reuters Key Development","Sanofi SA - Sanofi U.S. recalls Auvi-Q injections for severe allergy - Reuters","SNY","Sanofi Genzyme"
"467","Sanofi and Hanmi announce license agreement","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3296337","2015-11-05 01:02:00","Reuters Key Development","Sanofi and Hanmi announce license agreement","SNY","Sanofi Genzyme"
"468","Sanofi SA and Lexicon Pharmaceuticals to collaborate on Sotagliflozin","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3297020","2015-11-06 01:00:00","Reuters Key Development","Sanofi SA and Lexicon Pharmaceuticals to collaborate on Sotagliflozin","SNY","Sanofi Genzyme"
"469","Sanofi gives mid term outlook (2018-2020)","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3297021","2015-11-06 01:00:00","Reuters Key Development","Sanofi gives mid term outlook (2018-2020)","SNY","Sanofi Genzyme"
"470","Regeneron and Sanofi announce new Praluent (alirocumab) injection analyses presented at AHA scientific sessions 2015","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3298678","2015-11-10 18:00:00","Reuters Key Development","Regeneron and Sanofi announce new Praluent (alirocumab) injection analyses presented at AHA scientific sessions 2015","SNY","Sanofi Genzyme"
"471","Regeneron and Sanofi say Odyssey Outcomes Trial of Praluent injection fully enrolled","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3303529","2015-11-24 01:00:00","Reuters Key Development","Regeneron and Sanofi say Odyssey Outcomes Trial of Praluent injection fully enrolled","SNY","Sanofi Genzyme"
"472","Sanofi Submits New Drug Application for the Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3314589","2015-12-23 01:00:00","Reuters Key Development","Sanofi Submits New Drug Application for the Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide","SNY","Sanofi Genzyme"
"473","Sanofi Dengvaxia dengue vaccine approved in Brazil","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3315770","2015-12-28 05:31:00","Reuters Key Development","Sanofi Dengvaxia dengue vaccine approved in Brazil","SNY","Sanofi Genzyme"
"474","Sanofi and Innate Pharma collaborate on new bispecific NK cell engagers in immuno-oncology","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3318972","2016-01-10 21:00:00","Reuters Key Development","Sanofi and Innate Pharma collaborate on new bispecific NK cell engagers in immuno-oncology","SNY","Sanofi Genzyme"
"475","Sanofi says U.S. FDA accepts diabetes drug application","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3333646","2016-02-22 01:00:00","Reuters Key Development","Sanofi says U.S. FDA accepts diabetes drug application","SNY","Sanofi Genzyme"
"476","Sanofi Genzyme presents results from phase 1/2 study of therapy for pompe disease","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3338873","2016-03-03 17:00:00","Reuters Key Development","Sanofi Genzyme presents results from phase 1/2 study of therapy for pompe disease","SNY","Sanofi Genzyme"
"477","Sanofi and Regeneron announce results of study on sarilumab","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3341778","2016-03-11 01:00:00","Reuters Key Development","Sanofi and Regeneron announce results of study on sarilumab","SNY","Sanofi Genzyme"
"478","Sanofi SA (ADR): SNY Pipeline Is Overflowing With Potential","http://investorplace.com/2016/04/sanofi-stock-sny-pipeline/","2016-04-14 12:18:45","Investorplace.com","France-based Sanofi SA (ADR) (SNY) is one of the world's largest pharmaceutical companies. I mentioned where it's headquartered because the company actually pre-dates much of America.","SNY","Sanofi Genzyme"
"479","Sanofi SA (ADR) (NYSE:SNY) Looking To Acquire Medivation Inc (NASDAQ:MDVN) For ...","http://marketexclusive.com/sanofi-sa-adr-nysesny-looking-acquire-medivation-inc-nasdaqmdvn-9-3-billion/6124/","2016-04-29 10:37:30","Market Exclusive","Sanofi SA (ADR) (NYSE:SNY) has made public its intention of acquiring Medivation Inc (NASDAQ:MDVN), having tabled a $9.3 billion takeover bid.","SNY","Sanofi Genzyme"
"480","Sanofi files for Hart-Scott-Rodino notification regarding proposed acquisition of Medivation","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3373437","2016-05-12 14:17:01","Reuters Key Development","Sanofi files for Hart-Scott-Rodino notification regarding proposed acquisition of Medivation","SNY","Sanofi Genzyme"
"481","Sanofi seeking to replace entire Medivation board - CNBC","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3374639","2016-05-13 09:20:57","Reuters Key Development","Sanofi seeking to replace entire Medivation board - CNBC","SNY","Sanofi Genzyme"
"482","ALK-Abello names Carsten Hellmann new CEO","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3377205","2016-05-18 00:59:21","Reuters Key Development","ALK-Abello names Carsten Hellmann new CEO","SNY","Sanofi Genzyme"
"483","Sanofi says Pascale Witz, executive VP, diabetes &amp; cardiovascular, to leave company on June 1","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3379871","2016-05-23 08:19:03","Reuters Key Development","Sanofi says Pascale Witz, executive VP, diabetes & cardiovascular, to leave company on June 1","SNY","Sanofi Genzyme"
"484","Sanofi seeking shareholder support for removal of Medivation board","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3381348","2016-05-25 06:25:00","Reuters Key Development","Sanofi seeking shareholder support for removal of Medivation board","SNY","Sanofi Genzyme"
"485","Is Sanofi SA (ADR) (SNY) Overvalued at Current Levels?","http://investcorrectly.com/20160525/is-sanofi-sa-adr-sny-overvalued-at-current-levels/","2016-05-25 08:33:45","InvestCorrectly","Sanofi SA (ADR) (NYSE:SNY) valuation is a point of concern on the street, given the headwinds the drug maker is facing.","SNY","Sanofi Genzyme"
"486","Sanofi sends letter to Medivation board of directors","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3381444","2016-05-25 08:43:55","Reuters Key Development","Sanofi sends letter to Medivation board of directors","SNY","Sanofi Genzyme"
"487","FDA recommends approval of Sanofi treatment for Type 2 Diabetes","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3381713","2016-05-25 18:50:00","Reuters Key Development","FDA recommends approval of Sanofi treatment for Type 2 Diabetes","SNY","Sanofi Genzyme"
"488","Parnell Pharmaceuticals says manufacturing deal with Merial","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3384640","2016-05-31 16:05:00","Reuters Key Development","Parnell Pharmaceuticals says manufacturing deal with Merial","SNY","Sanofi Genzyme"
"489","Sanofi expected to request record date from Medivation today - CNBC, citing sources","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3385339","2016-06-01 09:52:01","Reuters Key Development","Sanofi expected to request record date from Medivation today - CNBC, citing sources","SNY","Sanofi Genzyme"
"490","Sanofi requests record date for consent solicitation to remove and replace Medivation&#39;s board","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3385442","2016-06-01 14:15:00","Reuters Key Development","Sanofi requests record date for consent solicitation to remove and replace Medivation's board","SNY","Sanofi Genzyme"
"491","Medivation sets record date for Sanofi&#39;s proposed consent solicitation","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3385522","2016-06-01 18:45:00","Reuters Key Development","Medivation sets record date for Sanofi's proposed consent solicitation","SNY","Sanofi Genzyme"
"492","Sanofi files investor presentation with SEC on proposed acquisition of Medivation","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3388592","2016-06-08 06:32:19","Reuters Key Development","Sanofi files investor presentation with SEC on proposed acquisition of Medivation","SNY","Sanofi Genzyme"
"493","Sanofi announces expiration of Hart-Scott-Rodino waiting period for proposed acquisition of Medivation&lt;MDVN.O&gt;&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3390853","2016-06-13 12:09:10","Reuters Key Development","Sanofi announces expiration of Hart-Scott-Rodino waiting period for proposed acquisition of Medivation<MDVN.O><SASY.PA>","SNY","Sanofi Genzyme"
"494","U.S. SEC accuses Christopher Plaford of insider trading, overstating fund&#39;s valuation&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3391640","2016-06-15 10:43:29","Reuters Key Development","U.S. SEC accuses Christopher Plaford of insider trading, overstating fund's valuation<SASY.PA>","SNY","Sanofi Genzyme"
"495","Icagen acquires Sanofi&#39;s Oro Valley, Arizona research facility","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3396485","2016-06-27 16:00:00","Reuters Key Development","Icagen acquires Sanofi's Oro Valley, Arizona research facility","SNY","Sanofi Genzyme"
"496","Sanofi sounding out Medivation shareholders as it prepares to raise bid- CNBC","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3397100","2016-06-28 09:56:10","Reuters Key Development","Sanofi sounding out Medivation shareholders as it prepares to raise bid- CNBC","SNY","Sanofi Genzyme"
"497","Sanofi Genzyme says Saskatchewan has added Lemtrada to province&#39;s MS drugs program","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3400571","2016-07-05 08:00:00","Reuters Key Development","Sanofi Genzyme says Saskatchewan has added Lemtrada to province's MS drugs program","SNY","Sanofi Genzyme"
"498","Sanofi raises Medivation offer, enters confidentiality agreement","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3400756","2016-07-05 16:28:03","Reuters Key Development","Sanofi raises Medivation offer, enters confidentiality agreement","SNY","Sanofi Genzyme"
"499","Sanofi Genzyme begins pivotal phase 2/3 trial","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3401178","2016-07-06 08:00:00","Reuters Key Development","Sanofi Genzyme begins pivotal phase 2/3 trial","SNY","Sanofi Genzyme"
"500","Sanofi SA (ADR) (SNY) Confirmed Confidentiality Agreement with Medivation Inc ...","http://www.thecountrycaller.com/29559-sanofi-sa-adr-sny-confirmed-confidentiality-agreement-with-medivation-inc-mdvn","2016-07-06 09:07:51","TCC","As Medivation Inc (NASDAQ:MDVN) is headed towards a selloff, it is in talks with many parties who seek to buy the company. With Board of Directors consent, Medivation and Sanofi SA (ADR) (NYSE:SNY) have entered into confidentiality agreement.","SNY","Sanofi Genzyme"
"501","Instant Analysis: Amgen&#39;s Latest Approval Raises the Bar Yet Again on ...","https://www.fool.com/investing/2016/07/12/instant-analysis-amgens-latest-approval-one-ups-re.aspx","2016-07-12 09:27:16","Motley Fool","This approval could help give Amgen's Repatha a clinical leg up over its primary PSCK9 inhibitor competitor, Praluent, which is marketed by Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NYSE:SNY). Praluent is currently approved to be ...","SNY","Sanofi Genzyme"
"502","Sanofi Enzyme says Ontario adds LEMTRADA to exceptional access program for eligible patients","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3409200","2016-07-21 08:00:00","Reuters Key Development","Sanofi Enzyme says Ontario adds LEMTRADA to exceptional access program for eligible patients","SNY","Sanofi Genzyme"
"503","Sanofi India June-qtr profit up about 33 pct&lt;SANO.NS&gt;&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3409952","2016-07-22 06:37:43","Reuters Key Development","Sanofi India June-qtr profit up about 33 pct<SANO.NS><SASY.PA>","SNY","Sanofi Genzyme"
"504","Sanofi pasteur ships seasonal influenza vaccine doses in U.S.","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3411659","2016-07-26 08:00:00","Reuters Key Development","Sanofi pasteur ships seasonal influenza vaccine doses in U.S.","SNY","Sanofi Genzyme"
"505","Sanofi, Pfizer, Gilead &amp; Celgene interested in Medivation - CNBC citing sources","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3415470","2016-07-29 09:40:53","Reuters Key Development","Sanofi, Pfizer, Gilead & Celgene interested in Medivation - CNBC citing sources","SNY","Sanofi Genzyme"
"506","Sanofi SA (ADR) (SNY) and Regeneron Pharmaceuticals Inc (REGN) Ready to Enter ...","http://www.thecountrycaller.com/65737-sanofi-sa-adr-sny-and-regeneron-pharmaceuticals-inc-regn-ready-to-enter-european-therapeutic-markets","2016-08-02 08:22:30","TCC","Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that their human monoclonal antibody, sarilumab has been given green signal by the European Medicines Agency (EMA) for the marketing authorization ...","SNY","Sanofi Genzyme"
"507","Will Pluristem Therapeutics Inc. (NASDAQ:PSTI) Succeed in CLI Where Sanofi SA ...","http://marketexclusive.com/will-pluristem-therapeutics-inc-nasdawqpsti-succeed-cli-sanofi-sa-adr-nysesny-failed/24337/","2016-08-11 10:09:14","Market Exclusive","Back in 2010, Sanofi SA (ADR) (NYSE:SNY) failed a promising Phase III CLI study for its drug called NV1FGF, even after positive Phase II results that were unfortunately not successfully replicated in the larger pivotal trial.","SNY","Sanofi Genzyme"
"508","Headwinds Ahead Of Sanofi SA (ADR) (SNY) Diabetes Portfolio In 2017","http://www.thecountrycaller.com/43265-headwinds-ahead-of-sanofi-sa-adr-sny-diabetes-portfolio-in-2017","2016-08-15 15:41:15","TCC","Berenberg analyst, Alistair Campbell made no change in Sanofi SA (NYSE:SNY) Hold rating and $93.00 price target, following second quarter earnings release.","SNY","Sanofi Genzyme"
"509","Zealand Pharma announces new timelines for U.S. FDA decision on iglarlixi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3429751","2016-08-19 18:28:57","Reuters Key Development","Zealand Pharma announces new timelines for U.S. FDA decision on iglarlixi","SNY","Sanofi Genzyme"
"510","FDA&#39;s Sanofi SA (ADR) (SNY) Delay Highlights Some Red Flags With IGlarLixi","http://www.insidermonkey.com/blog/fdas-sanofi-sa-adr-sny-delay-highlights-some-red-flags-with-iglarlixi-470046/","2016-08-22 11:56:15","Insider Monkey (blog)","We just learnt that the FDA has pushed back its decision day on Sanofi SA (ADR) (NYSE:SNY)'s insulin combo candidate IGlarLixi.","SNY","Sanofi Genzyme"
"511","Inside the FDA: Why Sanofi SA (ADR) (NYSE:SNY) IGlarLixi Was Delayed But Novo ...","https://marketexclusive.com/inside-fda-sanofi-sa-adr-nysesny-iglarlixi-delayed-novo-nordisk-adr-nysenvo-ideglira-wasnt/26122/","2016-09-02 09:49:41","Market Exclusive","The race between Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) combination diabetes therapies is now down to the wire, with Novo pulling ahead after a delay was slapped on Sanofi.","SNY","Sanofi Genzyme"
"512","Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo ...","http://www.insidermonkey.com/blog/inside-the-fda-why-sanofi-sa-adr-sny-iglarlixi-was-delayed-but-novo-nordisk-as-adr-nvo-ideglira-wasnt-472620/","2016-09-06 13:37:30","Insider Monkey (blog)","The race between Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) combination diabetes therapies is now down to the wire, with Novo pulling ahead after a delay was slapped on Sanofi.","SNY","Sanofi Genzyme"
"513","Sanofi SA (ADR) &amp; Alphabet Inc&#39;s Verily Life Sciences To Bet Big On Diabetes","http://www.thecountrycaller.com/47995-sanofi-sa-adr-alphabet-incs-verily-life-sciences-to-bet-big-on-diabetes","2016-09-12 07:48:45","TCC","According to a recent announcement, Sanofi SA (ADR) (NYSE:SNY) and Alphabet Inc's (NASDAQ:GOOGL) Verily Life Sciences are teaming up to spin out a collaborative venture, called Onduo.","SNY","Sanofi Genzyme"
"514","Sanofi files suit in U.S. to defend paten rights on Lantus and Lantus Solostar","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3442156","2016-09-19 01:00:42","Reuters Key Development","Sanofi files suit in U.S. to defend paten rights on Lantus and Lantus Solostar","SNY","Sanofi Genzyme"
"515","Sanofi SA (ADR) (SNY) Sues Merck &amp; Co., Inc. (MRK) Over Multiple Patent ...","http://investorplace.com/2016/09/sanofi-merck/","2016-09-19 12:18:45","Investorplace.com","Sanofi SA (ADR) (NYSE:SNY) is suing Merck & Co., Inc. (NYSE:MRK) for what it claims are several instances of patent infringement.","SNY","Sanofi Genzyme"
"516","Sanofi and Regeneron accepted for priority review by U.S. FDA","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3444832","2016-09-26 01:00:45","Reuters Key Development","Sanofi and Regeneron accepted for priority review by U.S. FDA","SNY","Sanofi Genzyme"
"517","U.S. Department of health and human services says BARDA awards funding to Sanofi Pasteur for Zika vaccine","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3445252","2016-09-26 10:36:46","Reuters Key Development","U.S. Department of health and human services says BARDA awards funding to Sanofi Pasteur for Zika vaccine","SNY","Sanofi Genzyme"
"518","Sanofi says BARDA grants $43.2 million to Sanofi Pasteur for Zika","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3445249","2016-09-26 11:05:24","Reuters Key Development","Sanofi says BARDA grants $43.2 million to Sanofi Pasteur for Zika","SNY","Sanofi Genzyme"
"519","Immune Design Announces Advancement of First GLAAS-based Allergy Program into Clinical Development","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3446435","2016-09-28 08:00:00","Reuters Key Development","Immune Design Announces Advancement of First GLAAS-based Allergy Program into Clinical Development","SNY","Sanofi Genzyme"
"520","Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN) Ready to Launch ...","http://smartstocknews.com/63782-sanofi-sa-adr-sny-regeneron-pharmaceuticals-inc-regn-ready-to-launch-dermatology-molecule/","2016-10-03 10:37:30","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi SA (ADR) (NYSE:SNY) have announced that the clinical results from the LIBERTY AD SOLO 1 and SOLO 2 tests to check the vitality of the investigational molecule Dupixent® (dupilumab) have ...","SNY","Sanofi Genzyme"
"521","Sanofi reports open market purchase of 450,000 shares of Myokardia","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3449608","2016-10-05 09:00:00","Reuters Key Development","Sanofi reports open market purchase of 450,000 shares of Myokardia","SNY","Sanofi Genzyme"
"522","Sanofi SA (ADR) (NYSE:SNY), Alphabet Inc (NASDAQ:GOOGL) Verily Life Sciences ...","http://marketexclusive.com/sanofi-sa-adr-nysesny-alphabet-inc-nasdaqgoogl-verily-life-sciences-llc-forms-joint-venture/33617/","2016-10-11 09:18:45","Market Exclusive","The company will tap the expertise of Sanofi in clinical development and of Verily Life Sciences in analytics, miniaturization, and software development.","SNY","Sanofi Genzyme"
"523","Science 37 secures $31m series B funding","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3455848","2016-10-18 07:30:00","Reuters Key Development","Science 37 secures $31m series B funding","SNY","Sanofi Genzyme"
"524","Myriad RBM announces agreement with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3460295","2016-10-25 07:05:00","Reuters Key Development","Myriad RBM announces agreement with Sanofi","SNY","Sanofi Genzyme"
"525","Earnings Whispers: Sanofi SA (ADR) (SNY) and Xerox Corp (XRX)","http://www.thecountrycaller.com/40702-earnings-whispers-sanofi-sa-adr-sny-and-xerox-corp-xrx","2016-10-27 12:12:39","TCC","Ahead of the third quarter earnings report of Sanofi SA (ADR) (NYSE:SNY) and Xerox Corp (NYSE:XRX) for the fiscal year 2016, The Country Caller discusses whisper numbers for both the companies.","SNY","Sanofi Genzyme"
"526","Sanofi CEO says share buyback doesn&#39;t preclude M&amp;A","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3463971","2016-10-28 01:40:50","Reuters Key Development","Sanofi CEO says share buyback doesn't preclude M&A","SNY","Sanofi Genzyme"
"527","Regeneron advised by Sanofi that manufacturing deficiencies have been raised by U.S. FDA","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3464548","2016-10-28 06:14:42","Reuters Key Development","Regeneron advised by Sanofi that manufacturing deficiencies have been raised by U.S. FDA","SNY","Sanofi Genzyme"
"528","Regeneron and Sanofi receive complete response letter from FDA for Sarilumab","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3464966","2016-10-28 14:35:00","Reuters Key Development","Regeneron and Sanofi receive complete response letter from FDA for Sarilumab","SNY","Sanofi Genzyme"
"529","Can Cempra Clear Solithera Hurdle After FDA Reveal?","http://www.benzinga.com/analyst-ratings/analyst-color/16/11/8638952/can-cempra-clear-solithera-hurdle-after-fda-reveal","2016-11-02 14:56:04","Benzinga","Solithromycin is based on Sanofi SA (ADR) (NYSE: SNY)'s Ketek, which was linked to fatal liver problems and largely withdrawn following public outcry over its contentious approval in 2004.","SNY","Sanofi Genzyme"
"530","Sanofi starts phase 3 trial of pompe disease treatment","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3470265","2016-11-04 08:00:00","Reuters Key Development","Sanofi starts phase 3 trial of pompe disease treatment","SNY","Sanofi Genzyme"
"531","Mannkind - Enters into settlement agreement with Sanofi-Aventis","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3473963","2016-11-09 17:47:37","Reuters Key Development","Mannkind - Enters into settlement agreement with Sanofi-Aventis","SNY","Sanofi Genzyme"
"532","Selecta Biosciences receives exclusive rights to peanut allergy and celiac disease programs","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3474848","2016-11-10 06:45:00","Reuters Key Development","Selecta Biosciences receives exclusive rights to peanut allergy and celiac disease programs","SNY","Sanofi Genzyme"
"533","Sanofi gets CHMP recommendation for approval of Suliqua in the EU","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3476256","2016-11-11 07:19:44","Reuters Key Development","Sanofi gets CHMP recommendation for approval of Suliqua in the EU","SNY","Sanofi Genzyme"
"534","Alnylam pharmaceuticals announces Sanofi Genzyme opt-in decision","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3477537","2016-11-14 08:00:00","Reuters Key Development","Alnylam pharmaceuticals announces Sanofi Genzyme opt-in decision","SNY","Sanofi Genzyme"
"535","Regeneron and Sanofi Present Results from late-stage Monarch study at American College of Rheumatology Annual Meeting","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3479949","2016-11-16 08:00:00","Reuters Key Development","Regeneron and Sanofi Present Results from late-stage Monarch study at American College of Rheumatology Annual Meeting","SNY","Sanofi Genzyme"
"536","Sanofi says Sarilumab phase 3 study shows positive results","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3479934","2016-11-16 08:00:23","Reuters Key Development","Sanofi says Sarilumab phase 3 study shows positive results","SNY","Sanofi Genzyme"
"537","Sanofi says receives FDA approval of Soliqua 100/33&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3482360","2016-11-21 18:20:58","Reuters Key Development","Sanofi says receives FDA approval of Soliqua 100/33<SASY.PA>","SNY","Sanofi Genzyme"
"538","Sanofi says receives FDA approval of Soliqua 100/33","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3482361","2016-11-21 19:06:41","Reuters Key Development","Sanofi says receives FDA approval of Soliqua 100/33","SNY","Sanofi Genzyme"
"539","Zealand Pharma: US FDA approves Soliqua 100/33 for treatment of adults with type 2 diabetes","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3482456","2016-11-21 19:38:20","Reuters Key Development","Zealand Pharma: US FDA approves Soliqua 100/33 for treatment of adults with type 2 diabetes","SNY","Sanofi Genzyme"
"540","Natrix Separations announces collaboration agreements with Merck and Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3487623","2016-11-30 09:30:00","Reuters Key Development","Natrix Separations announces collaboration agreements with Merck and Sanofi","SNY","Sanofi Genzyme"
"541","Sanofi SA (ADR) (SNY) Facing Manufacturing Headache On Two Blockbusters","http://www.insidermonkey.com/blog/sanofi-sa-adr-sny-facing-manufacturing-headache-on-two-blockbusters-495295/","2016-11-30 13:00:00","Insider Monkey (blog)","Manufacturing problems in France threaten to delay the release of Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN)'s blockbuster drug, dupilumab, according to analysts at Leerink.","SNY","Sanofi Genzyme"
"542","China Resources Sanjiu Medical &amp; Pharma plans framework agreement with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3488647","2016-12-01 23:20:46","Reuters Key Development","China Resources Sanjiu Medical & Pharma plans framework agreement with Sanofi","SNY","Sanofi Genzyme"
"543","Is Sanofi SA (ADR) (SNY) a Good Stock To Buy?","http://www.insidermonkey.com/blog/is-sanofi-sa-adr-sny-a-good-stock-to-buy-492320/","2016-12-04 17:07:30","Insider Monkey (blog)","Is Sanofi SA (ADR) (NYSE:SNY) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.","SNY","Sanofi Genzyme"
"544","Sanofi Genzyme says initiation of ICARIA-MM phase III trial of Isatuximab","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3490154","2016-12-05 12:50:00","Reuters Key Development","Sanofi Genzyme says initiation of ICARIA-MM phase III trial of Isatuximab","SNY","Sanofi Genzyme"
"545","Sanofi to explore counterbid for Actelion amid J&amp;J talks - Bloomberg, citing sources","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3490184","2016-12-05 16:25:37","Reuters Key Development","Sanofi to explore counterbid for Actelion amid J&J talks - Bloomberg, citing sources","SNY","Sanofi Genzyme"
"546","EMA Reviews Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Sanofi SA (ADR) (NYSE ...","https://marketexclusive.com/ema-reviews-regeneron-pharmaceuticals-inc-nasdaqregn-sanofi-sa-adr-nysesny-dupixent-maa/44430/","2016-12-09 08:07:30","Market Exclusive","The European Medicines Agency (EMA) has recently accepted to review the Marketing Authorization Application (MAA) of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) for Dupixent (dupilumab) as a treatment for adult ...","SNY","Sanofi Genzyme"
"547","Think Sanofi SA (ADR) (SNY) Stock When You Think Big Pharma","http://investorplace.com/2016/12/sanofi-sa-adr-sny-stock-pharma/","2016-12-09 12:14:57","Investorplace.com","Sanofi SA (ADR) (NYSE:SNY) is the world's No. 5 pharmaceutical company. It has over 100 manufacturing sites in 41 countries and has 110,000 employees in 100 countries.","SNY","Sanofi Genzyme"
"548","Sanofi in advanced talks to buy Actelion- Bloomberg, citing sources","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3496182","2016-12-15 20:43:43","Reuters Key Development","Sanofi in advanced talks to buy Actelion- Bloomberg, citing sources","SNY","Sanofi Genzyme"
"549","M&amp;A Drama Inspires Rare Round of Sanofi SA (SNY) Call Trading","http://www.schaeffersresearch.com/content/options/2016/12/21/ma-drama-inspires-rare-round-of-sanofi-sa-sny-call-trading","2016-12-21 14:18:47","Schaeffers Research (blog)","Sanofi SA's (ADR) (NYSE:SNY) hopes of buying Actelion have been dealt a serious blow, after Johnson & Johnson (NYSE:JNJ) ","SNY","Sanofi Genzyme"
"550","Sanofi SA (NYSE:SNY) Files Suit Against Novo Nordisk A/S (ADR) (NYSE:NVO) Over ...","https://marketexclusive.com/sanofi-sa-nysesny-files-suit-novo-nordisk-adr-nysenvo-false-insulin-claims/53087/","2016-12-28 12:41:22","Market Exclusive","Novo Nordisk A/S (NYSE:NVO) has been sued by Sanofi SA (NYSE:SNY) for making false claims. In the lawsuit filed in the United States, the French company has accused Novo Nordisk of claiming that the insulin drugs manufactured and distributed by ...","SNY","Sanofi Genzyme"
"551","Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3502754","2017-01-02 02:05:14","Reuters Key Development","Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe","SNY","Sanofi Genzyme"
"552","Myokardia says Sanofi has notified company that it has elected to continue global cardiomyopathy research collaboration","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3503366","2017-01-03 08:30:00","Reuters Key Development","Myokardia says Sanofi has notified company that it has elected to continue global cardiomyopathy research collaboration","SNY","Sanofi Genzyme"
"553","Mylan NV (NASDAQ:MYL), AbbVie Inc (NYSE:ABBV) Sanofi SA (NYSE:SNY) In ...","https://marketexclusive.com/mylan-abbvie-sanofi-in-spotlight-drug-price-hikes/57214/","2017-01-03 09:51:59","Market Exclusive","A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations. The bill seeks to shed more light on the world of prescription drug pricing, though as all prices are driven by supply and ...","SNY","Sanofi Genzyme"
"554","Sanofi announces Soliqua 100/33 now available in the U.S","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3503972","2017-01-04 08:00:00","Reuters Key Development","Sanofi announces Soliqua 100/33 now available in the U.S","SNY","Sanofi Genzyme"
"555","Impax confirms patent challenge relating to generic Aubagio","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3505064","2017-01-06 08:30:00","Reuters Key Development","Impax confirms patent challenge relating to generic Aubagio","SNY","Sanofi Genzyme"
"556","5 Key Takeaways In Regeneron&#39;s Praluent Suit, Steps Forward","https://www.benzinga.com/analyst-ratings/analyst-color/17/01/8877195/5-key-takeaways-in-regenerons-praluent-suit-steps-forwar","2017-01-06 09:01:09","Benzinga","... a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (ADR) (NYSE: SNY) due to infringement of patents from Amgen, Inc. (NASDAQ: AMGN).","SNY","Sanofi Genzyme"
"557","Sanofi and Immunext enter into agreement to develop treatments for autoimmune diseases","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3505805","2017-01-09 08:00:00","Reuters Key Development","Sanofi and Immunext enter into agreement to develop treatments for autoimmune diseases","SNY","Sanofi Genzyme"
"558","Amgen Wins Over Sanofi &amp; Regeneron; Here&#39;s How","http://www.thecountrycaller.com/54168-amgen-wins-over-sanofi-regeneron-heres-how","2017-01-09 14:41:15","TCC","According to the latest announcement by Amgen, Inc. (NASDAQ:AMGN), Delaware based US District Court has approved of its patent infringement allegations on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY). As per ...","SNY","Sanofi Genzyme"
"559","Amgen comments on Delaware court&#39;s ruling on PCSK9 patent litigation&lt;AMGN.O&gt;&lt;REGN.O&gt;&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3506103","2017-01-09 18:21:52","Reuters Key Development","Amgen comments on Delaware court's ruling on PCSK9 patent litigation<AMGN.O><REGN.O><SASY.PA>","SNY","Sanofi Genzyme"
"560","Regeneron says Sanofi plant used to fill drugs now deemed acceptable&lt;REGN.O&gt;&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3506085","2017-01-09 18:49:25","Reuters Key Development","Regeneron says Sanofi plant used to fill drugs now deemed acceptable<REGN.O><SASY.PA>","SNY","Sanofi Genzyme"
"561","Regeneron says Sanofi plant used to fill drugs now deemed acceptable","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3506087","2017-01-09 19:26:18","Reuters Key Development","Regeneron says Sanofi plant used to fill drugs now deemed acceptable","SNY","Sanofi Genzyme"
"562","Amgen comments on Delaware court&#39;s ruling on PCSK9 patent litigation","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3506101","2017-01-09 20:04:52","Reuters Key Development","Amgen comments on Delaware court's ruling on PCSK9 patent litigation","SNY","Sanofi Genzyme"
"563","Sanofi buys 87,298 shares of Regeneron&#39;s common stock on Jan 11","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3508508","2017-01-13 16:28:47","Reuters Key Development","Sanofi buys 87,298 shares of Regeneron's common stock on Jan 11","SNY","Sanofi Genzyme"
"564","Enteris Biopharma enters agreement with Sanofi to develop investigational oral therapeutic for type 2 diabetes","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3512764","2017-01-23 08:04:00","Reuters Key Development","Enteris Biopharma enters agreement with Sanofi to develop investigational oral therapeutic for type 2 diabetes","SNY","Sanofi Genzyme"
"565","Sanofi and Regeneron announce first approval of Kevzara","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3518398","2017-02-01 01:10:29","Reuters Key Development","Sanofi and Regeneron announce first approval of Kevzara","SNY","Sanofi Genzyme"
"566","Sanofi&#39;s Xyzal® Allergy 24HR approved for over-the-counter use in United States","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3518423","2017-02-01 01:35:10","Reuters Key Development","Sanofi's Xyzal® Allergy 24HR approved for over-the-counter use in United States","SNY","Sanofi Genzyme"
"567","Regeneron pharmaceuticals says appeals court grants stay of permanent injunction for praluent","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3523223","2017-02-08 17:30:00","Reuters Key Development","Regeneron pharmaceuticals says appeals court grants stay of permanent injunction for praluent","SNY","Sanofi Genzyme"
"568","Regeneron Pharmaceuticals Inc (NASDAQ:REGN) And Sanofi SA (ADR)(NYSE:SNY ...","https://marketexclusive.com/regeneron-pharmaceuticals-inc-nasdaqregnand-sanofi-sa-adrnysesny-loses-suit-blocking-amgen-inc-nasdaqamgn-selling-cholesterol-drug/71476/","2017-02-09 06:20:33","Market Exclusive","Sanofi SA (ADR)(NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) have lost an important court battle. The two were seeking to have Amgen, Inc. (NASDAQ:AMGN) blocked from selling their cholesterol-lowering drug Praluent in the U.S.","SNY","Sanofi Genzyme"
"569","Regeneron says price increases unrelated from innovation will be pushed back on","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3524093","2017-02-09 09:00:00","Reuters Key Development","Regeneron says price increases unrelated from innovation will be pushed back on","SNY","Sanofi Genzyme"
"570","Sanofi nearing deal to sell some over-the-counter products to Ipsen for about 100 mln euros- Bloomberg, citing source","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3525417","2017-02-12 20:43:20","Reuters Key Development","Sanofi nearing deal to sell some over-the-counter products to Ipsen for about 100 mln euros- Bloomberg, citing source","SNY","Sanofi Genzyme"
"571","Ipsen acquires a portfolio of select consumer healthcare products from Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3525545","2017-02-13 01:52:25","Reuters Key Development","Ipsen acquires a portfolio of select consumer healthcare products from Sanofi","SNY","Sanofi Genzyme"
"572","Sanofi initiates phase 2 clinical trial","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3527352","2017-02-14 08:00:00","Reuters Key Development","Sanofi initiates phase 2 clinical trial","SNY","Sanofi Genzyme"
"573","FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3535475","2017-02-24 13:47:00","Reuters Key Development","FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi","SNY","Sanofi Genzyme"
"574","Sanofi Genzyme says kevzara now available in Canada for treatment of adult patients with moderately to severely active rheumatoid arthritis","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3537660","2017-02-28 08:00:00","Reuters Key Development","Sanofi Genzyme says kevzara now available in Canada for treatment of adult patients with moderately to severely active rheumatoid arthritis","SNY","Sanofi Genzyme"
"575","Sanofi Pasteur and Medimmune collaborate on monoclonal antibody to prevent illnesses associated with RSV","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3540286","2017-03-03 02:00:31","Reuters Key Development","Sanofi Pasteur and Medimmune collaborate on monoclonal antibody to prevent illnesses associated with RSV","SNY","Sanofi Genzyme"
"576","Regeneron and Sanofi to present new phase 3 praluent (alirocumab) injection clinical trial analyses at ACC.17 Scientific Sessions","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3542328","2017-03-07 08:00:00","Reuters Key Development","Regeneron and Sanofi to present new phase 3 praluent (alirocumab) injection clinical trial analyses at ACC.17 Scientific Sessions","SNY","Sanofi Genzyme"
"577","Sanofi SA (ADR) (SNY) is Initiated by Liberum to “Hold”","https://www.highlandmirror.com/2017-03-09-sanofi-sa-adr-sny-is-initiated-by-liberum-to-hold","2017-03-09 10:11:15","Highland Mirror","Sanofi SA (ADR) (SNY) was Initiated by Liberum to “Hold”. Liberum advised their Clients and Investors in a research report released on Mar 9, 2017.","SNY","Sanofi Genzyme"
"578","UK regulator gives positive opinion on Sanofi/Regeneron&#39;s dupilumab product","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3546360","2017-03-14 04:30:36","Reuters Key Development","UK regulator gives positive opinion on Sanofi/Regeneron's dupilumab product","SNY","Sanofi Genzyme"
"579","Sanofi and Voluntis announce a global alliance to deliver digital insulin titration solutions for people with type 2 diabetes","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3546477","2017-03-14 05:46:00","Reuters Key Development","Sanofi and Voluntis announce a global alliance to deliver digital insulin titration solutions for people with type 2 diabetes","SNY","Sanofi Genzyme"
"580","How to Trade the Cratering Vale SA (ADR) (VALE) Stock","http://investorplace.com/2017/03/how-to-trade-the-cratering-vale-stock/","2017-03-20 09:18:45","Investorplace.com","How to Trade the Cratering Vale SA (ADR) (VALE) Stock. Geopolitical trade drivers for iron are tanking, ... Brazilian iron ore and coal mining specialist Vale SA (ADR) (NYSE:VALE) enjoyed a banner year in 2016. VALE stock rocketed more than 160% last ...","SNY","Sanofi Genzyme"
"581","Healthcare Highs: CytomX Therapeutics, Inc. (NASDAQ:CTMX), Sanofi SA (ADR ...","http://www.benchmarkmonitor.com/healthcare-highs-cytomx-therapeutics-inc-nasdaqctmx-sanofi-sa-adr-nysesny-la-jolla-pharmaceutical-company-nasdaqljpc/196281","2017-03-20 10:03:45","Benchmark Monitor","Sanofi SA (ADR) (NYSE:SNY) and Voluntis announced a non-exclusive agreement to deliver digital insulin titration solutions, featuring a mobile phone application designed to help improve decision-making and self-management of type 2 diabetes for people ...","SNY","Sanofi Genzyme"
"582","Insider Trading Activity Eagle Pharmaceuticals Inc (NASDAQ:EGRX) – Major ...","https://marketexclusive.com/insider-trading-activity-eagle-pharmaceuticals-inc-nasdaqegrx-major-shareholder-sold-1200-shares-of-stock-2/85937/","2017-03-21 20:22:30","Market Exclusive","On 2/18/2014 Jay Moorin, Director, bought 333,333 with an average share price of $15.00 per share and the total transaction amounting to $4,999,995.00.","SNY","Sanofi Genzyme"
"583","Flexion Therapeutics, HTG Molecular Diagnostics, Supervalu Stocks Moving Today","http://www.schaeffersresearch.com/content/news/2017/03/23/flexion-therapeutics-htg-molecular-diagnostics-supervalu-stocks-moving-today","2017-03-23 14:33:45","Schaeffers Research (blog)","FLXN is surging 36.3% higher to $26.83 today, and fresh off a new annual peak of $28.20, on reports the company is close to reaching an agreement with French drugmaker Sanofi SA (ADR) (NYSE:SNY), which is rumored to be mulling a buyout bid valued at ...","SNY","Sanofi Genzyme"
"584","Sanofi SA (ADR) (NYSE:SNY) Said to Be in Talks to Acquire Flexion Therapeutics ...","https://www.libraryforsmartinvestors.com/2017/03/sanofi-sa-adr-nysesny-said-talks-acquire-flexion-therapeutics-inc-nasdaqflxn/41370608.htm","2017-03-24 08:33:45","Library For Smart Investors","Reports indicate that Sanofi SA (ADR) (NYSE:SNY) is holding talks with a view to acquiring Flexion Therapeutics Inc (NASDAQ:FLXN).","SNY","Sanofi Genzyme"
"585","Western Digital NASDAQ:WDC) successfully repriced €881 million of new Euro ...","http://www.benchmarkmonitor.com/western-digital-nasdaqwdc-successfully-repriced-e881-million-of-new-euro-denominated-term-b-2-loans/198382","2017-03-24 09:41:15","Benchmark Monitor","Sanofi SA (ADR) (NYSE:SNY) Genzyme, the specialty care global business unit of Sanofi, announced the extension of the Multiple Myeloma Journey Partners Program that leverages storytelling as a tool to improve the patient experience with multiple ...","SNY","Sanofi Genzyme"
"586","VIX Streak in Jeopardy as Healthcare Vote Sparks Volatility","http://www.schaeffersresearch.com/content/news/2017/03/24/vix-streak-in-jeopardy-as-healthcare-vote-sparks-volatility","2017-03-24 13:26:13","Schaeffers Research (blog)","... Inc (NASDAQ:RARE) plunged after its treatment for seizures failed in a mid-stage study. Fellow drug stock Flexion Therapeutics Inc (NASDAQ:FLXN) jumped more than 33% on reports of a potential $1 billion bid from Sanofi SA (ADR) (NYSE:SNY).","SNY","Sanofi Genzyme"
"587","Stock Market Movers- Fifth Third Bancorp (NASDAQ:FITB), Sanofi SA (ADR) (NYSE:SNY)","http://www.wallstreetnews24.com/stock-market-movers-fifth-third-bancorp-nasdaqfitb-sanofi-sa-adr-nysesny/","2017-03-27 07:48:45","Wall Street Times (press release)","Fifth Third Bancorp (NASDAQ:FITB) traded at a yearly high level of $28.97 during the last trading session. The last session's volume of 5.98 million shares versus its average volume of 5.98 million shares.","SNY","Sanofi Genzyme"
"588","Vivus reacquires Stendra(R)(AVANAFIL)commercial rights from Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3555862","2017-03-27 08:30:00","Reuters Key Development","Vivus reacquires Stendra(R)(AVANAFIL)commercial rights from Sanofi","SNY","Sanofi Genzyme"
"589","Endeavour Silver (NYSE:EXK) reports initial NI43-101 Mineral Resource Estimate ...","http://www.benchmarkmonitor.com/endeavour-silver-nyseexk-reports-initial-ni43-101-mineral-resource-estimate-and-pea-for-its-el-compas-mine-project/199554","2017-03-27 09:18:45","Benchmark Monitor","Total revenue for the quarter of $12.4 million, including $10.2 million from insulin sales to Sanofi, and net income for the fourth quarter of $54.0 million including $72.0 million from the extinguishment of debt owed to Sanofi. On 24 March 2017 ...","SNY","Sanofi Genzyme"
"590","Stocks Attracting Some Extra Attention – Metlife Inc (NYSE:MET), Sanofi SA ...","http://www.wallstreetnews24.com/stocks-attracting-some-extra-attention-metlife-inc-nysemet-sanofi-sa-adr-nysesny/","2017-03-28 09:07:30","Wall Street Times (press release)","Metlife Inc (NYSE:MET) traded at a yearly high level of $58.09 during the last trading session. The last session's volume of 6.25 million shares was higher than its average volume of 6.04 million shares.","SNY","Sanofi Genzyme"
"591","Regeneron and Sanofi announce FDA approval of Dupixent","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3557089","2017-03-28 11:40:00","Reuters Key Development","Regeneron and Sanofi announce FDA approval of Dupixent","SNY","Sanofi Genzyme"
"592","U.S. FDA says approves new eczema drug Dupixent","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3557067","2017-03-28 11:47:00","Reuters Key Development","U.S. FDA says approves new eczema drug Dupixent","SNY","Sanofi Genzyme"
"593","U.S. list price for Sanofi, Regeneron&#39;s Dupixent $37,000","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3557064","2017-03-28 11:47:25","Reuters Key Development","U.S. list price for Sanofi, Regeneron's Dupixent $37,000","SNY","Sanofi Genzyme"
"594","Regeneron&#39;s Dupixent Passes The FDA Muster; Baird Sees Strong Lauch","https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9224919/regenerons-dupixent-passes-the-fda-muster-baird-sees-str","2017-03-28 12:41:15","Benzinga","Atopic dermatitis treatment candidate Dupixent jointly developed by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (ADR)(NYSE: SNY) has scaled the regulatory hurdle, a day ahead of the scheduled FDA examination day. The companies ...","SNY","Sanofi Genzyme"
"595","Express Scripts Holding Company (NASDAQ:ESRX) And Others Facing Legal Action ...","http://traders350.com/express-scripts-holding-company-nasdaqesrx-and-others-facing-legal-action-over-the-inflated-price-of-insulin/7212082/","2017-03-29 02:56:15","Traders350","... NASDAQ Stock Express Scripts Holding Company (NASDAQ:ESRX), OptumRx and CVS Health Corp (NYSE:CVS) as well as the three leading manufacturers of insulin Novo Nordisk A/S (ADR) (NYSE:NVO), Sanofi-Aventis and Eli Lilly and Co (NYSE:LLY).","SNY","Sanofi Genzyme"
"596","Stock Market Movers – FDC Ltd (Parent) (NSE:FDC), Sanofi SA (ADR) (NYSE:SNY)","http://www.wallstreetnews24.com/stock-market-movers-f-d-c-ltd-parent-nsefdc-sanofi-sa-adr-nysesny/","2017-03-29 09:30:00","Wall Street Times (press release)","Sanofi SA (ADR) (NYSE:SNY), after opening at $45.24, closed at $45.35 by scoring -0.07%. The last session's volume of 2.21 million shares was higher than its average volume of 1.51 million shares.","SNY","Sanofi Genzyme"
"597","Another lawsuit has- been filed in federal-court against Procter &amp; Gamble ...","http://www.benchmarkmonitor.com/another-lawsuit-has-been-filed-in-federal-court-against-procter-gamble-nysepg/200426","2017-03-29 10:03:45","Benchmark Monitor","Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc said the U.S. Food and Drug Administration has approved Dupixent Injection, the only biologic medicine approved for treating adults with moderate-to-severe atopic dermatitis that does not ...","SNY","Sanofi Genzyme"
"598","Stocks Attracting Some Extra Attention - Petroleo Brasileiro SA Petrobras (ADR ...","http://www.wallstreetnews24.com/stocks-attracting-some-extra-attention-petroleo-brasileiro-sa-petrobras-adr-nysepbr-eli-lilly-and-co-nyselly/","2017-04-03 07:17:38","Wall Street Times (press release)","Petroleo Brasileiro SA Petrobras (ADR) (NYSE:PBR) traded at a yearly high level of $12.56 during the last trading session.","SNY","Sanofi Genzyme"
"599","3 Stocks to Watch on Monday: Tesla Inc (TSLA), Sanofi SA (ADR) (SNY) and ...","http://investorplace.com/2017/04/3-stocks-to-watch-on-monday-tesla-inc-tsla-sanofi-sa-adr-sny-and-imagination-technologies-group-plc-img/","2017-04-03 07:48:45","Investorplace.com","Asian stocks took a step back in the new quarter following their 9% surge from January through the end of March. However, U.S. futures are tracking slightly higher in Monday morning's trade, so the S&P 500, Dow Jones Industrial Average and other major ...","SNY","Sanofi Genzyme"
"600","Evotec achieves first milestone in diabetes alliance with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3562599","2017-04-05 01:29:52","Reuters Key Development","Evotec achieves first milestone in diabetes alliance with Sanofi","SNY","Sanofi Genzyme"
"601","Sanofi appoints Bill Sibold as executive vice president for Sanofi Genzyme","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3562946","2017-04-05 08:30:47","Reuters Key Development","Sanofi appoints Bill Sibold as executive vice president for Sanofi Genzyme","SNY","Sanofi Genzyme"
"602","Benzinga&#39;s Top Upgrades, Downgrades For April 6, 2017","https://www.benzinga.com/analyst-ratings/upgrades/17/04/9270930/benzingas-top-upgrades-downgrades-for-april-6-2017","2017-04-06 09:28:53","Benzinga","Analysts at Argus initiated coverage on Sanofi SA (ADR) (NYSE: SNY) with a Buy rating. The price target for Sanofi is set to $50.","SNY","Sanofi Genzyme"
"603","Sanofi SA (ADR) (SNY) Strong New Product Pipeline and Solid Dividend","http://smartstocknews.com/87873-sanofi-sa-adr-sny-strong-new-product-pipeline-and-solid-dividend/","2017-04-06 12:30:00","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Argus initiated coverage of Sanofi SA (ADR) (NYSE:SNY), a leading global pharmaceutical company, with a BUY rating and a target price of $50.","SNY","Sanofi Genzyme"
"604","Sanofi May Now Have Moved Past Its Most Challenging Period, Analyst Initiates ...","https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9271801/sanofi-may-now-have-moved-past-its-most-challenging-peri","2017-04-06 13:03:45","Benzinga","Argus' Stephen Biggar initiated coverage of Sanofi SA (ADR) (NYSE: SNY) with a Buy rating and $50 price target as the company has moved past a challenging period.","SNY","Sanofi Genzyme"
"605","Anthrax And Government Contracts: PharmAthene And Altimmune Ahead Of Merger","https://www.benzinga.com/general/biotech/17/04/9258122/anthrax-and-government-contracts-pharmathene-and-altimmune-ahead-of-me","2017-04-06 15:52:30","Benzinga","This intra-nasally administered vaccine could replace AstraZeneca plc (ADR) (NYSE: AZN)'s FluMist, recently pulled from the market, as well as GlaxoSmithKline plc (ADR) (NYSE: GSK), Sanofi SA (ADR) (NYSE: SNY) and CSL's traditional flu vaccines, which ...","SNY","Sanofi Genzyme"
"606","Raymond James Financial Gives Texas Capital Bancshares (NDAQ:TCBI) $98.00 ...","http://kgazette.com/raymond-james-financial-gives-texas-capital-bancshares-ndaqtcbi-98-00-target-sanofi-sny-shorts-lowered-by-11-24/","2017-04-10 07:25:55","Key Gazette","With 1.12 million avg volume, 4 days are for Sanofi (NYSE:SNY)'s short sellers to cover SNY's short positions. The SI to Sanofi's float is 0.21%.","SNY","Sanofi Genzyme"
"607","HSBC Securities Downgrades Sanofi-aventis Sa (SNY), Teewinot Capital Advisers ...","http://utahherald.com/hsbc-securities-downgrades-sanofi-aventis-sa-sny-teewinot-capital-advisers-upped-by-5-80-million-its-netflix-nflx-stake/","2017-04-10 07:57:07","UtahHerald.com","The stock of Sanofi SA (ADR) (NYSE:SNY) has “Neutral” rating given on Tuesday, September 13 by BNP Paribas. On Friday, March 31 the stock rating was maintained by JP Morgan with “Sell”.","SNY","Sanofi Genzyme"
"608","Analysts Concerns on: Sanofi SA (ADR) (NYSE:SNY)","http://postregistrar.com/2017/04/10/analysts-concerns-on-sanofi-sa-adr-nysesny/","2017-04-10 08:56:15","Post Registrar","Sanofi SA (ADR) (NYSE:SNY) fell -1.10% during previous trade. HSBC Securities issued rating on the stock of Sanofi SA (ADR) (NYSE:SNY) in a research note issued to investors on Apr-07-17, the stock received “Downgrade” rating from Hold to Reduce.","SNY","Sanofi Genzyme"
"609","Cardiovascular Players Could Be Eyeing Esperion","https://www.benzinga.com/general/biotech/17/04/9282574/cardiovascular-players-could-be-eyeing-esperion","2017-04-10 11:45:00","Benzinga","The Seeking Alpha author didn't speculate as to potential bidders, but, according to a PMLive report, AstraZeneca plc (ADR) (NYSE: AZN), Sanofi SA (ADR) (NYSE: SNY) and Merck & Co., Inc. (NYSE: MRK) had the highest sales of cardiovascular products in ...","SNY","Sanofi Genzyme"
"610","Momentum Stocks in Focus Dicks Sporting Goods Inc (NYSE:DKS), Sanofi SA (ADR ...","http://www.journalfinance.net/2017/04/momentum-stocks-in-focus-dicks-sporting-goods-inc-nysedks-sanofi-sa-adr-nysesny/","2017-04-10 13:48:45","Daily News Journal","On Friday, Dicks Sporting Goods Inc (NYSE:DKS) stock opened its trade at $49.59 and after floating in a range of $49.52 to $50.29, settled at $49.97.","SNY","Sanofi Genzyme"
"611","Here&#39;s Our Take On MannKind Corporation (NASDAQ:MNKD)&#39;s Current Situation","https://www.insiderfinancial.com/heres-our-take-on-mannkind-corporation-nasdaqmnkds-current-situation/121101/","2017-04-11 13:37:30","Insider Financial","It's a biotech play that developed a diabetes asset in conjunction with pharma giant Sanofi SA (ADR) (NYSE:SNY).","SNY","Sanofi Genzyme"
"612","DHI Group (DHX) Reaches $4.03 After 6.00% Down Move; Dodge &amp; Cox Upped Its ...","https://huronreport.com/dhi-group-dhx-reaches-4-03-after-6-00-down-move-dodge-cox-upped-its-sanofi-sny-stake/","2017-04-12 12:41:15","HuronReport","Sanofi now has $117.77 billion valuation. The stock rose 0.13% or $0.06 reaching $45.23 per share. About 317,690 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 14.70% since September 6, 2016 and is uptrending. It has outperformed by 7.05% the ...","SNY","Sanofi Genzyme"
"613","Sanofi-aventis Sa (SNY) Upgraded By JP Morgan from “Underperform”, 3 Bullish ...","https://wolcottdaily.com/sanofi-aventis-sa-sny-upgraded-by-jp-morgan-from-underperform-3-bullish-analysts-covering-aerohive-networks-hive/","2017-04-13 07:02:01","Wolcott Daily","Sanofi-aventis Sa had 14 analyst reports since October 15, 2015 according to SRatingsIntel. The firm has “Overweight” rating by Barclays Capital given on Thursday, May 12.","SNY","Sanofi Genzyme"
"614","Courier Capital Has Decreased By $327520 Its Sanofi (SNY) Position, Plains All ...","https://wolcottdaily.com/courier-capital-has-decreased-by-327520-its-sanofi-sny-position-plains-all-american-pipeline-lp-paa-has-0-84-sentiment/","2017-04-14 13:15:00","Wolcott Daily","Sanofi now has $117.67 billion valuation. The stock increased 0.57% or $0.26 on April 13, reaching $45.65. About 1.37M shares traded or 7.03% up from the average.","SNY","Sanofi Genzyme"
"615","CVB Financial Corp. (CVBF) EPS Estimated At $0.25, Senzar Asset Management ...","https://kgazette.com/cvb-financial-corp-cvbf-eps-estimated-at-0-25-senzar-asset-management-lowered-by-8-02-million-its-sanofi-sny-position/","2017-04-18 06:18:45","Key Gazette","Sanofi now has $117.32B valuation. The stock decreased 0.26% or $0.12 on April 17, reaching $45.53. About shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 16.18% since September 9, 2016 and is uptrending. It has outperformed by 5.78% the ...","SNY","Sanofi Genzyme"
"616","Sanofi SA (ADR) (SNY) Reaches $44.28 After 7.00% Down Move; Basso Capital ...","https://heraldks.com/sanofi-sa-adr-sny-reaches-44-28-after-7-00-down-move-basso-capital-management-lp-raised-by-500000-its-spirit-rlty-cap-new-put-src-position/","2017-04-18 12:30:00","Herald KS","The stock of Sanofi SA (ADR) (NYSE:SNY) is a huge mover today! About 920,638 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 16.18% since September 9, 2016 and is uptrending. It has outperformed by 5.78% the S&P500.The move comes after 9 ...","SNY","Sanofi Genzyme"
"617","Sanofi SA (ADR) (SNY) Reaches $44.34 After 8.00% Gap Down; Heronetta ...","https://wolcottdaily.com/sanofi-sa-adr-sny-reaches-44-34-after-8-00-gap-down-heronetta-management-lp-upped-enbridge-energy-partners-lp-eep-position-by-642500/","2017-04-18 12:52:30","Wolcott Daily","Sanofi-aventis Sa had 14 analyst reports since October 15, 2015 according to SRatingsIntel. As per Thursday, May 12, the company rating was upgraded by Barclays Capital.","SNY","Sanofi Genzyme"
"618","Form 487 Advisors Disciplined","https://www.streetinsider.com/SEC+Filings/Form+487+Advisors+Disciplined/12787317.html","2017-04-18 13:03:45","StreetInsider.com","HIMCO sought to select high quality stocks with above average dividend yields by considering a broad universe including securities in the Russell 3000(R) Index and approximately 500 American Depository Receipts (""ADRs"") for inclusion in the trust's ...","SNY","Sanofi Genzyme"
"619","Sanofi SA (ADR) (SNY) Reaches $44.45 After 7.00% Gap Down, Strayer Education ...","https://huronreport.com/sanofi-sa-adr-sny-reaches-44-45-after-7-00-gap-down-strayer-education-stra-sentiment-is-1-07/","2017-04-18 16:37:30","HuronReport","The stock of Sanofi SA (ADR) (NYSE:SNY) gapped down by $0.61 today and has $41.34 target or 7.00% below today's $44.45 share price.","SNY","Sanofi Genzyme"
"620","Actis portfolio company MédiS Group announces acquisition of Winthrop Pharma Senegal from Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3570818","2017-04-19 09:00:00","Reuters Key Development","Actis portfolio company MédiS Group announces acquisition of Winthrop Pharma Senegal from Sanofi","SNY","Sanofi Genzyme"
"621","Cardinal Health (CAH) Lost It&#39;s William Blair “Outperform” Rating; Stephens ...","https://utahherald.com/cardinal-health-cah-lost-its-william-blair-outperform-rating-stephens-upped-by-1-05-million-its-sanofi-sny-holding/","2017-04-19 14:11:15","UtahHerald.com","Sanofi now has $111.80B valuation. The stock rose 0.02% or $0.01 reaching $44.46 per share. About 1.12M shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 11.63% since September 12, 2016 and is uptrending. It has outperformed by 3.14% the ...","SNY","Sanofi Genzyme"
"622","Benjamin F Edwards &amp; Company Trimmed By $539800 Its Sanofi (SNY) Holding ...","https://www.bibeypost.com/benjamin-f-edwards-artisan-partners-limited-partnership-decreased-its-alleghany-del-y-holding/","2017-04-19 16:48:45","Bibeypost.com","Sanofi now has $111.47 billion valuation. The stock declined 0.27% or $0.12 reaching $44.33 per share. About 1.19M shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 11.63% since September 12, 2016 and is uptrending. It has outperformed by 3.14% ...","SNY","Sanofi Genzyme"
"623","Courier Capital Decreased Sanofi (SNY) Position; Natures Sunshine Products ...","https://utahherald.com/courier-capital-decreased-sanofi-sny-position-natures-sunshine-products-natr-shorts-increased-by-5-33/","2017-04-20 11:00:00","UtahHerald.com","Sanofi now has $115.91 billion valuation. The stock rose 1.58% or $0.7 reaching $45.01. About 901,047 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 13.06% since September 13, 2016 and is uptrending. It has outperformed by 3.14% the S&P500.","SNY","Sanofi Genzyme"
"624","Ares Capital (ARCC) Analysts See $0.36 EPS; Sanofi SA (ADR) (SNY) Covered By 4 ...","http://www.mmahotstuff.com/2017/04/20/ares-capital-arcc-analysts-see-0-36-eps-sanofi-sa-adr-sny-covered-by-4-bulls.html","2017-04-20 13:26:15","MoneyMakingArticles","Among 10 analysts covering Sanofi-aventis Sa (NYSE:SNY), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive.","SNY","Sanofi Genzyme"
"625","Analysts See $0.75 EPS for Sanofi SA (ADR) (SNY), Sarepta Therapeutics DE ...","https://heraldks.com/analysts-see-0-75-eps-for-sanofi-sa-adr-sny-sarepta-therapeutics-de-srpt-shorts-up-by-9-96/","2017-04-21 12:18:45","Herald KS","After having $0.67 EPS previously, Sanofi SA (ADR)'s analysts see 11.94% EPS growth. About 859,482 shares traded.","SNY","Sanofi Genzyme"
"626","EU Medicines Agency recommendations for April 2017","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3572890","2017-04-21 13:51:48","Reuters Key Development","EU Medicines Agency recommendations for April 2017","SNY","Sanofi Genzyme"
"627","Sanofi-aventis Sa (SNY) Neutral Rating Reiterated at JP Morgan, Shorts at ...","https://kgazette.com/sanofi-aventis-sa-sny-neutral-rating-reiterated-at-jp-morgan-shorts-at-trican-well-service-tolwf-lowered-by-61-37/","2017-04-21 15:18:45","Key Gazette","Sanofi-aventis Sa had 14 analyst reports since October 15, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, September 8 by Berenberg.","SNY","Sanofi Genzyme"
"628","Merck announces publication of pivotal data from phase 3 clinical studies of ZERBAXA","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3200759","2015-04-27 18:30:00","Reuters Key Development","Merck announces publication of pivotal data from phase 3 clinical studies of ZERBAXA","MRK","Merck"
"629","Merck &amp; Co Inc reaffirms FY 2015 guidance, raises EPS outlook","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3201649","2015-04-28 07:07:00","Reuters Key Development","Merck & Co Inc reaffirms FY 2015 guidance, raises EPS outlook","MRK","Merck"
"630","Plexxikon and Merck to collaborate on combination study evaluating investigational immuno-oncology regimen","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3208233","2015-05-07 08:30:00","Reuters Key Development","Plexxikon and Merck to collaborate on combination study evaluating investigational immuno-oncology regimen","MRK","Merck"
"631","Merck &amp; Co., Inc receives positive CHMP opinion for Pembrolizumab for treatment of advanced melanoma","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3217696","2015-05-22 07:12:00","Reuters Key Development","Merck & Co., Inc receives positive CHMP opinion for Pembrolizumab for treatment of advanced melanoma","MRK","Merck"
"632","Merck &amp; Co Inc announces Q3 2015 Dividend","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3219198","2015-05-26 13:31:00","Reuters Key Development","Merck & Co Inc announces Q3 2015 Dividend","MRK","Merck"
"633","Merck and NanoString Announce Clinical Research Collaboration","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3220680","2015-05-28 08:30:00","Reuters Key Development","Merck and NanoString Announce Clinical Research Collaboration","MRK","Merck"
"634","Merck submits U.S. New Drug Application for Grazoprevir/Elbasvir","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3220865","2015-05-28 16:30:00","Reuters Key Development","Merck submits U.S. New Drug Application for Grazoprevir/Elbasvir","MRK","Merck"
"635","Amgen And Merck Announce Expansion Of Collaboration","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3221511","2015-05-29 08:30:00","Reuters Key Development","Amgen And Merck Announce Expansion Of Collaboration","MRK","Merck"
"636","Merck &amp; Co Inc and Dynavax Technologies Corp announce new collaboration investigating combination of Immuno-Oncology Therapies","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3222444","2015-06-01 08:30:00","Reuters Key Development","Merck & Co Inc and Dynavax Technologies Corp announce new collaboration investigating combination of Immuno-Oncology Therapies","MRK","Merck"
"637","Merck &amp; Co Inc announces results from investigational IMPROVE-IT Study of VYTORIN published in New England Journal of Medicine","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3224228","2015-06-03 17:00:00","Reuters Key Development","Merck & Co Inc announces results from investigational IMPROVE-IT Study of VYTORIN published in New England Journal of Medicine","MRK","Merck"
"638","Merck &amp; Co Inc&#39;s Keytruda (pembrolizumab) receives conditional approval in Canada for treatment of Advanced Melanoma","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3225840","2015-06-08 07:00:00","Reuters Key Development","Merck & Co Inc's Keytruda (pembrolizumab) receives conditional approval in Canada for treatment of Advanced Melanoma","MRK","Merck"
"639","Merck &amp; Co Inc Cardiovascular safety trial of Januvia (Sitagliptin), met primary endpoint in patients with type 2 diabetes","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3227308","2015-06-10 07:00:00","Reuters Key Development","Merck & Co Inc Cardiovascular safety trial of Januvia (Sitagliptin), met primary endpoint in patients with type 2 diabetes","MRK","Merck"
"640","Merck announces phase 3 study of single-dose EMEND","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3236566","2015-06-29 08:30:00","Reuters Key Development","Merck announces phase 3 study of single-dose EMEND","MRK","Merck"
"641","Merck announces fourth-quarter 2015 dividend","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3248875","2015-07-22 13:28:00","Reuters Key Development","Merck announces fourth-quarter 2015 dividend","MRK","Merck"
"642","Merck &amp; Co Inc Receives Positive CHMP Opinion for Investigational Antibiotic ZERBAXA","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3250931","2015-07-27 08:30:00","Reuters Key Development","Merck & Co Inc Receives Positive CHMP Opinion for Investigational Antibiotic ZERBAXA","MRK","Merck"
"643","Merck &amp; Co Inc announces U.S. FDA acceptance of NDA for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Genotypes 1, 4 and 6 Infection","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3251556","2015-07-28 06:30:00","Reuters Key Development","Merck & Co Inc announces U.S. FDA acceptance of NDA for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Genotypes 1, 4 and 6 Infection","MRK","Merck"
"644","Merck buys cCam Biotherapeutics for $95 mln upfront payment in cash","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3251655","2015-07-28 06:45:00","Reuters Key Development","Merck buys cCam Biotherapeutics for $95 mln upfront payment in cash","MRK","Merck"
"645","Merck &amp; Co Inc raises FY 2015 EPS outlook; raises low end of prior FY 2015 revenue guidance to a range in line with analysts&#39; estimates","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3251595","2015-07-28 07:00:00","Reuters Key Development","Merck & Co Inc raises FY 2015 EPS outlook; raises low end of prior FY 2015 revenue guidance to a range in line with analysts' estimates","MRK","Merck"
"646","Merck &amp; Co Inc announces approval of Brenzys in Korea","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3270830","2015-09-08 08:30:00","Reuters Key Development","Merck & Co Inc announces approval of Brenzys in Korea","MRK","Merck"
"647","Merck &amp; Co Inc says results of Phase 2 Study of Merck&#39;s Investigational Beta-Lactamase Inhibitor Relebactam Presented at ICAAC/ICC 2015","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3275352","2015-09-18 15:00:00","Reuters Key Development","Merck & Co Inc says results of Phase 2 Study of Merck's Investigational Beta-Lactamase Inhibitor Relebactam Presented at ICAAC/ICC 2015","MRK","Merck"
"648","Merck &amp; Co Inc&#39;s MARIZEV (Omarigliptin), Merck&#39;s Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes, Approved in Japan","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3278135","2015-09-28 07:30:00","Reuters Key Development","Merck & Co Inc's MARIZEV (Omarigliptin), Merck's Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes, Approved in Japan","MRK","Merck"
"649","Merck &amp; Co Inc and DNAtrix announce phase 2 immuno-oncology collaboration in patients with aggressive form of brain cancer","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3280184","2015-10-01 08:00:00","Reuters Key Development","Merck & Co Inc and DNAtrix announce phase 2 immuno-oncology collaboration in patients with aggressive form of brain cancer","MRK","Merck"
"650","Merck &amp; Co Inc says FDA approves KEYTRUDA for treatment of patients with metastatic non-small cell lung cancer","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3280757","2015-10-02 14:49:00","Reuters Key Development","Merck & Co Inc says FDA approves KEYTRUDA for treatment of patients with metastatic non-small cell lung cancer","MRK","Merck"
"651","OBI Pharma, Inc. enters exclusive agreement with Merck for rights to DIFICID (fidaxomicin) in Taiwan","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3280787","2015-10-04 05:58:00","Reuters Key Development","OBI Pharma, Inc. enters exclusive agreement with Merck for rights to DIFICID (fidaxomicin) in Taiwan","MRK","Merck"
"652","MacroGenics Inc and Merck to collaborate on Immuno-Oncology study","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3288628","2015-10-22 07:30:00","Reuters Key Development","MacroGenics Inc and Merck to collaborate on Immuno-Oncology study","MRK","Merck"
"653","Merck &amp; Co Inc says KEYTRUDA shows superior overall survival compared to chemotherapy in patients with previously treated advanced non-small cell lung cancer whose tumors express PD-l1","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3290092","2015-10-26 09:00:00","Reuters Key Development","Merck & Co Inc says KEYTRUDA shows superior overall survival compared to chemotherapy in patients with previously treated advanced non-small cell lung cancer whose tumors express PD-l1","MRK","Merck"
"654","Eli Lilly And Co and Merck &amp; Co Inc expand immuno-oncology collaboration with phase III nonsquamous non-small cell lung cancer trial","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3301983","2015-11-19 06:30:00","Reuters Key Development","Eli Lilly And Co and Merck & Co Inc expand immuno-oncology collaboration with phase III nonsquamous non-small cell lung cancer trial","MRK","Merck"
"655","Merck &amp; Co Inc announces increased quarterly dividend","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3303643","2015-11-24 12:35:00","Reuters Key Development","Merck & Co Inc announces increased quarterly dividend","MRK","Merck"
"656","Amgen And Merck Announce Cancer Immunotherapy Collaboration For Patients With Non-Hodgkin Lymphoma","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3307408","2015-12-04 08:01:00","Reuters Key Development","Amgen And Merck Announce Cancer Immunotherapy Collaboration For Patients With Non-Hodgkin Lymphoma","MRK","Merck"
"657","Merck &amp; Co Inc - FDA panel rejects Merck claim Zetia/Vytorin cut heart risk - Reuters","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3312671","2015-12-14 16:28:00","Reuters Key Development","Merck & Co Inc - FDA panel rejects Merck claim Zetia/Vytorin cut heart risk - Reuters","MRK","Merck"
"658","Merck &amp; Co Inc says FDA approves expanded age indication for Gardasil 9 in males","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3311388","2015-12-15 17:07:00","Reuters Key Development","Merck & Co Inc says FDA approves expanded age indication for Gardasil 9 in males","MRK","Merck"
"659","Biocartis Group announces collaboration with Merck","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3318287","2016-01-07 02:00:00","Reuters Key Development","Biocartis Group announces collaboration with Merck","MRK","Merck"
"660","Merck &amp; Co Inc acquires IOmet Pharma","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3319291","2016-01-11 16:08:00","Reuters Key Development","Merck & Co Inc acquires IOmet Pharma","MRK","Merck"
"661","Merck announces FDA acceptance of Biologics License Application for Bezlotoxumab","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3324546","2016-01-27 08:30:00","Reuters Key Development","Merck announces FDA acceptance of Biologics License Application for Bezlotoxumab","MRK","Merck"
"662","Merck &amp; Co Inc gives FY 2016 guidance","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3328130","2016-02-03 06:45:00","Reuters Key Development","Merck & Co Inc gives FY 2016 guidance","MRK","Merck"
"663","Merck &amp; Co Inc&#39;s investigational once-daily formulation of ISENTRESS meets primary and secondary endpoints in pivotal phase 3 study","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3333704","2016-02-22 08:00:00","Reuters Key Development","Merck & Co Inc's investigational once-daily formulation of ISENTRESS meets primary and secondary endpoints in pivotal phase 3 study","MRK","Merck"
"664","Merck sets quarterly dividend of 46 cents per share","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3380812","2016-05-24 14:35:00","Reuters Key Development","Merck sets quarterly dividend of 46 cents per share","MRK","Merck"
"665","Merck Global Health Innovation Fund hikes stake in OpGen to 37.5 pct from 11.8 pct","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3383227","2016-05-27 16:01:11","Reuters Key Development","Merck Global Health Innovation Fund hikes stake in OpGen to 37.5 pct from 11.8 pct","MRK","Merck"
"666","Merck to acquire Afferent Pharmaceuticals","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3389363","2016-06-09 17:07:00","Reuters Key Development","Merck to acquire Afferent Pharmaceuticals","MRK","Merck"
"667","Merck&#39;s Keytruda shows superior progression-free, overall survival in lung cancer patients","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3392163","2016-06-16 06:45:00","Reuters Key Development","Merck's Keytruda shows superior progression-free, overall survival in lung cancer patients","MRK","Merck"
"668","Merck, Premier Inc collaborate to improve care for osteoporosis patients","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3398666","2016-06-30 09:28:15","Reuters Key Development","Merck, Premier Inc collaborate to improve care for osteoporosis patients","MRK","Merck"
"669","Merck Animal Health to buy controlling interest in Vallée S.A","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3399527","2016-07-01 12:05:00","Reuters Key Development","Merck Animal Health to buy controlling interest in Vallée S.A","MRK","Merck"
"670","Merck&#39;s Healthcare invests majority stake in Staywell","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3403048","2016-07-11 07:00:00","Reuters Key Development","Merck's Healthcare invests majority stake in Staywell","MRK","Merck"
"671","Merck provides regulatory update on Biologics application","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3409440","2016-07-21 16:30:00","Reuters Key Development","Merck provides regulatory update on Biologics application","MRK","Merck"
"672","Merck designated breakthrough therapy by FDA and gets prime status from EMA for ebola vaccine","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3410766","2016-07-25 08:00:00","Reuters Key Development","Merck designated breakthrough therapy by FDA and gets prime status from EMA for ebola vaccine","MRK","Merck"
"673","Enigma biomedical announces research collaboration agreement with Biogen Inc and Merck","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3410983","2016-07-25 17:04:00","Reuters Key Development","Enigma biomedical announces research collaboration agreement with Biogen Inc and Merck","MRK","Merck"
"674","Merck sets quarterly dividend of $0.46 per share","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3411869","2016-07-26 12:50:00","Reuters Key Development","Merck sets quarterly dividend of $0.46 per share","MRK","Merck"
"675","Merck plans to end partnership agreement with Alk Abello","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3412227","2016-07-27 01:25:37","Reuters Key Development","Merck plans to end partnership agreement with Alk Abello","MRK","Merck"
"676","Merck Q2 adjusted earnings per share $0.93","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3415225","2016-07-29 06:45:00","Reuters Key Development","Merck Q2 adjusted earnings per share $0.93","MRK","Merck"
"677","Biogen has drawn takeover interest from drug companies including Merck &amp; Co and Allergan - WSJ","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3417355","2016-08-02 14:47:32","Reuters Key Development","Biogen has drawn takeover interest from drug companies including Merck & Co and Allergan - WSJ","MRK","Merck"
"678","Merck announces U.S. FDA filing acceptance of new drug application (NDA) for mk-1293","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3420409","2016-08-05 08:00:00","Reuters Key Development","Merck announces U.S. FDA filing acceptance of new drug application (NDA) for mk-1293","MRK","Merck"
"679","Merck &amp; Co says FDA approves keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3420654","2016-08-05 19:30:00","Reuters Key Development","Merck & Co says FDA approves keytruda","MRK","Merck"
"680","BRIEF-Merck &amp; Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5)","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3421406","2016-08-08 11:43:34","Reuters Key Development","BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5)","MRK","Merck"
"681","Biothera Pharmaceuticals expands relationship with Merck","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3431691","2016-08-24 11:25:00","Reuters Key Development","Biothera Pharmaceuticals expands relationship with Merck","MRK","Merck"
"682","Merck provides update on odanacatib development program","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3436751","2016-09-02 07:00:00","Reuters Key Development","Merck provides update on odanacatib development program","MRK","Merck"
"683","Merck says FDA grants breakthrough therapy designation to Keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3438299","2016-09-07 06:45:00","Reuters Key Development","Merck says FDA grants breakthrough therapy designation to Keytruda","MRK","Merck"
"684","Merck Canada says BRENZYS approved in Canada","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3439878","2016-09-12 08:00:00","Reuters Key Development","Merck Canada says BRENZYS approved in Canada","MRK","Merck"
"685","Merck, Pfizer say investigational Ertugliflozin met primary endpoint","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3441449","2016-09-15 08:31:00","Reuters Key Development","Merck, Pfizer say investigational Ertugliflozin met primary endpoint","MRK","Merck"
"686","Merck&#39;s bladder cancer drug meets primary endpoint and stops early","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3458288","2016-10-21 06:45:00","Reuters Key Development","Merck's bladder cancer drug meets primary endpoint and stops early","MRK","Merck"
"687","Merck &amp; Co says FDA also approves a labeling update for Keytruda for treatment of patients with metastatic NSCLC","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3459589","2016-10-24 18:04:00","Reuters Key Development","Merck & Co says FDA also approves a labeling update for Keytruda for treatment of patients with metastatic NSCLC","MRK","Merck"
"688","Merck prices EUR 1 bln debt offering","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3461738","2016-10-26 13:31:00","Reuters Key Development","Merck prices EUR 1 bln debt offering","MRK","Merck"
"689","Adaptimmune announces collaboration with MSD to evaluate Keytruda (pembrolizumab)","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3463232","2016-10-27 10:16:05","Reuters Key Development","Adaptimmune announces collaboration with MSD to evaluate Keytruda (pembrolizumab)","MRK","Merck"
"690","Biothera Pharma&#39;s announces new preclinical data on its immunotherapy drug","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3476469","2016-11-11 11:59:00","Reuters Key Development","Biothera Pharma's announces new preclinical data on its immunotherapy drug","MRK","Merck"
"691","OpGen collaborates with Merck to develop rapid diagnostics and informatics tools to help combat antimicrobial resistance","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3477399","2016-11-14 07:00:00","Reuters Key Development","OpGen collaborates with Merck to develop rapid diagnostics and informatics tools to help combat antimicrobial resistance","MRK","Merck"
"692","Genexine entered into a clinical research collaboration with Merck &amp; Co","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3479954","2016-11-16 08:00:00","Reuters Key Development","Genexine entered into a clinical research collaboration with Merck & Co","MRK","Merck"
"693","Merck raises quarterly dividend to $0.47/share from $0.46/share","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3483029","2016-11-22 13:22:00","Reuters Key Development","Merck raises quarterly dividend to $0.47/share from $0.46/share","MRK","Merck"
"694","Natrix Separations announces collaboration agreements with Merck and Sanofi","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3487624","2016-11-30 09:30:00","Reuters Key Development","Natrix Separations announces collaboration agreements with Merck and Sanofi","MRK","Merck"
"695","Merck CEO says importing drugs from outside U.S. not possible","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3488430","2016-12-01 11:18:11","Reuters Key Development","Merck CEO says importing drugs from outside U.S. not possible","MRK","Merck"
"696","Biothera Pharmaceuticals and Merck further expand research collaboration","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3490086","2016-12-05 09:30:00","Reuters Key Development","Biothera Pharmaceuticals and Merck further expand research collaboration","MRK","Merck"
"697","Merck presents updated findings from Keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3490122","2016-12-05 10:42:00","Reuters Key Development","Merck presents updated findings from Keytruda","MRK","Merck"
"698","Drugmakers trade group says government mandates wrong way to address drug costs","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3491584","2016-12-07 12:15:21","Reuters Key Development","Drugmakers trade group says government mandates wrong way to address drug costs","MRK","Merck"
"699","Europea&#39;s CHMP recommends Merck&#39;s Keytruda® for lung cancer treatment","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3496632","2016-12-16 07:26:00","Reuters Key Development","Europea's CHMP recommends Merck's Keytruda® for lung cancer treatment","MRK","Merck"
"700","Keytruda approved in japan for first-line treatment of patients with advanced non-small cell lung cancer","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3497456","2016-12-19 07:00:00","Reuters Key Development","Keytruda approved in japan for first-line treatment of patients with advanced non-small cell lung cancer","MRK","Merck"
"701","Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3502755","2017-01-02 02:05:14","Reuters Key Development","Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe","MRK","Merck"
"702","Cerveau Technologies signs license agreement with Merck for novel investigational Tau imaging agent","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3504677","2017-01-05 16:02:00","Reuters Key Development","Cerveau Technologies signs license agreement with Merck for novel investigational Tau imaging agent","MRK","Merck"
"703","Merck &amp; Co Inc gets FDA acceptance of supplemental biologics license application for Keytruda in combination with chemotherapy","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3506688","2017-01-10 16:06:00","Reuters Key Development","Merck & Co Inc gets FDA acceptance of supplemental biologics license application for Keytruda in combination with chemotherapy","MRK","Merck"
"704","Agenus Inc says collaboration with National Cancer Institute to evaluate combination of Pembrolizumab with prophage autologous vaccine","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3509610","2017-01-17 09:00:00","Reuters Key Development","Agenus Inc says collaboration with National Cancer Institute to evaluate combination of Pembrolizumab with prophage autologous vaccine","MRK","Merck"
"705","Merck announces license agreement resolving Keytruda patent litigation","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3511913","2017-01-20 16:01:00","Reuters Key Development","Merck announces license agreement resolving Keytruda patent litigation","MRK","Merck"
"706","Bristol-Myers squibb and Ono pharmaceutical enters license agreement with Merck","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3511915","2017-01-20 16:01:00","Reuters Key Development","Bristol-Myers squibb and Ono pharmaceutical enters license agreement with Merck","MRK","Merck"
"707","European Commission approves Keytruda for first-line treatment of patients with metastatic non-small cell lung cancer","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3518169","2017-01-31 16:00:00","Reuters Key Development","European Commission approves Keytruda for first-line treatment of patients with metastatic non-small cell lung cancer","MRK","Merck"
"708","Merck Q4 adjusted earnings per share $0.89","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3519577","2017-02-02 06:53:10","Reuters Key Development","Merck Q4 adjusted earnings per share $0.89","MRK","Merck"
"709","Merck CEO says business development a priority","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3519734","2017-02-02 09:11:01","Reuters Key Development","Merck CEO says business development a priority","MRK","Merck"
"710","FDA grants accelerated approval to Bristol-Myers Squibb&#39;s nivolumab","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3519859","2017-02-02 14:33:05","Reuters Key Development","FDA grants accelerated approval to Bristol-Myers Squibb's nivolumab","MRK","Merck"
"711","Merck says FDA accepts two SBLAs for Keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3520358","2017-02-03 06:45:00","Reuters Key Development","Merck says FDA accepts two SBLAs for Keytruda","MRK","Merck"
"712","Immunovaccine says Princess Margaret Cancer Centre to conduct Phase 2 clinical trial to evaluate use of co, Merck&#39;s combination of immunotherapies","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3521121","2017-02-06 07:05:00","Reuters Key Development","Immunovaccine says Princess Margaret Cancer Centre to conduct Phase 2 clinical trial to evaluate use of co, Merck's combination of immunotherapies","MRK","Merck"
"713","Boehringer Ingelheim - To evaluate Afatinib in combination with PD-1 inhibitor pembrolizumab","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3524069","2017-02-09 08:30:00","Reuters Key Development","Boehringer Ingelheim - To evaluate Afatinib in combination with PD-1 inhibitor pembrolizumab","MRK","Merck"
"714","Capital World Investors reports 5.1 pct passive stake in Merck &amp; Co as on Dec 30 - SEC Filing","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3526396","2017-02-13 17:14:45","Reuters Key Development","Capital World Investors reports 5.1 pct passive stake in Merck & Co as on Dec 30 - SEC Filing","MRK","Merck"
"715","Merck&#39;s doravirine meets primary efficacy endpoint in pivotal phase 3 trial","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3527699","2017-02-14 16:05:00","Reuters Key Development","Merck's doravirine meets primary efficacy endpoint in pivotal phase 3 trial","MRK","Merck"
"716","Merck announces Epoch study of Verubecestat","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3527787","2017-02-14 17:00:00","Reuters Key Development","Merck announces Epoch study of Verubecestat","MRK","Merck"
"717","Biothera Pharmaceuticals initiates patient dosing in phase 2 trial investigating Imprime PGG, Merck&#39;s Keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3534231","2017-02-23 09:00:00","Reuters Key Development","Biothera Pharmaceuticals initiates patient dosing in phase 2 trial investigating Imprime PGG, Merck's Keytruda","MRK","Merck"
"718","Merck to record $2.9 bln impairment charge related to uprifosbuvir program - SEC filing","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3534597","2017-02-23 17:53:32","Reuters Key Development","Merck to record $2.9 bln impairment charge related to uprifosbuvir program - SEC filing","MRK","Merck"
"719","In first phase 3 trial Merck&#39;s virus vaccine (V2120 reduced the incidence of confirmed herpes zoster cases","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3535487","2017-02-24 16:00:00","Reuters Key Development","In first phase 3 trial Merck's virus vaccine (V2120 reduced the incidence of confirmed herpes zoster cases","MRK","Merck"
"720","Merck sets quarterly dividend of $0.47/share","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3537961","2017-02-28 13:47:00","Reuters Key Development","Merck sets quarterly dividend of $0.47/share","MRK","Merck"
"721","Glenmark Pharmaceuticals and Evestra announce partnership agreement for generic NuvaRing","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3539073","2017-03-01 13:58:00","Reuters Key Development","Glenmark Pharmaceuticals and Evestra announce partnership agreement for generic NuvaRing","MRK","Merck"
"722","Merck and pfizer announce U.S. Fda and EMA filing acceptances","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3541355","2017-03-06 08:00:00","Reuters Key Development","Merck and pfizer announce U.S. Fda and EMA filing acceptances","MRK","Merck"
"723","Merck provides update on supplemental biologics license application (sbla) for KEYTRUDA® (pembrolizumab)","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3547338","2017-03-14 16:43:00","Reuters Key Development","Merck provides update on supplemental biologics license application (sbla) for KEYTRUDA® (pembrolizumab)","MRK","Merck"
"724","Merck says FDA approves keytruda for treatment of patients with refractory classical hodgkin lymphoma","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3547356","2017-03-14 17:05:00","Reuters Key Development","Merck says FDA approves keytruda for treatment of patients with refractory classical hodgkin lymphoma","MRK","Merck"
"725","U.S. appeals court revives claims against Merck over Fosamax","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3552991","2017-03-22 08:33:14","Reuters Key Development","U.S. appeals court revives claims against Merck over Fosamax","MRK","Merck"
"726","Merck &amp; Co., Inc. subtracted -0.64% in its Stock Price in the Previous Trading ...","http://www.freeobserver.com/merck-co-inc-subtracted-0-64-in-its-stock-price-in-the-previous-trading-session/","2017-03-23 08:00:00","Free Observer","If you look at the company's income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, MRK earned gross profit of 31.25 Billion, in 2015 29.67 Billion gross profit, while in 2016 Merck & Co., Inc ...","MRK","Merck"
"727","European Medicines Agency&#39;s CHMP recommends approval of Merck&#39;s keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3554887","2017-03-24 08:13:00","Reuters Key Development","European Medicines Agency's CHMP recommends approval of Merck's keytruda","MRK","Merck"
"728","Merck &amp; Co., Inc. Posted losses of -0.35% in the Last Trade","http://www.freeobserver.com/merck-co-inc-posted-losses-0-35-last-trade/","2017-03-24 10:37:30","Free Observer","If you look at the company's income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, MRK earned gross profit of 31.25 Billion, in 2015 29.67 Billion gross profit, while in 2016 Merck & Co., Inc ...","MRK","Merck"
"729","Merck &amp; Co., Inc. (MRK) Is Trying To Tell Investors Something Through Its ...","http://nystocknews.com/2017/03/27/merck-co-inc-mrk-is-trying-to-tell-investors-something-through-its-technicals/","2017-03-27 14:11:15","NY Stock News","The technicals for Merck & Co., Inc. (MRK) has spoken via its technical chart and the message is loud and clear.","MRK","Merck"
"730","How Merck &amp; Co., Inc. (MRK) And Its Technical Chart Is Making Things Clearer ...","http://nystocknews.com/2017/03/28/how-merck-co-inc-mrk-and-its-technical-chart-is-making-things-clearer-for-traders-2/","2017-03-28 11:33:45","NY Stock News","Merck & Co., Inc. (MRK) has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.","MRK","Merck"
"731","EOD Risers: Merck &amp; Co., Inc., Microsoft Corporation, Nike Inc","http://www.directorstalkinterviews.com/eod-risers-merck-co-inc-microsoft-corporation-nike-inc/412726432","2017-03-30 05:30:48","DirectorsTalk Interviews","Shares of Merck & Co., Inc. with company EPIC: (NYSE:MRK) a global healthcare company, rose 0.47% or 0.3 points throughout yesterday's trading day.","MRK","Merck"
"732","Noticeable Stock at:Merck &amp; Co., Inc. (MRK)","http://standardoracle.com/2017/03/31/noticeable-stock-atmerck-co-inc-mrk/","2017-03-30 08:00:00","StandardOracle","Merck & Co., Inc. (NYSE:MRK) lost -0.3% to reach $63.45 in the previous trading session. Overall, 5.32 Million shares exchanged hands versus its average trading volume of 10.8 Million shares.","MRK","Merck"
"733","Digging Up the Facts on Merck &amp; Co., Inc. (MRK)","http://www.stocknewsjournal.com/2017/03/30/digging-up-the-facts-on-merck-co-inc-mrk-2/","2017-03-30 13:37:30","StockNewsJournal","Merck & Co., Inc. (MRK) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers - Major.","MRK","Merck"
"734","What Merck&#39;s Strong Pipelines Means For Investors","https://seekingalpha.com/article/4060067-mercks-strong-pipelines-means-investors","2017-04-04 07:26:15","Seeking Alpha","That Merck has surpassed the performance of the broader market shouldn't be surprising: investors are rewarding the fact that company has exceeded Wall Street's earnings expectations in each of the last four quarters. Indeed, even though its sales were ...","MRK","Merck"
"735","10 things to know about Merck&#39;s proposal to come to Austin","https://communityimpact.com/austin/northwest-austin/city-county/2017/04/04/10-things-know-mercks-proposal-come-austin/","2017-04-04 09:50:07","Community Impact Newspaper","Inc. has shown interest in building an information technology center in Austin. ... Pending approval of an economic development agreement between Austin City Council and Merck, the company anticipates it could open this year in a temporary location.","MRK","Merck"
"736","All You Need To Know About Merck &amp; Co., Inc. (MRK) Revealed Perfectly In The ...","http://nystocknews.com/2017/04/04/all-you-need-to-know-about-merck-co-inc-mrk-revealed-perfectly-in-the-charts/","2017-04-04 12:07:30","NY Stock News","The technicals for Merck & Co., Inc. (MRK) have taken shape, and with them a comprehensive picture has emerged. This is the current state of play as presented by the current technical setup.","MRK","Merck"
"737","EOD Risers: Intel Corporation, JPMorgan Chase &amp; Co., Merck &amp; Co., Inc.","http://www.directorstalkinterviews.com/eod-risers-intel-corporation-jpmorgan-chase-co-merck-co-inc/412726766","2017-04-05 05:35:27","DirectorsTalk Interviews","The stock price for Intel Corporation ticker code: (NASDAQ:INTC) a company engaged in the design and manufacture of digital technology platforms, moved up 0.33% or 0.12 points in yesterday's trading session.","MRK","Merck"
"738","Merck &amp; Co. Inc Risk Points versus Health Care","http://news.cmlviz.com/2017/04/05/merck--co-inc-risk-points-versus-health-care.html","2017-04-05 07:14:00","CML News","This is a scatter plot analysis of the critical risk points from the option market for Merck & Co. Inc (NYSE:MRK) compared to its own past and the Health Care ETF.","MRK","Merck"
"739","Crazy Volume Spikes for: Merck &amp; Co., Inc. (MRK)","https://hugopress.com/2017/04/05/crazy-volume-spikes-for-merck-co-inc-mrk/","2017-04-05 07:37:30","HugoPress","Guggenheim Upgrades Merck & Co., Inc. (MRK)'s stock to Buy with the price target of $70. This rating was issued on 1/12/17.","MRK","Merck"
"740","Noteworthy Stock to Watch For: Merck &amp; Co., Inc. (MRK)","http://standardoracle.com/2017/04/06/noteworthy-stock-to-watch-for-merck-co-inc-mrk/","2017-04-06 07:48:45","StandardOracle","Merck & Co., Inc. (NYSE:MRK) lost -0.16% to reach $63.57 in the previous trading session. Overall, 7.7 Million shares exchanged hands versus its average trading volume of 10.53 Million shares.","MRK","Merck"
"741","Merck &amp; Co., Inc. (MRK) And Its Technicals Provide Timely Picture","http://nystocknews.com/2017/04/06/merck-co-inc-mrk-and-its-technicals-provide-timely-picture/","2017-04-06 09:30:00","NY Stock News","The technicals for Merck & Co., Inc. (MRK) has spoken via its technical chart and the message is loud and clear.","MRK","Merck"
"742","Merck receives complete response letter from the FDA for Tecos study with sitagliptin","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3564490","2017-04-07 07:30:00","Reuters Key Development","Merck receives complete response letter from the FDA for Tecos study with sitagliptin","MRK","Merck"
"743","The Technical Chart For Merck &amp; Co., Inc. (MRK) Has Spoken","http://nystocknews.com/2017/04/07/the-technical-chart-for-merck-co-inc-mrk-has-spoken/","2017-04-07 10:03:45","NY Stock News","Merck & Co., Inc. (MRK) has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.","MRK","Merck"
"744","Merck &amp; Co., Inc. closed with a change of -0.52% in the Previous Trading Session","http://www.freeobserver.com/merck-co-inc-closed-change-0-52-previous-trading-session/","2017-04-07 12:30:00","Free Observer","If you look at the company's income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, MRK earned gross profit of 31.25 Billion, in 2015 29.67 Billion gross profit, while in 2016 Merck & Co., Inc ...","MRK","Merck"
"745","Fred Alger Management Inc. Has $725000 Stake in Merck &amp; Co., Inc. (MRK)","https://www.thecerbatgem.com/2017/04/20/fred-alger-management-inc-sells-16850-shares-of-merck-co-inc-mrk-updated.html","2017-04-08 06:52:30","The Cerbat Gem","Merck & Co. logo Fred Alger Management Inc. lowered its position in Merck & Co., Inc. (NYSE:MRK) by 57.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission.","MRK","Merck"
"746","Merck &amp; Co., Inc. (MRK) Is Grabbing Attention With Its Chart Setup","http://nystocknews.com/2017/04/10/merck-co-inc-mrk-is-grabbing-attention-with-its-chart-setup/","2017-04-10 12:18:45","NY Stock News","Merck & Co., Inc. (MRK) has been having a set of eventful trading activity and it is clear from an examination of the charts that traders are now fully aware of the company's key metrics.","MRK","Merck"
"747","BRIEF-Merck &amp; Co Inc&#39;s CEO&#39;s 2016 total compensation was $21.8 mln","http://www.reuters.com/article/brief-merck-co-incs-ceos-2016-total-comp-idUSFWN1HI0K9","2017-04-10 17:00:00","Reuters","HONG KONG/SAN FRANCISCO, April 16 Documents and computer files released by hackers provide a blueprint for how the U.S. National Security Agency likely used weaknesses in commercially available software to gain access to the global system for ...","MRK","Merck"
"748","KYORIN Holdings unit gets license from Merck for drug KRP-114V","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3566015","2017-04-11 01:45:00","Reuters Key Development","KYORIN Holdings unit gets license from Merck for drug KRP-114V","MRK","Merck"
"749","Merck &amp; Co., Inc. Posted losses of -0.92% in the Last Trade","http://www.freeobserver.com/merck-co-inc-posted-losses-of-0-92-in-the-last-trade/","2017-04-11 10:55:02","Free Observer","Currently, the market capitalization of Merck & Co., Inc. (MRK) is 171.74 Billion. MRK has a 1-year high price of $ 66.32 and 1-year low price of $51.48.","MRK","Merck"
"750","Merck &amp; Company Inc. (new) (MRK) Closes 0.14% Down on the Day for April 20","https://www.equities.com/news/merck-company-inc-new-mrk-closes-0-14-down-on-the-day-for-april-20","2017-04-11 11:33:45","Equities.com","Shares of Merck & Company Inc. (new) (MRK) ended the trading day Thursday at $62.55, representing a move of -0.14%, or $0.09 per share, on volume of 8.66 million shares.","MRK","Merck"
"751","Merck And A Curiously Effective Buyback","https://seekingalpha.com/article/4061796-merck-curiously-effective-buyback","2017-04-11 15:52:30","Seeking Alpha","Acquisitions are a big deal for Merck and it spends a lot of money doing those but apart from that, shareholders rely upon capital returns as a principal source of total returns for the stock.","MRK","Merck"
"752","Analytical Guide for two rising stock&#39;s: Merck &amp; Co., Inc. (MRK), Twenty-First ...","http://stocknewsjournal.com/2017/04/13/analytical-guide-for-two-rising-stocks-merck-co-inc-mrk-twenty-first-century-fox-inc-foxa/","2017-04-13 08:00:00","StockNewsJournal","Merck & Co., Inc. (NYSE:MRK) market capitalization at present is $173.41B at the rate of $63.05 a share. The firm's price-to-sales ratio was noted 4.31 in contrast with an overall industry average of 3.62.","MRK","Merck"
"753","The Charts For Merck &amp; Co., Inc. (MRK) Is Attracting Massive Attention","http://nystocknews.com/2017/04/13/the-charts-for-merck-co-inc-mrk-is-attracting-massive-attention-3/","2017-04-13 14:33:45","NY Stock News","The technicals for Merck & Co., Inc. (MRK) have taken shape, and with them a comprehensive picture has emerged. This is the current state of play as presented by the current technical setup.","MRK","Merck"
"754","Austin OKs Merck incentives to build big pharma IT hub in Austin","http://www.bizjournals.com/austin/news/2017/04/13/austin-oks-merck-incentives-to-build-bigpharma-it.html","2017-04-13 19:03:45","Austin Business Journal","Merck & Co Inc. has received the first incentives agreement from the city of Austin… more. Michael Nagle. Austin City Council has approved its first economic incentive agreement in years, designed to lure pharmaceutical giant Merck & Co.","MRK","Merck"
"755","American National Insurance Co. TX Holds Position in Merck &amp; Co., Inc. (MRK)","https://www.thecerbatgem.com/2017/04/17/american-national-insurance-co-tx-holds-position-in-merck-co-inc-mrk.html","2017-04-14 09:52:30","The Cerbat Gem","Merck & Co. logo American National Insurance Co. TX held its stake in Merck & Co., Inc. (NYSE:MRK) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).","MRK","Merck"
"756","MML Investors Services LLC Takes Position in Merck &amp; Co., Inc. (MRK)","https://sportsperspectives.com/2017/04/19/mml-investors-services-llc-purchases-new-position-in-merck-co-inc-mrk-updated.html","2017-04-16 09:41:15","Sports Perspectives","Merck & Co. logo MML Investors Services LLC bought a new stake in Merck & Co., Inc. (NYSE:MRK) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.","MRK","Merck"
"757","Most Active Watch-list Mover: Merck &amp; Co., Inc.&#39;s (MRK) stock price settles at ...","http://www.wsnews4investors.com/2017/04/17/most-active-watch-list-mover-merck-co-inc-s-mrk-stock-price-settles-at-62-61-with-movement-of-0-70/","2017-04-17 07:26:15","WsNews 4investors","Merck & Co., Inc. (MRK) stock price distance from twenty day simple moving average slumped at -1.28% while its distance from fifty day simple moving average declined -2.50% along with 2.24% above distance from two hundred simple moving averages.","MRK","Merck"
"758","2 Stocks to keep an eye on Today: Merck &amp; Co., Inc. (MRK), U.S. Bancorp (USB)","http://stocknewsjournal.com/2017/04/17/2-stocks-to-keep-an-eye-on-today-merck-co-inc-mrk-u-s-bancorp-usb/","2017-04-17 09:18:45","StockNewsJournal","Merck & Co., Inc. (NYSE:MRK) market capitalization at present is $171.65B at the rate of $62.61 a share. The firm's price-to-sales ratio was noted 4.31 in contrast with an overall industry average of 3.64.","MRK","Merck"
"759","Sell-Side Analyst&#39;s Predictions: Merck &amp; Co., Inc. (MRK), Valero Energy ...","http://theusacommerce.com/2017/04/17/sell-side-analysts-predictions-merck-co-inc-mrk-valero-energy-corporation-vlo/","2017-04-17 09:18:45","The USA Commerce","Shares of Merck & Co., Inc. (NYSE:MRK) dropped -0.70% to $62.61. During the trading on 04/13/2017, Company's stock ranged from $63.00 to $62.56.","MRK","Merck"
"760","Form PX14A6G Merck &amp; Co., Inc. Filed by: TRILLIUM ASSET MANAGEMENT, LLC","https://www.streetinsider.com/SEC+Filings/Form+PX14A6G+Merck+%26amp%3B+Co.%2C+Inc.+Filed+by%3A+TRILLIUM+ASSET+MANAGEMENT%2C+LLC/12782113.html","2017-04-17 10:03:45","StreetInsider.com","issue a report (at reasonable cost, in a reasonable time and excluding confidential information) evaluating the merits and feasibility of Merck (1) strengthening Board expertise in pharmaceutical manufacturing and product quality and safety, (2 ...","MRK","Merck"
"761","One Put, One Call Option To Know About for Merck","http://www.nasdaq.com/article/one-put-one-call-option-to-know-about-for-merck-cm774731","2017-04-17 12:52:30","Nasdaq","Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co Inc (Symbol: MRK). So this week we highlight one interesting put contract, and one interesting call contract, from the ...","MRK","Merck"
"762","Aurinia completes licensing deal with Merck Animal Health","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3569298","2017-04-17 16:02:00","Reuters Key Development","Aurinia completes licensing deal with Merck Animal Health","MRK","Merck"
"763","EOD Risers: Merck &amp; Co., Inc., Microsoft Corporation, Nike Inc, Pfizer Inc ...","http://www.directorstalkinterviews.com/eod-risers-merck-co-inc-microsoft-corporation-nike-inc-pfizer-inc-procter-gamble-co-2/412727298","2017-04-18 05:33:45","DirectorsTalk Interviews","Shares of Merck & Co., Inc. with EPIC code: (NYSE:MRK) a global healthcare company, rose 0.3% or 0.19 points in yesterday's trading session.","MRK","Merck"
"764","Estimating the fair value of Merck &amp; Co Inc (MRK)","https://simplywall.st/news/2017/04/18/estimating-the-fair-value-of-merck-co-inc-mrk/","2017-04-18 07:37:30","Simply Wall St","In this article I am going to calculate the intrinsic value of Merck (NYSE:MRK) by estimating the Future Cash Flows and discounting them to their present value.","MRK","Merck"
"765","For Merck &amp; Co., Inc. (MRK), The Evidence Is In The Technical Chart","http://www.nystocknews.com/2017/04/18/for-merck-co-inc-mrk-the-evidence-is-in-the-technical-chart/","2017-04-18 08:33:45","NY Stock News","Merck & Co., Inc. (MRK) has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.","MRK","Merck"
"766","Buy/Sell Signals for Merck &amp; Co., Inc. (MRK) and ConocoPhillips (COP)","http://www.usacommercedaily.com/2017/04/18/buysell-signals-for-merck-co-inc-mrk-and-conocophillips-cop/","2017-04-18 09:07:30","USA Commerce Daily","Shares of Merck & Co., Inc. (NYSE:MRK) are on a recovery track as they have regained 21.99% since bottoming out at $53.06 on May.","MRK","Merck"
"767","Buy, Sell or Hold? Analysts Approach: Denbury Resources Inc. (DNR), Merck &amp; Co ...","http://theusacommerce.com/2017/04/18/buy-sell-or-hold-analysts-approach-denbury-resources-inc-dnr-merck-co-inc-mrk/","2017-04-18 09:41:15","The USA Commerce","Shares of Denbury Resources Inc. (NYSE:DNR) dropped -1.29% to $2.29. During the trading on 04/17/2017, Company's stock ranged from $2.35 to $2.25. The relative strength index or RSI highlights overbought (above 70) and oversold (below 30) areas.","MRK","Merck"
"768","Few Things investors Didn&#39;t Know About: Merck &amp; Co., Inc. (MRK), Express ...","http://stocknewsjournal.com/2017/04/18/few-things-investors-didnt-know-about-merck-co-inc-mrk-express-scripts-holding-company-esrx/","2017-04-18 09:56:45","StockNewsJournal","Merck & Co., Inc. (NYSE:MRK) market capitalization at present is $172.17B at the rate of $62.80 a share. The firm's price-to-sales ratio was noted 4.31 in contrast with an overall industry average of 3.64.","MRK","Merck"
"769","Merck &amp; Co., Inc. surged in the Previous Trading Session with the Change of 0.3%","http://www.freeobserver.com/merck-co-inc-surged-in-the-previous-trading-session-with-the-change-of-0-3/","2017-04-18 10:01:41","Free Observer","If you look at the company's income statement over the past years, you will see that the company is constantly posting gross profit: In 2014, MRK earned gross profit of 31.25 Billion, in 2015 29.67 Billion gross profit, while in 2016 Merck & Co., Inc ...","MRK","Merck"
"770","Current Market Buzz: Merck &amp; Co., Inc. (MRK), Mondelez International, Inc. (MDLZ)","https://topchronicle.com/current-market-buzz-merck-co-inc-mrk-mondelez-international-inc-mdlz/","2017-04-18 12:52:30","TopChronicle","Merck & Co., Inc. (MRK) is currently trading with the volume of 3.53 Million. The Stock opened today's session at $62.46 and currently the price is hovering at $62.12 by showing decrease of -1.09 percent.","MRK","Merck"
"771","Merck &amp; Co., Inc.&#39;s (MRK) stock price is Presently Worth at $62.27 while ends ...","https://www.hotstockspoint.com/merck-co-inc-s-mrk-stock-price-is-presently-worth-at-62-27-while-ends-tuesday-with-move-of-0-84/","2017-04-19 06:07:30","Hot Stocks Point","Merck & Co., Inc. (MRK) ended its day with loss -0.84% and finalized at the price of $62.27. During its last trading session, Stock traded with the total exchanged volume of 7.39 million shares.","MRK","Merck"
"772","These two stocks are dominating the market, As Expected: Cleveland BioLabs ...","http://stocknewsjournal.com/2017/04/19/these-two-stocks-are-dominating-the-market-as-expected-cleveland-biolabs-inc-cbli-merck-co-mrk/","2017-04-19 07:26:15","StockNewsJournal","Merck & Co., Inc. (NYSE:MRK) market capitalization at present is $170.72B at the rate of $62.27 a share. The firm's price-to-sales ratio was noted 4.33 in contrast with an overall industry average of 3.60.","MRK","Merck"
"773","Active stock to observe: Merck &amp; Co., Inc.&#39;s (MRK) stock price finalizes at ...","http://www.wsnews4investors.com/2017/04/19/active-stock-to-observe-merck-co-inc-s-mrk-stock-price-finalizes-at-62-27-with-performance-of-0-84-on-volume-of-7394699-shares/","2017-04-19 07:26:15","WsNews 4investors","Merck & Co., Inc. (MRK) stock price distance from twenty day simple moving average slumped at -1.61% while its distance from fifty day simple moving average declined -3.03% along with 1.56% above distance from two hundred simple moving averages.","MRK","Merck"
"774","Stephens Has Lowered Merck &amp; Co (MRK) Position; Franklin Electric Co. (FELE ...","https://wolcottdaily.com/stephens-has-lowered-merck-franklin-electric-co-fele-covered-by-2-bullish-analysts-last-week/","2017-04-19 07:37:30","Wolcott Daily","Merck & Co Inc now has $169.52B valuation. The stock decreased 0.84% or $0.53 during the last trading session, reaching $62.27.","MRK","Merck"
"775","Traders Take Note: Merck and Co. Inc (NYSE:MRK) Stock Drops, Weakness in ...","http://news.cmlviz.com/2017/04/19/traders-take-note-merck--co-inc-nyse-mrk--stock-drops-weakness-in-technical-momentum.html","2017-04-19 07:48:45","CML News","Take Note: Merck & Co. Inc (NYSE:MRK) has hit some technical weakness in its momentum, and while it has not broken down all the way through support ","MRK","Merck"
"776","Merck &amp; Co., Inc. (MRK): Ignore the noise and focus on the technicals","http://usacommercedaily.com/2017/04/19/merck-co-inc-mrk-ignore-the-noise-and-focus-on-the-technicals/","2017-04-19 11:00:00","USA Commerce Daily","With all other things going on, Merck & Co., Inc. (NYSE:MRK) has been on a run - rising 2.02 percent in just three months.","MRK","Merck"
"777","Barometer Capital Management Increased Merck &amp; Co (MRK) Stake by $13.33 ...","https://wolcottdaily.com/barometer-capital-management-increased-merck-co-mrk-stake-by-13-33-million-standard-motor-products-smps-sentiment-is-1-46/","2017-04-19 12:07:30","Wolcott Daily","Barometer Capital Management Inc increased Merck & Co Inc (NYSE:MRK) stake by 2116% reported in 2017Q1 SEC filing. Barometer Capital Management Inc acquired 211,600 shares as Merck & Co Inc (NYSE:MRK)'s stock rose 5.67%. The Barometer ...","MRK","Merck"
"778","EOD Risers: Merck &amp; Co., Inc., UnitedHealth Group Inc, Visa Inc, Wal-Mart ...","https://www.directorstalkinterviews.com/eod-risers-merck-co-inc-unitedhealth-group-inc-visa-inc-wal-mart-stores-inc/412727452","2017-04-20 05:11:15","DirectorsTalk Interviews","The share price for Merck & Co., Inc. with company EPIC: (NYSE:MRK) a global healthcare company, rose 0.59% or 0.37 points throughout yesterday's trading day.","MRK","Merck"
"779","Merck &amp; Co., Inc.&#39;s (MRK) stock price is at $62.64 on volume of 10349052 ...","http://www.wsnews4investors.com/2017/04/20/merck-co-inc-s-mrk-stock-price-is-at-62-64-on-volume-of-10349052-shares-with-last-change-of-0-59/","2017-04-20 07:15:00","WsNews 4investors","Merck & Co., Inc. (MRK) stock price distance from twenty day simple moving average slumped at -0.88% while its distance from fifty day simple moving average declined -2.41% along with 2.11% above distance from two hundred simple moving averages.","MRK","Merck"
"780","Stock-research Ratings: Merck &amp; Co., Inc. (MRK), LENDINGCLUB CORP (LC)","http://thewellesleysnews.com/2017/04/20/stock-research-ratings-merck-co-inc-mrk-lendingclub-corp-lc/","2017-04-20 07:26:15","W News","Merck & Co., Inc. (NYSE:MRK) tinted gains of +0.59% (+0.37 points) to US$62.64. The volume of 10.35 Million shares climbed down over an trading activity of 9.44 Million shares.","MRK","Merck"
"781","Merck &amp; Co., Inc. (NYSE:MRK) Says Researchers Have 25 Scientific Data ...","https://marketexclusive.com/merck-co-inc-nysemrk-says-researchers-25-scientific-data-presentations-infectious-disease/95003/","2017-04-20 08:22:30","Market Exclusive","Researchers have more than 25 scientific data presentations regarding infectious disease medicines. The investigational data was collected by Merck & Co., Inc. (NYSE:MRK) during this year's 27th European Congress of Clinical Microbiology and Infectious ...","MRK","Merck"
"782","Investors Checklist Healthcare Stocks: Merck &amp; Co., Inc.&#39;s (MRK) is at $62.64 ...","http://www.stocksgallery.com/investors-checklist-healthcare-stocks-merck-co-inc-s-mrk-is-at-62-64-per-share-and-teva-pharmaceutical-industries-limiteds-teva-is-listed-at-30-70/","2017-04-20 08:36:40","Stocks Gallery (press release)","In recent trading day Merck & Co., Inc. (MRK) stock showed the move of 0.59% with the closing price of $62.64. Closing price generally refers to the last price at which a stock trades during a regular trading session.","MRK","Merck"
"783","What&#39;s New with Merck &amp; Co., Inc.(NYSE:MRK), Silver Wheaton Corp. (USA) (NYSE ...","http://www.wallstreetnews24.com/whats-new-with-merck-co-inc-nysemrk-silver-wheaton-corp-usa-nyseslw-las-vegas-sands-corp-nyselvs/","2017-04-20 08:56:15","Wall Street Times (press release)","Merck & Co., Inc. (NYSE:MRK) traded at a yearly high level of $66.80 during the last trading session. The last session's volume of 10.34 million shares was higher than its average volume of 8.58 million shares.","MRK","Merck"
"784","Merck &amp; Co., Inc.&#39;s (MRK) stock price is Worth at $62.64 while ends Wednesday ...","http://www.hotstockspoint.com/merck-co-inc-s-mrk-stock-price-is-worth-at-62-64-while-ends-wednesday-with-move-of-0-59/","2017-04-20 09:07:30","Hot Stocks Point","Merck & Co., Inc. (MRK) stock price ended its day with gain 0.59% and finalized at the value of $62.64. During its last trading session, Stock traded with the total exchanged volume of 10.35 million shares.","MRK","Merck"
"785","The Chart Is Speaking Loud And Clear For Merck &amp; Co., Inc. (MRK)","http://nystocknews.com/2017/04/20/the-chart-is-speaking-loud-and-clear-for-merck-co-inc-mrk/","2017-04-20 11:22:30","NY Stock News","Merck & Co., Inc. (MRK) has been having a set of eventful trading activity and it is clear from an examination of the charts that traders are now fully aware of the company's key metrics.","MRK","Merck"
"786","Chartists Perspective on Merck &amp; Co., Inc. (NYSE:MRK)","https://providencestandard.com/chartists-perspective-on-merck-co-inc-nysemrk/55503/","2017-04-20 22:48:38","Providence Standard","Investors keeping an eye on shares of Merck & Co., Inc. (NYSE:MRK) may be analyzing the company's FCF or Free Cash Flow.","MRK","Merck"
"787","Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Signs a Licensing Deal with Merck ...","https://www.wallstreetpr.com/aurinia-pharmaceuticals-inc-nasdaqauph-signs-a-licensing-deal-with-merck-co-inc-nysemrk-animal-health-38678","2017-04-21 05:45:00","WallStreetPR","Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) completes a Definitive Agreement giving Merck & Co., Inc. (NYSE:MRK) Animal Health the rights to build up and distribute Aurinia's patented nano-micellar cyclosporin ophthalmic solution (VOS) for treating dry ...","MRK","Merck"
"788","Notable Wall Street Stock: Merck &amp; Co., Inc.&#39;s (MRK) stock price finalizes at ...","http://www.wsnews4investors.com/2017/04/21/notable-wall-street-stock-merck-co-inc-s-mrk-stock-price-finalizes-at-62-55-with-performance-of-0-14-on-volume-of-8962257-shares/","2017-04-21 07:03:45","WsNews 4investors","Merck & Co., Inc. (MRK) stock price tumbled -0.14% to finalize at $62.55 throughout previous buying and selling session.","MRK","Merck"
"789","These stock&#39;s have rarely let down their investors: Merck &amp; Co., Inc. (MRK ...","https://stocknewsjournal.com/2017/04/21/these-stocks-have-rarely-let-down-their-investors-merck-co-inc-mrk-lendingclub-corp-lc/","2017-04-21 07:48:45","StockNewsJournal","Merck & Co., Inc. (NYSE:MRK) market capitalization at present is $171.48B at the rate of $62.55 a share. The firm's price-to-sales ratio was noted 4.31 in contrast with an overall industry average of 3.61.","MRK","Merck"
"790","Atara bio announces collaboration with Merck","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3572731","2017-04-21 08:00:00","Reuters Key Development","Atara bio announces collaboration with Merck","MRK","Merck"
"791","Merck Leads Rivals In Novel Drug Approvals","https://seekingalpha.com/article/4064078-merck-leads-rivals-novel-drug-approvals","2017-04-21 08:11:15","Seeking Alpha","The annual tally of novel drug approvals is often taken as a barometer of productivity, and an analysis of the companies most responsible for bringing these medicines to market reveals some obvious leaders.","MRK","Merck"
"792","Growth Analysis of Merck &amp; Co., Inc. (MRK)","http://theriponadvance.com/growth-analysis-of-merck-co-inc-mrk/12173690/","2017-04-21 08:22:30","TRA","Merck & Co., Inc. (MRK) closed its previous trading session at $62.67 with the gain of 0.05%. The company's market cap is $171.73 Billion, and the average volume is 9.42 Million.","MRK","Merck"
"793","Altra Biotherapeutics (ATRA) Stock: Gaining On Merck (MRK) Collarboration","https://cnafinance.com/altra-biotherapeutics-atra-stock-gaining-on-merck-mrk-collarboration/14919","2017-04-21 08:56:15","CNA Finance (press release)","Atara Biotherapeutics Inc (NASDAQ:ATRA) is having an incredible time in the pre-market hours this morning and for good reason. The company announced that it has entered into a collaboration with Merck & Co., Inc. (NYSE:MRK). As a result, investor ...","MRK","Merck"
"794","Real-World Observational Study in the U.S. Veterans Affairs System Evaluating ...","http://www.businesswire.com/news/home/20170421005084/en/Real-World-Observational-Study-U.S.-Veterans-Affairs-System","2017-04-21 09:52:30","Business Wire (press release)","This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S.","MRK","Merck"
"795","Merck reports results from real-world observational study in U.S. Veterans Affairs System evaluating use of ZEPATIER","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3572825","2017-04-21 10:00:00","Reuters Key Development","Merck reports results from real-world observational study in U.S. Veterans Affairs System evaluating use of ZEPATIER","MRK","Merck"
"796","Overview of Price Moves: Merck &amp; Co., Inc. (MRK) ,Mazor Robotics Ltd. (MZOR)","http://www.streetupdates.com/2017/04/21/overview-of-price-moves-merck-co-inc-mrk-mazor-robotics-ltd-mzor/","2017-04-21 10:03:45","Street Updates","Merck & Co., Inc. (MRK) , a stock from Drug Manufacturers - Major Industry, has a value of $62.55 per share, noted a price change of -0.14% in recent trade close.","MRK","Merck"
"797","Bryan Garnier Initiated its coverage for Merck &amp; Co., Inc. (MRK)","http://standardoracle.com/2017/04/21/bryan-garnier-initiated-its-coverage-for-merck-co-inc-mrk/","2017-04-21 10:26:15","StandardOracle","Merck & Co., Inc. (MRK) lost -0.14% to reach $62.55 in the previous trading session. Overall, 8.96 Million shares exchanged hands versus its average trading volume of 9.42 Million shares.","MRK","Merck"
"798","Analysts&#39; Recommendations Stocks in Focus: Merck &amp; Co., Inc. (NYSE:MRK ...","http://www.journalfinance.net/2017/04/analysts-recommendations-stocks-in-focus-merck-co-inc-nysemrk-yamana-gold-inc-usa-nyseauy/","2017-04-21 12:41:15","Daily News Journal","Merck & Co., Inc. (NYSE:MRK) have shown a low EPS growth of -7.00% in the last 5 years and has earnings growth of -162.20% yoy.","MRK","Merck"
"799","Merck &amp; Co., Inc. (NYSE:MRK) Touching Most Active List","https://hiramherald.com/merck-co-inc-nysemrk-touching-most-active-list/","2017-04-21 14:22:30","The Herald","Session activity on Merck & Co., Inc.(NYSE:MRK) stock is placing it on today's most active list. After a recent spot-check, the stock has touched $62.08 which represents a change from the open of -0.43%.","MRK","Merck"
"800","Merck &amp; Co., Inc. (MRK): The Technicals As Seen Today","http://www.nystocknews.com/2017/04/21/merck-co-inc-mrk-the-technicals-as-seen-today-2/","2017-04-21 15:52:30","NY Stock News","Merck & Co., Inc. (MRK) has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment.","MRK","Merck"
"801","FDA approves Renflexis, biosimilar to Remicade","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3572906","2017-04-21 15:54:54","Reuters Key Development","FDA approves Renflexis, biosimilar to Remicade","MRK","Merck"
"802","Rogers Corp gives Q2 2015 revenue guidance below analysts&#39; estimates; gives EPS guidance","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3203237","2015-04-29 16:01:00","Reuters Key Development","Rogers Corp gives Q2 2015 revenue guidance below analysts' estimates; gives EPS guidance","ROG","Roche"
"803","Rogers Corp lowers Q2 2015 guidance","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3242345","2015-07-09 16:01:00","Reuters Key Development","Rogers Corp lowers Q2 2015 guidance","ROG","Roche"
"804","Rogers Corp gives Q3 2015 revenue guidance below analysts&#39; estimates","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3252701","2015-07-29 16:01:00","Reuters Key Development","Rogers Corp gives Q3 2015 revenue guidance below analysts' estimates","ROG","Roche"
"805","Rogers Corp engages PricewaterhouseCoopers as independent registered public accounting firm - Form 8-K","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3255589","2015-08-03 16:24:00","Reuters Key Development","Rogers Corp engages PricewaterhouseCoopers as independent registered public accounting firm - Form 8-K","ROG","Roche"
"806","Rogers Corp announces share repurchase program","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3257933","2015-08-06 16:59:00","Reuters Key Development","Rogers Corp announces share repurchase program","ROG","Roche"
"807","Rogers Corp gives Q4 2015 revenue guidance below analysts&#39; estimates","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3291955","2015-10-28 16:15:00","Reuters Key Development","Rogers Corp gives Q4 2015 revenue guidance below analysts' estimates","ROG","Roche"
"808","Rogers Corp&#39;s CFO Plans to Retire","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3291924","2015-10-28 16:20:00","Reuters Key Development","Rogers Corp's CFO Plans to Retire","ROG","Roche"
"809","Rogers Corp appoints Janice Stipp CFO","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3297652","2015-11-09 07:29:00","Reuters Key Development","Rogers Corp appoints Janice Stipp CFO","ROG","Roche"
"810","Rogers Corporation sells Polyimide and Thermoset Epoxy Laminate Operation","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3313780","2015-12-21 16:18:00","Reuters Key Development","Rogers Corporation sells Polyimide and Thermoset Epoxy Laminate Operation","ROG","Roche"
"811","CriticalPoint Capital acquires Electronic Materials Division from Rogers Corporation","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3314398","2015-12-22 16:36:00","Reuters Key Development","CriticalPoint Capital acquires Electronic Materials Division from Rogers Corporation","ROG","Roche"
"812","Rogers Corp gives Q1 2016 guidance","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3334403","2016-02-22 16:20:00","Reuters Key Development","Rogers Corp gives Q1 2016 guidance","ROG","Roche"
"813","Rogers Corp gives Q2 2016 guidance","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3366806","2016-05-02 16:20:00","Reuters Key Development","Rogers Corp gives Q2 2016 guidance","ROG","Roche"
"814","Rogers Corp says to relocate global headquarters to Arizona","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3421592","2016-08-08 16:24:00","Reuters Key Development","Rogers Corp says to relocate global headquarters to Arizona","ROG","Roche"
"815","BREAKING: New global corporate headquarters headed to Phoenix area","http://www.bizjournals.com/phoenix/news/2016/08/08/breaking-new-global-corporate-headquarters-headed.html","2016-08-08 17:02:48","Phoenix Business Journal","Rogers Advanced Connectivity Solutions division is headquarters in Chandler, and has been in the area for 50 years. The company has 400 Arizona employees.","ROG","Roche"
"816","Rogers Corp. Moving Headquarters After 184 Years In Connecticut","http://www.courant.com/business/hc-rogers-arizona-20160809-story.html","2016-08-09 13:08:14","Hartford Courant","Rogers Corp., a 184-year-old Connecticut laminates and materials manufacturer, is moving its headquarters to Arizona to be closer to West Coast markets.","ROG","Roche"
"817","Rogers Corporation Relocating Global HQ To Arizona","https://businessfacilities.com/2016/08/rogers-corporation-relocating-global-hq-to-arizona/","2016-08-25 13:37:30","Business Facilities Magazine","Rogers Corporation, a global leader in engineered materials solutions, will relocate its global headquarters from Rogers, CT to Chandler, AZ.","ROG","Roche"
"818","Chandler could pay Rogers Corp. up to $238K for firm&#39;s move to city","http://www.azcentral.com/story/news/local/chandler/2016/10/13/chandler-could-pay-rogers-corp-up-238k-firms-move-city/91861762/","2016-10-13 08:56:15","azcentral.com","The money, taken from a city economic-development fund for attracting new business, is based on up to 190 new jobs Rogers Corp. could bring to Chandler over the next five years as part of the move and a planned expansion of its manufacturing plant, ...","ROG","Roche"
"819","Rogers sees Q4 earnings per share $0.61 to $0.71","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3468330","2016-11-02 16:20:00","Reuters Key Development","Rogers sees Q4 earnings per share $0.61 to $0.71","ROG","Roche"
"820","Rogers Acquires DeWAL Industries","http://www.businesswire.com/news/home/20161123005600/en/Rogers-Acquires-DeWAL-Industries","2016-11-23 13:00:00","Business Wire (press release)","Rogers Corporation (NYSE:ROG), a global leader in engineered material solutions, announces the acquisition of DeWAL Industries, a leading manufacturer of high performance polymer films and pressure sensitive ...","ROG","Roche"
"821","Rogers Corp buys DeWAL Industries","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3483693","2016-11-23 13:06:00","Reuters Key Development","Rogers Corp buys DeWAL Industries","ROG","Roche"
"822","Rogers Corp. move will cost 50 jobs","http://www.norwichbulletin.com/news/20161203/rogers-corp-move-will-cost-50-jobs","2016-12-03 17:42:21","Norwich Bulletin","KILLINGLY - As part of its plan to relocate its corporate headquarters to Arizona, the Killingly-based Rogers Corp. will lay off 50 workers, according a state filing document.","ROG","Roche"
"823","Rogers acquires Diversified Silicone Products","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3505250","2017-01-06 13:01:00","Reuters Key Development","Rogers acquires Diversified Silicone Products","ROG","Roche"
"824","Rogers Corp. Looking To Harness Focused Innovation And Operating Efficiency","https://seekingalpha.com/article/4046930-rogers-corp-looking-harness-focused-innovation-operating-efficiency","2017-02-18 07:45:08","Seeking Alpha","That's not the model that Rogers Corp. (NYSE:ROG) is using. Instead, this small specialty materials company is looking to use selective innovation targeting more demanding high-growth applications to generate above-average growth and profitability.","ROG","Roche"
"825","Rogers Corp reports Q4 EPS $0.65","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3531211","2017-02-20 16:47:00","Reuters Key Development","Rogers Corp reports Q4 EPS $0.65","ROG","Roche"
"826","Breaking: Rogers Corporation (NYSE:ROG) Stock Through Resistance -- Technicals ...","http://news.cmlviz.com/2017/03/24/breaking-rogers-corporation-nyse-rog--stock-through-resistance--technicals-hit-extreme-strength.html","2017-03-24 11:00:00"," Technicals ...","Breaking: Rogers Corporation (NYSE:ROG) has hit maximum technical strength ","ROG","Roche"
"827","Rogers Corp (ROG) Files Form 4 Insider Selling : Jeffrey M Grudzien Sells 6400 ...","http://www.themarketdigest.org/2017/03/27/rogers-corp-rog-files-form-4-insider-selling-jeffrey-m-grudzien-sells-6400-shares/","2017-03-27 06:49:49","Market Digest","Rogers Corp (ROG): Jeffrey M Grudzien , SVP, ACS of Rogers Corp sold 6,400 shares on Feb 22, 2017. The Insider selling transaction was reported by the company on Feb 24, 2017 to the Securities and Exchange Commission.","ROG","Roche"
"828","Rogers Co. (ROG) Stake Held by Metropolitan Life Insurance Co. NY","https://baseballnewssource.com/markets/metropolitan-life-insurance-co-ny-continues-to-hold-position-in-rogers-co-rog-updated/532626.html","2017-03-27 08:22:30","BBNS","State Street Corp boosted its position in Rogers by 11.0% in the fourth quarter. State Street Corp now owns 405,784 shares of the company's stock worth $31,166,000 after buying an additional 40,274 shares in the last quarter.","ROG","Roche"
"829","The Rogers Co. (ROG) Receives Average Rating of “Buy” from Brokerages","http://petroglobalnews24.com/2017-03-28-rogers-co-rog-receives-average-rating-of-buy-from-brokerages/","2017-03-27 14:11:15","Petro Global News 24","Bank of New York Mellon Corp raised its stake in shares of Rogers by 2.5% in the third quarter. Bank of New York Mellon Corp now owns 501,280 shares of the company's stock worth $30,617,000 after buying an additional 12,229 shares in the last quarter.","ROG","Roche"
"830","Rogers named director of MSU-led UAS center of excellence","http://www.msstate.edu/newsroom/article/2017/03/rogers-named-director-msu-led-uas-center-excellence","2017-03-27 17:33:45","Mississippi State Newsroom","A Mississippi native, Rogers also has an extensive corporate background, serving in several roles in industry - including vice president of the international division of a large research and development corporation. He served in the U.S. Air Force ...","ROG","Roche"
"831","Global Engineered Foam Market 2017- Trelleborg AB Rogers Corporation BASF SE ...","http://www.military-technologies.net/2017/03/28/global-engineered-foam-market-2017-trelleborg-ab-rogers-corporation-basf-se-and-bayer-ag/","2017-03-28 03:30:00","MilTech","The market research report by QY Research provides detailed study on the overall Engineered Foam market size, its financial positions, its unique selling points, key products, and key developments.","ROG","Roche"
"832","Rogers Corporation (NYSE:ROG) Reviewed By Analysts","http://www.desotoedge.com/stocks/rogers-corporation-nyserog-reviewed-by-analysts-8/628563","2017-03-28 05:36:40","The De Soto Edge","Stock market analysts watching Rogers Corporation (NYSE:ROG) have recently changed their ratings on the stock. The latest reports which are outstanding on Tuesday 28th of March state 0 analysts have a rating of “strong buy”, 3 analysts “buy”, 2 ...","ROG","Roche"
"833","Finisar Corporation Appoints Helene Simonet as New Director","https://globenewswire.com/news-release/2017/03/28/945806/0/en/Finisar-Corporation-Appoints-Helene-Simonet-as-New-Director.html","2017-03-28 08:00:00","GlobeNewswire (press release)","She has been a Director of Rogers Corporation since October of 2014. ""I am pleased to welcome Leen as the newest member or our Board of Directors,"" said Jerry Rawls, Finisar's Chief Executive Officer and Chairman of the Board.","ROG","Roche"
"834","Foam Expo: Looking Back at Three Days of Unprecedented Foam Industry Activity","http://sprayfoam.com/foam-news/foam-expo-looking-back-at-three-days-of-unprecedented-foam-industry-activity/2964","2017-03-28 09:20:41","SprayFoam.com (press release) (registration)","... to more than 2,500 attendees and reaching capacity at the conference sessions, which featured a strong line-up of industry heavyweights from companies including Toyota, Ford, and Rogers Corporation discussing the latest foam application ...","ROG","Roche"
"835","Rogers Corporation (ROG): A Detailed Look at its Institutional Ownership","http://postanalyst.com/2017/03/30/rogers-corporation-rog-a-detailed-look-at-its-institutional-ownership/","2017-03-30 14:00:00","Post Analyst","Rogers Corporation (NYSE:ROG) reached 64.54% versus a 1-year low price of $51.98. The stock was last seen -1.98% lower, reaching at $85.53 on March 29, 2017.","ROG","Roche"
"836","GSA Capital Partners LLP Decreases Position in Rogers Co. (ROG)","https://sportsperspectives.com/2017/04/04/gsa-capital-partners-llp-decreases-position-in-rogers-co-rog.html","2017-04-04 08:56:15","Sports Perspectives","Rogers logo GSA Capital Partners LLP reduced its stake in shares of Rogers Co. (NYSE:ROG) by 81.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission.","ROG","Roche"
"837","Risk Malaise Alert in Option Market: Rogers Corporation Implied Price Swing ...","http://news.cmlviz.com/2017/04/04/risk-malaise-alert-in-option-market-rogers-corporation-implied-price-swing-hits-a-depressed-level.html","2017-04-04 10:48:45","CML News","Before we dive into any analysis we simply note that Rogers Corporation (NYSE:ROG) risk is actually priced pretty low by the option market as of right now.","ROG","Roche"
"838","Global Sponge Copper Market 2017- BASF SE , Evonik , SABIC Innovative Plastic ...","http://publicistreport.com/business/global-sponge-copper-market-2017.html","2017-04-05 03:46:02","Publicist Report - Market Research News by Market.Biz (press release)","Global Sponge Copper Market 2017 The Global Sponge Copper Market Report 2017 focuses on deep analysis of the current status of Sponge Copper industry.","ROG","Roche"
"839","Global Fire Barrier Blocks Market 2017 CS Group, Rogers Corporation, Thea ...","http://hitechreporter.com/102231/global-fire-barrier-blocks-market-2017-cs-group-rogers-corporation-thea-schoen-pfc-corofil-aimlimited/","2017-04-05 05:22:30","HiTechReporter","Global Fire Barrier Blocks Market key Manufactures are CS Group, Rogers Corporation, Thea & Schoen, PFC Corofil, Aimlimited.","ROG","Roche"
"840","Rogers (ROG) Receiving Favorable News Coverage, Study Finds","https://www.thecerbatgem.com/2017/04/06/rogers-rog-receiving-favorable-news-coverage-study-finds.html","2017-04-06 00:30:00","The Cerbat Gem","Rogers logo Headlines about Rogers (NYSE:ROG) have been trending positive this week, AlphaOne Sentiment Analysis reports. The research firm, a subsidiary of Accern, identifies positive and negative news coverage by monitoring more than 20 million news ...","ROG","Roche"
"841","Global High Density Microcellular Polyurethane Foam Market- Huntsman ...","https://dailyhover.com/global-high-density-microcellular-polyurethane-foam-market-2017-2022/","2017-04-07 04:17:32","DailyHover","The Report titled “Global High Density Microcellular Polyurethane Foam Market” gives important perceptions into global High Density Microcellular Polyurethane Foam industry along with new flanged industry details, chapter wise analysis of each section ...","ROG","Roche"
"842","Russell Investments Group Ltd. Invests $779000 in Rogers Co. (ROG)","https://www.baseball-news-blog.com/russell-investments-group-ltd-invests-779000-in-rogers-co-rog/","2017-04-07 05:22:30","BNB Daily (blog)","Rogers logo Russell Investments Group Ltd. purchased a new position in shares of Rogers Co. (NYSE:ROG) during the fourth quarter, Holdings Channel reports.","ROG","Roche"
"843","Blue Jays releasing Justin Smoak not a viable immediate solution","http://jaysjournal.com/2017/04/07/blue-jays-releasing-justin-smoak-not-a-solution-as-things-currently-stand/","2017-04-07 10:03:20","Jays Journal","There is an obvious ground swell, or at least groan, about Justin Smoak from the fans. Their gripe is not without reason. But to those that ask, “why don't the Jays just release him?","ROG","Roche"
"844","Positive Media Coverage Somewhat Unlikely to Impact Rogers (ROG) Share Price","https://www.chaffeybreeze.com/2017/04/08/positive-media-coverage-somewhat-unlikely-to-impact-rogers-rog-share-price.html","2017-04-08 20:11:15","Chaffey Breeze","Rogers logo Media headlines about Rogers (NYSE:ROG) have been trending positive on Saturday, according to AlphaOne Sentiment. The research group, a unit of Accern, rates the sentiment of news coverage by monitoring more than 20 million blog and news ...","ROG","Roche"
"845","Gough, Rogers to wed","http://mtairynews.com/features/announcements/engagements/49956/gough-rogers-to-wed","2017-04-09 06:41:15","Mount Airy News","... is the daughter of Mark and Deidre Rogers of Mount Airy. The prospective groom is the son of Chad and Kim Gough of Mount Airy.","ROG","Roche"
"846","Flexible Foam Market 2017 – BASF SE, Bayer AG, DOW Chemical Company, JSP ...","http://www.military-technologies.net/2017/04/10/flexible-foam-market-2017-basf-se-bayer-ag-dow-chemical-company-jsp-corporation-huntsman-corporation-rogers-corporation-ube-industries-ltd-recticel-zotefoams-plc/","2017-04-10 03:07:20","MilTech","The Global Flexible Foam Market 2017 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Flexible Foam industry.","ROG","Roche"
"847","Stock Alert: Rogers Corporation Price Volatility Hits A Lowered Level","http://news.cmlviz.com/2017/04/11/stock-alert-rogers-corporation-price-volatility-hits-a-lowered-level.html","2017-04-11 08:22:30","CML News","Before we cover the full analysis we make a quick alert here that Rogers Corporation (NYSE:ROG) has seen its stock price move at a lowered level.","ROG","Roche"
"848","Rogers Corporation (ROG) is Upgraded by Sidoti to ” Buy”","https://www.highlandmirror.com/2017-04-11-rogers-corporation-rog-is-upgraded-by-sidoti-to-buy","2017-04-11 12:52:30","Highland Mirror","Rogers Corporation (ROG) was Upgraded by Sidoti to ” Buy”. Earlier the firm had a rating of “Neutral ” on the company shares.","ROG","Roche"
"849","Noteworthy Stock of Tuesday: Rogers Corporation&#39;s (ROG) stock price settles at ...","http://www.wsnews4investors.com/2017/04/12/noteworthy-stock-of-tuesday-rogers-corporations-rog-stock-price-settles-at-84-36-with-movement-of-3-65-on-volume-of-296931-shares/","2017-04-12 08:22:30","WsNews 4investors","Rogers Corporation (ROG) stock price distance from twenty day simple moving average surged at 0.92% while its distance from fifty day simple moving average raised 1.97% along with 20.43% above distance from two hundred simple moving averages.","ROG","Roche"
"850","EPS for Rogers (ROG) Expected At $1.14, Endeavour Mining (TSE:EDV) Had 6 ...","http://normanobserver.com/eps-for-rogers-rog-expected-at-1-14-endeavour-mining-tseedv-had-6-bullish-analysts/","2017-04-12 13:37:30","NormanObserver.com","Among 6 analysts covering Endeavour Mining Corp (TSE:EDV), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive.","ROG","Roche"
"851","Rogers Sugar to Repay 5.7% Convertible Debentures in Cash at Maturity on April ...","http://www.marketwired.com/press-release/rogers-sugar-to-repay-57-convertible-debentures-in-cash-at-maturity-on-april-30-2017-tsx-rsi-2209555.htm","2017-04-12 17:00:00","Marketwired (press release)","(Marketwired - April 12, 2017) - Rogers Sugar Inc. (the ""Corporation"") (TSX:RSI) announced today that it will be repaying, in cash, its currently outstanding $49.565 million in principal of 5.7% convertible unsecured subordinated ...","ROG","Roche"
"852","Is Rogers Corporation&#39;s (ROG) growth strong enough to justify its April share ...","https://simplywall.st/news/2017/04/13/is-rogers-corporations-rog-growth-strong-enough-to-justify-its-april-share-price/","2017-04-12 17:33:45","Simply Wall St","Rogers Corporation (NYSE:ROG) is a stock well positioned for future growth, but many investors are wondering whether its last closing price of $84.36 is based on unrealistic expectations.","ROG","Roche"
"853","Two men charged after stolen trailer recovered in Isanti County","http://isanticountynews.com/2017/04/12/two-men-charged-after-stolen-trailer-recovered-in-isanti-county/","2017-04-12 20:00:00","Isanti County News","The men were charged after the trailer was located on April 5 on a property along the 34700 block of Hastings Street Northeast. The Isanti County Sheriff's Office worked with the Rogers Police Department and the Hennepin County Sheriff's Office on the ...","ROG","Roche"
"854","Government Doesn&#39;t Have To Be Broken","http://www.forbes.com/sites/jaredmeyer/2017/04/13/government-doesnt-have-to-be-broken/","2017-04-13 11:56:15","Forbes","Growing our economy has been a major focus since day one and the volume of business expansion announcements - Intel, Raytheon, Lucid, Apple, Caterpillar, Orbital, Google, Rogers Corporation, Houzz - shows the progress that we're making.","ROG","Roche"
"855","Raytheon&#39;s war lobbyist, Ed Rogers, thrives in the opinion pages of the ...","http://www.washingtonexaminer.com/raytheons-war-lobbyist-ed-rogers-thrives-in-the-opinion-pages-of-the-washington-post/article/2620250","2017-04-13 17:43:07","Washington Examiner","After staffing the Reagan and H.W. Bush White Houses, Rogers hung a shingle on K-Street. Around the time Marines were storming Fallujah, Raytheon signed on as a client.","ROG","Roche"
"856","Traders Take Note: Rogers Corporation (NYSE:ROG) Stock Drops, Weakness in ...","http://news.cmlviz.com/2017/04/13/traders-take-note-rogers-corporation-nyse-rog--stock-drops-weakness-in-technical-momentum.html","2017-04-13 22:03:45","CML News","Take Note: Rogers Corporation (NYSE:ROG) has hit some technical weakness in its momentum, and while it has not broken down all the way through support ","ROG","Roche"
"857","April Issue of The PCB Design Magazine Available Now","http://design.iconnect007.com/index.php/article/103763/april-issue-of-the-pcb-design-magazine-available-now/103766/?skin=design","2017-04-14 11:33:45","I-Connect007","Plus, columnist John Coonrod of Rogers Corporation discusses some of the challenges and remedies for woven glass weave effect.","ROG","Roche"
"858","State Street Corp Acquires 40274 Shares of Rogers Co. (ROG)","https://sportsperspectives.com/2017/04/16/rogers-co-rog-shares-bought-by-state-street-corp-updated.html","2017-04-16 00:18:45","Sports Perspectives","Rogers logo State Street Corp boosted its stake in shares of Rogers Co. (NYSE:ROG) by 11.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission.","ROG","Roche"
"859","The Rogers Co. (ROG) Stock Rating Reaffirmed by B. Riley","http://petroglobalnews24.com/2017-04-21-rogers-co-rog-stock-rating-reaffirmed-by-b-riley/","2017-04-17 23:00:00","Petro Global News 24","Rogers Corporation manufactures and sells engineered materials and components for mission critical applications. The Company's segments are Advanced Connectivity Solutions (ACS), Elastomeric Material Solutions (EMS), Power Electronics Solutions ...","ROG","Roche"
"860","The Raymond James Financial, Inc. Downgrades Rogers Co. (ROG) to Outperform","http://petroglobalnews24.com/2017-04-21-raymond-james-financial-inc-downgrades-rogers-co-rog-to-outperform/","2017-04-18 00:52:30","Petro Global News 24","Corporate insiders own 1.50% of the company's stock. Several hedge funds have recently bought and sold shares of the stock.","ROG","Roche"
"861","Earnings Scheduled For April 18, 2017","https://www.benzinga.com/news/earnings/17/04/9309091/earnings-scheduled-for-april-18-2017","2017-04-18 05:22:30","Benzinga","Rogers Corporation (NYSE: ROG) is projected to post quarterly earnings at $1.15 per share on revenue of $190.48 million. Lam Research Corporation (NASDAQ: LRCX) is expected to post quarterly earnings at $2.55 per share on revenue of $2.13 billion.","ROG","Roche"
"862","Packaging Foams Market by Structure Type (Flexible Foam, Rigid Foam), Material ...","http://finance.yahoo.com/news/packaging-foams-market-structure-type-162600272.html","2017-04-18 12:30:00","Yahoo Finance","Key companies profiled in this market research report include Armacell (Germany), JSP (Japan), Zotefoams Plc. (U.K.), BASF (Germany), Sealed Air Corporation (U.","ROG","Roche"
"863","Lithia Motors (LAD) EPS Estimated At $1.79; Rogers (ROG) Has 1.14 Sentiment","https://huronreport.com/lithia-motors-lad-eps-estimated-at-1-79-rogers-rog-has-1-14-sentiment/","2017-04-19 06:30:00","HuronReport","Rogers Corporation manufactures and sells engineered materials and components for mission critical applications. The company has market cap of $1.48 billion.","ROG","Roche"
"864","EPS for ManpowerGroup Inc. (MAN) Expected At $1.10, Tax Exempt Securities ...","https://normanobserver.com/eps-for-manpowergroup-inc-man-expected-at-1-10-tax-exempt-securities-trust-series-302-rogs-sentiment-is-1-14/","2017-04-19 06:30:00","NormanObserver.com","Rogers Corporation manufactures and sells engineered materials and components for mission critical applications. The company has market cap of $1.48 billion.","ROG","Roche"
"865","Rogers Communications Inc. Posts Impressive Earnings Results","http://www.fool.ca/2017/04/19/rogers-communications-inc-posts-impressive-earnings-results/","2017-04-19 08:11:15","The Motley Fool Canada","Rogers's share price closed 0.7% higher on news that the company's net income increased by 28% over the previous quarter, and both earnings and subscriber growth exceeded analysts' estimates during the first quarter of 2017.","ROG","Roche"
"866","&#39;Flexdude&#39; Tom Woznicki Celebrates Company&#39;s 25th Anniversary","http://design.iconnect007.com/index.php/article/103818/flexdude-tom-woznicki-celebrates-companys-25th-anniversary/103821/?skin=design","2017-04-19 11:11:15","I-Connect007","It started back in 1992 when I got laid off from Rogers Corporation. You know, necessity is the mother of adventure and invention.","ROG","Roche"
"867","Rogers Corporation (ROG) Moves Higher on Volume Spike for April 19","https://www.equities.com/news/rogers-corporation-rog-moves-higher-on-volume-spike-for-april-19","2017-04-19 17:30:18","Equities.com","Rogers Corporation (ROG) traded on unusually high volume on Apr. 19, as the stock gained 1.66% to close at $83.35. On the day, Rogers Corporation saw 210,401 shares trade hands on 2,325 trades. Considering that the stock averages only a daily volume ...","ROG","Roche"
"868","Revenio Group Corporation: Interim report January 1 - March 31, 2017","http://www.nasdaq.com/press-release/revenio-group-corporation-interim-report-january-1--march-31-2017-20170420-00064","2017-04-20 02:00:00","Nasdaq","In January, Seth Rogers joined our US team as its National Accounts Manager. He will strengthen our organization by bringing significant knowledge and experience of the sector.","ROG","Roche"
"869","Rogers (ROG) Getting Favorable Media Coverage, Study Finds","https://www.thecerbatgem.com/2017/04/20/rogers-rog-receiving-favorable-news-coverage-study-finds-updated.html","2017-04-20 07:48:45","The Cerbat Gem","Rogers logo Headlines about Rogers (NYSE:ROG) have been trending positive this week, AlphaOne reports. The research firm, a unit of Accern, identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real ...","ROG","Roche"
"870","Rogers (ROG) EPS Estimated At $1.14, State Auto Financial Has 1.64 Sentiment","http://highpointobserver.com/rogers-rog-eps-estimated-at-1-14-state-auto-financial-has-1-64-sentiment/","2017-04-20 09:30:00","High Point Observer","Analysts expect Rogers Corporation (NYSE:ROG) to report $1.14 EPS on May, 1.They anticipate $0.20 EPS change or 21.28% from last quarter's $0.94 EPS.","ROG","Roche"
"871","Rogers (ROG) Reaches $84.33 After 3.00% Up Move; 1 Analysts Bullish Universal ...","https://utahherald.com/rogers-rog-reaches-84-33-after-3-00-up-move-1-analysts-bullish-universal-technical-institute-inc-uti/","2017-04-20 11:45:00","UtahHerald.com","The stock of Rogers Corporation (NYSE:ROG) is a huge mover today! About 90,762 shares traded. Rogers Corporation (NYSE:ROG) has risen 49.43% since September 13, 2016 and is uptrending.","ROG","Roche"
"872","What&#39;s put WDAV among nation&#39;s top classical stations?","http://www.charlotteobserver.com/entertainment/tv/media-scene-blog/article145715614.html","2017-04-20 12:12:17","Charlotte Observer (blog)","Other well-known hosts with years of service at WDAV include morning host Mike McKay, Myelita Melton, Matt Rogers, Rachel Stewart and Joe Brant.","ROG","Roche"
"873","EPS for Rogers Sugar (RSI) Expected At $0.09, Payden &amp; Rygel Raised Bank Of ...","http://www.mmahotstuff.com/2017/04/20/eps-for-rogers-sugar-rsi-expected-at-0-09-payden-rygel-raised-bank-of-hawaii-boh-stake-by-1-96-million.html","2017-04-20 12:41:15","MoneyMakingArticles","Bank of Hawaii Corporation (NYSE:BOH) has risen 12.10% since September 13, 2016 and is uptrending. It has outperformed by 2.18% the S&P500.","ROG","Roche"
"874","Mamma Mia! It&#39;s a wonderful season: Neptune Theatre will bring musical ...","http://www.metronews.ca/news/halifax/2017/04/20/neptune-theatre-musical-holiday-favourites-major-renovations.html","2017-04-20 17:22:30","MetroNews Canada","Until the major renovations finish in November, the recently revamped Scotiabank Theatre will be the home of Neptune's productions, beginning with the first summer production in 20 years: Stan Rogers: A Matter of Heart, a lively, foot stomping, tribute ...","ROG","Roche"
"875","IU awarding honorary degrees to seven individuals for distinguished careers","https://news.iu.edu/stories/2017/04/iu/releases/20-honorary-degree-recipients.html","2017-04-21 02:56:15","IU Newsroom"," A scholar in the study of Chinese literature, the first African-American to serve as U.S. secretary of education, a professor whose contributions changed the course of how universities access the internet, one of the world's 100 ...","ROG","Roche"
"876","Hayward school administrator files whistle-blower complaint","http://www.eastbaytimes.com/2017/04/21/hayward-school-administrator-files-whistle-blower-complaint/","2017-04-21 07:15:00","East Bay Times","“Mr. Fallon had experience in that particular industry and realized that the number of special needs students requiring private taxi service was grossly out of proportion with other school districts,” Fallon's attorney Richard Rogers, of San Francisco ...","ROG","Roche"
"877","Caps All, Folks: Marvel Drops Massive Bombshell On Evil Captain America","https://moviepilot.com/p/marvel-comics-reveal-captain-america-has-always-been-hydra-agent/4251117","2017-04-21 08:10:18","moviepilot.com","If you thought time-meddling villains and a reality-warping Cosmic Cube was bad enough in the fictional worlds of comic books, how about when they go and fundamentally alter real history too?","ROG","Roche"
"878","Supreme Court of Canada Bulletin - April 20, 2017","http://www.lexology.com/library/detail.aspx?g=55785c37-d3cf-420f-8f5a-1c513a6612f8","2017-04-21 08:11:15","Lexology (registration)","On May 12, 1969, the applicant Churchill Falls (Labrador) Corporation Limited and the respondent Hydro-Québec entered into a contract pursuant to which the respondent undertook to purchase almost all the energy generated by a hydroelectric plant that ...","ROG","Roche"
"879","Buildings on leafy boulevard set to excite investors","http://www.smh.com.au/business/property/buildings-on-leafy-boulevard-set-to-excite-investors-20170420-gvoi7k.html","2017-04-21 10:15:00","The Sydney Morning Herald","Melbourne's premier office boulevard, St Kilda Road, will be the centre of vigorous investor attention as tightening supply and rising rents prompt two vendors to offer neighbouring office towers to the market.","ROG","Roche"
"880","Art and design hub Artscape Daniels Launchpad receives $21.4 million to ...","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170421C4008&filter=5611","2017-04-21 10:15:00","Montreal Gazette","The hub is named in recognition of the outstanding financial support of The Daniels Corporation and the John and Myrna Daniels Foundation, whose leadership gift of $5.75 million includes $625,000 in support from 'City of the Arts' development partner ...","ROG","Roche"
"881","Market Spotlight: Focusing on Shares of Rogers Corporation (NYSE:ROG)","https://6milestandard.com/market-spotlight-focusing-on-shares-of-rogers-corporation-nyserog-2/51786/","2017-04-21 12:41:15","The Standard","Taking a closer look at some quality ratios for Rogers Corporation (NYSE:ROG), the firm has a Gross Margin (Marx) ratio of 0.236143.","ROG","Roche"
"882","Judge slaps VW with $2.8 billion fine","http://www.marketwatch.com/story/judge-slaps-vw-with-28-billion-fine-2017-04-21","2017-04-21 14:00:00","MarketWatch","""This is a very serious and troubling case involving an iconic automobile company,"" Judge Cox said during the hearing, describing the plea deal as providing ""just punishment"" to the corporation. ""This is a deliberate and massive fraud perpetrated on ...","ROG","Roche"
"883","Roxgold (TSE:ROG) Had Its Price Target Raises by Researchers at RBC Capital ...","https://heraldks.com/roxgold-tserog-had-its-price-target-raises-by-researchers-at-rbc-capital-markets-to-1-95-tower-semiconductor-limited-ord-tsem-sellers-increased-by-0-79-their-shorts/","2017-04-21 15:18:45","Herald KS","Analysts await Rogers Corporation (NYSE:ROG) to report earnings on May, 1. They expect $1.14 EPS, up 21.28% or $0.20 from last year's $0.94 per share.","ROG","Roche"
"884","Dermira (DERM) EPS Estimated At $0.00, TOWERSTREAM CORPORATION (TWER) Shorts ...","https://heraldks.com/dermira-derm-eps-estimated-at-0-00-towerstream-corporation-twer-shorts-lowered-by-6-86/","2017-04-21 16:15:00","Herald KS","TOWERSTREAM CORPORATION (OTCMKTS:TWER) had a decrease of 6.86% in short interest. TWER's SI was 109,900 shares in April as released by FINRA.","ROG","Roche"
"885","$0.00 EPS Expected for China Hgs Real Estate (HGSH), 3 Analysts Covering ...","https://heraldks.com/0-00-eps-expected-for-china-hgs-real-estate-hgsh-3-analysts-covering-spartan-motors-spar/","2017-04-21 16:37:30","Herald KS","Moreover, Wilen Investment Management Corporation has 0.19% invested in Spartan Motors Inc (NASDAQ:SPAR). The New York-based Hutchin Hill Cap Limited Partnership has invested 0.01% in Spartan Motors Inc (NASDAQ:SPAR).","ROG","Roche"
"886","Greenberg Traurig Participates in HNBA&#39;s 8th Corporate Counsel Conference","https://www.benzinga.com/pressreleases/17/04/p9332351/greenberg-traurig-participates-in-hnbas-8th-corporate-counsel-conferenc","2017-04-21 18:30:00","Benzinga","Angelika Hunnefeld, a shareholder in the Miami office of global law firm Greenberg Traurig, LLP, and Elizabeth C. Rogers, a shareholder in the firm's Austin office, participated as speakers during the Hispanic National Bar Association's (HNBA) 8th ...","ROG","Roche"
"887","Wall Financial Corporation announces Q4 operating results and financial statements","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170421C8127&filter=5611","2017-04-21 19:26:15","Montreal Gazette","VANCOUVER, April 21, 2017 /CNW/ - Wall Financial Corporation (the ""Company"") released its operating results and financial statements for the year ended January 31, 2017.","ROG","Roche"
"888","Pfizer Inc declares Q2 2015 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3198278","2015-04-23 14:07:00","Reuters Key Development","Pfizer Inc declares Q2 2015 dividend","PFE","Pfizer"
"889","Pfizer Inc lowers FY 2015 guidance","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3201648","2015-04-28 07:00:00","Reuters Key Development","Pfizer Inc lowers FY 2015 guidance","PFE","Pfizer"
"890","Pfizer Inc says Palbociclib more than doubled progression-free survival in phase 3 trial for patients with HR+, HER2- metastatic breast cancer whose disease has progressed following endocrine therapy","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3221779","2015-05-30 07:30:00","Reuters Key Development","Pfizer Inc says Palbociclib more than doubled progression-free survival in phase 3 trial for patients with HR+, HER2- metastatic breast cancer whose disease has progressed following endocrine therapy","PFE","Pfizer"
"891","Pfizer Inc reports top line results from a phase 3 study evaluating desvenlafaxine succinate sustained-release formulation in pediatric patients with major depressive disorder","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3228182","2015-06-11 15:00:00","Reuters Key Development","Pfizer Inc reports top line results from a phase 3 study evaluating desvenlafaxine succinate sustained-release formulation in pediatric patients with major depressive disorder","PFE","Pfizer"
"892","Pfizer Inc to acquire Nimenrix And Mencevax from GlaxoSmithKline Plc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3232667","2015-06-22 07:10:00","Reuters Key Development","Pfizer Inc to acquire Nimenrix And Mencevax from GlaxoSmithKline Plc","PFE","Pfizer"
"893","Pfizer Inc declares 28-cent third-quarter 2015 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3235107","2015-06-25 11:15:00","Reuters Key Development","Pfizer Inc declares 28-cent third-quarter 2015 dividend","PFE","Pfizer"
"894","Pfizer Inc Announces FDA acceptance for review of New Drug Application for a once-daily formulation of XELJANZ modified release tablets","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3239310","2015-07-02 16:30:00","Reuters Key Development","Pfizer Inc Announces FDA acceptance for review of New Drug Application for a once-daily formulation of XELJANZ modified release tablets","PFE","Pfizer"
"895","Pfizer Inc raises low end of prior FY 2015 revenue guidance and raises FY 2015 EPS guidance","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3251590","2015-07-28 07:00:00","Reuters Key Development","Pfizer Inc raises low end of prior FY 2015 revenue guidance and raises FY 2015 EPS guidance","PFE","Pfizer"
"896","Pfizer and synthon enter into U.S. commercialization agreement for potential generic treatment of multiple sclerosis","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3255131","2015-08-03 08:30:00","Reuters Key Development","Pfizer and synthon enter into U.S. commercialization agreement for potential generic treatment of multiple sclerosis","PFE","Pfizer"
"897","Gliknik licensee Pfizer Inc receives orphan drug designation from U.S.FDA for drug candidate directed towards rare neurological disorder","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3259240","2015-08-10 08:00:00","Reuters Key Development","Gliknik licensee Pfizer Inc receives orphan drug designation from U.S.FDA for drug candidate directed towards rare neurological disorder","PFE","Pfizer"
"898","Pfizer Inc gets Canadian Competition Bureau approval for Hospira acquisition","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3261946","2015-08-14 08:35:00","Reuters Key Development","Pfizer Inc gets Canadian Competition Bureau approval for Hospira acquisition","PFE","Pfizer"
"899","Pfizer announces positive topline results of two phase 3 studies of Trumenba","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3264475","2015-08-21 08:00:00","Reuters Key Development","Pfizer announces positive topline results of two phase 3 studies of Trumenba","PFE","Pfizer"
"900","Pfizer Inc receives clearance from U.S. Federal Trade Commission for Hospira acquisition","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3265010","2015-08-24 08:00:00","Reuters Key Development","Pfizer Inc receives clearance from U.S. Federal Trade Commission for Hospira acquisition","PFE","Pfizer"
"901","Alvogen to acquire product portfolio from Pfizer for the U.S. Market","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3266059","2015-08-26 06:12:00","Reuters Key Development","Alvogen to acquire product portfolio from Pfizer for the U.S. Market","PFE","Pfizer"
"902","Pfizer Inc completes acquisition of Hospira","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3269602","2015-09-03 09:00:00","Reuters Key Development","Pfizer Inc completes acquisition of Hospira","PFE","Pfizer"
"903","Pfizer announces positive top-line results from two phase 3 trials of Oral Tofacitinib in Adults with Moderate-to-Severe Ulcerative Colitis","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3275668","2015-09-21 08:00:00","Reuters Key Development","Pfizer announces positive top-line results from two phase 3 trials of Oral Tofacitinib in Adults with Moderate-to-Severe Ulcerative Colitis","PFE","Pfizer"
"904","Merck and Pfizer announce FDA orphan drug designation for investigational immunotherapy avelumab in merkel cell carcinoma","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3277667","2015-09-25 07:00:00","Reuters Key Development","Merck and Pfizer announce FDA orphan drug designation for investigational immunotherapy avelumab in merkel cell carcinoma","PFE","Pfizer"
"905","Pfizer declares 28-Cent fourth-quarter 2015 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3277740","2015-09-25 10:10:00","Reuters Key Development","Pfizer declares 28-Cent fourth-quarter 2015 dividend","PFE","Pfizer"
"906","Pfizer Inc updates FY 2015 financial guidance solely to include Hospira operations in financial results from Sept. 3, 2015 through year-end 2015","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3279547","2015-09-30 08:30:00","Reuters Key Development","Pfizer Inc updates FY 2015 financial guidance solely to include Hospira operations in financial results from Sept. 3, 2015 through year-end 2015","PFE","Pfizer"
"907","Pfizer Inc completes acquisition of nimenrix and mencevax from GlaxoSmithKline Plc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3280166","2015-10-01 08:00:00","Reuters Key Development","Pfizer Inc completes acquisition of nimenrix and mencevax from GlaxoSmithKline Plc","PFE","Pfizer"
"908","Pfizer receives complete response letter from FDA for Oral XELJANZ","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3284894","2015-10-14 17:00:00","Reuters Key Development","Pfizer receives complete response letter from FDA for Oral XELJANZ","PFE","Pfizer"
"909","Pfizer Inc enters multi-year collaboration with GSK on development of a next-generation equipment design","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3292623","2015-10-29 08:00:00","Reuters Key Development","Pfizer Inc enters multi-year collaboration with GSK on development of a next-generation equipment design","PFE","Pfizer"
"910","Merck kgaa, Darmstadt, Germany, and Pfizer Inc receive FDA breakthrough therapy designation for avelumab in metastatic merkel cell carcinoma","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3301540","2015-11-18 07:00:00","Reuters Key Development","Merck kgaa, Darmstadt, Germany, and Pfizer Inc receive FDA breakthrough therapy designation for avelumab in metastatic merkel cell carcinoma","PFE","Pfizer"
"911","Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3301593","2015-11-18 08:00:00","Reuters Key Development","Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer","PFE","Pfizer"
"912","Pfizer Inc - U.S. Treasury clamps down on corporate tax inversion deals - Reuters","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3302390","2015-11-19 17:09:00","Reuters Key Development","Pfizer Inc - U.S. Treasury clamps down on corporate tax inversion deals - Reuters","PFE","Pfizer"
"913","Pfizer and Allergan to Combine","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3303022","2015-11-23 07:03:00","Reuters Key Development","Pfizer and Allergan to Combine","PFE","Pfizer"
"914","Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICA (pregabalin) Capsules CV in Adults with Post-Traumatic Peripheral Neuropathic Pain","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3304105","2015-11-25 08:00:00","Reuters Key Development","Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICA (pregabalin) Capsules CV in Adults with Post-Traumatic Peripheral Neuropathic Pain","PFE","Pfizer"
"915","Pfizer Inc&#39;s Lyrica shows no relief from post-traumatic nerve pain - Reuters","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3304660","2015-11-25 08:29:00","Reuters Key Development","Pfizer Inc's Lyrica shows no relief from post-traumatic nerve pain - Reuters","PFE","Pfizer"
"916","Pfizer Inc announces FDA acceptance of IBRANCE® (palbociclib) supplemental new drug application","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3309474","2015-12-10 08:00:00","Reuters Key Development","Pfizer Inc announces FDA acceptance of IBRANCE® (palbociclib) supplemental new drug application","PFE","Pfizer"
"917","Pfizer Inc approves increase in quarterly cash dividend to $0.30 per share","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3310747","2015-12-14 16:30:00","Reuters Key Development","Pfizer Inc approves increase in quarterly cash dividend to $0.30 per share","PFE","Pfizer"
"918","Pfizer Inc Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3313763","2015-12-21 16:00:00","Reuters Key Development","Pfizer Inc Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation","PFE","Pfizer"
"919","Pfizer Inc - SAC Capital to pay $10 million in investors&#39; insider trading lawsuit - Reuters","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3315991","2015-12-24 10:16:00","Reuters Key Development","Pfizer Inc - SAC Capital to pay $10 million in investors' insider trading lawsuit - Reuters","PFE","Pfizer"
"920","KineMed Inc enters collaboration with Pfizer Inc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3317230","2016-01-04 06:00:00","Reuters Key Development","KineMed Inc enters collaboration with Pfizer Inc","PFE","Pfizer"
"921","Merck KGaA,Darmstadt, Germany, Pfizer and Syndax announces collaboration to evaluate combination of avelumab and entinostat in ovarian cancer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3317281","2016-01-04 08:00:00","Reuters Key Development","Merck KGaA,Darmstadt, Germany, Pfizer and Syndax announces collaboration to evaluate combination of avelumab and entinostat in ovarian cancer","PFE","Pfizer"
"922","Pfizer Inc enters into translational research collaboration with Adaptive Biotechnologies","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3318816","2016-01-08 08:00:00","Reuters Key Development","Pfizer Inc enters into translational research collaboration with Adaptive Biotechnologies","PFE","Pfizer"
"923","HemoShear Therapeutics, LLC Announces Next Stage of Safety Collaboration with Pfizer Inc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3319166","2016-01-11 07:00:00","Reuters Key Development","HemoShear Therapeutics, LLC Announces Next Stage of Safety Collaboration with Pfizer Inc","PFE","Pfizer"
"924","Bristol-Myers Squibb and Pfizer sign collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3326789","2016-02-01 06:55:00","Reuters Key Development","Bristol-Myers Squibb and Pfizer sign collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan","PFE","Pfizer"
"925","Pfizer Inc gives FY 2016 guidance","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3327485","2016-02-02 06:45:00","Reuters Key Development","Pfizer Inc gives FY 2016 guidance","PFE","Pfizer"
"926","Pfizer Inc says Wyeth reaches agreement in principle to resolve medicaid drug rebate claims for 2001-2006 period for Protonix","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3332047","2016-02-16 06:45:00","Reuters Key Development","Pfizer Inc says Wyeth reaches agreement in principle to resolve medicaid drug rebate claims for 2001-2006 period for Protonix","PFE","Pfizer"
"927","Pfizer Inc receives expanded FDA approval For IBRANCE (palbociclib) In HR+, HER2- Metastatic Breast Cancer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3333361","2016-02-19 16:35:00","Reuters Key Development","Pfizer Inc receives expanded FDA approval For IBRANCE (palbociclib) In HR+, HER2- Metastatic Breast Cancer","PFE","Pfizer"
"928","Pfizer Inc announces FDA approval of XELJANZ","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3334878","2016-02-24 11:15:00","Reuters Key Development","Pfizer Inc announces FDA approval of XELJANZ","PFE","Pfizer"
"929","Pfizer Inc commences $5 bln accelerated share repurchase","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3340552","2016-03-09 06:45:00","Reuters Key Development","Pfizer Inc commences $5 bln accelerated share repurchase","PFE","Pfizer"
"930","Pfizer Inc says oral tofacitinib meets primary and key secondary endpoints in two ph 3 trials","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3345173","2016-03-18 11:00:00","Reuters Key Development","Pfizer Inc says oral tofacitinib meets primary and key secondary endpoints in two ph 3 trials","PFE","Pfizer"
"931","Pfizer Inc - New U.S. inversion rules threaten Pfizer-Allergan deal - Reuters News","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3353948","2016-04-04 23:06:00","Reuters Key Development","Pfizer Inc - New U.S. inversion rules threaten Pfizer-Allergan deal - Reuters News","PFE","Pfizer"
"932","Pfizer Inc must face revived Celebrex, Bextra safety lawsuit - Reuters News","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3356536","2016-04-12 22:59:00","Reuters Key Development","Pfizer Inc must face revived Celebrex, Bextra safety lawsuit - Reuters News","PFE","Pfizer"
"933","Pfizer Inc to pay $784.6 million to resolve Wyeth false claims lawsuit - Reuters News","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3365415","2016-04-27 21:35:00","Reuters Key Development","Pfizer Inc to pay $784.6 million to resolve Wyeth false claims lawsuit - Reuters News","PFE","Pfizer"
"934","First dosing of Pfizer DART candidate in phase 1 study triggers milestone payment to MacroGenics","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3370332","2016-05-10 07:30:00","Reuters Key Development","First dosing of Pfizer DART candidate in phase 1 study triggers milestone payment to MacroGenics","PFE","Pfizer"
"935","Pfizer Canada says Health Canada has given conditional approval of IBRANCE TM","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3370384","2016-05-10 08:29:45","Reuters Key Development","Pfizer Canada says Health Canada has given conditional approval of IBRANCE TM","PFE","Pfizer"
"936","Anacor-Pfizer merger agreement includes $180.8 mln termination fee - SEC filing","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3375748","2016-05-16 07:25:04","Reuters Key Development","Anacor-Pfizer merger agreement includes $180.8 mln termination fee - SEC filing","PFE","Pfizer"
"937","Moody&#39;s affirms Pfizer&#39;s A1/P-1 ratings","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3376091","2016-05-16 13:06:23","Reuters Key Development","Moody's affirms Pfizer's A1/P-1 ratings","PFE","Pfizer"
"938","Pfozer- Champix EU label updated to include new data from EAGLES clinical trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3379796","2016-05-23 07:00:00","Reuters Key Development","Pfozer- Champix EU label updated to include new data from EAGLES clinical trial","PFE","Pfizer"
"939","Biorap Technologies enters into an agreement with Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3384515","2016-05-31 09:00:00","Reuters Key Development","Biorap Technologies enters into an agreement with Pfizer","PFE","Pfizer"
"940","Pfizer prices $5.0 billion debt offering","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3384722","2016-05-31 19:05:00","Reuters Key Development","Pfizer prices $5.0 billion debt offering","PFE","Pfizer"
"941","Pfizer says takes 7.1 pct passive stake in Merus NV","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3387386","2016-06-06 17:39:01","Reuters Key Development","Pfizer says takes 7.1 pct passive stake in Merus NV","PFE","Pfizer"
"942","Mayne Pharma says FDA granted approval of its abbreviated new drug application&lt;MYX.AX&gt;&lt;PFE.N&gt;","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3387411","2016-06-06 18:29:57","Reuters Key Development","Mayne Pharma says FDA granted approval of its abbreviated new drug application<MYX.AX><PFE.N>","PFE","Pfizer"
"943","Pfizer announces positive top-line results from second Phase 3 oral Xeljanz trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3387838","2016-06-07 07:00:00","Reuters Key Development","Pfizer announces positive top-line results from second Phase 3 oral Xeljanz trial","PFE","Pfizer"
"944","Pfizer says FDA advisory committees&#39; recommend ALO-02 extended-release capsules for approval","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3388874","2016-06-08 19:15:00","Reuters Key Development","Pfizer says FDA advisory committees' recommend ALO-02 extended-release capsules for approval","PFE","Pfizer"
"945","DKSH and Pfizer expand collaboration in Thailand","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3388922","2016-06-09 00:51:06","Reuters Key Development","DKSH and Pfizer expand collaboration in Thailand","PFE","Pfizer"
"946","ICON signed new three-year agreement with Pfizer Inc.","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3389649","2016-06-10 06:00:00","Reuters Key Development","ICON signed new three-year agreement with Pfizer Inc.","PFE","Pfizer"
"947","Icon announces service agreement with Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3389631","2016-06-10 06:00:00","Reuters Key Development","Icon announces service agreement with Pfizer","PFE","Pfizer"
"948","Shire to license investigational gastric drug from Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3390852","2016-06-14 07:00:52","Reuters Key Development","Shire to license investigational gastric drug from Pfizer","PFE","Pfizer"
"949","Hospira says Inflectra has been approved by Health Canada for 3 additional indications","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3391032","2016-06-14 15:01:00","Reuters Key Development","Hospira says Inflectra has been approved by Health Canada for 3 additional indications","PFE","Pfizer"
"950","Merck KGaA says plans to apply for authorization for Avelumab in H2","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3393359","2016-06-20 05:00:00","Reuters Key Development","Merck KGaA says plans to apply for authorization for Avelumab in H2","PFE","Pfizer"
"951","Pfizer declares Q3 2016 $0.30 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3395370","2016-06-23 16:00:00","Reuters Key Development","Pfizer declares Q3 2016 $0.30 dividend","PFE","Pfizer"
"952","Pfizer completes acquisition of Anacor","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3395848","2016-06-24 09:00:00","Reuters Key Development","Pfizer completes acquisition of Anacor","PFE","Pfizer"
"953","Bind Therapeutics files motion for sale of assets after accepting stalking horse bid from Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3399564","2016-07-01 17:30:00","Reuters Key Development","Bind Therapeutics files motion for sale of assets after accepting stalking horse bid from Pfizer","PFE","Pfizer"
"954","Pfizer and Merck initiate phase III trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3401180","2016-07-06 08:00:00","Reuters Key Development","Pfizer and Merck initiate phase III trial","PFE","Pfizer"
"955","BRIEF-Pfizer and Germany&#39;s Merck KGaA initiate phase III trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3401863","2016-07-07 11:56:45","Reuters Key Development","BRIEF-Pfizer and Germany's Merck KGaA initiate phase III trial","PFE","Pfizer"
"956","Pfizer announces positive top-line results from phase 3 S-TRAC trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3402404","2016-07-08 08:00:00","Reuters Key Development","Pfizer announces positive top-line results from phase 3 S-TRAC trial","PFE","Pfizer"
"957","ARIA study shows superior efficacy of Triumeq for treatment-naïve women with HIV","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3406901","2016-07-18 06:16:10","Reuters Key Development","ARIA study shows superior efficacy of Triumeq for treatment-naïve women with HIV","PFE","Pfizer"
"958","Pfizer gets WHO prequalification for multi-dose vial presentation of Prevenar 13","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3407718","2016-07-19 08:00:00","Reuters Key Development","Pfizer gets WHO prequalification for multi-dose vial presentation of Prevenar 13","PFE","Pfizer"
"959","Bind Therapeutics says two bidders join Pfizer&#39;s stalking horse bid","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3410673","2016-07-25 07:00:00","Reuters Key Development","Bind Therapeutics says two bidders join Pfizer's stalking horse bid","PFE","Pfizer"
"960","Bind Therapeutics determines Pfizer&#39;s $40 mln bid highest","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3412044","2016-07-26 17:27:00","Reuters Key Development","Bind Therapeutics determines Pfizer's $40 mln bid highest","PFE","Pfizer"
"961","Pfizer and Western Oncolytics announce immuno-oncology research collaboration","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3414145","2016-07-28 10:00:00","Reuters Key Development","Pfizer and Western Oncolytics announce immuno-oncology research collaboration","PFE","Pfizer"
"962","Bind Therapeutics says it entered into an asset purchase agreement with Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3414375","2016-07-28 16:07:47","Reuters Key Development","Bind Therapeutics says it entered into an asset purchase agreement with Pfizer","PFE","Pfizer"
"963","Pfizer says it has reached $486 million settlement of litigation over Celebrex, Bextra&lt;PFE.N&gt;","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3417194","2016-08-02 07:30:00","Reuters Key Development","Pfizer says it has reached $486 million settlement of litigation over Celebrex, Bextra<PFE.N>","PFE","Pfizer"
"964","Pfenex will regain full rights to PF582","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3421200","2016-08-08 08:03:18","Reuters Key Development","Pfenex will regain full rights to PF582","PFE","Pfizer"
"965","Pfizer says as of July 3 offsetting foreign currency exposures was $31.5 bln","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3424796","2016-08-11 17:58:00","Reuters Key Development","Pfizer says as of July 3 offsetting foreign currency exposures was $31.5 bln","PFE","Pfizer"
"966","FDA approves Pfizer&#39;s TROXYCA ER extended-release capsules CII for pain management","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3429750","2016-08-19 18:21:00","Reuters Key Development","FDA approves Pfizer's TROXYCA ER extended-release capsules CII for pain management","PFE","Pfizer"
"967","Medivation to pay fee of $510 mln, upon Pfizer deal termination","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3430246","2016-08-22 08:30:01","Reuters Key Development","Medivation to pay fee of $510 mln, upon Pfizer deal termination","PFE","Pfizer"
"968","Moody&#39;s affirms Pfizer at A1/P-1; outlook remains negative","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3430372","2016-08-22 13:46:03","Reuters Key Development","Moody's affirms Pfizer at A1/P-1; outlook remains negative","PFE","Pfizer"
"969","Fitch: Pfizer deal highlights US Pharma trend for targeted M&amp;A","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3430991","2016-08-23 11:03:21","Reuters Key Development","Fitch: Pfizer deal highlights US Pharma trend for targeted M&A","PFE","Pfizer"
"970","Clovis enters into first amendment to license agreement between Clovis and pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3434931","2016-08-30 16:15:13","Reuters Key Development","Clovis enters into first amendment to license agreement between Clovis and pfizer","PFE","Pfizer"
"971","Pfizer appoints Chief Scientific Officer for Neuroscience Research","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3438319","2016-09-07 08:00:00","Reuters Key Development","Pfizer appoints Chief Scientific Officer for Neuroscience Research","PFE","Pfizer"
"972","Medivation and Pfizer file premerger notification","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3439325","2016-09-09 07:22:19","Reuters Key Development","Medivation and Pfizer file premerger notification","PFE","Pfizer"
"973","FDA staff say neuropsychiatric risk with Pfizer&#39;s quit-smoking drug varies in studies, trial design has limitations","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3439924","2016-09-12 09:22:09","Reuters Key Development","FDA staff say neuropsychiatric risk with Pfizer's quit-smoking drug varies in studies, trial design has limitations","PFE","Pfizer"
"974","U.S. FDA panel votes in favor of removing boxed warning on Pfizer&#39;s quit-smoking drug Chantix","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3441119","2016-09-14 16:15:00","Reuters Key Development","U.S. FDA panel votes in favor of removing boxed warning on Pfizer's quit-smoking drug Chantix","PFE","Pfizer"
"975","Merck, Pfizer say investigational Ertugliflozin met primary endpoint","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3441448","2016-09-15 08:31:00","Reuters Key Development","Merck, Pfizer say investigational Ertugliflozin met primary endpoint","PFE","Pfizer"
"976","Oncoimmune announces option and license agreement with Pfizer Inc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3441468","2016-09-15 09:00:00","Reuters Key Development","Oncoimmune announces option and license agreement with Pfizer Inc","PFE","Pfizer"
"977","Pfizer declares 30-cent fourth-quarter 2016 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3444159","2016-09-22 11:56:00","Reuters Key Development","Pfizer declares 30-cent fourth-quarter 2016 dividend","PFE","Pfizer"
"978","Pfizer says it will not pursue splitting into two separate publicly traded companies","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3445096","2016-09-26 06:45:00","Reuters Key Development","Pfizer says it will not pursue splitting into two separate publicly traded companies","PFE","Pfizer"
"979","Moody&#39;s changes outlook on Pfizer&#39;s to stable from negative, affirms ratings","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3445301","2016-09-26 13:08:15","Reuters Key Development","Moody's changes outlook on Pfizer's to stable from negative, affirms ratings","PFE","Pfizer"
"980","Fitch says Pfizer&#39;s scrapped split decision will not affect ratings","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3445869","2016-09-27 10:52:23","Reuters Key Development","Fitch says Pfizer's scrapped split decision will not affect ratings","PFE","Pfizer"
"981","ICU Medical to buy Hospira Infusion Systems business from Pfizer for $1 bln in cash, stock","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3450083","2016-10-06 07:52:59","Reuters Key Development","ICU Medical to buy Hospira Infusion Systems business from Pfizer for $1 bln in cash, stock","PFE","Pfizer"
"982","Pfizer announces results from Phase 3 S-TRAC clinical trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3450969","2016-10-10 02:15:00","Reuters Key Development","Pfizer announces results from Phase 3 S-TRAC clinical trial","PFE","Pfizer"
"983","Icu Medical says termination rights in connection of Hospira deal include payment of $75 mln from Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3453528","2016-10-13 17:52:00","Reuters Key Development","Icu Medical says termination rights in connection of Hospira deal include payment of $75 mln from Pfizer","PFE","Pfizer"
"984","Pfizer says company to begin shipping Inflectra to wholesalers in late November","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3455320","2016-10-17 16:05:00","Reuters Key Development","Pfizer says company to begin shipping Inflectra to wholesalers in late November","PFE","Pfizer"
"985","Pfizer awarded grant to evaluate vaccine for newborns","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3456590","2016-10-19 08:00:00","Reuters Key Development","Pfizer awarded grant to evaluate vaccine for newborns","PFE","Pfizer"
"986","CDC&#39;s ACIP votes to recommend new dosing schedule for vaccination with Pfizer&#39;s trumenba","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3456882","2016-10-19 18:02:00","Reuters Key Development","CDC's ACIP votes to recommend new dosing schedule for vaccination with Pfizer's trumenba","PFE","Pfizer"
"987","Debiopharm reports clinical collaboration with Merck KGaA and Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3457491","2016-10-20 08:00:00","Reuters Key Development","Debiopharm reports clinical collaboration with Merck KGaA and Pfizer","PFE","Pfizer"
"988","Merck and Pfizer say EMA validated Avelumab for MMA review","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3465523","2016-10-31 03:08:10","Reuters Key Development","Merck and Pfizer say EMA validated Avelumab for MMA review","PFE","Pfizer"
"989","Pfizer Q3 adjusted EPS $0.61","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3466763","2016-11-01 06:45:00","Reuters Key Development","Pfizer Q3 adjusted EPS $0.61","PFE","Pfizer"
"990","Pfizer discontinues global development of Bococizumab, its investigational pcsk9 inhibitor","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3466754","2016-11-01 06:45:00","Reuters Key Development","Pfizer discontinues global development of Bococizumab, its investigational pcsk9 inhibitor","PFE","Pfizer"
"991","Pfizer Q3 worldwide Ibrance revenue $550 mln vs.$230 mln last year","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3466807","2016-11-01 06:45:00","Reuters Key Development","Pfizer Q3 worldwide Ibrance revenue $550 mln vs.$230 mln last year","PFE","Pfizer"
"992","EMA says CHMP recommends approving Afstyla","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3476217","2016-11-11 07:11:27","Reuters Key Development","EMA says CHMP recommends approving Afstyla","PFE","Pfizer"
"993","Pfizer to collaborate with National Cancer Institute","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3477530","2016-11-14 08:00:00","Reuters Key Development","Pfizer to collaborate with National Cancer Institute","PFE","Pfizer"
"994","Pfizer says announces tender offer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3477650","2016-11-14 08:47:00","Reuters Key Development","Pfizer says announces tender offer","PFE","Pfizer"
"995","Paulson &amp; Co cuts share stake in Pfizer, raises share stake in Facebook","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3478208","2016-11-14 17:35:31","Reuters Key Development","Paulson & Co cuts share stake in Pfizer, raises share stake in Facebook","PFE","Pfizer"
"996","Pfizer prices $6 billion debt offering&lt;PFE.N&gt;","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3478278","2016-11-14 18:55:00","Reuters Key Development","Pfizer prices $6 billion debt offering<PFE.N>","PFE","Pfizer"
"997","Pfizer prices $6 billion debt offering","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3478279","2016-11-14 19:37:40","Reuters Key Development","Pfizer prices $6 billion debt offering","PFE","Pfizer"
"998","Pfizer announces pricing of tender offer for any and all of its 6.200 pct senior notes due March 15, 2019","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3481614","2016-11-18 14:55:00","Reuters Key Development","Pfizer announces pricing of tender offer for any and all of its 6.200 pct senior notes due March 15, 2019","PFE","Pfizer"
"999","Pfizer says Pfizer Global Supply President to retire","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3482212","2016-11-21 10:11:00","Reuters Key Development","Pfizer says Pfizer Global Supply President to retire","PFE","Pfizer"
"1000","FDA accepts the Biologics&#39; license application for Avelumab for priority review","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3486669","2016-11-29 08:17:00","Reuters Key Development","FDA accepts the Biologics' license application for Avelumab for priority review","PFE","Pfizer"
"1001","Pfizer Inc, IBM announced a collaboration that will utilize IBM watson for drug discovery","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3488323","2016-12-01 08:00:00","Reuters Key Development","Pfizer Inc, IBM announced a collaboration that will utilize IBM watson for drug discovery","PFE","Pfizer"
"1002","UK&#39;s CMA fines Pfizer, Flynn Pharma for epilepsy drug price hike","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3491150","2016-12-07 02:18:33","Reuters Key Development","UK's CMA fines Pfizer, Flynn Pharma for epilepsy drug price hike","PFE","Pfizer"
"1003","Pfizer to appeal all aspects of decision by UK&#39;s CMA","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3491162","2016-12-07 02:27:34","Reuters Key Development","Pfizer to appeal all aspects of decision by UK's CMA","PFE","Pfizer"
"1004","Drugmakers trade group says government mandates wrong way to address drug costs","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3491583","2016-12-07 12:15:21","Reuters Key Development","Drugmakers trade group says government mandates wrong way to address drug costs","PFE","Pfizer"
"1005","Pfizer declares first-quarter 2017 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3493661","2016-12-12 11:57:27","Reuters Key Development","Pfizer declares first-quarter 2017 dividend","PFE","Pfizer"
"1006","Ab Initio Biotherapeutics announces strategic collaboration with Pfizer to discover GPCR activating antibodies","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3494411","2016-12-13 13:03:00","Reuters Key Development","Ab Initio Biotherapeutics announces strategic collaboration with Pfizer to discover GPCR activating antibodies","PFE","Pfizer"
"1007","U.S. FDA approves Eucrisa for eczema","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3495181","2016-12-14 13:10:39","Reuters Key Development","U.S. FDA approves Eucrisa for eczema","PFE","Pfizer"
"1008","Catalyst Biosciences entered into agreement with Wyeth Llc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3495231","2016-12-14 16:18:23","Reuters Key Development","Catalyst Biosciences entered into agreement with Wyeth Llc","PFE","Pfizer"
"1009","EMA recommends approval of Pfizer&#39;s lifmior drug","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3496637","2016-12-16 07:39:54","Reuters Key Development","EMA recommends approval of Pfizer's lifmior drug","PFE","Pfizer"
"1010","Pfizer says FDA drops black box warning on anti-smoking drug Chantix","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3496828","2016-12-16 14:09:00","Reuters Key Development","Pfizer says FDA drops black box warning on anti-smoking drug Chantix","PFE","Pfizer"
"1011","Portola Pharmaceuticals enters loan agreement with Bristol-Myers Squibb and Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3497499","2016-12-19 08:00:00","Reuters Key Development","Portola Pharmaceuticals enters loan agreement with Bristol-Myers Squibb and Pfizer","PFE","Pfizer"
"1012","Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3500133","2016-12-23 02:05:00","Reuters Key Development","Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca","PFE","Pfizer"
"1013","ICU Medical updates on Hospira Infusion Systems deal","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3504672","2017-01-05 16:05:00","Reuters Key Development","ICU Medical updates on Hospira Infusion Systems deal","PFE","Pfizer"
"1014","Pfizer reports positive top-line results from phase 2 study of investigational clostridium difficile vaccine","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3515892","2017-01-26 08:00:00","Reuters Key Development","Pfizer reports positive top-line results from phase 2 study of investigational clostridium difficile vaccine","PFE","Pfizer"
"1015","Pfizer Inc reports Q4 reported diluted EPS of $0.13","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3517905","2017-01-31 06:45:00","Reuters Key Development","Pfizer Inc reports Q4 reported diluted EPS of $0.13","PFE","Pfizer"
"1016","Pfizer&#39;s Q4 Lyrica IH revenue was $1.06 bln vs $955 mln yr ago","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3517901","2017-01-31 07:16:13","Reuters Key Development","Pfizer's Q4 Lyrica IH revenue was $1.06 bln vs $955 mln yr ago","PFE","Pfizer"
"1017","Pfizer sees 2017 Prevnar sales flat to slightly down","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3518084","2017-01-31 11:42:43","Reuters Key Development","Pfizer sees 2017 Prevnar sales flat to slightly down","PFE","Pfizer"
"1018","Pfizer said to hire JPMorgan to weigh $2 bln portfolio sale - Bloomberg, citing sources","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3519827","2017-02-02 12:27:33","Reuters Key Development","Pfizer said to hire JPMorgan to weigh $2 bln portfolio sale - Bloomberg, citing sources","PFE","Pfizer"
"1019","Pfizer commences $5 billion accelerated share repurchase","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3520455","2017-02-03 08:10:00","Reuters Key Development","Pfizer commences $5 billion accelerated share repurchase","PFE","Pfizer"
"1020","ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3526433","2017-02-13 18:55:53","Reuters Key Development","ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine","PFE","Pfizer"
"1021","Appaloosa LP dissolves share stake in Citigroup, Bank of America - SEC Filing","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3527762","2017-02-14 16:47:43","Reuters Key Development","Appaloosa LP dissolves share stake in Citigroup, Bank of America - SEC Filing","PFE","Pfizer"
"1022","Paulson &amp; Co ups share stake in Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3527812","2017-02-14 18:23:24","Reuters Key Development","Paulson & Co ups share stake in Pfizer","PFE","Pfizer"
"1023","Pfizer announces top-line results from oral strategy trial of Xeljanz compared to Humira","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3529501","2017-02-16 08:00:00","Reuters Key Development","Pfizer announces top-line results from oral strategy trial of Xeljanz compared to Humira","PFE","Pfizer"
"1024","Momenta Pharmaceuticals announces FDA warning letter to contracted Glatopa","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3530506","2017-02-17 19:02:15","Reuters Key Development","Momenta Pharmaceuticals announces FDA warning letter to contracted Glatopa","PFE","Pfizer"
"1025","Pfizer says U.S. FDA accepts regulatory submission for inotuzumab ozogamicin","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3531823","2017-02-21 08:00:00","Reuters Key Development","Pfizer says U.S. FDA accepts regulatory submission for inotuzumab ozogamicin","PFE","Pfizer"
"1026","Pfizer said SIX swiss exchange approved delisting of its shares","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3532434","2017-02-22 01:05:48","Reuters Key Development","Pfizer said SIX swiss exchange approved delisting of its shares","PFE","Pfizer"
"1027","Pfizer to cancel listing in the United Kingdom","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3532612","2017-02-22 02:00:07","Reuters Key Development","Pfizer to cancel listing in the United Kingdom","PFE","Pfizer"
"1028","Ronald Blaylock elected to Pfizer&#39;s board of directors","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3534484","2017-02-23 16:15:00","Reuters Key Development","Ronald Blaylock elected to Pfizer's board of directors","PFE","Pfizer"
"1029","Pfizer says monitoring potential impact related to any changes to ACA","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3534594","2017-02-23 17:49:11","Reuters Key Development","Pfizer says monitoring potential impact related to any changes to ACA","PFE","Pfizer"
"1030","Pfizer announces pricing of $1.07 bln debt offering","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3535471","2017-02-24 13:12:25","Reuters Key Development","Pfizer announces pricing of $1.07 bln debt offering","PFE","Pfizer"
"1031","Pfizer says FDA accepts Biologics License Application for Avelumab for priority review","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3537567","2017-02-28 07:00:00","Reuters Key Development","Pfizer says FDA accepts Biologics License Application for Avelumab for priority review","PFE","Pfizer"
"1032","Merck and pfizer announce U.S. Fda and EMA filing acceptances","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3541354","2017-03-06 08:00:00","Reuters Key Development","Merck and pfizer announce U.S. Fda and EMA filing acceptances","PFE","Pfizer"
"1033","Servier, Pfizer announce FDA clearance of IND application for UCART19","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3543630","2017-03-09 02:04:23","Reuters Key Development","Servier, Pfizer announce FDA clearance of IND application for UCART19","PFE","Pfizer"
"1034","Pfizer announces approval by China FDA of XELJANZ","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3548374","2017-03-15 21:05:30","Reuters Key Development","Pfizer announces approval by China FDA of XELJANZ","PFE","Pfizer"
"1035","EOD Risers: Microsoft Corporation, Pfizer Inc., Travelers Companies Inc","https://www.directorstalkinterviews.com/eod-risers-microsoft-corporation-pfizer-inc-travelers-companies-inc/412726041","2017-03-23 06:53:55","DirectorsTalk Interviews","Shares of Pfizer Inc. company symbol: (NYSE:PFE) a research-based global biopharmaceutical company, gained 0.64% or 0.22 points throughout yesterday's trading day.","PFE","Pfizer"
"1036","FDA approves treatment for metastatic merkel cell carcinoma","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3554136","2017-03-23 14:28:58","Reuters Key Development","FDA approves treatment for metastatic merkel cell carcinoma","PFE","Pfizer"
"1037","Pfizer Inc (NYSE:PFE) Excited By The Positive Chmp&#39;s Opinion On Trumenba As A ...","https://www.journaltranscript.com/2017/03/pfizer-inc-nysepfe-excited-by-the-positive-chmps-opinion-on-trumenba-as-a-preventive-measure-for-meningococcal-disease/","2017-03-28 07:14:45","Journal Transcript","Pfizer Inc (NYSE:PFE) has today made an announcement to inform all the concerned parties about the decision by the European Medicines Agency's Committee for Medicinal Products for Human Use to grant marketing authorization in the European Union ...","PFE","Pfizer"
"1038","Why Investors remained confident on Delcath Systems, Inc. (DCTH), Pfizer Inc ...","http://stocknewsjournal.com/2017/03/28/why-investors-remained-confident-on-delcath-systems-inc-dcth-pfizer-inc-pfe/","2017-03-28 07:15:00","StockNewsJournal","Pfizer Inc. (NYSE:PFE), maintained return on investment for the last twelve months at 5.20, higher than what Reuters data shows regarding industry's average.","PFE","Pfizer"
"1039","Pfizer, Ex-Employee Reach Agreement In Trade Secrets Row","https://www.law360.com/articles/906565/pfizer-ex-employee-reach-agreement-in-trade-secrets-row","2017-03-28 16:24:21","Law360 (subscription)"," A Pennsylvania federal judge Monday dismissed a case in which Pfizer Inc. accused a former global marketing director of misappropriating its trade secrets, after Pfizer and the former employee ...","PFE","Pfizer"
"1040","Recommendation Trends Analysis: Pfizer Inc. (PFE)","http://standardoracle.com/2017/03/29/recommendation-trends-analysis-pfizer-inc-pfe/","2017-03-29 09:07:30","StandardOracle","Guggenheim Initiated its coverage for Pfizer Inc. (PFE) in a note sent to investors on 2-Dec-16. The research firm Initiated the stock to Neutral.","PFE","Pfizer"
"1041","EOD Risers: Pfizer Inc., Visa Inc, Wal-Mart Stores Inc","http://www.directorstalkinterviews.com/eod-risers-pfizer-inc-visa-inc-wal-mart-stores-inc/412726433","2017-03-30 05:22:30","DirectorsTalk Interviews","The trading price for Pfizer Inc. found using EPIC: (NYSE:PFE) a research-based global biopharmaceutical company, rose 0.5% or 0.17 points by the close of business yesterday.","PFE","Pfizer"
"1042","Revenue Approximations Analysis: Pfizer Inc. (PFE), Marathon Oil Corporation (MRO)","http://www.stocknewsjournal.com/2017/03/31/revenue-approximations-analysis-pfizer-inc-pfe-marathon-oil-corporation-mro/","2017-03-31 09:07:30","StockNewsJournal","Pfizer Inc. (PFE) have shown a high EPS growth of 3.30% in the last 5 years and has earnings decline of 5.20% yoy. Analysts have a mean recommendation of 2.50 on this stock (A rating of less than 2 means buy, “hold” within the 3 range, “sell” within ...","PFE","Pfizer"
"1043","Could Pfizer Buy Esperion Therapeutics?","http://host.madison.com/business/investment/markets-and-stocks/could-pfizer-buy-esperion-therapeutics/article_f730e19c-bb00-5cf3-8690-5a0ec5d2a2e2.html","2017-03-31 09:21:53","Madison.com","Pfizer Inc. (NYSE: PFE) is back in growth mode, and it has been acquiring smaller companies as part of its effort to boost revenue and profitability.","PFE","Pfizer"
"1044","Mylan provides update on Meridian Medical Technologies&#39;, expands voluntary worldwide recall of epipen auto-injector","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3560744","2017-03-31 17:11:00","Reuters Key Development","Mylan provides update on Meridian Medical Technologies', expands voluntary worldwide recall of epipen auto-injector","PFE","Pfizer"
"1045","U.S. FDA alerts consumers of nationwide voluntary recall of Epipen and Epipen JR","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3560778","2017-03-31 18:08:07","Reuters Key Development","U.S. FDA alerts consumers of nationwide voluntary recall of Epipen and Epipen JR","PFE","Pfizer"
"1046","Pfizer Inc. (PFE) Stock Could Be a Second-Quarter Star","http://investorplace.com/2017/04/pfizer-inc-pfe-stock-second-quarter-star/","2017-04-03 08:19:13","Investorplace.com","Today, we enter a fresh month and a fresh quarter. That means it's time to sniff out opportunities in the stock market that might offer great reward for little risk in the second quarter.","PFE","Pfizer"
"1047","Pfizer Gets Regular Approval for Breast Cancer Drug Ibrance","http://finance.yahoo.com/news/pfizer-gets-regular-approval-breast-133901393.html","2017-04-03 10:27:58","Yahoo Finance","Pfizer, Inc. PFE announced that its supplemental new drug application (sNDA) to convert accelerated approval for Ibrance to regular approval has been approved by the FDA.","PFE","Pfizer"
"1048","EOD Risers: Microsoft Corporation, Pfizer Inc., Procter &amp; Gamble Co","http://www.directorstalkinterviews.com/eod-risers-microsoft-corporation-pfizer-inc-procter-gamble-co/412726767","2017-04-05 05:33:45","DirectorsTalk Interviews","The share price for Microsoft Corporation company symbol: (NASDAQ:MSFT) a technology company, climbed 0.27% or 0.18 points throughout yesterday's trading day.","PFE","Pfizer"
"1049","The 3 Most Important Numbers for Pfizer Inc.","https://www.fool.com/investing/2017/04/05/the-3-most-important-numbers-for-pfizer-inc.aspx","2017-04-05 16:37:30","Motley Fool","From the company's accumulated post-retirement benefit obligation to Zoloft revenue, there are a lot of numbers involved in understanding Pfizer's business. But I think that there are three numbers that are most important to Pfizer. What are the numbers?","PFE","Pfizer"
"1050","The Charts For Pfizer Inc. (PFE) Is Speaking Volumes Today","http://www.nystocknews.com/2017/04/07/the-charts-for-pfizer-inc-pfe-is-speaking-volumes-today/","2017-04-07 06:52:30","NY Stock News","Pfizer Inc. (PFE) has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment.","PFE","Pfizer"
"1051","Risk Malaise Alert in Option Market: Pfizer Inc Implied Price Swing Hits An ...","http://news.cmlviz.com/2017/04/07/risk-malaise-alert-in-option-market-pfizer-inc-implied-price-swing-hits-an-extreme-low.html","2017-04-07 08:23:56","CML News","Before we dive into any analysis we simply note that Pfizer Inc (NYSE:PFE) risk is actually priced pretty low by the option market as of right now.","PFE","Pfizer"
"1052","Pfizer Inc. (PFE) Closes 0.03% Down on the Day for April 07","http://www.equities.com/news/pfizer-inc-pfe-closes-0-03-down-on-the-day-for-april-07","2017-04-07 17:30:05","Equities.com","Shares of Pfizer Inc. (PFE) ended the trading day Friday at $34.10, representing a move of -0.03%, or $0.01 per share, on volume of 13.95 million shares.","PFE","Pfizer"
"1053","Bristol-Myers Squibb and Pfizer sue to block generic Eliquis","http://www.reuters.com/article/bristol-myers-squibb-and-pfizer-sue-to-b-idUSL1N1HF1WL","2017-04-07 17:56:15","Reuters","Bristol-Myers Squibb Company and Pfizer Inc have asked a judge to uphold the validity of patents on their blockbuster blood thinner Eliquis and halt a planned generic version by Mylan Inc. BMS and Pfizer, who jointly developed Eliquis, sued Mylan in ...","PFE","Pfizer"
"1054","How to Trade these Stock After an unavoidable Selloff: Pfizer Inc. (PFE ...","http://stocknewsjournal.com/2017/04/10/how-to-trade-these-stock-after-an-unavoidable-selloff-pfizer-inc-pfe-cisco-systems-inc-csco/","2017-04-10 08:39:04","StockNewsJournal","Pfizer Inc. (NYSE:PFE) market capitalization at present is $203.13B at the rate of $34.10 a share. The firm's price-to-sales ratio was noted 3.84 in contrast with an overall industry average of 3.64.","PFE","Pfizer"
"1055","Pfizer Inc. (PFE) Has Finally Shown Its Full Hand Via The Chart Setup","http://nystocknews.com/2017/04/10/pfizer-inc-pfe-has-finally-shown-its-full-hand-via-the-chart-setup/","2017-04-10 13:16:30","NY Stock News","Pfizer Inc. (PFE) has been having a set of eventful trading activity and it is clear from an examination of the charts that traders are now fully aware of the company's key metrics.","PFE","Pfizer"
"1056","Pfizer Inc. (PFE) is expected to report earnings of $0.67 a share for the next ...","http://standardoracle.com/2017/04/10/pfizer-inc-pfe-is-expected-to-report-earnings-of-0-67-a-share-for-the-next-quarter/","2017-04-10 13:26:15","StandardOracle","Pfizer Inc. (PFE) lost -0.03% to reach $34.1 in the previous trading session. Overall, 13.95 Million shares exchanged hands versus its average trading volume of 24.81 Million shares.","PFE","Pfizer"
"1057","Pfizer Inc. Posted losses of -0.18% in the Last Trade","http://www.freeobserver.com/pfizer-inc-posted-losses-0-18-last-trade/","2017-04-11 11:33:45","Free Observer","Currently, the market capitalization of Pfizer Inc. (PFE) is 202.71 Billion. PFE has a 1-year high price of $ 36.35 and 1-year low price of $29.24.","PFE","Pfizer"
"1058","Pfizer Isn&#39;t Just A Dividend Stock","https://seekingalpha.com/article/4061825-pfizer-just-dividend-stock","2017-04-11 18:14:18","Seeking Alpha","Pfizer has produced one of the most effective buybacks in this market. The company's spending has been in the tens of billions, but it has also reduced the float by a fifth in the past five years.","PFE","Pfizer"
"1059","A Keen Look At The Chart For Pfizer Inc. (PFE)","http://www.nystocknews.com/2017/04/18/a-keen-look-at-the-chart-for-pfizer-inc-pfe-4/","2017-04-12 09:30:00","NY Stock News","Pfizer Inc. (PFE) has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment.","PFE","Pfizer"
"1060","Bristol-Myers Squibb, Pfizer Unload Slew of Eliquis Infringement Cases","http://www.delawarelawweekly.com/id=1202783503245/BristolMyers-Squibb-Pfizer-Unload-Slew-of-Eliquis-Infringement-Cases","2017-04-12 12:30:00","Delaware Law Weekly","Bristol-Myers Squibb Co. and Pfizer Inc. on Monday filed a slew of patent infringement suits in Delaware to protect their patents for the successful drug Eliquis and halt the development of generic versions of the profitable blood thinner.","PFE","Pfizer"
"1061","Stocks to Watch: Freeport-McMoRan Inc. (FCX), Pfizer Inc. (PFE)","https://topchronicle.com/stocks-to-watch-freeport-mcmoran-inc-fcx-pfizer-inc-pfe/","2017-04-12 13:03:45","TopChronicle","Freeport-McMoRan Inc. (FCX) is currently trading with the volume of 10.73 Million. The Stock opened today's session at $13.44 and currently the price is hovering at $12.94 by showing decrease of -5.02 percent.","PFE","Pfizer"
"1062","For Pfizer Inc. (PFE), The Evidence Is In The Technical Chart","http://nystocknews.com/2017/04/13/for-pfizer-inc-pfe-the-evidence-is-in-the-technical-chart/","2017-04-13 13:37:30","NY Stock News","Pfizer Inc. (PFE) has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.","PFE","Pfizer"
"1063","Pfizer Says Execution Drugs Sold to Arkansas Without Knowing","https://www.bloomberg.com/news/articles/2017-04-13/pfizer-says-execution-drugs-sold-to-arkansas-without-it-knowing","2017-04-13 18:33:18","Bloomberg","Pfizer Inc. said drugs that can be used to execute inmates by lethal injection were sold to the Arkansas Department of Corrections without its knowledge by the distributor McKesson Corp.","PFE","Pfizer"
"1064","Orbimed Advisors LLC Raises Stake in Pfizer Inc. (PFE)","https://www.thecerbatgem.com/2017/04/16/orbimed-advisors-llc-raises-stake-in-pfizer-inc-pfe.html","2017-04-16 07:26:15","The Cerbat Gem","Pfizer logo Orbimed Advisors LLC raised its position in Pfizer Inc. (NYSE:PFE) by 46.3% during the fourth quarter, according to its most recent disclosure with the SEC.","PFE","Pfizer"
"1065","HitGen and Pfizer Enter Research Collaboration and License Agreement to Build ...","http://www.businesswire.com/news/home/20170418005640/en/HitGen-Pfizer-Enter-Research-Collaboration-License-Agreement","2017-04-17 00:18:45","Business Wire (press release)","HitGen Ltd. is pleased to announce that the company has entered into a multi-year research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) to build and screen novel DNA-encoded libraries (DELs) in ...","PFE","Pfizer"
"1066","Pfizer: 8 Reasons To Buy This Dividend Stock","https://seekingalpha.com/article/4062694-pfizer-8-reasons-buy-dividend-stock","2017-04-17 02:33:45","Seeking Alpha","Prescription drug spending is projected to grow at an average of 6.3% per year through 2025, which will be a catalyst for Pfizer. Strong free cash flow allows Pfizer to return a significant amount of capital back to shareholders through dividends (3.6 ...","PFE","Pfizer"
"1067","Pfizer Inc. (PFE) And Its Technicals Provide Timely Picture","http://nystocknews.com/2017/04/17/pfizer-inc-pfe-and-its-technicals-provide-timely-picture/","2017-04-17 08:00:00","NY Stock News","The technicals for Pfizer Inc. (PFE) has spoken via its technical chart and the message is loud and clear. Based on that message, this is the relevant information necessary to make sense of that current setup.","PFE","Pfizer"
"1068","Two sizzlers stock&#39;s are not to be missed: KeyCorp (KEY), Pfizer Inc. (PFE)","http://stocknewsjournal.com/2017/04/17/two-sizzlers-stocks-are-not-to-be-missed-keycorp-key-pfizer-inc-pfe/","2017-04-17 08:22:30","StockNewsJournal","KeyCorp (NYSE:KEY) market capitalization at present is $18.39B at the rate of $17.00 a share. The firm's price-to-sales ratio was noted 3.69 in contrast with an overall industry average of 4.79.","PFE","Pfizer"
"1069","Pfizer Inc. (PFE) has a 52-Week High of $36.35","http://standardoracle.com/2017/04/17/pfizer-inc-pfe-has-a-52-week-high-of-36-35/","2017-04-17 09:07:30","StandardOracle","Pfizer Inc. (PFE) lost -0.12% to reach $33.88 in the previous trading session. Overall, 12.85 Million shares exchanged hands versus its average trading volume of 24.14 Million shares.","PFE","Pfizer"
"1070","Current Market Buzz: Amyris, Inc. (AMRS), Pfizer Inc. (PFE)","https://topchronicle.com/current-market-buzz-amyris-inc-amrs-pfizer-inc-pfe/","2017-04-17 13:48:45","TopChronicle","Amyris, Inc. (AMRS) is currently trading with the volume of 5.71 Million. The Stock opened today's session at $0.7 and currently the price is hovering at $0.69 by showing increase of 1.46 percent.","PFE","Pfizer"
"1071","EOD Risers: Merck &amp; Co., Inc., Microsoft Corporation, Nike Inc, Pfizer Inc ...","http://www.directorstalkinterviews.com/eod-risers-merck-co-inc-microsoft-corporation-nike-inc-pfizer-inc-procter-gamble-co-2/412727298","2017-04-18 05:33:45","DirectorsTalk Interviews","Shares of Merck & Co., Inc. with EPIC code: (NYSE:MRK) a global healthcare company, rose 0.3% or 0.19 points in yesterday's trading session.","PFE","Pfizer"
"1072","ICU Medical receives grand jury subpoena issued by U.S. District Court","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3570219","2017-04-18 17:21:26","Reuters Key Development","ICU Medical receives grand jury subpoena issued by U.S. District Court","PFE","Pfizer"
"1073","Why Is Pfizer (PFE) Up 8.7% Since the Last Earnings Report?","http://finance.yahoo.com/news/why-pfizer-pfe-8-7-110511955.html","2017-04-19 07:50:26","Yahoo Finance","It has been about a month since the last earnings report for Pfizer, Inc. PFE. Shares have added about 8.7% in that time frame, outperforming the market.","PFE","Pfizer"
"1074","Stable Stock: Pfizer Inc. (PFE)","http://standardoracle.com/2017/04/19/stable-stock-pfizer-inc-pfe-2/","2017-04-19 08:56:15","StandardOracle","Pfizer Inc. (PFE) lost -0.47% to reach $33.84 in the previous trading session. Overall, 21.15 Million shares exchanged hands versus its average trading volume of 23.72 Million shares.","PFE","Pfizer"
"1075","Pfizer Inc. (NYSE:PFE) To Build And Screen DNA-Encoded Libraries- Nomad Foods ...","http://www.emarketsdaily.com/pfizer-inc-nysepfe-to-build-and-screen-dna-encoded-libraries-nomad-foods-nysenomd/1854067/","2017-04-19 09:41:15","eMarketsDaily","Stocks of Pfizer Inc. (NYSE:PFE) closed at $33.84 in last session with the total traded volume of 21.15 Million. HitGen Ltd.","PFE","Pfizer"
"1076","Pfizer receives subpoenas in US intravenous saline solution probe","http://www.reuters.com/article/pfizer-antitrust-idUSL1N1HR1NG","2017-04-19 11:00:00","Reuters","BOSTON Pfizer Inc said on Wednesday that the company had received grand jury subpoenas from the U.S. Justice Department amid an antitrust investigation focused on drugmakers that market intravenous saline solution.","PFE","Pfizer"
"1077","Pfizer subpoenaed in US intravenous saline solution probe","http://www.reuters.com/article/us-pfizer-antitrust-idUSKBN17L1XT","2017-04-19 11:03:09","Reuters","The drugmaker disclosed the subpoenas in a statement on Wednesday after ICU Medical Inc, which recently acquired Pfizer's global infusion therapy business, and Baxter International Inc said they received similar subpoenas. ICU Medical said the probe ...","PFE","Pfizer"
"1078","Pfizer Inc. (PFE) Makes A Compelling Case Via Its Technical Chart","http://www.nystocknews.com/2017/04/19/pfizer-inc-pfe-makes-a-compelling-case-via-its-technical-chart/","2017-04-19 12:30:00","NY Stock News","Pfizer Inc. (PFE) has been having a set of eventful trading activity and it is clear from an examination of the charts that traders are now fully aware of the company's key metrics.","PFE","Pfizer"
"1079","Analysts mean rating score stands at 2.50 while Pfizer Inc.&#39;s (PFE) stock ...","http://www.hotstockspoint.com/analysts-mean-rating-score-stands-at-2-50-while-pfizer-inc-s-pfe-stock-price-is-now-at-33-84-stock-buzzer/","2017-04-19 12:52:30","Hot Stocks Point","Pfizer Inc. (PFE), a part of Healthcare sector and belongs to Drug Manufacturers - Major industry; ended its day with loss -0.47% and finalized at the price of $33.84.","PFE","Pfizer"
"1080","Pfizer is latest to get Justice Department subpoena in intravenous saline ...","http://www.marketwatch.com/story/pfizer-is-latest-to-get-justice-department-subpoena-in-intravenous-saline-investigation-2017-04-19","2017-04-19 15:53:15","MarketWatch","Pfizer Inc. PFE, -0.37% has been subpoenaed by the Justice Department as part of an antitrust investigation into intravenous saline sales practices, requests that it is ""evaluating,"" the company said Wednesday.","PFE","Pfizer"
"1081","Pfizer Inc. (NYSE:PFE): A Look at the Stock&#39;s F-Score","http://rockvilleregister.com/pfizer-inc-nysepfe-a-look-at-the-stocks-f-score/52387/","2017-04-19 17:22:30","Rockville Register","Pfizer Inc. (NYSE:PFE) has a Piotroski F-Score of 6 at the time of writing. The F-Score may help discover companies with strengthening balance sheets.","PFE","Pfizer"
"1082","Would You Buy Pfizer, Inc. (NYSE:PFE) On These Analyst Ratings?","http://www.fiscalstandard.com/2017/04/20/would-you-buy-pfizer-inc-nysepfe-on-these-analyst-ratings/","2017-04-20 04:26:15","Fiscal Standard","Recently analysts working for various investment brokerages have changed their ratings and price targets on shares of Pfizer, Inc. (NYSE:PFE). According to the the latest analyst ratings which have been released, 4 brokers have issued a rating of “buy ...","PFE","Pfizer"
"1083","Analytical Guide for Southwestern Energy Company (SWN), Pfizer Inc. (PFE ...","http://theusacommerce.com/2017/04/20/analytical-guide-for-southwestern-energy-company-swn-pfizer-inc-pfe-stakeholders/","2017-04-20 06:52:30","The USA Commerce","Shares of Southwestern Energy Company (NYSE:SWN) dropped -0.27% to $7.31. During the trading on 04/19/2017, Company's stock ranged from $7.63 to $7.29. The relative strength index or RSI highlights overbought (above 70) and oversold (below 30) ...","PFE","Pfizer"
"1084","2 Stocks to keep an eye on Today: Pfizer Inc. (PFE), Verizon Communications ...","http://stocknewsjournal.com/2017/04/20/2-stocks-to-keep-an-eye-on-today-pfizer-inc-pfe-verizon-communications-inc-vz/","2017-04-20 07:03:45","StockNewsJournal","Pfizer Inc. (NYSE:PFE) market capitalization at present is $200.15B at the rate of $33.61 a share. The firm's price-to-sales ratio was noted 3.81 in contrast with an overall industry average of 3.61.","PFE","Pfizer"
"1085","Pfizer Inc.&#39;s (PFE) stock price finalizes at $33.61 with recent daily ...","http://www.wsnews4investors.com/2017/04/20/pfizer-inc-s-pfe-stock-price-finalizes-at-33-61-with-recent-daily-performance-of-0-68-on-volume-of-23902778-shares/","2017-04-20 07:37:30","WsNews 4investors","Pfizer Inc. (PFE) stock price distance from twenty day simple moving average slumped at -1.56% while its distance from fifty day simple moving average declined -0.80% along with 1.37% above distance from two hundred simple moving averages.","PFE","Pfizer"
"1086","Traders Watch list Healthcare Stocks: Pfizer Inc.&#39;s (PFE) registers a price ...","http://www.stocksgallery.com/traders-watch-list-healthcare-stocks-pfizer-inc-s-pfe-registers-a-price-change-of-0-68-while-therapeuticsmd-inc-s-txmd-finishes-with-a-flow-of-3-30/","2017-04-20 08:33:45","Stocks Gallery (press release)","In recent trading day Pfizer Inc. (PFE) stock showed the move of -0.68% with the closing price of $33.61. Closing price generally refers to the last price at which a stock trades during a regular trading session.","PFE","Pfizer"
"1087","Have a Glance at Pfizer Inc. (NYSE:PFE), Stillwater Mining Company (NYSE:SWC ...","http://www.wallstreetnews24.com/have-a-glance-at-pfizer-inc-nysepfe-stillwater-mining-company-nyseswc-fortuna-silver-mines-inc-nysefsm/","2017-04-20 08:56:15","Wall Street Times (press release)","Pfizer Inc. (NYSE:PFE) traded at a yearly high level of $37.39 during the last trading session. The last session's volume of 23.91 million shares was higher than its average volume of 20.55 million shares.","PFE","Pfizer"
"1088","Pfizer Inc.: PSI And Pfizer Partner To Address Hypertension In Vietnam And Myanmar","https://www.twst.com/update/pfizer-inc-psi-and-pfizer-partner-to-address-hypertension-in-vietnam-and-myanmar/","2017-04-20 09:07:30","The Wall Street Transcript","The international nonprofit organization Population Services International (PSI) and the biopharmaceutical company Pfizer Inc. (NYSE:PFE) today announced Healthy Communities, a US $1 million collaboration to expand access to life-saving hypertension ...","PFE","Pfizer"
"1089","Pfizer Inc. (NYSE:PFE) Received Grand Jury Subpoenas from U.S. Justice Department","http://www.emarketsdaily.com/pfizer-inc-nysepfe-received-grand-jury-subpoenas-from-u-s-justice-department/1854615/","2017-04-20 11:56:15","eMarketsDaily","Pfizer Inc. (NYSE:PFE) shares price knocked down -0.68% during last trading session. Pfizer Inc (PFE) has received grand jury subpoenas from U.S.","PFE","Pfizer"
"1090","Analysts&#39; Recommendations Stocks Traders Alert: Pfizer Inc. (NYSE:PFE ...","http://www.journalfinance.net/2017/04/analysts-recommendations-stocks-traders-alert-pfizer-inc-nysepfe-kinross-gold-corporation-usa-nysekgc/","2017-04-20 13:37:30","Daily News Journal","Pfizer Inc. (NYSE:PFE) have shown a low EPS growth of -2.80% in the last 5 years and has earnings growth of 600.90% yoy. Analysts have a mean recommendation of 2.50 on this stock (A rating of less than 2 means buy, “hold” within the 3 range, “sell ...","PFE","Pfizer"
"1091","Pfizer Invites Public To Listen To Webcast Of April 27 Annual Meeting Of ...","http://www.businesswire.com/news/home/20170420006321/en/Pfizer-Invites-Public-Listen-Webcast-April-27","2017-04-20 14:56:15","Business Wire (press release)","Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 9:00 a.m.","PFE","Pfizer"
"1092","Pfizer: Relatively High Yield Healthcare Blue Chip","https://seekingalpha.com/article/4063867-pfizer-relatively-high-yield-healthcare-blue-chip","2017-04-20 15:07:30","Seeking Alpha","Pfizer (NYSE:PFE) was on my watch list back in 2009 when they cut the dividend from $.32 per quarter in Q1 to $.16 in Q2. At that time I removed Pfizer from my watch list. In retrospect, PFE cut the dividend at the low point of the bear market that ...","PFE","Pfizer"
"1093","Advancing Technology - Hemophilia Market Growing Popularity of Gene Therapy ...","https://www.medgadget.com/2017/04/advancing-technology-hemophilia-market-growing-popularity-of-gene-therapy-pfizer-inc-bayer-group-shire-plc-and-novo-nordisk-industry-analysis-outlook-2017-2021.html","2017-04-20 17:45:00","Medgadget (blog)","The hemophilia market has entered into an era of unprecedented growth rate with a variety of treatment options. Development of new therapeutics along with expansion in the current treatment options has presented new opportunities to the market.","PFE","Pfizer"
"1094","EOD Risers: JPMorgan Chase &amp; Co., McDonald&#39;s Corporation, Microsoft ...","http://www.directorstalkinterviews.com/eod-risers-jpmorgan-chase-co-mcdonalds-corporation-microsoft-corporation-nike-inc-pfizer-inc/412727514","2017-04-21 05:45:00","DirectorsTalk Interviews","Shares of JPMorgan Chase & Co. with ticker code: (NYSE:JPM) a financial holding company engaged in investment banking, financial services, rose 1.29% or 1.09 points during the course of yesterday's session.","PFE","Pfizer"
"1095","Two Stocks within Traders Limelight: Pfizer Inc. (PFE) ,Raymond James ...","http://www.streetupdates.com/2017/04/21/two-stocks-within-traders-limelight-pfizer-inc-pfe-raymond-james-financial-inc-rjf/","2017-04-21 07:48:45","Street Updates","Pfizer Inc. (PFE) , a stock from Drug Manufacturers - Major Industry, has a value of $33.74 per share, noted a price change of 0.39% in recent trade close.","PFE","Pfizer"
"1096","Traders Take Note: Pfizer Inc (NYSE:PFE) Stock Drops, Weakness in Technical ...","http://news.cmlviz.com/2017/04/21/traders-take-note-pfizer-inc-nyse-pfe--stock-drops-weakness-in-technical-momentum.html","2017-04-21 08:11:15","CML News","Take Note: Pfizer Inc (NYSE:PFE) has hit some technical weakness in its momentum, and while it has not broken down all the way through support ","PFE","Pfizer"
"1097","Pfizer Inc. (NYSE:PFE): VC in The Spotlight","https://twincitytelegraph.com/pfizer-inc-nysepfe-vc-in-the-spotlight/","2017-04-21 08:29:40","TCT","Checking in on some valuation rankings, Pfizer Inc. (NYSE:PFE) has a Value Composite score of 50. Developed by James O'Shaughnessy, the VC score uses five valuation ratios.","PFE","Pfizer"
"1098","Pfizer Unveils ATLAS®, An Interactive, User-Friendly Website That Provides ...","http://www.businesswire.com/news/home/20170421005363/en/Pfizer-Unveils-ATLAS%C2%AE-Interactive-User-Friendly-Website-Global","2017-04-21 08:33:45","Business Wire (press release)","Pfizer Inc. today announced the launch of the company's Antimicrobial Testing Leadership and Surveillance (ATLAS) website, which is designed to provide physicians and the global health community with easy access to ...","PFE","Pfizer"
"1099","These stock&#39;s might change the kismet of Investors: Pfizer Inc. (PFE), Immune ...","https://www.stocknewsjournal.com/2017/04/21/these-stocks-might-change-the-kismet-of-investors-pfizer-inc-pfe-immune-pharmaceuticals-inc-imnp/","2017-04-21 08:56:15","StockNewsJournal","Pfizer Inc. (NYSE:PFE) closed at $33.74 a share in the latest session and the stock value rose almost 4.94% since the beginning of this year.","PFE","Pfizer"
"1100","Analysts Chime In On Pfizer Inc. (NYSE:PFE), Brocade Communications Systems ...","http://www.wallstreetnews24.com/analysts-chime-in-on-pfizer-inc-nysepfe-brocade-communications-systems-inc-nasdaqbrcd-baxter-international-inc-nysebax/","2017-04-21 10:37:30","Wall Street Times (press release)","Pfizer Inc. (NYSE:PFE) traded at a yearly high level of $37.39 during the last trading session. The last session's volume of 18.35 million shares was lower than its average volume of 20.37 million shares.","PFE","Pfizer"
"1101","Encana Corp (USA) (NYSE:ECA) &amp; Pfizer Inc. (NYSE:PFE) Worth Watching Stocks","http://www.journalfinance.net/2017/04/encana-corp-usa-nyseeca-pfizer-inc-nysepfe-worth-watching-stocks/","2017-04-21 12:18:45","Daily News Journal","Shares of Pfizer Inc. (NYSE:PFE) inclined 0.39% to $33.74. The share price of the stock surged 5.39% for the year. Pfizer Inc. invites shareholders and the general public to listen to a webcast of the Annual Meeting of Shareholders at 9:00 a.m ...","PFE","Pfizer"
"1102","Pfizer Inc. (PFE): Mid-Term Estimates Modestly Lowered","http://smartstocknews.com/72777-pfizer-inc-pfe-mid-term-estimates-modestly-lowered/","2017-04-21 12:41:15","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Jefferies sees a weaker than expected revenue performance for Pfizer Inc. (NYSE:PFE) in Q1'17. With subpar revenue and EPS CAGRs of 3% and 7%, respectively (2016A-2021E), Jefferies expects that management will step up business development to ...","PFE","Pfizer"
"1103","The Technical Facts on Pfizer Inc. (PFE)","http://www.theusacommerce.com/2017/04/21/the-technical-facts-on-pfizer-inc-pfe-4/","2017-04-21 13:26:15","The USA Commerce","We have gathered the technical data on Pfizer Inc. (PFE), and see some interesting trends in the stock's behavior of late.","PFE","Pfizer"
"1104","Pfizer Inc. (PFE) Exposed Via Its Technical Chart","http://www.nystocknews.com/2017/04/21/pfizer-inc-pfe-exposed-via-its-technical-chart-2/","2017-04-21 13:48:45","NY Stock News","Pfizer Inc. (PFE) is now trading with a very clear set of technicals. Taken together they paint a very compelling picture of how investors and traders should be approaching PFE.","PFE","Pfizer"
"1105","Bustling Stock in Focus: Pfizer Inc. (NYSE:PFE)","https://hiramherald.com/bustling-stock-in-focus-pfizer-inc-nysepfe/","2017-04-21 14:45:00","The Herald","Following trading activity for Pfizer Inc.(NYSE:PFE), we can see that the stock has moved onto today's list of most actives.","PFE","Pfizer"
"1106","Pfizer Receives Positive CHMP Opinion for BESPONSA® (Inotuzumab Ozogamicin ...","http://www.businesswire.com/news/home/20170421005735/en/Pfizer-Receives-Positive-CHMP-Opinion-BESPONSA%C2%AE-Inotuzumab","2017-04-21 14:56:15","Business Wire (press release)","Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of BESPONSA® ...","PFE","Pfizer"
"1107","Pfizer Inc. (NYSE:PFE) Valuation in Focus","http://www.concordregister.com/pfizer-inc-nysepfe-valuation-in-focus/","2017-04-21 20:56:28","Concord Register","Pfizer Inc. (NYSE:PFE) has an ERP5 rank of 3815. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.","PFE","Pfizer"
"2015-04-23 01:01:00","Novartis AG confirms FY 2015 outlook","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3197912","2015-04-23 01:01:00","Reuters Key Development","Novartis AG confirms FY 2015 outlook","NVS","Novartis"
"2015-04-26 20:00:00","Novartis AG says leukaemia drug Arzerra meets main goal in trial","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3201723","2015-04-26 20:00:00","Reuters Key Development","Novartis AG says leukaemia drug Arzerra meets main goal in trial","NVS","Novartis"
"2015-05-08 01:15:00","Novartis says lung cancer drug Zykadia gains EU approval","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3209214","2015-05-08 01:15:00","Reuters Key Development","Novartis says lung cancer drug Zykadia gains EU approval","NVS","Novartis"
"2015-05-20 11:30:00","Novartis announces two positive U.S. phase III programs in COPD for QVA149 and NVA237","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3216147","2015-05-20 11:30:00","Reuters Key Development","Novartis announces two positive U.S. phase III programs in COPD for QVA149 and NVA237","NVS","Novartis"
"2015-05-21 01:16:00","Novartis drug Afinitor extended progression-free survival in Phase III trial in advanced gastrointestinal or lung neuroendocrine tumors","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3216709","2015-05-21 01:16:00","Reuters Key Development","Novartis drug Afinitor extended progression-free survival in Phase III trial in advanced gastrointestinal or lung neuroendocrine tumors","NVS","Novartis"
"2015-05-31 10:46:00","Novartis AG says drugs show survival benefit for metastatic melanoma patients","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3221820","2015-05-31 10:46:00","Reuters Key Development","Novartis AG says drugs show survival benefit for metastatic melanoma patients","NVS","Novartis"
"2015-06-02 01:15:00","Novartis says data shows drug relieves inflammatory disease AS","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3223227","2015-06-02 01:15:00","Reuters Key Development","Novartis says data shows drug relieves inflammatory disease AS","NVS","Novartis"
"2015-06-11 18:31:00","Novartis AG gains FDA approval for Promacta providing new option for children, ages 6 and older, with chronic ITP, a rare blood disorder","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3228213","2015-06-11 18:31:00","Reuters Key Development","Novartis AG gains FDA approval for Promacta providing new option for children, ages 6 and older, with chronic ITP, a rare blood disorder","NVS","Novartis"
"2015-06-13 05:45:00","Novartis AG announces data show majority of patients with polycythemia vera treated with Jakavi achieved long-term disease control","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3228951","2015-06-13 05:45:00","Reuters Key Development","Novartis AG announces data show majority of patients with polycythemia vera treated with Jakavi achieved long-term disease control","NVS","Novartis"
"2015-06-16 01:15:00","Novartis AG says Alcon receives European approval for PanOptix","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3230166","2015-06-16 01:15:00","Reuters Key Development","Novartis AG says Alcon receives European approval for PanOptix","NVS","Novartis"
"2015-06-25 20:00:00","Novartis AG says Farydak recommended by CHMP for EU approval","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3235789","2015-06-25 20:00:00","Reuters Key Development","Novartis AG says Farydak recommended by CHMP for EU approval","NVS","Novartis"
"2015-06-29 20:00:00","Novartis AG&#39;s Otrivin nasal spray withdrawn in UAE - Emirates247.com","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3239277","2015-06-29 20:00:00","Reuters Key Development","Novartis AG's Otrivin nasal spray withdrawn in UAE - Emirates247.com","NVS","Novartis"
"2015-07-01 01:15:00","Novartis says Alcon receives EU approval for lens in cataract patients","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3238234","2015-07-01 01:15:00","Reuters Key Development","Novartis says Alcon receives EU approval for lens in cataract patients","NVS","Novartis"
"2015-07-20 20:00:00","Novartis AG blocked from selling Neupogen copycat until Sept. 2 - Reuters","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3248210","2015-07-20 20:00:00","Reuters Key Development","Novartis AG blocked from selling Neupogen copycat until Sept. 2 - Reuters","NVS","Novartis"
"2015-07-21 01:01:00","Novartis AG reconfirms FY 2015 outlook","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3248029","2015-07-21 01:01:00","Reuters Key Development","Novartis AG reconfirms FY 2015 outlook","NVS","Novartis"
"2015-07-24 07:12:00","Novartis drug Revolade recommended by CHMP for EU approval to treat patients with severe aplastic anemia","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3250234","2015-07-24 07:12:00","Reuters Key Development","Novartis drug Revolade recommended by CHMP for EU approval to treat patients with severe aplastic anemia","NVS","Novartis"
"2015-07-24 10:54:00","Novartis says FDA approves Odomzo to treat form of skin cancer","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3250325","2015-07-24 10:54:00","Reuters Key Development","Novartis says FDA approves Odomzo to treat form of skin cancer","NVS","Novartis"
"2015-08-02 18:30:00","Novartis AG completes divestiture of influenza vaccines business to CSL Limited for $275 million","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3255140","2015-08-02 18:30:00","Reuters Key Development","Novartis AG completes divestiture of influenza vaccines business to CSL Limited for $275 million","NVS","Novartis"
"2015-08-20 01:15:00","Novartis gains EU approval for Odomzo","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3263955","2015-08-20 01:15:00","Reuters Key Development","Novartis gains EU approval for Odomzo","NVS","Novartis"
"2015-08-21 01:25:00","Novartis buys remaining rights to GSK treatment","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3264456","2015-08-21 01:25:00","Reuters Key Development","Novartis buys remaining rights to GSK treatment","NVS","Novartis"
"2015-08-31 20:00:00","Novartis AG wins EU approval for tafinlar and mekinist, combination for melanoma","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3268694","2015-08-31 20:00:00","Reuters Key Development","Novartis AG wins EU approval for tafinlar and mekinist, combination for melanoma","NVS","Novartis"
"2015-09-01 20:00:00","Novartis wins EU approval for new Revolade use as therapy for patients with severe aplastic anemia","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3269089","2015-09-01 20:00:00","Reuters Key Development","Novartis wins EU approval for new Revolade use as therapy for patients with severe aplastic anemia","NVS","Novartis"
"2015-09-24 01:16:00","Novartis launches portfolio for low- and low-middle-income countries","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3277266","2015-09-24 01:16:00","Reuters Key Development","Novartis launches portfolio for low- and low-middle-income countries","NVS","Novartis"
"2015-09-25 01:15:00","Novartis says heart drug Entresto backed by EU regulator","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3277721","2015-09-25 01:15:00","Reuters Key Development","Novartis says heart drug Entresto backed by EU regulator","NVS","Novartis"
"2015-09-30 17:05:00","Novartis AG announces NEJM publication of secukinumab phase III data confirming significant efficacy in patients with Psoriatic Arthritis","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3279755","2015-09-30 17:05:00","Reuters Key Development","Novartis AG announces NEJM publication of secukinumab phase III data confirming significant efficacy in patients with Psoriatic Arthritis","NVS","Novartis"
"2015-10-08 01:15:00","Novartis says long-term efficacy of Gilenya reinforced by 7-year data","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3282502","2015-10-08 01:15:00","Reuters Key Development","Novartis says long-term efficacy of Gilenya reinforced by 7-year data","NVS","Novartis"
"2015-10-21 01:15:00","Novartis broadens cancer immune therapy pipeline with acquisition, licensing pacts","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3288030","2015-10-21 01:15:00","Reuters Key Development","Novartis broadens cancer immune therapy pipeline with acquisition, licensing pacts","NVS","Novartis"
"2015-10-27 02:00:00","Novartis AG confirms FY 2015 outlook","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3291013","2015-10-27 02:00:00","Reuters Key Development","Novartis AG confirms FY 2015 outlook","NVS","Novartis"
"2015-11-23 01:15:00","Novartis gets two EU approvals for Cosentyx","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3302969","2015-11-23 01:15:00","Reuters Key Development","Novartis gets two EU approvals for Cosentyx","NVS","Novartis"
"2015-11-24 01:15:00","Novartis &#39;s Entresto drug approved by European Commission","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3303480","2015-11-24 01:15:00","Reuters Key Development","Novartis 's Entresto drug approved by European Commission","NVS","Novartis"
"2015-11-24 19:01:00","Novartis AG - Research raises questions over ADHD drug effects - Reuters","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3304430","2015-11-24 19:01:00","Reuters Key Development","Novartis AG - Research raises questions over ADHD drug effects - Reuters","NVS","Novartis"
"2015-12-05 19:00:00","Novartis announces positive results from the global Phase III RATIFY clinical trial","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3307861","2015-12-05 19:00:00","Reuters Key Development","Novartis announces positive results from the global Phase III RATIFY clinical trial","NVS","Novartis"
"2015-12-07 10:45:00","Novartis AG: phase III data shows Sandoz&#39; pegfilgrastim has similar safety and efficacy as reference product","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3307980","2015-12-07 10:45:00","Reuters Key Development","Novartis AG: phase III data shows Sandoz' pegfilgrastim has similar safety and efficacy as reference product","NVS","Novartis"
"2015-12-08 01:15:00","Novartis says advances biosimilars program with EMA acceptance of regulatory submission","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3308388","2015-12-08 01:15:00","Reuters Key Development","Novartis says advances biosimilars program with EMA acceptance of regulatory submission","NVS","Novartis"
"2016-01-04 19:00:00","Novartis announces collaboration with Qualcomm Incorporated through its subsidiary, Qualcomm Life, Inc.","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3318041","2016-01-04 19:00:00","Reuters Key Development","Novartis announces collaboration with Qualcomm Incorporated through its subsidiary, Qualcomm Life, Inc.","NVS","Novartis"
"2016-01-11 01:15:00","Novartis AG sets immuno-oncology licensing deal with Surface","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3319219","2016-01-11 01:15:00","Reuters Key Development","Novartis AG sets immuno-oncology licensing deal with Surface","NVS","Novartis"
"2016-01-15 17:28:00","Novartis gets FDA approvals for cosentyx for ankylosing spondylitis, psoriatic arthritis","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3321225","2016-01-15 17:28:00","Reuters Key Development","Novartis gets FDA approvals for cosentyx for ankylosing spondylitis, psoriatic arthritis","NVS","Novartis"
"2016-01-27 01:00:00","Novartis comments on FY 2016 outlook, proposes FY 2015 dividend","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3324492","2016-01-27 01:00:00","Reuters Key Development","Novartis comments on FY 2016 outlook, proposes FY 2015 dividend","NVS","Novartis"
"2016-02-11 01:15:00","Novartis says EMA accepts Sandoz application for pegfilgrastim biosimilar","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3330783","2016-02-11 01:15:00","Reuters Key Development","Novartis says EMA accepts Sandoz application for pegfilgrastim biosimilar","NVS","Novartis"
"2016-02-18 01:00:00","Novartis says Alcon entered into agreement to acquire Transcend Medical, Inc.","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3332783","2016-02-18 01:00:00","Reuters Key Development","Novartis says Alcon entered into agreement to acquire Transcend Medical, Inc.","NVS","Novartis"
"2016-02-19 01:15:00","Novartis drug PKC412 (midostaurin) receives Breakthrough Therapy","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3333296","2016-02-19 01:15:00","Reuters Key Development","Novartis drug PKC412 (midostaurin) receives Breakthrough Therapy","NVS","Novartis"
"2016-02-23 22:22:00","Novartis AG - Prosecutors raid Novartis Korea over alleged rebates - Yonhap - Reuters","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3334719","2016-02-23 22:22:00","Reuters Key Development","Novartis AG - Prosecutors raid Novartis Korea over alleged rebates - Yonhap - Reuters","NVS","Novartis"
"2016-03-23 16:25:00","Novartis AG settles charges alleging bribery in China - SEC - Reuters News","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3347484","2016-03-23 16:25:00","Reuters Key Development","Novartis AG settles charges alleging bribery in China - SEC - Reuters News","NVS","Novartis"
"2016-03-29 11:17:00","Novartis AG investigating $85 mln bribery allegations in Turkey - Reuters News","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3350235","2016-03-29 11:17:00","Reuters Key Development","Novartis AG investigating $85 mln bribery allegations in Turkey - Reuters News","NVS","Novartis"
"2016-03-30 20:00:00","Novartis comments on FY 2016 outlook","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3351685","2016-03-30 20:00:00","Reuters Key Development","Novartis comments on FY 2016 outlook","NVS","Novartis"
"2016-03-31 00:13:00","Novartis AG - Turkish health ministry says investigating drugmaker over bribe allegations - Reuters News","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3351939","2016-03-31 00:13:00","Reuters Key Development","Novartis AG - Turkish health ministry says investigating drugmaker over bribe allegations - Reuters News","NVS","Novartis"
"2016-03-31 20:00:00","Novartis receives positive EMA CHMP opinon on Neparvis","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3352706","2016-03-31 20:00:00","Reuters Key Development","Novartis receives positive EMA CHMP opinon on Neparvis","NVS","Novartis"
"2016-04-07 01:15:00","Novartis receives EU approval for Revolade for children with chronic ITP","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3354084","2016-04-07 01:15:00","Reuters Key Development","Novartis receives EU approval for Revolade for children with chronic ITP","NVS","Novartis"
"2016-04-08 01:00:00","Novartis AG&#39; Sandoz unit receives EC approval for biosimilar Binocrit&#39;s nephrology indication","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3354626","2016-04-08 01:00:00","Reuters Key Development","Novartis AG' Sandoz unit receives EC approval for biosimilar Binocrit's nephrology indication","NVS","Novartis"
"2016-04-21 01:00:00","Novartis confirms FY 2016 outlook","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3359602","2016-04-21 01:00:00","Reuters Key Development","Novartis confirms FY 2016 outlook","NVS","Novartis"
"2016-04-25 04:50:00","Novartis AG discussing Roche stake sale, but not imminent -sources - Reuters","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3360970","2016-04-25 04:50:00","Reuters Key Development","Novartis AG discussing Roche stake sale, but not imminent -sources - Reuters","NVS","Novartis"
"2016-04-27 01:15:00","Novartis AG receives three FDA breakthrough therapy designations for Ilaris","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3363653","2016-04-27 01:15:00","Reuters Key Development","Novartis AG receives three FDA breakthrough therapy designations for Ilaris","NVS","Novartis"
"2016-04-29 07:50:00","Novartis AG says Afinitor gets nod in EU for some GI, lung neuroendocrine tumors","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3365650","2016-04-29 07:50:00","Reuters Key Development","Novartis AG says Afinitor gets nod in EU for some GI, lung neuroendocrine tumors","NVS","Novartis"
"2016-05-17 16:03:45","Genmab - PDUFA target action date of September 10 for Ofatumumab","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3377061","2016-05-17 16:03:45","Reuters Key Development","Genmab - PDUFA target action date of September 10 for Ofatumumab","NVS","Novartis"
"2016-05-18 10:39:08","China NT Pharma says co entered into asset purchase agreement with Novartis&lt;1011.HK&gt;&lt;NOVN.S&gt;","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3377712","2016-05-18 10:39:08","Reuters Key Development","China NT Pharma says co entered into asset purchase agreement with Novartis<1011.HK><NOVN.S>","NVS","Novartis"
"2016-05-24 01:15:14","Novartis: Sandoz&#39; biosimilar rituximab regulatory submission accepted by European Medicines Agency","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3380206","2016-05-24 01:15:14","Reuters Key Development","Novartis: Sandoz' biosimilar rituximab regulatory submission accepted by European Medicines Agency","NVS","Novartis"
"2016-05-25 03:28:00","Novartis CEO: Willing to sell Roche stake without premium","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3381158","2016-05-25 03:28:00","Reuters Key Development","Novartis CEO: Willing to sell Roche stake without premium","NVS","Novartis"
"2016-05-31 10:00:00","Sandoz broadens pharma portfolio with addition of Euro-Pharm product line","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3384713","2016-05-31 10:00:00","Reuters Key Development","Sandoz broadens pharma portfolio with addition of Euro-Pharm product line","NVS","Novartis"
"2016-06-02 16:15:00","Eisai and Novartis enter deal to co-promote Lenvima with Everolimus in U.S.","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3386155","2016-06-02 16:15:00","Reuters Key Development","Eisai and Novartis enter deal to co-promote Lenvima with Everolimus in U.S.","NVS","Novartis"
"2016-06-03 08:02:00","Novartis reports 13.6 pct passive stake in Merus NV as of May 24, 2016","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3386633","2016-06-03 08:02:00","Reuters Key Development","Novartis reports 13.6 pct passive stake in Merus NV as of May 24, 2016","NVS","Novartis"
"2016-06-06 02:10:46","Mereo Biopharma to list on London&#39;s AIM","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3386875","2016-06-06 02:10:46","Reuters Key Development","Mereo Biopharma to list on London's AIM","NVS","Novartis"
"2016-06-09 06:15:14","Spectrum Pharmaceuticals&#39; unit, Allos Therapeutics and Sandoz enter settlement agreement","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3389083","2016-06-09 06:15:14","Reuters Key Development","Spectrum Pharmaceuticals' unit, Allos Therapeutics and Sandoz enter settlement agreement","NVS","Novartis"
"2016-06-28 01:15:00","Xencor enteres into collaboration and license agreement with Novartis","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3396645","2016-06-28 01:15:00","Reuters Key Development","Xencor enteres into collaboration and license agreement with Novartis","NVS","Novartis"
"2016-06-29 00:47:37","Xencor Inc (NASDAQ:XNCR) to Collaborate with Pharma Giant Novartis AG (ADR ...","http://smallcapexclusive.com/xencor-inc-nasdaqxncr-collaborate-pharma-giant-novartis/","2016-06-29 00:47:37","Small Cap Exclusive (press release)","Xencor Inc (NASDAQ:XNCR) shares rose 32.06% to $16.56 on Tuesday after the company officially signed its collaboration agreement with Novartis AG (ADR) (NYSE:NVS), which has agreed to pay $150 million to have access to Xencor's top two product ...","NVS","Novartis"
"2016-07-07 16:40:00","FDA approves Roche&#39;s Xolair for allergic asthma in children","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3401939","2016-07-07 16:40:00","Reuters Key Development","FDA approves Roche's Xolair for allergic asthma in children","NVS","Novartis"
"2016-07-19 01:55:12","Novartis to spend extra $200 mln to push Entresto - CEO","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3407333","2016-07-19 01:55:12","Reuters Key Development","Novartis to spend extra $200 mln to push Entresto - CEO","NVS","Novartis"
"2016-07-25 07:30:00","Genvec says FDA lifts hold on clinical trial of hearing loss treatment","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3410760","2016-07-25 07:30:00","Reuters Key Development","Genvec says FDA lifts hold on clinical trial of hearing loss treatment","NVS","Novartis"
"2016-08-11 07:45:00","Jacobs wins contract for Novartis Biotechnology Center expansion","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3424399","2016-08-11 07:45:00","Reuters Key Development","Jacobs wins contract for Novartis Biotechnology Center expansion","NVS","Novartis"
"2016-08-30 07:03:45","Novartis AG (ADR) (NYSE:NVS) Says A Picture Is Worth A Thousand Words","https://marketexclusive.com/novartis-ag-adr-nysenvs-says-picture-worth-thousand-words/25054/","2016-08-30 07:03:45","Market Exclusive","How do you mix medicine and photography? That's what Novartis AG (ADR) (NYSE:NVS) is doing and it feels nothing strange about it.","NVS","Novartis"
"2016-08-30 16:25:36","U.S. FDA approves Erelzi, a biosimilar to Enbrel","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3434925","2016-08-30 16:25:36","Reuters Key Development","U.S. FDA approves Erelzi, a biosimilar to Enbrel","NVS","Novartis"
"2016-09-01 06:54:48","Genvec says Novartis informed co that it remains engaged on CGF166 program","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3436154","2016-09-01 06:54:48","Reuters Key Development","Genvec says Novartis informed co that it remains engaged on CGF166 program","NVS","Novartis"
"2016-09-19 09:53:06","Can Novartis AG (ADR) (NVS) Survive with Alcon Crisis?","http://smartstocknews.com/50247-can-novartis-ag-adr-nvs-survive-with-alcon-crises/","2016-09-19 09:53:06","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Novartis AG (ADR) (NYSE:NVS) is considering the sale of its eye care division, Alcon, due to its revenue decline in the last two years.","NVS","Novartis"
"2016-09-19 10:37:30","Novartis AG (ADR) (NVS) Multiple Sclerosis Molecule: Ray of Hope","http://www.thecountrycaller.com/36958-novartis-ag-adr-nvs-multiple-sclerosis-molecule-ray-of-hope","2016-09-19 10:37:30","TCC","Novartis AG (ADR) (NYSE:NVS) investigational molecule for the treatment and management of multiple sclerosis has shown remarkable reduction in the disease progression up to 21%.","NVS","Novartis"
"2016-10-05 08:22:30","Will Novartis AG (ADR) (NVS) Cosentyx Lead Psoriasis Therapeutic Market?","http://smartstocknews.com/45892-will-novartis-ag-adr-nvs-cosentyx-lead-psoriasis-therapeutic-market/","2016-10-05 08:22:30","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Keeping in view fierce competition in the future as well as the patent cliff side effects, Novartis AG (ADR) (NYSE:NVS) is working on its blockbuster molecule Cosentyx to be the market leader in the management and treatment of psoriasis.","NVS","Novartis"
"2016-10-20 14:37:23","Novartis AG (ADR) (NVS) Q3 Earnings: What Leerink Expects","http://smartstocknews.com/40519-novartis-ag-adr-nvs-q3-earnings-what-leerink-expects/","2016-10-20 14:37:23","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Novartis AG (ADR) (NYSE:NVS) is expected to report its third quarter financial results on October 25. Leerink Partners analyst Seamus Fernandez expects data to be broadly in line with his estimates and consensus.","NVS","Novartis"
"2016-10-25 02:14:40","Novartis says Entresto sales force&#39;s impact to come in 2017","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3459820","2016-10-25 02:14:40","Reuters Key Development","Novartis says Entresto sales force's impact to come in 2017","NVS","Novartis"
"2016-10-27 16:03:39","Novartis: Peak Patent Exposure Offers Opportunity","http://seekingalpha.com/article/4015929-novartis-peak-patent-exposure-offers-opportunity","2016-10-27 16:03:39","Seeking Alpha","Novartis AG (NYSE:NVS) is a large pharmaceutical firm based in Switzerland. Its shares trade on the NYSE as an American Depository Receipt, or ADR. The company was created by the merger of Sandoz AG and Ciba-Geigy AG in December 1996.","NVS","Novartis"
"2016-11-01 07:30:00","Novartis says LEE011 (ribociclib) granted FDA priority review","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3466912","2016-11-01 07:30:00","Reuters Key Development","Novartis says LEE011 (ribociclib) granted FDA priority review","NVS","Novartis"
"2016-11-12 09:48:45","Novartis AG (NVS) May Fancy AstraZeneca plc (AZN) for Takoever: Reports","http://smartstocknews.com/56404-novartis-ag-nvs-may-fancy-astrazeneca-plc-azn-for-takoever-reports/","2016-11-12 09:48:45","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","The American depository receipts of AstraZeneca plc (ADR) (NYSE:AZN) traded up over 1% on the New York exchange Friday, after a report suggested that the company may attract a takeover interest from Novartis AG (ADR) (NYSE:NVS). Novartis' ADRs ...","NVS","Novartis"
"2016-11-14 07:30:00","Novartis drug PKC412 granted FDA priority review for newly-diagnosed flt3-mutated aml and advanced systemic mastocytosis","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3477467","2016-11-14 07:30:00","Reuters Key Development","Novartis drug PKC412 granted FDA priority review for newly-diagnosed flt3-mutated aml and advanced systemic mastocytosis","NVS","Novartis"
"2016-11-15 08:28:00","Novartis AG (NVS) Seeks M&amp;A as It Mulls Possible Alcon Sale","http://smartstocknews.com/50539-novartis-ag-adr-nvs-seeks-ma-as-it-mulls-possible-alcon-sale/","2016-11-15 08:28:00","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Novartis AG (ADR) (NYSE:NVS) is planning to enter into mergers and acquisitions as it continues to weigh options for the long-struggling eye-care business Alcon.","NVS","Novartis"
"2016-11-15 10:11:15","Novartis AG Ready to Capture Leukemia Therapeutic Market","http://www.thecountrycaller.com/65514-novartis-ag-ready-to-capture-leukemia-therapeutic-market","2016-11-15 10:11:15","TCC","Novartis AG (ADR) (NYSE:NVS) is putting efforts to capture the lucrative market of immuno-oncology with its investigational molecules covering multiple therapeutic areas.","NVS","Novartis"
"2016-11-21 07:00:00","BioLine RX in-licenses novel anti-inflammatory treatment for dry eye syndrome under strategic collaboration with major global pharmaceutical company","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3482104","2016-11-21 07:00:00","Reuters Key Development","BioLine RX in-licenses novel anti-inflammatory treatment for dry eye syndrome under strategic collaboration with major global pharmaceutical company","NVS","Novartis"
"2016-11-27 14:30:00","Novartis Stock Is Worth $90 A Share","https://seekingalpha.com/article/4026472-novartis-stock-worth-90-share","2016-11-27 14:30:00","Seeking Alpha","Novartis AG (ADR) (NYSE:NVS) is now trading over 30% off its 2015 highs. The market has taken the last two earnings reports negatively and has penalized the share price accordingly.","NVS","Novartis"
"2016-12-09 09:15:00","Analyst Review Alert on Price Target: Novartis AG (ADR) (NYSE:NVS)","http://postregistrar.com/2016/12/09/analyst-review-alert-on-price-target-novartis-ag-adr-nysenvs/","2016-12-09 09:15:00","Post Registrar","Novartis AG (ADR) (NYSE:NVS) plunged -1.50% during previous trade, a total of 5.42M shares exchanged hands compared with its average trading volume of 3.39M shares whereas its relative volume is 1.96.","NVS","Novartis"
"2016-12-14 22:02:33","Meganesuper and Alcon Japan to buy MEGANE HOUSE for 300 mln yen","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3495360","2016-12-14 22:02:33","Reuters Key Development","Meganesuper and Alcon Japan to buy MEGANE HOUSE for 300 mln yen","NVS","Novartis"
"2016-12-16 07:26:25","Novartis says Votubia recommended by CHMP for TSC patients","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3496619","2016-12-16 07:26:25","Reuters Key Development","Novartis says Votubia recommended by CHMP for TSC patients","NVS","Novartis"
"2016-12-16 07:31:14","Novartis gets positive CHMP nod for Ilaris for periodic fever syndromes","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3496628","2016-12-16 07:31:14","Reuters Key Development","Novartis gets positive CHMP nod for Ilaris for periodic fever syndromes","NVS","Novartis"
"2016-12-20 07:00:00","Here&#39;s What The Novartis AG (ADR) (NYSE:NVS) Deal Means For Conatus ...","https://marketexclusive.com/heres-novartis-ag-adr-nysenvs-deal-means-conatus-pharmaceuticals-inc-nasdaqcnat/48021/","2016-12-20 07:00:00","Market Exclusive","Conatus Pharmaceuticals Inc (NASDAQ:CNAT) just announced that it has inked a deal with pharma giant Novartis AG (ADR) (NYSE:NVS); a deal that will see the latter team up with the microcap on the development of a drug called Emricasan. It's a NASH ...","NVS","Novartis"
"2016-12-21 08:00:00","Novartis signs licensing deal with Sunovion Pharma","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3498950","2016-12-21 08:00:00","Reuters Key Development","Novartis signs licensing deal with Sunovion Pharma","NVS","Novartis"
"2016-12-21 22:01:10","Sun Pharma to buy Novartis&#39; cancer drug Odomzo","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3499223","2016-12-21 22:01:10","Reuters Key Development","Sun Pharma to buy Novartis' cancer drug Odomzo","NVS","Novartis"
"2016-12-22 18:00:00","Alcon receives U.S. FDA approval for acrysof® iq restor® +3.0d multifocal toric intraocular lens","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3499926","2016-12-22 18:00:00","Reuters Key Development","Alcon receives U.S. FDA approval for acrysof® iq restor® +3.0d multifocal toric intraocular lens","NVS","Novartis"
"2016-12-28 08:07:30","Analyst Viewpoints on Price Reaction History: Novartis AG (ADR) (NYSE:NVS)","http://postregistrar.com/2016/12/28/analyst-viewpoints-on-price-reaction-history-novartis-ag-adr-nysenvs-2/","2016-12-28 08:07:30","Post Registrar","Novartis AG (ADR) (NYSE:NVS) soared 0.24% during previous trade, a total of 1.86M shares exchanged hands compared with its average trading volume of 3.16M shares whereas its relative volume is 0.60.","NVS","Novartis"
"2016-12-29 07:11:15","Novartis AG (NVS) To Buy Intercept Pharmaceuticals Inc (ICPT) in Mid-Jan?","http://www.thecountrycaller.com/48757-novartis-ag-nvs-to-buy-intercept-pharmaceuticals-inc-icpt-in-mid-jan","2016-12-29 07:11:15","TCC","Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares soared as much as 9.34% in Wednesday's trading session amid speculations that Novartis AG (ADR) (NYSE:NVS) is interested in acquiring the company. The deal could be announced in mid-January, ...","NVS","Novartis"
"2017-01-06 12:26:15","Ionis Pharmaceuticals Inc (IONS), Akcea Strike Favorable Deal with Novartis AG ...","https://www.smarteranalyst.com/2017/01/06/ionis-pharmaceuticals-inc-ions-akcea-strike-favorable-deal-novartis-ag-adr-nvs-cowen-top-analyst/","2017-01-06 12:26:15","Smarter Analyst","Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares were initially up 6% this morning after the biotech firm and its wholly-owned subsidiary Akcea Therapeutics signed an exclusive cardiovascular disease treatment collaborative agreement with Novartis AG ...","NVS","Novartis"
"2017-01-18 03:13:42","Novartis CEO says sees downward pressure on pharma prices -CNBC","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3510059","2017-01-18 03:13:42","Reuters Key Development","Novartis CEO says sees downward pressure on pharma prices -CNBC","NVS","Novartis"
"2017-01-25 01:09:39","Novartis proposes raising dividend to 2.75 Sfr/share","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3514236","2017-01-25 01:09:39","Reuters Key Development","Novartis proposes raising dividend to 2.75 Sfr/share","NVS","Novartis"
"2017-01-25 01:35:07","Novartis CEO: All options for alcon on table, &quot;we have not ruled anything out&quot;","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3514281","2017-01-25 01:35:07","Reuters Key Development","Novartis CEO: All options for alcon on table, ""we have not ruled anything out""","NVS","Novartis"
"2017-01-25 06:26:15","Novartis Considering Sale Of Alcon Unit After Mixed Q4 Results And Outlook","http://etfdailynews.com/2017/01/25/novartis-considering-sale-of-alcon-unit-after-mixed-q4-results-and-outlook/","2017-01-25 06:26:15","ETF Daily News (blog)","In perhaps the biggest news stemming from the report, Novartis noted is considering strategic options for the consumer eye care Alcon Division.","NVS","Novartis"
"2017-01-25 07:06:54","Novartis CEO plans to meet with US President Trump, no date set","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3514804","2017-01-25 07:06:54","Reuters Key Development","Novartis CEO plans to meet with US President Trump, no date set","NVS","Novartis"
"2017-01-25 08:36:56","Novartis&#39;s Alcon head expects op. profit to hit trough in 2017","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3514894","2017-01-25 08:36:56","Reuters Key Development","Novartis's Alcon head expects op. profit to hit trough in 2017","NVS","Novartis"
"2017-01-25 08:50:05","Novartis expects CART therapy CTL019 to exceed $1 bln in annual sales","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3514898","2017-01-25 08:50:05","Reuters Key Development","Novartis expects CART therapy CTL019 to exceed $1 bln in annual sales","NVS","Novartis"
"2017-01-25 09:08:56","Analysts Review on Earnings Estimates: Novartis AG (ADR) (NYSE:NVS)","http://postregistrar.com/2017/01/25/analysts-review-on-earnings-estimates-novartis-ag-adr-nysenvs/","2017-01-25 09:08:56","Post Registrar","Novartis AG (ADR) (NYSE:NVS) plunged -0.16% or -0.11 points during previous trade after opening at the price of $69.94, a total of 4,068,100 shares exchanged hands compared with its average trading volume of 3.47M shares.","NVS","Novartis"
"2017-01-26 01:00:15","Novartis says Alcon launches new lens for astigmatism","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3515379","2017-01-26 01:00:15","Reuters Key Development","Novartis says Alcon launches new lens for astigmatism","NVS","Novartis"
"2017-02-14 11:07:30","Novartis AG (ADR) (NVS) Greater Use Of Technology In Transforming Medical ...","http://www.insidermonkey.com/blog/novartis-ag-adr-nvs-greater-use-of-technology-in-transforming-medical-education-551756/","2017-02-14 11:07:30","Insider Monkey (blog)","Novartis AG (ADR) (NYSE:NVS) is quickly entering into an engagement with the use of digital technology. The idea is to enhance and increase interaction with healthcare professionals.","NVS","Novartis"
"2017-02-23 01:18:15","Novartis says Zykadia drug gets FDA priority review","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3533475","2017-02-23 01:18:15","Reuters Key Development","Novartis says Zykadia drug gets FDA priority review","NVS","Novartis"
"2017-02-23 07:30:00","Novartis says Zykadia drug receives FDA priority review","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3534139","2017-02-23 07:30:00","Reuters Key Development","Novartis says Zykadia drug receives FDA priority review","NVS","Novartis"
"2017-02-28 06:13:32","Novartis Chairman: No decision yet on Alcon&#39;s future","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3537485","2017-02-28 06:13:32","Reuters Key Development","Novartis Chairman: No decision yet on Alcon's future","NVS","Novartis"
"2017-03-01 09:37:30","Novartis AG (NVS) Dividend Payout Ratio","http://www.moneyflowtrends.com/2017-03-01-novartis-ag-nvs-dividend-payout-ratio/","2017-03-01 09:37:30","Money Flow Index & Trends","Novartis AG (ADR) Last issued its quarterly earnings results on Jan 25, 2017. The company reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.02.","NVS","Novartis"
"2017-03-03 07:11:15","Novartis AG (ADR) (NYSE:NVS) Fined And Some Products To Be Temporarily ...","https://marketexclusive.com/novartis-ag-adr-nysenvs-fined-products-temporarily-suspended-south-korea/78526/","2017-03-03 07:11:15","Market Exclusive","Novartis AG (ADR) (NYSE:NVS) has been fined approximately $174,000 in South Korea after the company was found guilty of bribing physicians in order to induce them to recommend the pharmaceutical firm's products.","NVS","Novartis"
"2017-03-14 02:33:45","Smart Money Buying the Price Weakness of Novartis AG (NVS)","http://www.energyindexwatch.com/2017-03-14-smart-money-buying-the-price-weakness-of-novartis-ag-nvs","2017-03-14 02:33:45","Energy Index","Novartis AG (ADR) was Initiated by Liberum to Buy on Mar 9, 2017. Novartis AG (ADR) was Upgraded by Societe Generale to Buy on Mar 8, 2017.","NVS","Novartis"
"2017-03-14 04:16:58","Shares in pharma company Genfit surge for second day in row","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3546334","2017-03-14 04:16:58","Reuters Key Development","Shares in pharma company Genfit surge for second day in row","NVS","Novartis"
"2017-03-16 14:45:00","Flexi-Pricing Scheme Unveiled For Novartis AG (ADR) (NVS) Kisqali In The Face ...","http://www.insidermonkey.com/blog/flexi-pricing-scheme-unveiled-for-novartis-ag-adr-nvs-kisqali-in-the-face-of-stiff-competition-566887/","2017-03-16 14:45:00","Insider Monkey (blog)","Last year, Novartis AG (ADR) (NYSE:NVS) entered into pay-for-performance agreements for its Entresto heart failure drug.","NVS","Novartis"
"2017-03-21 10:15:00","Movers Stock Analysis – Dollar General Corp. (NYSE:DG), Novartis AG (ADR ...","http://www.wallstreetnews24.com/movers-stock-analysis-dollar-general-corp-nysedg-novartis-ag-adr-nysenvs/","2017-03-21 10:15:00","Wall Street Times (press release)","Dollar General Corp. (NYSE:DG) traded at a yearly high level of $96.88 during the last trading session. The last session's volume of 2.83 million shares was lower than its average volume of 3.23 million shares.","NVS","Novartis"
"2017-03-23 10:03:45","Stock Market Movers- Novartis AG (ADR) (NYSE:NVS), Quintiles IMS Holdings Inc ...","http://www.wallstreetnews24.com/stock-market-movers-novartis-ag-adr-nysenvs-quintiles-ims-holdings-inc-nyseq/","2017-03-23 10:03:45","Wall Street Times (press release)","Novartis AG (ADR) (NYSE:NVS) traded at a yearly high level of $83.58 during the last trading session. The last session's volume of 3.27 million shares was higher than its average volume of 2.99 million shares.","NVS","Novartis"
"2017-03-24 09:30:00","Stock List: Harmony Gold Mining Co. (NYSE:HMY), Novartis AG (NYSE:NVS ...","http://www.benchmarkmonitor.com/stock-list-harmony-gold-mining-co-nysehmy-novartis-ag-nysenvs-genworth-financial-inc-nysegnw/198440","2017-03-24 09:30:00","Benchmark Monitor","This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to US investors. Harmony Gold Mining Co.","NVS","Novartis"
"2017-03-26 07:02:47","Best Healthcare Stocks Under Trump in 2017","http://www.profitconfidential.com/stocks/best-healthcare-stocks-trump-2017/","2017-03-26 07:02:47","Profit Confidential","Healthcare company stocks have taken their fair share of beatings in the last two years. But President Donald Trump's proposed American Health Care Act is breathing some life back into them.","NVS","Novartis"
"2017-03-27 06:17:54","Akcea Therapeutics files for initial public offering of up to $100 million","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3555716","2017-03-27 06:17:54","Reuters Key Development","Akcea Therapeutics files for initial public offering of up to $100 million","NVS","Novartis"
"2017-03-30 08:45:00","Galectin Shares Upgraded To Buy; NASH-CX Results In December A &#39;Major Stock ...","https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9235328/galectin-shares-upgraded-to-buy-nash-cx-results-in-decem","2017-03-30 08:45:00","Benzinga","These are emricasan, developed by Conatus Pharmaceuticals Inc (NASDAQ: CNAT) (Buy Rated) and licensed by Novartis AG (ADR) (NYSE: NVS), and selonsertib, by Gilead Sciences, Inc. (NASDAQ: GILD). The analyst pointed out, however, that Galectin is ...","NVS","Novartis"
"2017-03-31 08:45:00","Novartis AG (ADR) (NYSE:NVS)&#39; Leukemia Drug Allowed Priority Review By The FDA","https://marketexclusive.com/novartis-ag-adr-nysenvs-leukemia-drug-allowed-priority-review-fda/88494/","2017-03-31 08:45:00","Market Exclusive","Novartis AG (ADR) (NYSE:NVS) has revealed that CTL019 has been granted a priority review designation by the U.S. Food and Drug Administration.","NVS","Novartis"
"2017-03-31 09:42:57","2 Stocks Are Just So Hot Right Now- Unilever NV (ADR) (NYSE:UN), Novartis AG ...","http://www.wallstreetnews24.com/2-stocks-are-just-so-hot-right-now-unilever-n-v-adr-nyseun-novartis-ag-adr-nysenvs/","2017-03-31 09:42:57","Wall Street Times (press release)","Unilever N.V. (ADR) (NYSE:UN) traded at a yearly high level of $50.78 during the last trading session. The last session's volume of 4.24 million shares was lower than its average volume of 4.70 million shares.","NVS","Novartis"
"2017-04-03 01:18:16","Novartis says drug combination Tafinlar + Mekinist receives EU approval","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3561023","2017-04-03 01:18:16","Reuters Key Development","Novartis says drug combination Tafinlar + Mekinist receives EU approval","NVS","Novartis"
"2017-04-03 10:03:45","Novartis AG (ADR) (NYSE:NVS) Denies It Is Selling Its Portfolio of Respiratory ...","https://www.libraryforsmartinvestors.com/2017/04/novartis-ag-adr-nysenvs-denies-selling-portfolio-respiratory-drugs/41370668.htm","2017-04-03 10:03:45","Library For Smart Investors","Novartis AG (ADR) (NYSE:NVS) has denied reports that it intends to sell off some of its drugs that are used in the treatment of COPD and asthma.","NVS","Novartis"
"2017-04-03 10:14:19","Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Risky","http://investorplace.com/2017/04/teva-pharmaceutical-industries-ltd-adr-teva-stock-risky/","2017-04-03 10:14:19","Investorplace.com","Novartis AG (ADR) (NYSE:NVS) and Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) already launched a generic version of Copaxone, Glatopa, in 2015.","NVS","Novartis"
"2017-04-03 11:56:12","Vectura says US licensee of group&#39;s partner Novartis AG launched Utibron Neohaler in US","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3561722","2017-04-03 11:56:12","Reuters Key Development","Vectura says US licensee of group's partner Novartis AG launched Utibron Neohaler in US","NVS","Novartis"
"2017-04-03 14:45:00","Regeneron Pharmaceuticals Inc (REGN): Grey Sky Risk Associated with RTH258 ...","http://smartstocknews.com/46728-regeneron-pharmaceuticals-inc-regn-grey-sky-risk-associated-with-rth258-from-novartis-ag-adr-nvs/","2017-04-03 14:45:00","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Credit Suisse expects Regeneron Pharmaceuticals Inc.'s (NASDAQ:REGN) Novartis data for RTH258 coming down the pike in May 2017.","NVS","Novartis"
"2017-04-05 09:30:00","Benzinga&#39;s Top Upgrades, Downgrades For April 5, 2017","https://www.benzinga.com/analyst-ratings/upgrades/17/04/9265362/benzingas-top-upgrades-downgrades-for-april-5-2017","2017-04-05 09:30:00","Benzinga","Cowen & Co. downgraded Novartis AG (ADR) (NYSE: NVS) from Outperform to Market Perform. Novartis shares fell 1.04 percent to $73.99 in pre-market trading.","NVS","Novartis"
"2017-04-05 09:41:15","5 Biggest Price Target Changes For Wednesday","https://www.benzinga.com/analyst-ratings/price-target/17/04/9265521/5-biggest-price-target-changes-for-wednesday","2017-04-05 09:41:15","Benzinga","Keefe Bruyette & Woods raised Wells Fargo & Co (NYSE: WFC) price target from $53 to $63. Wells Fargo shares closed at $55.20 on Tuesday.","NVS","Novartis"
"2017-04-05 12:30:00","Cowen Downgrades Novartis, Strengths &#39;Now Balance Its Risks&#39;","https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9265932/cowen-downgrades-novartis-strengths-now-balance-its-risk","2017-04-05 12:30:00","Benzinga","Steve Scala of Cowen downgraded shares of Novartis AG (ADR) (NYSE: NVS) from Outperform to Market Perform with a price target lowered to $77 from $87 as the company's strengths ""now balance its risks.","NVS","Novartis"
"2017-04-06 01:20:53","Novartis to in-license ECF843 for ophthalmic indications","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3563300","2017-04-06 01:20:53","Reuters Key Development","Novartis to in-license ECF843 for ophthalmic indications","NVS","Novartis"
"2017-04-07 00:52:30","Novartis AG (ADR) (NYSE:NVS) target price raised to $78.32, released a report ...","http://breakingfinancenews.com/investing/novartis-ag-adr-nysenvs-target-price-raised-to-78-32-released-a-report-earlier-today-by-vetr-inc/225090/","2017-04-07 00:52:30","Breaking Finance News","Reporting a possible upside of 0.06%, Vetr Inc. increased the target of Novartis AG (ADR) (NYSE:NVS) to $78.32. On 4/5/2017, Cowen and Company released a statement on Novartis AG (ADR) (NYSE:NVS) bumped down the target price from $87.00 to ...","NVS","Novartis"
"2017-04-07 09:52:30","Stocks in Focus Cognizant Technology Solutions Corp (NASDAQ:CTSH), Novartis AG ...","http://www.journalfinance.net/2017/04/stocks-in-focus-cognizant-technology-solutions-corp-nasdaqctsh-novartis-ag-adr-nysenvs/","2017-04-07 09:52:30","Daily News Journal","Shares of Novartis AG (ADR) (NYSE:NVS) declined -0.08% to $73.71. Stock exchanged hands with the total volume of 0.46 Million shares, as contrast to its average volume of 2.64 Million shares.","NVS","Novartis"
"2017-04-07 10:15:00","Novartis AG (NYSE:NVS) exercised option to in-license ECF843","http://www.benchmarkmonitor.com/novartis-ag-nysenvs-exercised-option-to-in-license-ecf843/202892","2017-04-07 10:15:00","Benchmark Monitor","Novartis AG (NYSE:NVS) announced it has exercised an option to in-license ECF843 for ophthalmic indications worldwide (outside Europe).","NVS","Novartis"
"2017-04-10 12:30:00","Galectin Therapeutics Inc (NASDAQ:GALT): Here&#39;s What&#39;s Important","https://www.insiderfinancial.com/galectin-therapeutics-inc-nasdaqgalt-heres-whats-important/121025/","2017-04-10 12:30:00","Insider Financial","There are a couple of other companies working on NASH therapies right now, most notably Novartis AG (ADR) (NYSE: NVS), and selonsertib, by Gilead Sciences, Inc. (NASDAQ: GILD), and Galectin has actually picked up a bit of strength in the past on the ...","NVS","Novartis"
"2017-04-10 14:00:00","Eye Catching Stocks Mastercard Inc (NYSE:MA), Novartis AG (ADR) (NYSE:NVS)","http://www.journalfinance.net/2017/04/eye-catching-stocks-mastercard-inc-nysema-novartis-ag-adr-nysenvs/","2017-04-10 14:00:00","Daily News Journal","On Friday, Mastercard Inc (NYSE:MA) stock opened its trade at $112.18 and after floating in a range of $11.84 to $1123.112.75, settled at $112.24.","NVS","Novartis"
"2017-04-11 08:11:15","Stock Market Movers- Pandora Media Inc (NYSE:P), Novartis AG (ADR) (NYSE:NVS)","http://www.wallstreetnews24.com/stock-market-movers-pandora-media-inc-nysep-novartis-ag-adr-nysenvs/","2017-04-11 08:11:15","Wall Street Times (press release)","Pandora Media Inc (NYSE:P) traded at a yearly high level of $14.98 during the last trading session. The last session's volume of 11.58 million shares was higher than its average volume of 7.93 million shares.","NVS","Novartis"
"2017-04-11 09:13:08","Torrent Pharma says it had signed deals with Novartis AG to buy generic pharmaceutical products","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3566518","2017-04-11 09:13:08","Reuters Key Development","Torrent Pharma says it had signed deals with Novartis AG to buy generic pharmaceutical products","NVS","Novartis"
"2017-04-12 06:27:59","Waste Management, Inc. (WM) Is At $72.87 Formed Wedge, 4 Analysts Covering ...","http://utahherald.com/waste-management-inc-wm-is-at-72-87-formed-wedge-4-analysts-covering-novartis-ag-adr-nvs/","2017-04-12 06:27:59","UtahHerald.com","Credit Suisse downgraded the stock to “Neutral” rating in Wednesday, January 11 report. As per Wednesday, March 23, the company rating was downgraded by Leerink Swann.","NVS","Novartis"
"2017-04-12 08:08:52","Incyte: Why This Biotech Beauty Can Stay Hot","http://www.barrons.com/articles/incyte-why-this-biotech-beauty-can-stay-hot-1491998918","2017-04-12 08:08:52","Barron's","Wall Street expects revenue to jump 43% this year to $1.6 billion, and to keep rising via its only marketed product, the orphan drug Jakafi, and royalties from licensing deals with Novartis NOVN.","NVS","Novartis"
"2017-04-12 10:06:39","Enable Midstream Partners LP (ENBL) Is At $16.43 Formed Wedge; Novartis AG ...","https://kgazette.com/enable-midstream-partners-lp-enbl-is-at-16-43-formed-wedge-novartis-ag-nvs-si-decreased-by-19-09/","2017-04-12 10:06:39","Key Gazette","With 3.41 million avg volume, 1 days are for Novartis AG (NYSE:NVS)'s short sellers to cover NVS's short positions. The SI to Novartis AG's float is 0.2%.","NVS","Novartis"
"2017-04-12 11:00:00","News Buzz QEP Resources Inc (NYSE:QEP), Novartis AG (ADR) (NYSE:NVS)","http://www.journalfinance.net/2017/04/news-buzz-qep-resources-inc-nyseqep-novartis-ag-adr-nysenvs/","2017-04-12 11:00:00","Daily News Journal","Shares of Novartis AG (ADR) (NYSE:NVS) inclined 0.61% to $73.96. Stock exchanged hands with the total volume of 1.67 Million shares, as contrast to its average volume of 2.54 Million shares.","NVS","Novartis"
"2017-04-12 11:22:30","Celgene, Biogen to Gain From Higher Prices","http://www.barrons.com/articles/celgene-biogen-to-gain-from-higher-prices-1492010746","2017-04-12 11:22:30","Barron's","We think the Novartis NOVN.EB -0.5454793399699986% Novartis AG ADR U.S.: NYSE USD72.93 -0.4 -0.5454793399699986% /Date(1492549324264-0500)/ Volume (Delayed 15m) : 2364826 AFTER HOURS USD72.93 % Volume (Delayed 15m) : P/E ...","NVS","Novartis"
"2017-04-14 14:11:15","Amg National Trust Bank Trimmed Novartis AG Sponsored Adr (NVS) Position By ...","http://www.mmahotstuff.com/2017/04/14/amg-national-trust-bank-trimmed-novartis-a-g-sponsored-adr-nvs-position-by-801576-1-analysts-covering-jernigan-capital-jcap.html","2017-04-14 14:11:15","MoneyMakingArticles","Among 2 analysts covering Jernigan Capital Inc (NYSE:JCAP), 1 have Buy rating, 1 Sell and 0 Hold. Therefore 50% are positive. Jernigan Capital Inc had 6 analyst reports since August 14, 2015 according to SRatingsIntel.","NVS","Novartis"
"2017-04-15 00:18:45","As Drug Prices Fall, These Stocks Could Rise","http://www.barrons.com/articles/as-drug-prices-fall-these-stocks-could-rise-1492230223","2017-04-15 00:18:45","Barron's","In September 2015, presidential candidate Hillary Clinton dashed off a quick message vowing to take on price gouging in specialty drugs—a veiled reference to industry toad Martin Shkreli, whose Turing Pharmaceuticals had just cornered the market on a ...","NVS","Novartis"
"2017-04-17 06:07:30","Bristol John W &amp; Company Increased Novartis A G (NVS) Stake by $16.37 Million ...","https://huronreport.com/bristol-john-w-federal-realty-investment-trust-frt-sentiment-is-1-03/","2017-04-17 06:07:30","HuronReport","Bristol John W & Company Inc increased Novartis A G (NYSE:NVS) stake by 26.39% reported in 2017Q1 SEC filing. Bristol John W & Company Inc acquired 221,250 shares as Novartis A G (NYSE:NVS)'s stock rose 2.27%. The Bristol John W & Company Inc ...","NVS","Novartis"
"2017-04-17 09:19:22","Attention Seekers Stocks: Barrick Gold Corp (USA) (NYSE:ABX), Bank of New York ...","https://www.wallstreetnews24.com/attention-seekers-stocks-barrick-gold-corp-usa-nyseabx-bank-of-new-york-mellon-corp-nysebk-novartis-ag-adr-nysenvs/","2017-04-17 09:19:22","Wall Street Times (press release)","Novartis AG (ADR) (NYSE:NVS) was trading -9.29% below its 52-week high and +13.27% above its 52-week low. Its last 5-Year EPS growth stands at -5.80% with earnings growth of -8.00% yoy.","NVS","Novartis"
"2017-04-17 09:52:30","Analyst&#39;s Report Recap: Novartis AG (ADR) (NYSE:NVS)","http://postregistrar.com/2017/04/17/analysts-report-recap-novartis-ag-adr-nysenvs/","2017-04-17 09:52:30","Post Registrar","Novartis AG (ADR) (NYSE:NVS) plunged -1.16% during previous trade, a total of 2.28M shares exchanged hands compared with its average trading volume of 2.33M shares whereas its relative volume is 0.74.","NVS","Novartis"
"2017-04-17 14:45:00","Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Double","http://investorplace.com/2017/04/teva-pharmaceutical-industries-ltd-adr-teva-stock-double/","2017-04-17 14:45:00","Investorplace.com","Already, the 20-mg version is subject to generic competition from the likes of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) and Novartis AG (ADR) (NYSE:NVS). If the 40-mg competition starts, Teva management estimates it will take $1 billion to $1.3 ...","NVS","Novartis"
"2017-04-17 17:56:15","10 Most Profitable Companies In Europe","http://www.insidermonkey.com/blog/10-most-profitable-companies-in-europe-574528/","2017-04-17 17:56:15","Insider Monkey (blog)","... AG (OTCMKTS:DDAIF), Nestle SA (ADR) (OTCMKTS:NSRGY), Novartis AG (ADR) (NYSE:NVS), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Schweizerische Nationalbank (Swiss National Bank), and Sberbank Rossii PAO - ADR (OTCMKTS:SBRCY) ...","NVS","Novartis"
"2017-04-18 01:17:14","Novartis&#39; Cart-T Therapy CTl019 gets FDA breakthrough therapy designation","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3569502","2017-04-18 01:17:14","Reuters Key Development","Novartis' Cart-T Therapy CTl019 gets FDA breakthrough therapy designation","NVS","Novartis"
"2017-04-18 01:22:40","Novartis expands trials for NASH via collaboration with Allergan","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3569506","2017-04-18 01:22:40","Reuters Key Development","Novartis expands trials for NASH via collaboration with Allergan","NVS","Novartis"
"2017-04-18 06:30:00","Cadence Bank Na Upped Unum (UNM) Position, Sabra Health Care REIT Has 1.31 ...","https://heraldks.com/cadence-bank-na-upped-unum-unm-position-sabra-health-care-reit-has-1-31-sentiment/","2017-04-18 06:30:00","Herald KS","It also reduced Novartis Ag Sponsored Adr (NYSE:NVS) stake by 12,055 shares and now owns 23,440 shares. Merck & Co Inc (NYSE:MRK) was reduced too.","NVS","Novartis"
"2017-04-18 06:41:15","Ngam Advisors LP Trimmed Its Novartis A G (NVS) Position, Broadwood Capital ...","https://huronreport.com/ngam-advisors-lp-trimmed-its-novartis-a-g-nvs-position-broadwood-capital-upped-cynosure-cyno-stake/","2017-04-18 06:41:15","HuronReport","Novartis A G now has $191.78B valuation. The stock increased 0.25% or $0.18 during the last trading session, reaching $73.33. About 64 shares traded.","NVS","Novartis"
"2017-04-19 06:41:15","$1.15 EPS Expected for Novartis AG (ADR) (NVS); Fifth Third Bancorp (FITB ...","https://kgazette.com/1-15-eps-expected-for-novartis-ag-adr-nvs-fifth-third-bancorp-fitb-sellers-decreased-by-2-67-their-shorts/","2017-04-19 06:41:15","Key Gazette","Fifth Third Bancorp (NASDAQ:FITB) had a decrease of 2.67% in short interest. FITB's SI was 19.25 million shares in April as released by FINRA.","NVS","Novartis"
"2017-04-19 08:00:00","Parvus Therapeutics announces license and collaboration agreement of its lead nanomedicine to treat type 1 diabetes","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3570774","2017-04-19 08:00:00","Reuters Key Development","Parvus Therapeutics announces license and collaboration agreement of its lead nanomedicine to treat type 1 diabetes","NVS","Novartis"
"2017-04-19 08:56:15","Motco Has Upped Novartis Ag (NVS) Position By $343512; Glendon Capital ...","https://huronreport.com/motco-has-upped-novartis-ag-nvs-position-by-343512-glendon-capital-management-lp-has-upped-whiting-pete-new-wll-holding/","2017-04-19 08:56:15","HuronReport","The Motco holds 102,248 shares with $7.45M value, up from 97,477 last quarter. Novartis Ag now has $189.66B valuation. The stock declined 0.12% or $0.08 reaching $72.85 on the news.","NVS","Novartis"
"2017-04-19 09:30:00","Sometimes the Road to Wealth Is Paved by Tech - and Toothpaste","https://moneymorning.com/investing/sometimes-the-road-to-wealth-is-paved-by-tech-and-toothpaste/","2017-04-19 09:30:00","Money Morning","GlaxoSmithKline Plc. (NYSE ADR: GSK) decided back in 2014 to smooth out its cash flow and R&D spending by moving into consumer healthcare.","NVS","Novartis"
"2017-04-19 13:26:15","EPS for State Street (STT) Expected At $1.13, 4 Bullish Analysts Covering ...","https://normanobserver.com/eps-for-state-street-stt-expected-at-1-13-4-bullish-analysts-covering-novartis-ag-adr-nvs/","2017-04-19 13:26:15","NormanObserver.com","Among 13 analysts covering Novartis Ag (NYSE:NVS), 4 have Buy rating, 2 Sell and 7 Hold. Therefore 31% are positive. Novartis Ag had 20 analyst reports since July 28, 2015 according to SRatingsIntel. The company was downgraded on Friday, April 1 by ...","NVS","Novartis"
"2017-04-19 16:26:15","JP Morgan Reaffirmed Novartis AG NVS (NVS)&#39;s “Neutral” Rating; Ceco ...","https://huronreport.com/jp-morgan-reaffirmed-novartis-ag-nvs-nvss-neutral-rating-ceco-environmental-has-1-36-sentiment/","2017-04-19 16:26:15","HuronReport","On Tuesday, January 3 the stock rating was downgraded by JP Morgan to “Neutral”. The stock of Novartis AG (ADR) (NYSE:NVS) has “Neutral” rating given on Thursday, March 23 by Goldman Sachs.","NVS","Novartis"
"2017-04-20 06:07:30","Citigroup Reiterated Henderson Group PLC (LON:HGG) As “Neutral”; Has Target Of ...","https://heraldks.com/citigroup-reiterated-henderson-group-plc-lonhgg-as-neutral-has-target-of-gbx-240-00-nelson-roberts-investment-advisors-has-upped-its-procter-gamble-co-pg-position/","2017-04-20 06:07:30","Herald KS","It also reduced Novartis A G Spon Adr (NYSE:NVS) stake by 4,639 shares and now owns 61,085 shares. Illumina Inc. (NASDAQ:ILMN) was reduced too.","NVS","Novartis"
"2017-04-20 06:30:00","Analysts See $0.00 EPS for Siliconware Precision Industries (ADR) (SPIL ...","https://heraldks.com/analysts-see-0-00-eps-for-siliconware-precision-industries-adr-spil-provise-management-group-has-lowered-by-704088-its-novartis-a-g-nvs-position/","2017-04-20 06:30:00","Herald KS","Novartis A G now has $189.16B valuation. The stock decreased 0.26% or $0.19 on April 19, reaching $72.74. About shares traded. Novartis AG (ADR) (NYSE:NVS) has declined 8.06% since September 13, 2016 and is downtrending. It has underperformed ...","NVS","Novartis"
"2017-04-20 07:26:15","Cape Cod Five Cents Savings Bank Has Cut By $319320 Its Novartis A G (NVS ...","http://www.mmahotstuff.com/2017/04/20/cape-cod-five-cents-savings-bank-has-cut-by-319320-its-novartis-a-g-nvs-stake-cell-therapeutics-has-0-62-sentiment.html","2017-04-20 07:26:15","MoneyMakingArticles","Novartis A G now has $189.16B valuation. The stock decreased 0.26% or $0.19 on April 19, reaching $72.74. About shares traded. Novartis AG (ADR) (NYSE:NVS) has declined 8.06% since September 13, 2016 and is downtrending. It has underperformed ...","NVS","Novartis"
"2017-04-20 13:37:30","What Would A $5.8 Billion NIH Cut Look Like? Devastation","https://www.benzinga.com/news/17/04/9308625/what-would-a-5-8-billion-nih-cut-look-like-devastation","2017-04-20 13:37:30","Benzinga","Their funding restrictions could cripple major pharmaceuticals vulnerable to licensing droughts. The budgets of Johnson & Johnson (NYSE: JNJ), Novartis AG (ADR) (NYSE: NVS), Pfizer Inc. (NYSE: PFE), Eli Lilly and Co (NYSE: LLY), Merck & Co., Inc. (NYSE ...","NVS","Novartis"
"2017-04-20 13:48:45","Novartis AG (ADR) (NVS) Reaches $73.86 After 3.00% Gap Up; Patrick Industries ...","https://kgazette.com/novartis-ag-adr-nvs-reaches-73-86-after-3-00-gap-up-patrick-industries-patk-shorts-decreased-by-22-55/","2017-04-20 13:48:45","Key Gazette","The stock of Novartis AG (ADR) (NYSE:NVS) gapped up by $0.19 today and has $76.08 target or 3.00% above today's $73.86 share price.","NVS","Novartis"
"2017-04-20 16:37:30","Arcadia Investment Management Has Trimmed Its Cbre Group (CBG) Stake; Novartis ...","https://www.whatsonthorold.com/2017/04/20/arcadia-investment-management-has-trimmed-its-cbre-group-cbg-stake-novartis-ag-nvs-shorts-lowered-by-19-09/","2017-04-20 16:37:30","Thorold News","With 3.41M avg volume, 1 days are for Novartis AG (NYSE:NVS)'s short sellers to cover NVS's short positions. The SI to Novartis AG's float is 0.2%.","NVS","Novartis"
"2017-04-21 06:30:00","Allergan plc Ordinary Shares (NYSE:AGN) Incorporates Novartis AG (ADR) (NYSE ...","https://marketexclusive.com/allergan-plc-ordinary-shares-nyseagn-incorporates-novartis-ag-adrnysenvs-nash-combo-trial/95507/","2017-04-21 06:30:00","Market Exclusive","Allergan plc Ordinary Shares (NYSE:AGN) will be collaborating with Novartis AG (ADR)(NYSE:NVS) in its Phase IIb study.","NVS","Novartis"
"2017-04-21 11:22:30","2 Stocks to Watch For Novartis AG (ADR) (NYSE:NVS), Mitsubishi UFJ Financial ...","http://www.journalfinance.net/2017/04/2-stocks-to-watch-for-novartis-ag-adr-nysenvs-mitsubishi-ufj-financial-group-inc-adr-nysemtu/","2017-04-21 11:22:30","Daily News Journal","Shares of Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU) inclined 1.31% to $6.20. Stock exchanged hands with the total volume of 4.02 Million shares, as contrast to its average volume of 1.54 Million shares.","NVS","Novartis"
"2017-04-21 13:51:48","EU Medicines Agency recommendations for April 2017","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3572891","2017-04-21 13:51:48","Reuters Key Development","EU Medicines Agency recommendations for April 2017","NVS","Novartis"
"1108","Bay National Corp. Announces Intention To Delist From NASDAQ","http://www.reuters.com/finance/stocks/BAYN.PK/key-developments/article/1900856","2010-05-26 17:00:00","Reuters Key Development","Bay National Corp. Announces Intention To Delist From NASDAQ","BAYN","Bayer"
"2100","Trump slashing arts, health care? Here&#39;s a non-ice bucket response","http://www.record-bee.com/article/NQ/20170323/LOCAL1/170329920","2017-03-22 11:11:15","Record Bee","The president's first budget draft eliminates funding for the National Endowment for the Arts and for the Corporation for National Service. His first ... Longer ago I ran City Year San Jose/Silicon Valley, the premiere AmeriCorps program in the South ...","BAYN","Bayer"
"3100","Opinion: Why California should boost legal aid funding","http://www.mercurynews.com/2017/03/23/opinion-why-california-should-boost-legal-aid-funding/","2017-03-23 09:45:59","The Mercury News","Soaring rent increases in the Bay Area the past few years have left many families scrambling to find a place they can afford.","BAYN","Bayer"
"4100","Clearwater Beacon","http://www.tbnweekly.com/pubs/clearwater_beacon/content_articles/032317_clw-04.txt","2017-03-23 13:06:15","Tampa Bay Newspapers","Previously, Coba also held key leadership roles in growing global and national category leading franchise brands on a variety of levels, including mergers and acquisitions.","BAYN","Bayer"
"5100","Aboriginal leaders bid to take over neglected national park at Watsons Bay","https://www.domain.com.au/news/aboriginal-leaders-bid-to-take-over-neglected-national-park-at-watsons-bay-20170324-gv4c7z/","2017-03-24 09:19:39","Domain News","Two Aboriginal community leaders have put in a bid to take over one of Sydney's most prestigious harbourside national parks at Watsons Bay, with the idea of turning it into an “all-encompassing indigenous experience”. The park, currently neglected and ...","BAYN","Bayer"
"6100","Lights go off across the UAE to mark Earth Hour","http://www.thenational.ae/lights-go-off-across-the-uae-to-mark-earth-hour","2017-03-25 14:45:00","The National","Residents and businesses across the country took part in Earth Hour festivities on Saturday evening by switching off their lights for 60 minutes.","BAYN","Bayer"
"7100","Bay County service providers weigh Trump&#39;s budget proposal","http://www.newsherald.com/news/20170325/bay-county-service-providers-weigh-trumps-budget-proposal","2017-03-25 18:37:30","The News Herald","The proposed budget also would devastate the local AmeriCorps program, said John Schaffer, director of the AmeriCorps Goodwill GoodWorks!","BAYN","Bayer"
"8100","Trump cuts worry officials","http://www.dailyadvance.com/News/2017/03/26/Trump-cuts-worry-officials.html","2017-03-25 23:56:15","The Daily Advance","Elimination of all funding for the National Endowment for the Arts, the Corporation for Public Broadcasting and the Corporation for National and Community Service, the latter of which includes the volunteerism program AmeriCorps. River City Community ...","BAYN","Bayer"
"9100","Fact-checking Donald Trump&#39;s tweets about Hillary Clinton and Russia","http://www.politifact.com/truth-o-meter/article/2017/mar/28/fact-checking-donald-trumps-tweets-about-hillary-c/","2017-03-28 16:26:15","PolitiFact","It was part of a regular process for approving international deals involving strategic assets, such as uranium, that could have implications for national security. Uranium One's U.S. mines produced about 11 percent of the country's total uranium ...","BAYN","Bayer"
"10100","New marketing alliance to promote Bay Harbor nationally","http://www.petoskeynews.com/news/business/new-marketing-alliance-to-promote-bay-harbor-nationally/article_3ce32e82-1419-11e7-bb11-f7891a009eef.html","2017-03-28 20:58:30","Petoskey News-Review","""This long-term resident-controlled strategic partnership combines Boyne Resorts' expertise in golf, skiing and hospitality with Bay Harbor Co.'s unique approach to luxury lifestyle communities to increase national and regional awareness of Bay Harbor.”.","BAYN","Bayer"
"1110","Popular vote change looks to grass-roots spark","http://www.eastbaytimes.com/2017/03/29/popular-vote-change-looks-to-grass-roots-spark/","2017-03-29 14:44:53","East Bay Times","Fadem is a partner in the law firm Fadem & Associates in Lafayette, co-author of “Every Vote Equal,” and president of National Popular Vote. The nonprofit corporation educates and advocates for implementation of a nationwide popular election of the ...","BAYN","Bayer"
"1210","Hudson Bay Capital Management LP Buys Shares of 125000 Centene Corp (CNC)","https://sportsperspectives.com/2017/03/29/hudson-bay-capital-management-lp-buys-shares-of-125000-centene-corp-cnc.html","2017-03-29 17:11:15","Sports Perspectives","Centene Corp logo Hudson Bay Capital Management LP bought a new position in shares of Centene Corp (NYSE:CNC) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.","BAYN","Bayer"
"1310","Why Copper Could Be The Top Performing Commodity of 2017","http://www.baystreet.ca/articles/stockstowatch.aspx?articleid=29788","2017-03-29 20:11:15","Baystreet.ca","This is the elephant hunt of the decade, and early indications are that the edge of a porphyry system has already been hit by one of Arena's partners on the ground, JOGMEC (Japan Oil, Gas and Metals National Corporation). As they work towards the ...","BAYN","Bayer"
"1410","Priscilla Chan Named San Francisco Chronicle&#39;s Visionary of the Year in Third ...","http://www.businesswire.com/news/home/20170330006328/en/Priscilla-Chan-Named-San-Francisco-Chronicle%E2%80%99s-Visionary","2017-03-31 00:07:30","Business Wire (press release)","The Chronicle, along with founding partner Saint Mary's College of California's School of Economics and Business Administration, and in 2016 joined by proud supporter of the Bay Area business community and presenting sponsor City National Bank ...","BAYN","Bayer"
"1510","Opinion: Abandoning the arts is a foolhardy plan","http://www.mercurynews.com/2017/03/31/opinion-abandoning-the-arts-is-a-foolhardy-plan/","2017-03-31 13:54:45","The Mercury News","President Trump's budget proposal to eliminate all funding for the National Endowment for the Arts, the National Endowment for the Humanities, Corporation for Public Broadcasting and the Institute for Museum and Library Services is shortsighted and ...","BAYN","Bayer"
"1610","Abandoning the arts is a foolhardy plan","http://www.record-bee.com/article/NQ/20170405/LOCAL1/170409924","2017-03-31 14:00:00","Record Bee","President Trump's budget proposal to eliminate all funding for the National Endowment for the Arts, the National Endowment for the Humanities, Corporation for Public Broadcasting and the Institute for Museum and Library Services is shortsighted and ...","BAYN","Bayer"
"1710","Govt attracts more investors","http://www.znbc.co.zm/?p=51376","2017-04-01 07:48:45","ZNBC","Recently, a delegation comprising Cabinet Ministers, permanent secretaries and potential investors visited Kasaba Bay and other tourism sites in Northern Province to explore the possibilities of opening up the region to future tourism investment.","BAYN","Bayer"
"1810","Newmont Mining Corp - Receive News &amp; Ratings Daily","https://baseballnewssource.com/markets/9823-shares-in-newmont-mining-corp-nem-acquired-by-hudson-bay-capital-management-lp/548021.html","2017-04-01 08:56:15","BBNS","Newmont Mining Corp logo Hudson Bay Capital Management LP bought a new position in shares of Newmont Mining Corp (NYSE:NEM) during the fourth quarter, Holdings Channel reports. The firm bought 9,823 shares of the company's stock, valued at ...","BAYN","Bayer"
"1910","Eitel, Ethics, Education","http://www.nationalreview.com/corner/446330/robert-eitel-trump-administration-education-lawyer-unfairly-attacked","2017-04-01 20:56:15","National Review","Should the Obama-Holder Justice Department hire lawyers who went out of their way to fight for Guantanamo Bay's enemy combatants and against the congressionally approved law governing their treatment, well, the Left has a conniption fit if ...","BAYN","Bayer"
"2010","Terrified Australian left clinging on after shark took bite out of kayak","http://www.thenational.ae/world/asia-pacific/terrified-australian-left-clinging-on-after-shark-took-bite-out-of-kayak","2017-04-03 05:18:51","The National","Gavin Kleidon's ordeal began late on Sunday as he was paddling in a leisurely fashion to Mud Island in Moreton Bay off Brisbane.","BAYN","Bayer"
"2110","What to Expect From Alaska&#39;s Record Cruise Season","http://www.travelagentcentral.com/cruises/north-to-alaska","2017-04-03 10:03:45","Travel Agent","Princess is the launch brand for Carnival Corporation's new Ocean Medallion technology. Island Princess, the fourth ship to get the technology, will sail with it in Alaska in 2018.","BAYN","Bayer"
"2210","NARRATIVE Drift","http://folioweekly.com/stories/narrative-drift,17265","2017-04-05 09:14:10","Folio Weekly","The earliest example: the first meeting of the Duval County Legislative Delegation, in which the administration launched a $50M ask for money to close the Hart Bridge offramps and route traffic down Bay Street. At least one delegation ... Cummings may ...","BAYN","Bayer"
"2310","Young pulls punches as Myron Naneng testifies against King Cove road","http://kdlg.org/post/young-pulls-punches-myron-naneng-testifies-against-king-cove-road","2017-04-06 12:05:25","KDLG","Naneng is now the board president of Hooper Bay's village corporation. His region, the Yukon-Kuskokwim Delta, is a few hundred miles from Izembek, but he said the people in the Delta have traditionally depended on the waterfowl that feed in the Izembek ...","BAYN","Bayer"
"2410","Leaking Barge Capsizes In San Francisco Bay, Cleanup Underway [Updated]","http://hoodline.com/2017/04/leaking-barge-capsizes-in-san-francisco-bay-cleanup-underway","2017-04-07 16:02:53","Hoodline","National Response Corporation Emergency Services, a private company, has deployed 3,000 feet of boom around the barge to keep the spill contained, and cleanup strategies are underway, Stanton said.","BAYN","Bayer"
"2510","Cramer Remix: Why I&#39;m standing alone on Coca-Cola","http://www.cnbc.com/2017/04/07/cramer-remix-why-im-standing-alone-on-coca-cola.html","2017-04-07 19:01:09","CNBC","The rest of Wall Street may have lost faith in Coca Cola's struggling stock, but Jim Cramer is fearlessly standing behind the ubiquitous multinational.","BAYN","Bayer"
"2610","Chair of the Presidio Trust: Who Is Paula Collins?","http://www.allgov.com/news/top-stories/chair-of-the-presidio-trust-who-is-paula-collins-170411?news=860142","2017-04-11 07:48:45","AllGov","The Presidio Trust is a federal corporation created by Congress to manage the Presidio of San Francisco, which was designated a National Historic Landmark in 1962. The oldest continuously operated military post in the United States, the Presidio of San ...","BAYN","Bayer"
"2710","Japan looks to grow its presence across Africa","http://www.theworldfolio.com/news/japan-looks-to-grow-its-presence-across-africa/4264/","2017-04-11 11:00:00","The Worldfolio","Japanese companies tapping oil and gas opportunities are supported by the Japan Oil, Gas and Metals National Corporation (JOGMEC), which provides financial and technical assistance, as well as offering up to 75 percent equity and taking on up to 75 ...","BAYN","Bayer"
"2810","Community Calendar","http://www.dundalkeagle.com/news/community_calendar/community-calendar/article_7c5a8614-2959-52c7-b8f8-a93c295782ad.html","2017-04-11 13:37:30","Dundalk Eagle (blog)","•Annual Third Sunday Dinner on the Bay at Bethlehem Council Knights of Columbus #2605, 7401 Bayfront Road, from 2 to 5 p.m.","BAYN","Bayer"
"2910","Pasco County real estate transactions for April 14, 2017","http://www.tampabay.com/news/business/realestate/pasco-county-real-estate-transactions-for-april-14-2017/2319927","2017-04-11 14:56:15","Tampabay.com","20442 Trilby Cutoff Rd., to Joseph C. Paterson by Federal Home Loan Mortgage Corporation, $42,000, 3/17/2017. HOLIDAY. 5815 Lenmar Ct.","BAYN","Bayer"
"3010","Opinion: If SBW&#39;s faith in Islam is genuine then why is he playing Super Rugby ...","http://www.nzherald.co.nz/hawkes-bay-today/news/article.cfm?c_id=1503462&objectid=11837090","2017-04-12 12:51:25","New Zealand Herald","HSBC is a British multi-national banking corporation. So where does he stand with nib Stadium (nib is a global financier that profits), the home of Western Force in Perth?","BAYN","Bayer"
"3110","Long Hill main road danger deepens","http://jamaica-gleaner.com/article/lead-stories/20170413/long-hill-main-road-danger-deepens","2017-04-13 01:11:30","Jamaica Gleaner","Montego Bay Mayor Homer Davis says that the St James Municipal Corporation is also prepared to do some work on the Long Hill main road to help make it safer after numerous complaints about its treacherousness.","BAYN","Bayer"
"3210","Community briefs for Point Loma and Ocean Beach","http://www.sdnews.com/view/full_story/27397721/article-Community-briefs-for-Point-Loma-and-Ocean-Beach-?instance=most_popular1","2017-04-13 09:41:15","San Diego Community News","The Californian sails through San Diego Bay with downtown as a backdrop. The Californian is a ... Easter is April 16 this year and the gates to Cabrillo National Monument will open at 6 a.m. with the non-denominational service beginning at 6:30 a.m ...","BAYN","Bayer"
"3310","Yet Another Multi-National Oil Company Mulls Exiting Canada&#39;s Oil Sands","http://www.baystreet.ca/articles/heard_on_the_street.aspx?articleid=30004","2017-04-13 14:33:45","Baystreet.ca","The latest company to consider getting out of the oil sands is Chevron Corporation (NYSE:CVX). According to people close to the situation, Chevon has contacted investment bankers about selling its 20% interest in the Athabasca Oil Sands Project.","BAYN","Bayer"
"3410","Immigration, inmate bills recommended by Trump working group","http://www.heraldnews.com/news/20170414/immigration-inmate-bills-recommended-by-trump-working-group","2017-04-14 09:41:15","Fall River Herald News","James Arciero noted would sharply pare back dollars that flow through the National Institutes of Health to Bay State hospitals and research facilities.","BAYN","Bayer"
"3510","Proven under Pressure: USGS Advances Capabilities for High-Pressure Seafloor ...","https://www.usgs.gov/news/proven-under-pressure-usgs-advances-capabilities-high-pressure-seafloor-samples-containing-gas","2017-04-14 16:21:54","United States Geological Survey (press release)","In 2015, a drilling expedition staffed by scientists from India, Japan, and the United States discovered widespread, high-saturation accumulations of natural gas hydrate in the sediments of the Bay of Bengal during the second Indian National Gas ...","BAYN","Bayer"
"3610","Computer pioneer Robert W. Taylor dies at 85","http://www.eastbaytimes.com/2017/04/15/computer-pioneer-robert-w-taylor-dies-at-85/","2017-04-15 19:15:00","East Bay Times","A few years later, Taylor went on to work at the Xerox Corp.'s famous ... In 2004, he and other PARC researchers were awarded the Draper Prize from the National Academy of Engineering for development of “the first practical networked personal computers.”.","BAYN","Bayer"
"3710","North Korean missile test fails, US and South Korea say","http://www.wearegreenbay.com/news/world-news/south-korea-north-korea-missile-test-fails/692559581","2017-04-15 19:28:50","WeAreGreenBay.com","South Korean officials convened a meeting of the National Security Council in the wake of the failed test. ""Our government condemns this serious threat on the Korean peninsula and overall international society,"" the South Korean foreign ministry said ...","BAYN","Bayer"
"3810","Meet Evan Siddall, the CEO who remade the CMHC","http://www.canadianbusiness.com/economy/evan-siddall-cmhc-profile/","2017-04-17 05:56:15","CanadianBusiness.com","Siddall took the reins at the Canada Mortgage and Housing Corp. in 2013 and quickly changed its culture. But with home prices soaring, was it enough?","BAYN","Bayer"
"3910","Passenger rail service on track for 2018 - Henry","http://www.loopjamaica.com/content/passenger-rail-service-track-2018-henry","2017-04-17 10:03:45","Loop Jamaica","Once approved by the Government of Jamaica, Henry said Herzog plans to rehabilitate and revitalise the railway in a three-phase programme, starting from Montego Bay to Appleton (Phase 1); Spanish Town to Ewarton and Spanish Town to Clarendon as ... ""In ...","BAYN","Bayer"
"4010","Dollar Bulls To Remain at Bay","http://www.marketpulse.com/20170417/dollar-bulls-remain-bay/","2017-04-17 23:56:15","MarketPulse (blog)","Stephen has an extensive trading experience in Interest Rate Futures, Money Markets and Precious Metals. Prior to joining OANDA, he worked with organizations like Cambridge Mercantile, Nat West, Garvin Guy Butler, Sumitomo Mitsui Banking Corporation.","BAYN","Bayer"
"4110","Alaska LNG line submitted to FERC for permit","http://www.ktuu.com/content/news/Alaska-LNG-line-submitted-to-FERC-for-permit-419666063.html","2017-04-18 00:30:00","KTUU.com","ANCHORAGE (KTUU) The Alaska Gasline Development Corp. filed its application for a permit from the Federal Energy Regulatory Commission today, in the first formal step toward getting the Alaska LNG project permitted.","BAYN","Bayer"
"4210","Bay may get water relief from the sea","http://www.heraldlive.co.za/news/2017/04/18/bay-may-get-water-relief-sea/","2017-04-18 04:35:55","Herald live","“The Adopt-a-Municipality programme is driven by the national Department of Cooperative Governance and SABMiller's agreement, through which the company has played various significant roles in the socioeconomic upliftment in the metro, is about to be ...","BAYN","Bayer"
"4310","Foran Engages Micon to Conduct a Technical Review of McIlvenna Bay","http://www.marketwired.com/press-release/foran-engages-micon-to-conduct-a-technical-review-of-mcilvenna-bay-tsx-venture-fom-2210149.htm","2017-04-18 08:00:00","Marketwired (press release)","(Marketwired - April 18, 2017) - Foran Mining Corporation (TSX VENTURE: FOM) (""Foran"" or the ""Company"") is pleased to announce that it has engaged Micon International Limited (""Micon""), an international independent mining consultancy ...","BAYN","Bayer"
"4410","AmeriCorps takes on Miami","http://www.miamiok.com/news/20170418/americorps-takes-on-miami","2017-04-18 15:07:30","Miami News Record","According to the Corporation for National Community Service, NCCC is a full-time, team-based residential service program for individuals ages 18-24 from across the country and all backgrounds.","BAYN","Bayer"
"4510","Larry McCarren to serve as emcee for Hall&#39;s induction of Driver, Lee","http://www.packers.com/news-and-events/article-press-release/article-1/Larry-McCarren-to-serve-as-emcee-for-Halls-induction-of-Driver-Lee/2708d7d7-2057-4cd3-9e0a-a0f9c82ff9b5","2017-04-18 16:48:45","Packers.com","The Green Bay Packers Hall of Fame, Inc. is a nonprofit corporation independent of the Green Bay Packers that guides the Hall as a historic national sports venue and educational resource to the Green Bay community and the state of Wisconsin. The Hall ...","BAYN","Bayer"
"4610","Countdown is on for tow of massive Hebron oil platform to field off Newfoundland","http://www.nationalobserver.com/2017/04/18/news/countdown-tow-massive-hebron-oil-platform-field-newfoundland","2017-04-18 16:48:45","National Observer","He called that an ""amazing"" achievement on a project that will reap dividends over the next two decades. Hebron project partners led by ExxonMobil Canada include Chevron Canada, Suncor Energy, Statoil Canada and provincial Crown corporation Nalcor ...","BAYN","Bayer"
"4710","Gravesend Bay: 7000 Gallons Of Spilled Oil Recovered. But What About The Other ...","http://bklyner.com/gravesend-bay-7000-gallons-spilled-oil-recovered-20000/","2017-04-19 13:16:02","BKLYNER","As of this week, 7,000 gallons of diesel oil - of the 27,000 spilled by a private fuel depot - have been recovered from the Gravesend Bay using concentric booms, the State DEC told BKLYNER. However, about 20,000 gallons ... But there's a ton of life ...","BAYN","Bayer"
"4810","DeSaulnier&#39;s town hall drumbeat: civic engagement","http://www.eastbaytimes.com/2017/04/19/wcj-townhall-0421/","2017-04-19 19:01:16","East Bay Times","“Zeroing-out” or partial cuts to the EPA, Corporation for Public Broadcasting, National Endowment for the Arts, State Department, Chemical Safety Board, education, and a Labor Department that he said is “basically being eviscerated” were only the tip ...","BAYN","Bayer"
"4910","Trust collected cash for Mayor","http://www.townsvillebulletin.com.au/news/national/ccc-probe-into-council-elections-told-trust-provided-fundraising-for-moreton-bay-mayor/news-story/8e73f2195f75a35aa8919ec7f709e4b2","2017-04-20 08:00:00","Townsville Bulletin","Day three of a Crime and Corruption Commission's hearing into last year's local council elections was told David Trask hand-delivered three cheques - each for $20,000 - made out to Moreton Futures Trust, which provided fundraising for Moreton Bay Mayor ...","BAYN","Bayer"
"5010","Trump&#39;s &#39;Extreme&#39; Budget Is Just Paul Ryan&#39;s Old Bad Plan With a Comb-Over","https://www.thenation.com/article/trumps-extreme-budget-is-just-paul-ryans-old-bad-plan-with-a-combover/","2017-04-20 09:30:00","The Nation.","Before President Trump's budget proposal became public, rumors were flying that he would eliminate funding for the Corporation for Public Broadcasting, the National Endowment for the Arts, the Legal Services Corporation, and even the Manufacturing ...","BAYN","Bayer"
"5110","Power Americas Announces New Director and Corporate Appointments","http://www.stockhouse.com/news/press-releases/2017/04/20/power-americas-announces-new-director-and-corporate-appointments","2017-04-20 10:26:15","Stockhouse","April 20, 2017) - Power Americas Minerals Corp. (TSXV: PAM) (""Power ... Mr. Pettigrew, M.Sc., P.Geo is a founder, part owner and Vice President of Fladgate Exploration Consulting Corporation of Thunder Bay, ON, a full service mineral exploration ...","BAYN","Bayer"
"5210","RI debt totals $10.5 billion, new study finds","http://wpri.com/2017/04/20/ri-debt-totals-10-5-billion-new-study-finds/","2017-04-20 11:43:00","WPRI 12 Eyewitness News","At the state level, Magaziner said the study shows Rhode Island is “slightly higher than the national median, but we are in much better shape than some of our closest neighbors including Massachusetts and Connecticut.","BAYN","Bayer"
"5310","GM shutters operations in Venezuela after government seizes factory","http://www.tampabay.com/news/world/gm-shutters-operations-in-venezuela-after-government-seizes-factory/2321049","2017-04-20 13:20:14","Tampabay.com","Last July, the government said it would take over a factory belonging to Kimberly-Clark Corp. after the American personal care giant said it was no longer possible to manufacture because materials weren't available in Venezuela.","BAYN","Bayer"
"5410","How New York City Is Rediscovering Its Maritime Spirit","http://www.smithsonianmag.com/travel/new-york-rediscovering-maritime-spirit-180962769/","2017-04-20 13:47:48","Smithsonian","Now, as I made my way from the subway to Jamaica Bay, part of a unique urban national park bordered by the Rockaway Peninsula and complete with its own campground, the centuries peeled away.","BAYN","Bayer"
"5510","Boswell heads to Agriculture Department","http://www.politico.com/tipsheets/politico-influence/2017/04/boswell-heads-to-agriculture-department-219888","2017-04-20 14:22:30","Politico","His lobbying clients from his previous stint at Prime Policy Group included the National School Transportation Association, the United Motorcoach Association, Google, IBM and the National Restaurant Association. LEWANDOWSKI'S FIRM LOSES FIRST ...","BAYN","Bayer"
"5610","India awaits to invest in Trinco Oil Tank farm","http://www.dailymirror.lk/article/India-awaits-to-invest-in-Trinco-Oil-Tank-farm-127498.html","2017-04-20 14:22:30","Daily Mirror","The Hambantota Port, to be developed in partnership with a Chinese company, entails a great deal of engagement in Sino-Lanka relations.","BAYN","Bayer"
"5710","The History Behind the First 100 Days of an American President","http://www.thefiscaltimes.com/2017/04/20/History-Behind-First-100-Days-American-President","2017-04-20 16:53:34","The Fiscal Times","The Smithsonian museums and National Park Service sites were closed, including the Statue of Liberty, Independence Hall in Philadelphia and the Washington monuments and memorials.","BAYN","Bayer"
"5810","From NFL Owners to Florida Retirees, a Who&#39;s Who of Inaugural Donors","https://www.nytimes.com/2017/04/20/us/politics/trump-inauguration-donors.html","2017-04-20 17:59:56","New York Times","Jerry Jones, owner of the Dallas Cowboys, is listed as the president of a corporation that controls a group that contributed $1 million to the Trump inaugural committee.","BAYN","Bayer"
"5910","Roadway wrangle","http://www.townsvillebulletin.com.au/news/island-leader-says-cost-for-radical-bay-rd-upgrade-should-be-shared/news-story/7415c893bac66ff4549a0aa27a60c370","2017-04-20 19:26:15","Townsville Bulletin","Mr Turnbull said there was a case for the developer and Government to share the cost because the road serviced the national park, the popular fort walk and Arthur, Florence and Radical bays. “Those beaches down there are close to perfection,” Mr ...","BAYN","Bayer"
"6010","Seven public bodies to be put on arrears leash ... Gov&#39;t targets cuts in ...","http://jamaica-gleaner.com/article/news/20170421/seven-public-bodies-be-put-arrears-leash-govt-targets-cuts-number-under-imf","2017-04-21 01:06:35","Jamaica Gleaner","... Kingston Waterfront Hotel Company Limited, Montego Bay Shopping Centre Limited and the Portmore Commercial Development Company, according to the Government's Memorandum of Economic and Financial Policies which was released by the IMF on ... Those ...","BAYN","Bayer"
"6110","Kings Bay Receives Preliminary Geophysical Maps From VTEM Plus Survey over ...","http://www.stockhouse.com/news/press-releases/2017/04/21/kings-bay-receives-preliminary-geophysical-maps-from-vtem-plus-survey-over-lynx","2017-04-21 03:41:15","Stockhouse","Vancouver, British Columbia (FSCwire) - King's Bay Gold Corporation (TSX.V: KBG), (FSE: KGB1), operating as “King's Bay”, a mining exploration and development company based in Vancouver Canada is pleased to announce that through preliminary assessment ...","BAYN","Bayer"
"6210","GreenLight Fund Hires Detroit Leader; New Grammy Museum Group Names Head","https://www.philanthropy.com/article/GreenLight-Fund-Hires-Detroit/239850","2017-04-21 08:33:09","Chronicle of Philanthropy (subscription)","GreenLight, which was already active in Boston, Philadelphia, the San Francisco Bay Area, and Cincinnati, announced plans last year to expand to a fifth location.","BAYN","Bayer"
"6310","Guantánamo&#39;s feral cats get no defense from U.S. Navy","http://www.mcclatchydc.com/news/nation-world/national/article145954069.html","2017-04-21 11:33:45","McClatchy Washington Bureau","Cats probably arrived on the first sailing ship from the Old World, according to Erika Kelly, who spotted the problem on a visit to the base and has now set up Operation Git-Meow as a corporation seeking IRS 501(c)(3) tax-exempt status. Others might ...","BAYN","Bayer"
"6410","City National Corp (CYN) Earns Media Impact Rating of 0.35","https://transcriptdaily.com/2017/04/21/city-national-corp-cyn-earns-media-impact-rating-of-0-35.html","2017-04-21 11:56:15","Transcript Daily","City National Corp logo Media stories about City National Corp (NYSE:CYN) have been trending positive recently, according to Alpha One Sentiment Analysis.","BAYN","Bayer"
"6510","Bank First reports quarterly earnings per share of $0.64, declares a per share ...","http://finance.yahoo.com/news/bank-first-reports-quarterly-earnings-165000898.html","2017-04-21 12:57:58","Yahoo Finance"," Bank First National Corporation (BFNC) reported net income for the first quarter of 2017 of $3.99 million, or $0.64 per share, as compared to $3.85 million, or $0.61 per share, for the first quarter of ...","BAYN","Bayer"
"6610","Terreno Realty Co. (TRNO) Downgraded to &quot;Sell&quot; at Zacks Investment Research","https://www.thecerbatgem.com/2017/04/21/terreno-realty-co-trno-downgraded-to-sell-at-zacks-investment-research.html","2017-04-21 13:15:00","The Cerbat Gem","The Company's main focus is on markets in Los Angeles Area; Northern New Jersey/New York City; San Francisco Bay Area; Seattle Area; Miami Area; and Washington, D.C.","BAYN","Bayer"
"6710","First-quarter lobbying numbers shows firms still gearing up for Trump era","http://www.politico.com/tipsheets/politico-influence/2017/04/first-quarter-lobbying-numbers-shows-firms-still-gearing-up-for-trump-era-219913","2017-04-21 16:31:47","Politico","POLITICO Event - Rebuilding America: A New Infrastructure Agenda - Join POLITICO for a discussion on the prospects for a major national infrastructure push from the new administration and Congress. ... “Target Corp., Best Buy Co. Inc. and Gap Inc ...","BAYN","Bayer"
"6810","GDP On Tap Next Week","http://www.baystreet.ca/articles/the_week_ahead.aspx?id=184","2017-04-21 16:37:30","Baystreet.ca","Canadian National Railway Company (T.CNR) (Q1) EPS estimates of $1.13, compared to $1.00 in the prior-year quarter. Barrick Gold Corporation (T.ABX) (Q1) EPS estimates of 20 cents, compared to 11 cents in the prior-year quarter. In mid-April, ATAC ...","BAYN","Bayer"
"6910","Company that makes Ziploc bags expanding Michigan plant","http://www.charlotteobserver.com/news/business/national-business/article146103364.html","2017-04-21 19:48:45","Charlotte Observer","A company that produces Ziploc storage bags is expanding a plant in Bay City, Michigan. SC Johnson says the plant ... is based in Racine, Wisconsin.","BAYN","Bayer"
"7010","Thumbs up, thumbs down","http://www.houstonchronicle.com/opinion/editorials/article/Thumbs-up-thumbs-down-11090695.php","2017-04-21 20:11:15","Houston Chronicle","Protestors from the National Organization for Women of New York hold a protest in front of the News Corporation Headquarters in New York Thursday, the morning after Fox News officially cut ties with Bill O' Reilly over sexual harassment allegations ...","BAYN","Bayer"
"1109","Johnson &amp; Johnson announces dividend increase of 7.1 pct","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3198222","2015-04-23 10:59:00","Reuters Key Development","Johnson & Johnson announces dividend increase of 7.1 pct","JNJ","Johnson & Johnson"
"2101","Johnson &amp; Johnson announces acceptance of binding offer from cardinal health to acquire cordis","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3220651","2015-05-28 08:00:00","Reuters Key Development","Johnson & Johnson announces acceptance of binding offer from cardinal health to acquire cordis","JNJ","Johnson & Johnson"
"3101","Carna Biosciences announces collaboration with Johnson &amp; Johnson innovation","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3228041","2015-06-11 08:00:00","Reuters Key Development","Carna Biosciences announces collaboration with Johnson & Johnson innovation","JNJ","Johnson & Johnson"
"4101","Johnson &amp; Johnson increases FY 2015 EPS guidance","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3244262","2015-07-14 07:45:00","Reuters Key Development","Johnson & Johnson increases FY 2015 EPS guidance","JNJ","Johnson & Johnson"
"5101","Johnson &amp; Johnson announces quarterly dividend for third quarter 2015","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3247524","2015-07-20 11:40:00","Reuters Key Development","Johnson & Johnson announces quarterly dividend for third quarter 2015","JNJ","Johnson & Johnson"
"6101","Johnson &amp; Johnson gets partial win against Covidien in surgical patent case - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3258641","2015-08-06 20:00:00","Reuters Key Development","Johnson & Johnson gets partial win against Covidien in surgical patent case - Reuters","JNJ","Johnson & Johnson"
"7101","Johnson &amp; Johnson starts Clinical Trial of Ebola Vaccine Regimen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3282835","2015-10-09 02:00:00","Reuters Key Development","Johnson & Johnson starts Clinical Trial of Ebola Vaccine Regimen","JNJ","Johnson & Johnson"
"8101","Johnson &amp; Johnson - Surgical funder ordered to turn over information on hip surgeries - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3285451","2015-10-13 20:00:00","Reuters Key Development","Johnson & Johnson - Surgical funder ordered to turn over information on hip surgeries - Reuters","JNJ","Johnson & Johnson"
"9101","Johnson &amp; Johnson defeats first lawsuit on Tylenol&#39;s link to liver damage - Bloomberg - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3286676","2015-10-15 20:00:00","Reuters Key Development","Johnson & Johnson defeats first lawsuit on Tylenol's link to liver damage - Bloomberg - Reuters","JNJ","Johnson & Johnson"
"10101","Johnson &amp; Johnson announces quarterly dividend for fourth quarter","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3288829","2015-10-22 13:26:00","Reuters Key Development","Johnson & Johnson announces quarterly dividend for fourth quarter","JNJ","Johnson & Johnson"
"1111","Johnson &amp; Johnson announces agreement to acquire Novira Therapeutics Inc","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3295869","2015-11-04 12:01:00","Reuters Key Development","Johnson & Johnson announces agreement to acquire Novira Therapeutics Inc","JNJ","Johnson & Johnson"
"1211","Johnson &amp; Johnson - Court revives Oregon suit over &#39;phantom recall&#39; of Motrin - AP","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3306837","2015-11-25 18:32:00","Reuters Key Development","Johnson & Johnson - Court revives Oregon suit over 'phantom recall' of Motrin - AP","JNJ","Johnson & Johnson"
"1311","Johnson &amp; Johnson announces completion of Novira Therapeutics, Inc. acquisition","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3307492","2015-12-04 16:30:00","Reuters Key Development","Johnson & Johnson announces completion of Novira Therapeutics, Inc. acquisition","JNJ","Johnson & Johnson"
"1411","Johnson &amp; Johnson announces formation of verb surgical inc., in collaboration with verily","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3309520","2015-12-10 09:00:00","Reuters Key Development","Johnson & Johnson announces formation of verb surgical inc., in collaboration with verily","JNJ","Johnson & Johnson"
"1511","Johnson &amp; Johnson - Kentucky reaches $39.5 mln settlement with Purdue, Johnson &amp; Johnson - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3315120","2015-12-23 17:41:00","Reuters Key Development","Johnson & Johnson - Kentucky reaches $39.5 mln settlement with Purdue, Johnson & Johnson - Reuters","JNJ","Johnson & Johnson"
"1611","Johnson &amp; Johnson announces quarterly dividend for first quarter 2016","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3317247","2016-01-04 06:45:00","Reuters Key Development","Johnson & Johnson announces quarterly dividend for first quarter 2016","JNJ","Johnson & Johnson"
"1711","Johnson &amp; Johnson gives FY 2016 guidance","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3323919","2016-01-26 06:41:00","Reuters Key Development","Johnson & Johnson gives FY 2016 guidance","JNJ","Johnson & Johnson"
"1811","Johnson &amp; Johnson must pay $72 million for cancer death linked to talcum powder: lawyers - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3334478","2016-02-23 06:47:00","Reuters Key Development","Johnson & Johnson must pay $72 million for cancer death linked to talcum powder: lawyers - Reuters","JNJ","Johnson & Johnson"
"1911","Johnson &amp; Johnson - UK cost agency rejects leukaemia drug from J&amp;J and AbbVie - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3338183","2016-03-01 14:01:00","Reuters Key Development","Johnson & Johnson - UK cost agency rejects leukaemia drug from J&J and AbbVie - Reuters","JNJ","Johnson & Johnson"
"2011","Johnson &amp; Johnson hit with $500 mln verdict in hip implant trial - Reuters News","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3344731","2016-03-17 16:18:00","Reuters Key Development","Johnson & Johnson hit with $500 mln verdict in hip implant trial - Reuters News","JNJ","Johnson & Johnson"
"2111","Johnson &amp; Johnson updates FY 2016 sales guidance; increases EPS guidance","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3358527","2016-04-19 06:40:00","Reuters Key Development","Johnson & Johnson updates FY 2016 sales guidance; increases EPS guidance","JNJ","Johnson & Johnson"
"2211","Johnson &amp; Johnson announces dividend","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3364796","2016-04-28 10:30:00","Reuters Key Development","Johnson & Johnson announces dividend","JNJ","Johnson & Johnson"
"2311","J&amp;J says Janssen received civil investigative demand from U.S. Attorney’s office on contractual relationships with pharmacy benefit managers","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3370184","2016-05-10 06:02:47","Reuters Key Development","J&J says Janssen received civil investigative demand from U.S. Attorney’s office on contractual relationships with pharmacy benefit managers","JNJ","Johnson & Johnson"
"2411","Johnson &amp; Johnson says Janssen unit received civil investigative demand from U.S. Attorney’s office for Southern district of New York","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3370195","2016-05-10 06:40:37","Reuters Key Development","Johnson & Johnson says Janssen unit received civil investigative demand from U.S. Attorney’s office for Southern district of New York","JNJ","Johnson & Johnson"
"2511","Manitex Capital declares a dividend-in-kind","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3370881","2016-05-10 16:51:00","Reuters Key Development","Manitex Capital declares a dividend-in-kind","JNJ","Johnson & Johnson"
"2611","Johnson &amp; Johnson says collaborating with HP Inc&#39;s unit","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3376875","2016-05-17 08:52:23","Reuters Key Development","Johnson & Johnson says collaborating with HP Inc's unit","JNJ","Johnson & Johnson"
"2711","European Commission approves Johnson &amp; Johnson&#39;s TREVICTA","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3384404","2016-05-31 07:00:00","Reuters Key Development","European Commission approves Johnson & Johnson's TREVICTA","JNJ","Johnson & Johnson"
"2811","Janssen Pharmaceutica NV says Idylla ebola virus test granted emergency use authorization by U.S. FDA","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3385111","2016-06-01 01:00:00","Reuters Key Development","Janssen Pharmaceutica NV says Idylla ebola virus test granted emergency use authorization by U.S. FDA","JNJ","Johnson & Johnson"
"2911","Johnson &amp; Johnson to acquire Vogue International for about $3.3 bln","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3385893","2016-06-02 06:45:00","Reuters Key Development","Johnson & Johnson to acquire Vogue International for about $3.3 bln","JNJ","Johnson & Johnson"
"3011","Amyris announces collaboration with Johnson &amp; Johnson Innovation","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3387209","2016-06-06 08:30:00","Reuters Key Development","Amyris announces collaboration with Johnson & Johnson Innovation","JNJ","Johnson & Johnson"
"3111","Janssen announces data from Phase 3 MMY3003 (POLLUX) trial","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3389676","2016-06-10 07:00:00","Reuters Key Development","Janssen announces data from Phase 3 MMY3003 (POLLUX) trial","JNJ","Johnson & Johnson"
"3211","UK&#39;s CMA says Reckitt Benckiser licensed K-Y brand to Thornton &amp; Ross","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3393462","2016-06-20 09:10:32","Reuters Key Development","UK's CMA says Reckitt Benckiser licensed K-Y brand to Thornton & Ross","JNJ","Johnson & Johnson"
"3311","Gilead says European Commission grants marketing authorization for Odefsey®","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3395262","2016-06-23 07:53:00","Reuters Key Development","Gilead says European Commission grants marketing authorization for Odefsey®","JNJ","Johnson & Johnson"
"3411","Abbvie announces fourth breakthrough therapy designation granted by FDA","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3397728","2016-06-29 07:30:00","Reuters Key Development","Abbvie announces fourth breakthrough therapy designation granted by FDA","JNJ","Johnson & Johnson"
"3511","Fitch affirms Johnson &amp; Johnson&#39;s IDR at &#39;AAA&#39;; outlook stable","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3398741","2016-06-30 10:03:51","Reuters Key Development","Fitch affirms Johnson & Johnson's IDR at 'AAA'; outlook stable","JNJ","Johnson & Johnson"
"3611","Adjuvant Cosme Japan forms business and capital alliance with JNJ&#39;s units","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3402812","2016-07-11 02:53:47","Reuters Key Development","Adjuvant Cosme Japan forms business and capital alliance with JNJ's units","JNJ","Johnson & Johnson"
"3711","Johnson &amp; Johnson to buy 20 pct stake in CI:Z Holdings Co - Nikkei","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3403242","2016-07-11 14:02:38","Reuters Key Development","Johnson & Johnson to buy 20 pct stake in CI:Z Holdings Co - Nikkei","JNJ","Johnson & Johnson"
"3811","Johnson &amp; Johnson sets quarterly cash dividend of $0.80 per share","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3407131","2016-07-18 14:30:00","Reuters Key Development","Johnson & Johnson sets quarterly cash dividend of $0.80 per share","JNJ","Johnson & Johnson"
"3911","Ionis Pharmaceuticals licenses oral antisense drug to Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3407678","2016-07-19 07:00:00","Reuters Key Development","Ionis Pharmaceuticals licenses oral antisense drug to Janssen","JNJ","Johnson & Johnson"
"4011","Johnson &amp; Johnson posts Q2 earnings of $1.43/share","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3407648","2016-07-19 07:00:00","Reuters Key Development","Johnson & Johnson posts Q2 earnings of $1.43/share","JNJ","Johnson & Johnson"
"4111","Health Canada approves INVOKAMET for treatment of adults with type 2 diabetes","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3408324","2016-07-20 07:00:00","Reuters Key Development","Health Canada approves INVOKAMET for treatment of adults with type 2 diabetes","JNJ","Johnson & Johnson"
"4211","Janssen says Health Canada approves Imbruvica for treatment of chronic lymphocytic leukemia","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3408351","2016-07-20 08:00:00","Reuters Key Development","Janssen says Health Canada approves Imbruvica for treatment of chronic lymphocytic leukemia","JNJ","Johnson & Johnson"
"4311","Bristol-Myers Squibb collaborates with Johnson and Johnson for lung cancer research","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3411570","2016-07-26 06:59:00","Reuters Key Development","Bristol-Myers Squibb collaborates with Johnson and Johnson for lung cancer research","JNJ","Johnson & Johnson"
"4411","Johnson &amp; Johnson announces ruling related to Remicade","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3428215","2016-08-17 13:54:00","Reuters Key Development","Johnson & Johnson announces ruling related to Remicade","JNJ","Johnson & Johnson"
"4511","Janssen submits application to U.S. FDA to expand indication for daratumumab","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3428228","2016-08-17 15:25:00","Reuters Key Development","Janssen submits application to U.S. FDA to expand indication for daratumumab","JNJ","Johnson & Johnson"
"4611","Genmab to receive $15 mln in milestone payments from Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3428238","2016-08-17 15:40:32","Reuters Key Development","Genmab to receive $15 mln in milestone payments from Janssen","JNJ","Johnson & Johnson"
"4711","Johnson &amp; Johnson reports 15 pct passive stake in Protagonist Therapeutics - SEC filing","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3429614","2016-08-19 10:31:23","Reuters Key Development","Johnson & Johnson reports 15 pct passive stake in Protagonist Therapeutics - SEC filing","JNJ","Johnson & Johnson"
"4811","J&amp;J wins dismissal of New Jersey lawsuits over talc claims - Bloomberg","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3436903","2016-09-02 16:04:47","Reuters Key Development","J&J wins dismissal of New Jersey lawsuits over talc claims - Bloomberg","JNJ","Johnson & Johnson"
"4911","Janssen receives CHMP positive opinion for Stelara (Ustekinumab)","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3441983","2016-09-16 09:45:00","Reuters Key Development","Janssen receives CHMP positive opinion for Stelara (Ustekinumab)","JNJ","Johnson & Johnson"
"5011","Abbott to sell Abbott Medical Optics to Johnson &amp; Johnson for $4.325 bln","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3442037","2016-09-16 15:00:00","Reuters Key Development","Abbott to sell Abbott Medical Optics to Johnson & Johnson for $4.325 bln","JNJ","Johnson & Johnson"
"5111","Johnson &amp; Johnson to buy Abbott Medical Optics for $4.325 bln","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3442035","2016-09-16 15:00:00","Reuters Key Development","Johnson & Johnson to buy Abbott Medical Optics for $4.325 bln","JNJ","Johnson & Johnson"
"5211","Argentum Pharmaceuticals succeeds in starting patent cancellation trial against Janssen&#39;s Zytiga","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3442492","2016-09-19 11:00:00","Reuters Key Development","Argentum Pharmaceuticals succeeds in starting patent cancellation trial against Janssen's Zytiga","JNJ","Johnson & Johnson"
"5311","Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3444644","2016-09-23 08:00:00","Reuters Key Development","Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis","JNJ","Johnson & Johnson"
"5411","Tracon Pharmaceuticals announces a strategic licensing collaboration for two Janssen Oncology assets and a $5 mln equity investment from Johnson &amp; Johnson Innovation – JJDC Inc","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3446434","2016-09-28 08:00:00","Reuters Key Development","Tracon Pharmaceuticals announces a strategic licensing collaboration for two Janssen Oncology assets and a $5 mln equity investment from Johnson & Johnson Innovation – JJDC Inc","JNJ","Johnson & Johnson"
"5511","U.S. FDA warns about the risk of Hepatitis B","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3449271","2016-10-04 17:31:00","Reuters Key Development","U.S. FDA warns about the risk of Hepatitis B","JNJ","Johnson & Johnson"
"5611","U.S. Department of Homeland Security warns on vulnerabilities in J&amp;J insulin pumps","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3449677","2016-10-05 12:39:54","Reuters Key Development","U.S. Department of Homeland Security warns on vulnerabilities in J&J insulin pumps","JNJ","Johnson & Johnson"
"5711","Astrazeneca divests rights to Rhinocort Aqua outside US","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3450406","2016-10-07 02:00:08","Reuters Key Development","Astrazeneca divests rights to Rhinocort Aqua outside US","JNJ","Johnson & Johnson"
"5811","Genmab says U.S. FDA grants priority review for daratumumab in relapsed multiple myeloma","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3450803","2016-10-07 18:07:30","Reuters Key Development","Genmab says U.S. FDA grants priority review for daratumumab in relapsed multiple myeloma","JNJ","Johnson & Johnson"
"5911","Johnson &amp; Johnson reports Q3 EPS $1.53","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3455810","2016-10-18 06:59:07","Reuters Key Development","Johnson & Johnson reports Q3 EPS $1.53","JNJ","Johnson & Johnson"
"6011","J&amp;J sets quarterly cash dividend of $0.80 per share","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3457739","2016-10-20 16:10:00","Reuters Key Development","J&J sets quarterly cash dividend of $0.80 per share","JNJ","Johnson & Johnson"
"6111","Janssen Therapeutics receives funding from a special RFA","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3460447","2016-10-25 08:00:00","Reuters Key Development","Janssen Therapeutics receives funding from a special RFA","JNJ","Johnson & Johnson"
"6211","BRIEF-Janssen Therapeutics announces recipients of funding from special RFA (Oct 25)","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3461681","2016-10-26 11:43:56","Reuters Key Development","BRIEF-Janssen Therapeutics announces recipients of funding from special RFA (Oct 25)","JNJ","Johnson & Johnson"
"6311","Johnson &amp; Johnson reports 6.4 pct passive stake in Tracon Pharmaceuticals","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3466168","2016-10-31 15:25:17","Reuters Key Development","Johnson & Johnson reports 6.4 pct passive stake in Tracon Pharmaceuticals","JNJ","Johnson & Johnson"
"6411","British artificial intelligence firm announces license agreement with Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3472185","2016-11-08 06:03:00","Reuters Key Development","British artificial intelligence firm announces license agreement with Janssen","JNJ","Johnson & Johnson"
"6511","Genmab says combination of drugs from J&amp;J, Amgen will be tested in study","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3475062","2016-11-10 08:27:42","Reuters Key Development","Genmab says combination of drugs from J&J, Amgen will be tested in study","JNJ","Johnson & Johnson"
"6611","Janssen reports clinical trial collaboration and supply agreement with Amgen to evaluate Daratumumab in combination with Carfilzomib","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3475067","2016-11-10 08:34:00","Reuters Key Development","Janssen reports clinical trial collaboration and supply agreement with Amgen to evaluate Daratumumab in combination with Carfilzomib","JNJ","Johnson & Johnson"
"6711","Janssen Pharma says new late-stage results from pioneer AF-PCI study meets main goal","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3477816","2016-11-14 11:45:00","Reuters Key Development","Janssen Pharma says new late-stage results from pioneer AF-PCI study meets main goal","JNJ","Johnson & Johnson"
"6811","Paulson &amp; Co cuts share stake in Alexion Pharmaceuticals, Johnson &amp; Johnson","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3478214","2016-11-14 17:38:35","Reuters Key Development","Paulson & Co cuts share stake in Alexion Pharmaceuticals, Johnson & Johnson","JNJ","Johnson & Johnson"
"6911","Janssen&#39;s Guselkumab shows promise in psoriatic arthritis treatment in Phase 2 trial","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3479127","2016-11-15 08:00:00","Reuters Key Development","Janssen's Guselkumab shows promise in psoriatic arthritis treatment in Phase 2 trial","JNJ","Johnson & Johnson"
"7011","Janssen submits application to FDA seeking approval of anti-interleukin-23 monoclonal antibody guselkumab","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3480805","2016-11-17 08:00:00","Reuters Key Development","Janssen submits application to FDA seeking approval of anti-interleukin-23 monoclonal antibody guselkumab","JNJ","Johnson & Johnson"
"7110","Genmab announces U.S. FDA approval of Darzalex (Daratumumab) for relapsed multiple myeloma","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3482264","2016-11-21 15:46:31","Reuters Key Development","Genmab announces U.S. FDA approval of Darzalex (Daratumumab) for relapsed multiple myeloma","JNJ","Johnson & Johnson"
"7210","J&amp;J said to make takeover approach for Swiss drugmaker Actelion - Bloomberg","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3484690","2016-11-24 13:55:31","Reuters Key Development","J&J said to make takeover approach for Swiss drugmaker Actelion - Bloomberg","JNJ","Johnson & Johnson"
"7310","Actelion has given J&amp;J access to some of its financial information as part of the deal negotiations - Bloomberg, citing sources","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3486775","2016-11-29 11:05:08","Reuters Key Development","Actelion has given J&J access to some of its financial information as part of the deal negotiations - Bloomberg, citing sources","JNJ","Johnson & Johnson"
"7410","Johnson &amp; Johnson says it has ended discussions with Actelion","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3494524","2016-12-13 18:38:00","Reuters Key Development","Johnson & Johnson says it has ended discussions with Actelion","JNJ","Johnson & Johnson"
"7510","Actelion says in discussions with another party regarding possible strategic transaction","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3494544","2016-12-13 20:11:07","Reuters Key Development","Actelion says in discussions with another party regarding possible strategic transaction","JNJ","Johnson & Johnson"
"7610","FDA clears wireless integration for WellDoc, Lifescan project","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3495084","2016-12-14 09:24:00","Reuters Key Development","FDA clears wireless integration for WellDoc, Lifescan project","JNJ","Johnson & Johnson"
"7710","Ionis Pharmaceuticals says earned $5 mln milestone payment from Janssen Biotech","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3499641","2016-12-22 07:00:00","Reuters Key Development","Ionis Pharmaceuticals says earned $5 mln milestone payment from Janssen Biotech","JNJ","Johnson & Johnson"
"7810","Mylan launches generic Concerta tablets","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3502192","2016-12-29 16:23:00","Reuters Key Development","Mylan launches generic Concerta tablets","JNJ","Johnson & Johnson"
"7910","Johnson &amp; Johnson announces quarterly dividend for Q1 2017","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3503289","2017-01-03 06:40:00","Reuters Key Development","Johnson & Johnson announces quarterly dividend for Q1 2017","JNJ","Johnson & Johnson"
"8010","J&amp;J&#39;s DePuy Synthes acquires technology from Interventional Spine Inc","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3503532","2017-01-03 13:09:29","Reuters Key Development","J&J's DePuy Synthes acquires technology from Interventional Spine Inc","JNJ","Johnson & Johnson"
"8110","Bird Rock Bio receives approval to start first in human clinical trial for Namacizumab, enters into agreement with GE Healthcare for process development and scale-up to provide clinical phase 2","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3507178","2017-01-11 08:00:00","Reuters Key Development","Bird Rock Bio receives approval to start first in human clinical trial for Namacizumab, enters into agreement with GE Healthcare for process development and scale-up to provide clinical phase 2","JNJ","Johnson & Johnson"
"8210","Orthocell announces collaboration with Johnson &amp; Johnson&lt;JNJ.N&gt;&lt;OCC.AX&gt;","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3507342","2017-01-11 17:58:34","Reuters Key Development","Orthocell announces collaboration with Johnson & Johnson<JNJ.N><OCC.AX>","JNJ","Johnson & Johnson"
"8310","Orthocell announces collaboration with Johnson &amp; Johnson","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3507344","2017-01-11 19:21:10","Reuters Key Development","Orthocell announces collaboration with Johnson & Johnson","JNJ","Johnson & Johnson"
"8410","Johnson &amp; Johnson reports 7.4 pct stake in Merus NV as of Dec 31, 2016","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3510520","2017-01-18 17:59:24","Reuters Key Development","Johnson & Johnson reports 7.4 pct stake in Merus NV as of Dec 31, 2016","JNJ","Johnson & Johnson"
"8510","Ethicon Endo-Surgery announces acquisition of Megadyne Medical Products","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3511818","2017-01-20 08:30:00","Reuters Key Development","Ethicon Endo-Surgery announces acquisition of Megadyne Medical Products","JNJ","Johnson & Johnson"
"8610","Johnson &amp; Johnson reports Q4 adj. earnings $1.58 per share","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3513588","2017-01-24 05:32:03","Reuters Key Development","Johnson & Johnson reports Q4 adj. earnings $1.58 per share","JNJ","Johnson & Johnson"
"8710","J&amp;J sees 2017 effective tax rate 19-20 percent","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3513757","2017-01-24 10:07:09","Reuters Key Development","J&J sees 2017 effective tax rate 19-20 percent","JNJ","Johnson & Johnson"
"8810","Pacira Pharmaceuticals collaborates with Depuy Synthes to support promotion, education and training of exparel in orthopedics","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3514858","2017-01-25 07:30:00","Reuters Key Development","Pacira Pharmaceuticals collaborates with Depuy Synthes to support promotion, education and training of exparel in orthopedics","JNJ","Johnson & Johnson"
"8910","Jupiter says J&amp;J purchase of Actelion &quot;very good outcome&quot;","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3515745","2017-01-26 06:00:00","Reuters Key Development","Jupiter says J&J purchase of Actelion ""very good outcome""","JNJ","Johnson & Johnson"
"9010","Actelion CEO hopes new R&amp;D business to collaborate with J&amp;J on products","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3515877","2017-01-26 08:04:27","Reuters Key Development","Actelion CEO hopes new R&D business to collaborate with J&J on products","JNJ","Johnson & Johnson"
"9110","J&amp;J has two-year agreement on stake in R&amp;D company","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3515936","2017-01-26 09:04:23","Reuters Key Development","J&J has two-year agreement on stake in R&D company","JNJ","Johnson & Johnson"
"9210","DePuy Synthes receives FDA clearance for cement-augmented pedicle screw systems","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3515976","2017-01-26 10:00:00","Reuters Key Development","DePuy Synthes receives FDA clearance for cement-augmented pedicle screw systems","JNJ","Johnson & Johnson"
"9310","Fitch affirms Johnson &amp; Johnson&#39;s IDR at &#39;AAA&#39;; outlook stable","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3516799","2017-01-27 15:42:33","Reuters Key Development","Fitch affirms Johnson & Johnson's IDR at 'AAA'; outlook stable","JNJ","Johnson & Johnson"
"9410","ChemDiv announces multi-year hit identification collaboration with Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3518013","2017-01-31 09:00:00","Reuters Key Development","ChemDiv announces multi-year hit identification collaboration with Janssen","JNJ","Johnson & Johnson"
"9510","BRIEF-J&amp;J says upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3519128","2017-02-01 16:05:00","Reuters Key Development","BRIEF-J&J says upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee","JNJ","Johnson & Johnson"
"9610","Renova Therapeutics enters into agreement to receive Stresscopin investigational new drug file from Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3521234","2017-02-06 11:00:00","Reuters Key Development","Renova Therapeutics enters into agreement to receive Stresscopin investigational new drug file from Janssen","JNJ","Johnson & Johnson"
"9710","Akebia to pay Janssen to access come intellectual property","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3526002","2017-02-13 07:00:00","Reuters Key Development","Akebia to pay Janssen to access come intellectual property","JNJ","Johnson & Johnson"
"9810","Akebia Therapeutics provides update on Janssen deal","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3526028","2017-02-13 07:24:04","Reuters Key Development","Akebia Therapeutics provides update on Janssen deal","JNJ","Johnson & Johnson"
"9910","Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson &amp; Johnson for $1.045 bln","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3528463","2017-02-15 07:00:00","Reuters Key Development","Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson & Johnson for $1.045 bln","JNJ","Johnson & Johnson"
"10010","Integra Lifesciences says Depuy Synthes entitled to get termination fee of $60 million if co fails to complete deal","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3528510","2017-02-15 08:03:00","Reuters Key Development","Integra Lifesciences says Depuy Synthes entitled to get termination fee of $60 million if co fails to complete deal","JNJ","Johnson & Johnson"
"10110","X-Chem expands collaboration with Janssen in inflammatory diseases","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3528514","2017-02-15 08:15:00","Reuters Key Development","X-Chem expands collaboration with Janssen in inflammatory diseases","JNJ","Johnson & Johnson"
"10210","Trianni signs licensing agreement with Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3528545","2017-02-15 09:00:00","Reuters Key Development","Trianni signs licensing agreement with Janssen","JNJ","Johnson & Johnson"
"10310","Swiss Takeover Commission OKs J&amp;J offer for Actelion","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3529235","2017-02-16 03:01:07","Reuters Key Development","Swiss Takeover Commission OKs J&J offer for Actelion","JNJ","Johnson & Johnson"
"10410","Ethicon announces agreement to acquire Torax Medical","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3530414","2017-02-17 10:00:00","Reuters Key Development","Ethicon announces agreement to acquire Torax Medical","JNJ","Johnson & Johnson"
"10510","Johnson &amp; Johnson says received a subpoena in Feb. from the U.S. attorney&#39;s office for the District of Massachusetts","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3536672","2017-02-27 16:59:23","Reuters Key Development","Johnson & Johnson says received a subpoena in Feb. from the U.S. attorney's office for the District of Massachusetts","JNJ","Johnson & Johnson"
"10610","Janssen provides Nuevolution with further technology access fee payment","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3541014","2017-03-06 02:30:00","Reuters Key Development","Janssen provides Nuevolution with further technology access fee payment","JNJ","Johnson & Johnson"
"10710","Actelion says granted marketing authorization by European Commission for Ledaga","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3541784","2017-03-07 01:00:14","Reuters Key Development","Actelion says granted marketing authorization by European Commission for Ledaga","JNJ","Johnson & Johnson"
"10810","Actelion says drug discovery business to be called Idorsia","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3547558","2017-03-15 02:40:09","Reuters Key Development","Actelion says drug discovery business to be called Idorsia","JNJ","Johnson & Johnson"
"10910","AT&amp;T and Johnson &amp; Johnson Pull Ads From YouTube","https://www.nytimes.com/2017/03/22/business/atampt-and-johnson-amp-johnson-pull-ads-from-youtube-amid-hate-speech-concerns.html","2017-03-22 21:29:14","New York Times","AT&T and Johnson & Johnson, among the biggest advertisers in the United States, were among several companies to say Wednesday that they would stop their ads from running on YouTube and other Google properties amid concern that Google is not doing ...","JNJ","Johnson & Johnson"
"11010","Verizon, AT&amp;T, Johnson &amp; Johnson Join YouTube Boycott","http://www.digitalmusicnews.com/2017/03/23/verizon-att-google-youtube-boycott/","2017-03-23 13:02:32","Digital Music News","“The Johnson & Johnson Family of Consumer Companies takes this matter very seriously, and we have made the decision to pause all YouTube digital advertising globally to ensure our product advertising does not appear on channels that promote offensive ...","JNJ","Johnson & Johnson"
"1112","Johnson &amp; Johnson&#39;s CEO Believes Trump Is Missing the Point on Drug-Price Reform","https://www.fool.com/investing/2017/03/24/johnson-johnsons-ceo-believes-trump-is-missing-the.aspx","2017-03-24 17:45:14","Motley Fool","However, an oft-overlooked key to success at Johnson & Johnson is the company's cohesive management team. Little change at the top (J&J has had just nine CEOs since it was founded 121 years ago) means the company's growth strategy and the vision of ...","JNJ","Johnson & Johnson"
"1121","Johnson &amp; Johnson and GM join companies suspending their YouTube ads over ...","http://www.latimes.com/business/la-fi-tn-youtube-ads-20170327-story.html","2017-03-27 14:29:41","Los Angeles Times","Healthcare product maker Johnson & Johnson and automaker General Motors Co. are among the latest companies to halt advertising on YouTube after concerns that Google is not doing enough to ensure brands' ads are not appearing near terrorist content.","JNJ","Johnson & Johnson"
"1131","Why Johnson &amp; Johnson Would Like to Forget 2016: QuickTake Q&amp;A","https://www.bloomberg.com/news/articles/2017-03-28/why-johnson-johnson-would-like-to-forget-2016-quicktake-q-a","2017-03-28 05:56:15","Bloomberg"," it lost six of 2016's seven largest jury verdicts in the U.S. over product defect claims.","JNJ","Johnson & Johnson"
"1141","Ligand announces licensing partner Janssen has filed an IND for an antibody discovered using the OmniAB Technology","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3556965","2017-03-28 09:00:00","Reuters Key Development","Ligand announces licensing partner Janssen has filed an IND for an antibody discovered using the OmniAB Technology","JNJ","Johnson & Johnson"
"1151","Actinium names long-time Johnson &amp; Johnson exec to board of directors","http://www.drugstorenews.com/article/actinium-names-long-time-johnson-johnson-exec-board-directors","2017-03-28 09:52:30","Drug Store News","NEW YORK - Actinium Pharmaceuticals appointed Dr. Ajit Shetty to its board of directors. Dr. Shetty is a pharmaceutical industry executive with 36 years of experience at Johnson & Johnson and its subsidiary Janssen. Most recently Dr. Shetty served as ...","JNJ","Johnson & Johnson"
"1161","Johnson &amp; Johnson just launched a $100000 burnout prevention bootcamp for CEOs","http://www.businessinsider.com/johnson-johnson-ceos-burnt-out-2017-3","2017-03-28 11:00:00","Business Insider","Now, 36 years later, Johnson & Johnson is finally tackling the problem in full with what it's calling Premier Executive Leadership - a collection of physical, mental, and emotional programs designed to make leaders happier, healthier, and, ideally ...","JNJ","Johnson & Johnson"
"1171","By How Much Will Johnson &amp; Johnson Raise Its Dividend?","https://seekingalpha.com/article/4058589-much-will-johnson-and-johnson-raise-dividend","2017-03-28 14:56:15","Seeking Alpha","Johnson & Johnson (NYSE:JNJ) is expected to raise its dividend in April. As most of its shareholders hold the stock for its reliable and growing dividend, it is only natural that they are looking forward to this raise.","JNJ","Johnson & Johnson"
"1181","Johnson &amp; Johnson: The Senate Probe And Other Risks","https://seekingalpha.com/article/4059098-johnson-and-johnson-senate-probe-risks","2017-03-30 10:03:45","Seeking Alpha","At the beginning of the year, analysts at Credit Suisse warned of a ""herd mentality"" among investors in Johnson & Johnson and other large caps widely-held by active managers. Credit Suisse's concern was these stocks could see outflows due to ...","JNJ","Johnson & Johnson"
"1191","Genmab A/S says Phase II study in NHL will not proceed","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3559427","2017-03-30 12:29:04","Reuters Key Development","Genmab A/S says Phase II study in NHL will not proceed","JNJ","Johnson & Johnson"
"1201","BRIEF-Johnson &amp; Johnson says Janssen Holding to acquire all publicly held ...","http://www.reuters.com/article/brief-johnson-johnson-says-janssen-holdi-idUSFWN1H800N","2017-03-31 01:03:45","Reuters","Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news ...","JNJ","Johnson & Johnson"
"1212","BRIEF-Genmab A/S says Phase II study in NHL will not proceed","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3559847","2017-03-31 02:02:20","Reuters Key Development","BRIEF-Genmab A/S says Phase II study in NHL will not proceed","JNJ","Johnson & Johnson"
"1221","3 Reasons Why Merck Is No Match for Dividend King Johnson &amp; Johnson","https://www.thestreet.com/story/14068018/1/3-reasons-why-merck-is-no-match-for-dividend-king-johnson-amp-johnson.html","2017-03-31 15:47:53","TheStreet.com","It is a Dividend Aristocrat, a group of companies in the S&P 500 that have raised dividends for 25-plus years. You can see the entire list of Dividend Aristocrats here.","JNJ","Johnson & Johnson"
"1231","Here&#39;s How Much Johnson &amp; Johnson Will Probably Raise Its Dividend Next Month","https://www.fool.com/investing/2017/03/31/heres-how-much-johnson-johnson-will-likely-raise-i.aspx","2017-03-31 17:45:00","Motley Fool","Among healthcare stocks, Johnson & Johnson (NYSE:JNJ) can arguably be described as the cream of the crop. It's one of just two publicly traded companies to still bear Standard & Poor's highest credit rating of AAA (Microsoft is the other), and until ...","JNJ","Johnson & Johnson"
"1241","Johnson &amp; Johnson settles Maryland lawsuit over contact lens prices","http://www.baltimoresun.com/business/bs-md-johnson-contacts-20170331-story.html","2017-03-31 21:40:38","Baltimore Sun","Consumer goods giant Johnson & Johnson has settled a lawsuit brought by the Maryland Attorney General alleging it agreed to fix the price of contact lenses.","JNJ","Johnson & Johnson"
"1251","Janssen collaborates with Premier on unique study to improve stroke risk management","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3561550","2017-04-03 08:00:00","Reuters Key Development","Janssen collaborates with Premier on unique study to improve stroke risk management","JNJ","Johnson & Johnson"
"1261","Johnson &amp; Johnson: Selling And Still Getting Richer","https://seekingalpha.com/article/4059826-johnson-and-johnson-selling-still-getting-richer","2017-04-03 12:18:45","Seeking Alpha","As any part owner of say Johnson & Johnson (NYSE:JNJ), Coca-Cola (NYSE:KO) or McDonald's (NYSE:MCD) can attest, this ""increased contribution"" thing doesn't really apply.","JNJ","Johnson & Johnson"
"1271","Abbvie submits supplemental new drug application for ibrutinib","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3562202","2017-04-04 07:00:00","Reuters Key Development","Abbvie submits supplemental new drug application for ibrutinib","JNJ","Johnson & Johnson"
"1281","Melinda Richter, Johnson &amp; Johnson","http://www.mmm-online.com/top-40-transformers/jnj-technology-innovation/article/644728/","2017-04-04 07:03:45","Medical Marketing and Media","Johnson & Johnson, one of the few major-league pharma companies that embraced the health-tech community early in its evolution, would prove the perfect parent for any such incubator.","JNJ","Johnson & Johnson"
"1291","Here&#39;s Why The Best Is Yet to Come for Johnson &amp; Johnson","https://www.fool.com/investing/2017/04/04/heres-why-the-best-is-yet-to-come-for-johnson-john.aspx","2017-04-04 08:22:30","Motley Fool","It's become common knowledge that most fund managers fail to outperform the S&P 500 index over the long term, but did you know Johnson & Johnson (NYSE:JNJ) has nearly doubled that benchmark over the past 20 years? That's right. By reinvesting ...","JNJ","Johnson & Johnson"
"1301","Steven Brill on Johnson &amp; Johnson America&#39;s Most Admired Lawbreaker","http://www.corporatecrimereporter.com/news/200/steven-brill-johnson-johnson-americas-admired-lawbreaker/","2017-04-06 11:08:30","Corporate Crime Reporter","Brill focuses Johnson & Johnson's corporate crime of selling Risperdal off label. In November 2013, a Johnson & Johnson unit, Janssen Pharmaceuticals, pled guilty to marketing Risperdal for unapproved uses - namely to the elderly. Risperdal was ...","JNJ","Johnson & Johnson"
"1312","Owning Johnson &amp; Johnson With A 5% Yield","https://seekingalpha.com/article/4060795-owning-johnson-and-johnson-5-percent-yield","2017-04-06 12:04:29","Seeking Alpha","If Johnson & Johnson were to pay the same $0.80 quarterly dividend from today throughout your investing lifetime, the ""current"" dividend yield would be an accurate representation of the cash flow you might anticipate receiving.","JNJ","Johnson & Johnson"
"1321","Johnson &amp; Johnson extends partnership with MLS, US Soccer","https://www.mlssoccer.com/post/2017/04/06/johnson-johnson-extends-partnership-mls-us-soccer","2017-04-06 15:30:00","MLSsoccer.com","Johnson & Johnson Consumer Inc. announced on Thursday a multi-year renewal extending the company as the official healthcare partner of MLS and US Soccer.","JNJ","Johnson & Johnson"
"1331","Johnson &amp; Johnson Set for Earnings Upside","http://www.barrons.com/articles/johnson-johnson-set-for-earnings-upside-1491555877","2017-04-07 05:04:48","Barron's","We are raising our valuation range on Johnson & Johnson to $139-$141 from $122-$124, based on 18 times our new 2018 pro forma Actelion earnings-per-share estimate of $7.78.","JNJ","Johnson & Johnson"
"1341","PeptiDream enters into collaboration with Janssen Pharmaceuticals","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3564403","2017-04-07 06:06:33","Reuters Key Development","PeptiDream enters into collaboration with Janssen Pharmaceuticals","JNJ","Johnson & Johnson"
"1351","Johnson &amp; Johnson-sponsored documentary underscores global pandemic threats","http://www.fiercepharma.com/marketing/infectious-diseases-and-specter-global-pandemic-underscored-new-j-j-sponsored-documentary","2017-04-07 10:48:45","FiercePharma","Johnson & Johnson is the sole sponsor of CNN Films' new documentary about a global pandemic that may be just around the corner.","JNJ","Johnson & Johnson"
"1361","Google still scrambling for solutions after Johnson &amp; Johnson, others depart ...","http://www.fiercepharma.com/marketing/google-scrambling-for-solutions-after-advertiser-departures-youtube","2017-04-10 03:42:04","FiercePharma","From offering third-party tools, teaching computers to be offended and even recharacterizing the problems as “very small,” Google has been scrambling to institute brand safety measures and spin the narrative after dozens of advertisers, including ...","JNJ","Johnson & Johnson"
"1371","Johnson &amp; Johnson buys Irish stroke care firm in multimillion euro deal","http://www.irishtimes.com/business/health-pharma/johnson-johnson-buys-irish-stroke-care-firm-in-multimillion-euro-deal-1.3043551","2017-04-10 07:16:07","Irish Times","Galway medtech company Neuravi has been taken over by US life sciences giant Johnson & Johnson Codman Neuro business in a landmark deal that gives J&J access to the fast-growing strokecare market.","JNJ","Johnson & Johnson"
"1381","Geron Corp and Janssen Research &amp; Development LLC has completed second internal data reviews of Imerge and Imbark","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3565530","2017-04-10 07:30:00","Reuters Key Development","Geron Corp and Janssen Research & Development LLC has completed second internal data reviews of Imerge and Imbark","JNJ","Johnson & Johnson"
"1391","Johnson &amp; Johnson hangs fire on Geron decision after latest data review","http://www.fiercebiotech.com/biotech/j-j-hangs-fire-geron-decision-after-latest-data-review","2017-04-10 09:18:45","FierceBiotech","Johnson & Johnson has deferred making a decision about whether to drop or commit to Geron's imetelstat. The inaction means trials of the telomerase inhibitor in myelodysplastic syndromes and relapsed or refractory myelofibrosis will keep moving forward ...","JNJ","Johnson & Johnson"
"1401","The Zacks Analyst Blog Highlights: Johnson &amp; Johnson, Verizon, Visa, General ...","http://www.nasdaq.com/article/the-zacks-analyst-blog-highlights-johnson-johnson-verizon-visa-general-dynamics-and-abbott-cm772178","2017-04-10 10:03:45","Nasdaq","Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson (NYSE: JNJ - Free Report ), Verizon (NYSE: VZ - Free Report ...","JNJ","Johnson & Johnson"
"1412","The best parenting advice from KBULL-93&#39;s Johnson &amp; Johnson","http://fox13now.com/2017/04/10/the-best-parenting-advice-from-kbull-93s-johnson-johnson/","2017-04-10 17:00:53","fox13now.com","Tommy and Joe Johnson from KBULL-93 stopped by the studio to offer their best parenting advice tips to moms-to-be Brooke and Britt.","JNJ","Johnson & Johnson"
"1421","Foundation Resource Management Inc Buys Johnson &amp; Johnson, Sells SPDR S&amp;P 500 ...","http://www.nasdaq.com/article/foundation-resource-management-inc-buys-johnson-johnson-sells-spdr-sp-500-vectrus-cm773210","2017-04-11 15:41:15","Nasdaq","Foundation Resource Management Inc initiated holdings in Johnson & Johnson. The purchase prices were between $111.76 and $128.96, with an estimated average price of $119.46.","JNJ","Johnson & Johnson"
"1431","Johnson &amp; Johnson Investors: Get Ready For A 6-7% Raise This Spring","https://seekingalpha.com/article/4061819-johnson-and-johnson-investors-get-ready-6minus-7-percent-raise-spring","2017-04-11 17:22:30","Seeking Alpha","If you're searching for companies offering consistent earnings growth, you'll be hard-pressed to find anyone beating Johnson & Johnson (NYSE:JNJ). Last year it held, to my knowledge, the record with 32 consecutive years of adjusted operational earnings ...","JNJ","Johnson & Johnson"
"1441","Phagelux announces collaboration with Johnson &amp; Johnson Innovation for new antibacterial solution","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3567183","2017-04-12 07:00:00","Reuters Key Development","Phagelux announces collaboration with Johnson & Johnson Innovation for new antibacterial solution","JNJ","Johnson & Johnson"
"1451","Johnson &amp; Johnson&#39;s latest talc powder showdown kicks off, with thousands more ...","http://www.fiercepharma.com/legal/j-j-s-latest-talc-powder-courtroom-showdown-kicks-off-st-louis","2017-04-12 11:45:00","FiercePharma","A month after scoring a rare victory in a fight to defend the safety of its talcum powder, Johnson & Johnson is back in court hoping to extend the winning streak.","JNJ","Johnson & Johnson"
"1461","Should You Sell Johnson &amp; Johnson (JNJ) Before Earnings?","http://finance.yahoo.com/news/sell-johnson-johnson-jnj-earnings-125512042.html","2017-04-13 09:42:19","Yahoo Finance","Investors are always looking for stocks that are poised to beat at earnings season and Johnson & Johnson JNJ may be one such company.","JNJ","Johnson & Johnson"
"1471","Johnson &amp; Johnson&#39;s Revenue Estimates: Expect Growth!","http://marketrealist.com/2017/04/johnson-johnsons-revenue-estimates-expect-growth/","2017-04-13 13:03:45","Market Realist","Analysts expect 3.0% growth in Johnson & Johnson's (JNJ) 1Q17 revenue at ~$18.01 billion. The growth is expected to be driven by the strong performance of few of its key products including Xarelto, Zytiga, Remicade, Stelara, and Olysio among others.","JNJ","Johnson & Johnson"
"1481","Johnson &amp; Johnson: Up Or Down From $125?","https://seekingalpha.com/article/4062309-johnson-and-johnson-125","2017-04-13 13:37:30","Seeking Alpha","The Lawsuits Keep Coming for Johnson & Johnson (NYSE:JNJ)"". The headline from Bloomberg in early March was unequivocal.","JNJ","Johnson & Johnson"
"1491","Johnson &amp; Johnson announces earnings April 18","http://www.nasdaq.com/article/johnson-johnson-announces-earnings-april-18-cm774318","2017-04-15 08:00:00","Nasdaq","Johnson & Johnson ( JNJ ) will report its first-quarter numbers on April 18. The company will post its quarterly numbers before the market open, with the consensus calling for earnings of $1.76 per share, versus $1.68 during the same period last year.","JNJ","Johnson & Johnson"
"1501","Earnings: Dow Stalwarts Johnson &amp; Johnson and IBM Report Tomorrow","https://tickertape.tdameritrade.com/trading/2017/04/jnj-ibm-q1-2017-earnings-36367","2017-04-17 13:37:30","The Ticker Tape (blog)","Earnings season is in full swing this week and several Dow stalwarts report Q1 results. On Tuesday, International Business Machines (IBM) and pharma giant Johnson & Johnson (JNJ) report before market open. IBM is up just over 2% year-to-date, or YTD, ...","JNJ","Johnson & Johnson"
"1512","Johnson &amp; Johnson go monthly with Vita","https://www.aop.org.uk/ot/industry/contact-lenses/2017/04/18/johnson-and-johnson-go-monthly-with-vita","2017-04-18 03:18:45","AOP","Acuvue Vita packshoot Johnson & Johnson Vision Care has announced that it has entered the monthly contact lens market in the UK with the launch of Acuvue Vita.","JNJ","Johnson & Johnson"
"1521","Earnings Reaction History: Johnson &amp; Johnson, 54.5% Follow-Through Indicator ...","http://www.nasdaq.com/article/earnings-reaction-history-johnson-johnson-545-follow-through-indicator-17-sensitive-cm774983","2017-04-18 06:30:00","Nasdaq","Johnson & Johnson ( JNJ ) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect very active trading in the issue immediately following its quarterly earnings announcement.","JNJ","Johnson & Johnson"
"1531","Johnson &amp; Johnson Q1 earnings per share $1.61","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3569899","2017-04-18 06:40:00","Reuters Key Development","Johnson & Johnson Q1 earnings per share $1.61","JNJ","Johnson & Johnson"
"1541","Johnson &amp; Johnson Q1 Profit Rises 4%","http://www.nasdaq.com/article/johnson--johnson-q1-profit-rises-4-20170418-00244","2017-04-18 06:41:15","Nasdaq","(RTTNews.com) - Johnson & Johnson ( JNJ ) released earnings for its first quarter that climbed from last year. The company said its bottom line rose to $5.04 billion, or $1.83 per share.","JNJ","Johnson & Johnson"
"1551","Johnson &amp; Johnson&#39;s stock falls after sales miss offset profit beat and raised ...","http://www.marketwatch.com/story/johnson-johnsons-stock-falls-after-sales-miss-offset-profit-beat-and-raised-outlook-2017-04-18","2017-04-18 06:52:30","MarketWatch","Johnson & Johnson's stock JNJ, +0.41% shed 1% in premarket trade Tuesday, after the drug and consumer products giant reported first-quarter profit that beat expectations but sales that missed.","JNJ","Johnson & Johnson"
"1561","BRIEF-Johnson &amp; Johnson Q1 earnings per share $1.61","http://www.reuters.com/article/brief-johnson-johnson-q1-earnings-per-sh-idUSASA09IX3","2017-04-18 06:52:30","Reuters","WASHINGTON, April 18 The U.S. Supreme Court, in a case with wide consequences for the policing of Wall Street, indicated on Tuesday it may diminish the Securities and Exchange Commission's ability to get back ill-gotten profits reaped through ...","JNJ","Johnson & Johnson"
"1571","Genmab Q1 net sales of Darzalex at $255 million","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3569919","2017-04-18 06:55:17","Reuters Key Development","Genmab Q1 net sales of Darzalex at $255 million","JNJ","Johnson & Johnson"
"1581","Johnson &amp; Johnson&#39;s Profits Exceeds Analysts&#39; Expectations","https://www.thestreet.com/video/14089793/johnson-amp-johnson-s-profits-exceeds-analysts-expectations.html","2017-04-18 07:37:30","TheStreet.com","Johnson & Johnson have posted first-quarter profits of $1.83 a share, exceeding analysts' expectations of just $1.77 a share.","JNJ","Johnson & Johnson"
"1591","Johnson &amp; Johnson, Harley-Davidson Inc Beat On Earnings, Miss On Sales","http://www.valuewalk.com/2017/04/johnson-johnson-harley-davidson-earnings/","2017-04-18 08:18:32","ValueWalk","Johnson & Johnson and Harley-Davidson released their latest quarterly results before opening bell this morning. Johnson & Johnson posted adjusted earnings of $1.83 per share on $17.8 billion in revenue, compared to the consensus estimates of $1.77 per ...","JNJ","Johnson & Johnson"
"1601","Johnson &amp; Johnson sees Actelion adding 35-50 cents to 2018 EPS","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3570054","2017-04-18 09:36:03","Reuters Key Development","Johnson & Johnson sees Actelion adding 35-50 cents to 2018 EPS","JNJ","Johnson & Johnson"
"1612","BRIEF-Johnson &amp; Johnson sees Actelion adding 35-50 cents to 2018 EPS","http://www.reuters.com/article/brief-johnson-johnson-sees-actelion-addi-idUSL1N1HQ0MA","2017-04-18 09:41:15","Reuters","April 18 Intuitive Surgical Inc on Tuesday increased its 2017 forecast for growth in procedures using its da Vinci surgical robots after reporting higher-than-expected first-quarter revenue and profit, and its shares rose nearly 4 percent.","JNJ","Johnson & Johnson"
"1621","MARKET SNAPSHOT: Stocks Drop As Goldman, Johnson &amp; Johnson Earnings Disappoint","https://www.morningstar.com/news/dow-jones/health/TDJNDN_201704185877/market-snapshot-stocks-drop-as-goldman-johnson-johnson-earnings-disappoint.html","2017-04-18 10:03:45","Morningstar.com","Wall Street opened lower on Tuesday, as a spate of weak earnings compounded concerns over this weekend's French election and U.S.","JNJ","Johnson & Johnson"
"1631","BUZZ-US STOCKS ON THE MOVE-Goldman, Cardinal Health, Johnson &amp; Johnson","http://www.nasdaq.com/article/buzzus-stocks-on-the-movegoldman-cardinal-health-johnson--johnson-20170418-00909","2017-04-18 11:00:00","Nasdaq","O>: up 82.5 pct at $3.92 UPDATE 2-Insurer UnitedHealth posts strong results, boosts forecast [nL3N1HQ3SZ] BUZZ-UnitedHealth to cover Interpace Diagnostics' cancer test [nL3N1HQ4CC] ** Johnson & Johnson <JNJ.N>: down 3.3 pct at $121.53 UPDATE ...","JNJ","Johnson & Johnson"
"1641","Johnson &amp; Johnson Pummeled After Mixed Q1 Report","https://www.benzinga.com/trading-ideas/technicals/17/04/9311720/johnson-johnson-pummeled-after-mixed-q1-report","2017-04-18 11:33:45","Benzinga","After a lower open, Johnson & Johnson's stock managed only a $0.19 bounce to $123.37 before continuing its move lower.","JNJ","Johnson & Johnson"
"1651","Johnson &amp; Johnson Posts Sluggish Sales, Boosts Guidance on Actelion Deal","http://www.foxbusiness.com/markets/2017/04/18/johnson-johnson-posts-sluggish-sales-boosts-guidance-on-actelion-deal.html","2017-04-18 11:44:39","Fox Business","The healthcare industry is in constant flux, but Johnson & Johnson (NYSE: JNJ) aims to be a blue-chip stalwart for investors in the space to get wide-ranging exposure throughout the sector.","JNJ","Johnson & Johnson"
"1661","Stocks Hold Lower as Goldman Sachs and Johnson &amp; Johnson Disappoint","https://www.thestreet.com/story/14090743/1/stocks-extend-declines-as-goldman-sachs-bank-of-america-fall.html","2017-04-18 12:11:10","TheStreet.com","Wall Street closed Tuesday in negative territory after Goldman Sachs' (GS) first-quarter earnings came up short and Johnson & Johnson's (JNJ) revenue missed forecasts. The S&P 500 fell 0.36%, the Dow Jones Industrial Average dropped 0.61%, and the ...","JNJ","Johnson & Johnson"
"1671","Dow slumps as Goldman, Johnson &amp; Johnson weigh","http://finance.yahoo.com/news/dow-slumps-goldman-johnson-johnson-weigh-191206356.html","2017-04-18 15:17:54","Yahoo Finance","Stocks on the move lower include Harley Davidson as revenue missed and profit was down 25% from a year ago; Barracuda Networks as the cybersecurity firm did not issue a current-quarter forecast; and Johnson & Johnson, with shares of the health care ...","JNJ","Johnson & Johnson"
"1681","Johnson &amp; Johnson&#39;s Weak Pharma Revenue Could Spell Doom for Rest of Sector","https://www.thestreet.com/story/14091562/1/johnson-amp-johnson-s-weak-pharma-revenues-could-spell-doom-for-rest-of-sector.html","2017-04-18 15:38:25","TheStreet.com","Johnson & Johnson ( JNJ) shares closed down about 3% after the company reported first quarter revenue that missed analysts' expectations due to lighter than expected pharmaceutical sales.","JNJ","Johnson & Johnson"
"1691","Goldman Sachs, Johnson &amp; Johnson Sink the DJIA Tuesday","http://finance.yahoo.com/news/goldman-sachs-johnson-johnson-sink-200128647.html","2017-04-18 16:03:45","Yahoo Finance","Johnson & Johnson (JNJ) traded down 2.99% at $121.96. The stock's 52-week range is $109.32 to $129.00. Volume was about 70% above the daily average of around 73 million shares.","JNJ","Johnson & Johnson"
"1701","Johnson &amp; Johnson, Goldman sneeze and stocks catch a cold","http://www.dailyprogress.com/news/business/wire/johnson-johnson-goldman-sneeze-and-stocks-catch-a-cold/article_0262a96f-3566-5d1a-841c-4cb5ca56a9f9.html","2017-04-18 16:26:15","The Daily Progress","NEW YORK (AP) - U.S. stocks fell Tuesday after weak first-quarter reports from Johnson & Johnson and Goldman Sachs frustrated investors who hope that company earnings are on the rise.","JNJ","Johnson & Johnson"
"1712","JNJ&#39;s Valuation? Questionable, Despite Solid Earnings","http://www.investopedia.com/news/jnj-valuation-questionable-despite-solid-earnings/","2017-04-18 16:48:57","Investopedia","reported sales of $17.8 billion, adjusted net earnings of $5.0 billion, and adjusted diluted EPS of $1.83. According to YCharts, analysts had been looking for revenue of $18.02 billion and EPS $1.77.","JNJ","Johnson & Johnson"
"1721","Dow Jones Futures (DJIA) Dragged Lower by Goldman Sachs, Johnson &amp; Johnson","http://www.economiccalendar.com/2017/04/18/dow-jones-futures-djia-dragged-lower-by-goldman-sachs-johnson-johnson/","2017-04-18 16:51:29","Economic Calendar","Johnson & Johnson (NYSE: JNJ) sold off 3.1% on mixed quarterly results. The diversified healthcare giant reported a fiscal first quarter EPS of $1.83, which was 6 cents higher than expected.","JNJ","Johnson & Johnson"
"1731","Johnson &amp; Johnson and Goldman sneeze, and stocks catch a cold","https://www.bostonglobe.com/business/2017/04/18/johnson-johnson-and-goldman-sneeze-and-stocks-catch-cold/V7JX12KX42502KKHnRMGxJ/story.html","2017-04-18 18:52:30","The Boston Globe","US stocks fell Tuesday after weak first-quarter reports from Johnson & Johnson and Goldman Sachs frustrated investors. Health care companies lost the most.","JNJ","Johnson & Johnson"
"1741","ShareRoot shares ride higher on signing Johnson &amp; Johnson","http://www.proactiveinvestors.com.au/companies/news/176554/shareroot-shares-ride-higher-on-signing-johnson-johnson-176554.html","2017-04-18 20:00:00","Proactive Investors Australia","Major multinationals, such as Johnson & Johnson, are increasingly waking up to the mounting risks involved in intellectual property litigation from sharing user-generated media content.","JNJ","Johnson & Johnson"
"1751","Johnson &amp; Johnson: Not Too Late To Take Chips Off The Table","https://seekingalpha.com/article/4063252-johnson-and-johnson-late-take-chips-table","2017-04-19 00:07:30","Seeking Alpha","That ended up being a pretty good call. As you can see, since that time shares of J&J have dropped to almost $110, before recovering to a 'candlestick' top that hit almost $130.","JNJ","Johnson & Johnson"
"1761","September 15th Options Now Available For Johnson &amp; Johnson (JNJ)","http://www.nasdaq.com/article/september-15th-options-now-available-for-johnson-johnson-jnj-cm775843","2017-04-19 11:00:00","Nasdaq","Investors in Johnson & Johnson (Symbol: JNJ) saw new options become available today, for the September 15th expiration.","JNJ","Johnson & Johnson"
"1771","Better Buy: Merck &amp; Co. Inc. vs. Johnson &amp; Johnson","https://www.fool.com/investing/2017/04/19/better-buy-merck-co-inc-vs-johnson-johnson.aspx","2017-04-19 15:41:15","Motley Fool","If you'd been given the choice between buying either Merck & Co. (NYSE:MRK) stock or Johnson & Johnson (NYSE:JNJ) stock 10 years ago, the smart choice would have definitely been J&J.","JNJ","Johnson & Johnson"
"1781","Today&#39;s Research Reports on Stocks to Watch: Johnson &amp; Johnson and United ...","http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000100.html","2017-04-20 03:41:15","Yahoo Finance","Johnson & Johnson's shares declined 0.37 percent to close at $121.37 a share on Wednesday. The stock traded between $121.11 and $122.28 on volume of 6.99 million shares traded.","JNJ","Johnson & Johnson"
"1791","Johnson &amp; Johnson target Actelion could exit Swiss benchmark SMI index this month","http://www.euronews.com/2017/04/20/johnson-johnson-target-actelion-could-exit-swiss-benchmark-smi-index-this-month","2017-04-20 07:48:45","euronews","S> poised to fall out of the Swiss Market Index (SMI) ahead of the completion of the biotechnology company's takeover by Johnson & Johnson <JNJ.N>. Friday is the next deadline for Actelion shareholders to take J&J's $30 billion, $280 per share offer ...","JNJ","Johnson & Johnson"
"1801","Johnson &amp; Johnson Wants to Use 3D Printing to Heal Broken Bones","http://fortune.com/2017/04/20/johnson-johnson-3d-printing-bones/","2017-04-20 10:28:44","Fortune","ThereDePuy Synthes Products, Inc., an arm of pharmaceutical giant Johnson & Johnson (jnj), is setting out to use 3D printed bones to fix injuries and deformities.","JNJ","Johnson & Johnson"
"1812","The Technical Chart Johnson &amp; Johnson (JNJ) Is Speaking Volumes","https://nystocknews.com/2017/04/20/the-technical-chart-johnson-johnson-jnj-is-speaking-volumes/","2017-04-20 12:30:00","NY Stock News","The technicals for Johnson & Johnson (JNJ) has spoken via its technical chart and the message is loud and clear. Based on that message, this is the relevant information necessary to make sense of that current setup.","JNJ","Johnson & Johnson"
"1821","Johnson &amp; Johnson Not Best Value in Healthcare","http://news.morningstar.com/cover/videocenter.aspx?id=803616","2017-04-21 06:07:30","Morningstar.com","Jeremy Glaser: Johnson & Johnson not the best value in healthcare; IBM aims to find its footing; and Netflix is still pricey.","JNJ","Johnson & Johnson"
"1831","3 Reasons Gilead Sciences Is a Better Dividend Stock Than Johnson &amp; Johnson","https://www.fool.com/investing/2017/04/21/3-reasons-gilead-sciences-is-a-better-dividend-sto.aspx","2017-04-21 07:48:45","Motley Fool","It's been over half a century since Johnson & Johnson (NYSE:JNJ) went a full year without increasing its payout, and if you want a dependable source of income you'd be hard-pressed to find a better stock.","JNJ","Johnson & Johnson"
"1841","Johnson &amp; Johnson: Modest Price Decline Presents Buying Opportunity","http://finance.yahoo.com/news/johnson-johnson-modest-price-decline-173810398.html","2017-04-21 12:42:39","Yahoo Finance","Johnson & Johnson's dividend history is particularly impressive. The company qualifies to be not only a Dividend Aristocrat, but a member of the Dividend Kings - a group of elite companies with over 50 years of consecutive annual dividend increases.","JNJ","Johnson & Johnson"
"1851","Meet The Latina Exec Changing The Face of Corporate America","http://people.com/chica/michelle-freyre-latina-executive-johnson-and-johnson/","2017-04-21 13:15:00","PEOPLE.com","Seeing more Latinas in executive roles definitely counts as an empowering moment for young Latinas. That's why we are featuring Michelle Freyre, the President of U.S.","JNJ","Johnson & Johnson"
"1861","The Technical Case for and Against Johnson &amp; Johnson (JNJ)","http://theusacommerce.com/2017/04/21/the-technical-case-for-and-against-johnson-johnson-jnj-3/","2017-04-21 13:26:15","The USA Commerce","We have gathered the technical data on Johnson & Johnson (JNJ), and see some interesting trends in the stock's behavior of late.","JNJ","Johnson & Johnson"
"1871","Nationwide Fund Advisors Decreased Johnson &amp; Common (JNJ) Stake By $31.60 ...","https://wolcottdaily.com/nationwide-fund-advisors-decreased-johnson-1-analysts-covering-veolia-environnement-sa-adr-veoey/","2017-04-21 15:30:00","Wolcott Daily","Nationwide Fund Advisors decreased Johnson & Common (NYSE:JNJ) stake by 13.11% reported in 2017Q1 SEC filing. Nationwide Fund Advisors sold 254,865 shares as Johnson & Common (NYSE:JNJ)'s stock declined 3.03%. The Nationwide Fund ...","JNJ","Johnson & Johnson"
"1881","FDA approves Renflexis, biosimilar to Remicade","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3572905","2017-04-21 15:54:54","Reuters Key Development","FDA approves Renflexis, biosimilar to Remicade","JNJ","Johnson & Johnson"
"1891","FDA approves Samsung Bioepis&#39; copy of J&amp;J&#39;s Remicade: company","http://www.reuters.com/article/us-samsung-bioepis-approval-usa-idUSKBN17N2LQ","2017-04-21 18:52:30","Reuters","SEOUL South Korea's Samsung Bioepis Co Ltd said on Saturday the U.S. Food and Drug Administration approved its copy of Johnson & Johnson's rheumatoid arthritis drug Remicade, the first drug developed by the Samsung Group unit approved in the ...","JNJ","Johnson & Johnson"
